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ABSTRACT
Theileria parva is an intracellular protozoan parasite that produces an acute and often 
fatal lymphoproliferative disease (East Coast fever) in susceptible cattle. Studies of 
experimentally infected cattle have demonstrated a massive increase in the cellularity of 
the lymph node draining the site of inoculation in the early stages of the infection, when 
the proportion of parasitized cells in the node was very low. The increased cellularity 
was associated with a marked increase in the number of lymphoblasts within the node. 
This suggested that an immune response to the parasite does occur in the regional lymph 
nodes of naive animals, but is ineffective in controlling the infection.
, The objective of this study was to characterize the primary immune response in the 
drainage lymph nodes of cattle infected with T. parva and , in particular, to determine 
whether or not a superantigen was responsible for inducing lymphocyte activation. Flow 
cytometric analysis of the phenotype of lymph node cells from infected animals 
revealed that an unusual CD2"CD8+ subset of cc/p T cells formed a major component of 
the responding population. The appearance of this subset coincided with the initial 
detection of parasites in the node; the numbers peaked 1-2 days later, and then declined 
rapidly as the proportion of parasitized cells increased. These cells were refractory to 
stimulation in vitro, and cells with this phenotype did not participate in the in vitro 
proliferative response of peripheral blood mononuclear cells from naive animals to 
autologous parasitized cells. Another interesting feature of the lymph node response in 
T. parva-infected animals was a large influx of macrophages between days 7 and 9 post­
infection. The possibility that a superantigen might be triggering the lymph node 
response of infected animals was investigated by comparing the TCRBV gene usage of 
responding cells with the TCRBV repertoire expressed by normal lymph node T cells. 
Purified populations of activated T cells and CD2'CD8+ T cells expressed a diverse 
repertoire of TCRBV genes, which suggests that a superantigen is not involved in the 
response. In this study a total of 29 new TCRBV gene segments were sequenced, 
permitting the first detailed classification of bovine TCRBV subfamilies, and revealing 
that diversification of the TCRBV repertoire in cattle has involved gene duplication 
events distinct from those of humans and mice.
XX
CHAPTER ONE
GENERAL INTRODUCTION.
1.1. Theileria parva.
Theileria parva is an intracellular protozoan parasite that infects cattle and causes an 
acute lymphoproliferative disease known as East Coast fever (ECF). The parasite is 
transmitted by the three-host tick Rhipicephalus appendiculatus, and the incidence of the 
disease closely follows the distribution of the tick vector throughout East and Central 
Africa. T. parva also infects the African buffalo (Syncerus caffer), but establishes 
clinically inapparent persistent infections in this species. The buffalo acts as a reservoir of 
parasites maintaining infection in the tick population. The number of ticks varies 
according to local climatic conditions and season, so that in some areas there is a 
relatively constant challenge, while in others disease occurs only when rainfall and 
temperature permits.
The classification of T. parva places it in the phylum Apicomplexa and the order 
Piroplasmida. Three subtypes of T. parva have been described; T. p. parva, T. p. bovis 
and T. p. lawrencei, which are distinguished on the basis of their clinical and 
epidemiological characteristics (Uilenberg, 1981). T. p. parva is transmitted between 
cattle and causes classic ECF; T. p. lawrencei is transmitted from buffalo to cattle, 
causing corridor disease; and T. p. bovis is much less virulent than the other two 
subtypes and is responsible for seasonal outbreaks of disease in Southern Africa. 
Although T. p. parva and T. p. lawrencei may produce clinical reactions of equal severity 
in cattle, the latter subtype gives rise to lower levels of schizonts and death occurs before 
high levels of piroplasms are produced. However, passage of buffalo-derived parasites 
through cattle gives rise to T. p. parva-Yikt parasites. Although this could reflect parasite 
adaptation to the bovine host, analyses of parasitized cell lines derived from infected 
buffalo indicate that they often contain a mixed population of parasites, thus there may 
be selection for strains that produce piroplasms before the death of the host (Conrad et 
al., 1987b). The three subtypes are morphologically and serologically indistinguishable, 
and monoclonal antibodies and DNA probes that have been used to detect heterogeneity
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among different parasite isolates fail to show a clear distinction between the buffalo- and 
cattle-derived parasites (Conrad et al., 1989a). Thus, there is no clear biological or 
genetic basis for the classification of T. parva into distinct subspecies.
Originally parasite strains were distinguished by the geographical location where they 
were originally isolated, and by cross-protection experiments in cattle. With the 
development of in vitro assays for detection of genotypic and phenotypic variation, a 
more precise terminology based on that used for defining trypanosome populations was 
adopted for use with Theileria (Irvin et al., 1983). The definitions relevant to the present 
discussion are:
1. Isolate: viable organisms isolated on a single occasion from a field sample in 
experimental hosts, culture systems or stabilate.
2. Stock: all the populations derived from an isolate without any implication of 
homogeneity or characterization. Populations comprising a single stock include infected 
cell lines and tick stabilates and subsequent parasite preparations derived from them.
3. Stabilate: a sample of organisms preserved alive (usually in replicate) on a single 
occasion.
4. Parasite clone: Theileria species line derived from a single parasite.
5. Strain: A population of homogeneous organisms possessing a set of defined 
characters. Unambiguous characterization of a strain can be assured only if the 
population of organisms was initiated from a parasite clone.
1.1.1. Parasite life cycle and disease pathogenesis.
The life cycle of T. parva has been described in detail by Mehlhorn and Schein (1984) 
and reviewed by Morrison et al. (1986). Transmission of T. parva by R. appendiculatus 
occurs trans-stadially i.e. infection acquired during larval and nymphal stages is 
transmitted, after moulting, in the succeeding developmental stage. Ticks become 
infected by ingestion of erythrocytes containing piroplasms from infected buffalo or 
cattle. Infected erythrocytes are lysed in the tick gut, and the parasite differentiates into 
male and female gametes which fuse to produce a zygote. Zygotes invade cells of the
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intestinal wall (Schein et al., 1977), and undergo transformation into motile kinetes. 
Kinetes are released into the haemolymph during and after tick moulting and migrate to 
the salivary glands where they invade E cells of the type III acini (Fawcett et a l,  
1982a,b). Sporogony proceeds when the tick begins to feed on another host; a large 
multinucleate labyrinthine structure is formed which gives rise to large numbers of 
mature sporozoites. Infective sporozoites are released into the saliva 3-5 days after 
feeding commences and injected into the host.
Following inoculation into the bovine host, the parasite is not readily detected for several 
days, thus events occurring during this early period have not been studied in detail. 
However, in vitro studies have shown that sporozoites can enter bovine lymphocytes 
within minutes by a process of receptor-mediated endocytosis. The surrounding host cell 
membrane is rapidly broken down, and sporozoites are released into the cytoplasm where 
they become closely associated with host cell microtubules. Disintegration of the host 
cell membrane is associated with release of the contents of parasite rhoptries and 
microspheres (Fawcett et al., 1982c; Shaw et a l, 1991). Prior incubation of lymphocytes 
with tick salivary gland extract or human recombinant interleukin-2 (IL-2) has been 
shown to increase their susceptibility to infection (Shaw et a l, 1993). Within three days 
the parasite nucleus divides to form a multinucleate schizont located in the Golgi region 
of the cell (Stagg et a l,  1981). At this stage, the infected lymphocyte undergoes blast 
transformation and starts to divide. Microscopic examination of parasitized cell lines has 
shown that the schizonts divide at the same time as the host cells (Hulliger et a l ,  1964; 
Irvin et a l,  1982). The parasite is closely associated with the mitotic spindle during cell 
division, resulting in infection of both daughter cells and clonal expansion of the infected 
cell population (Hulliger et a l, 1964).
Following inoculation of susceptible cattle with sporozoites, schizont-infected 
lymphocytes are first detected in the lymph node draining the site of inoculation after 4- 
14 days, depending on the initial infective dose. During this period infected lymphocytes 
become disseminated to lymphoid tissues throughout the body, where they are detectable 
a few days after their initial appearance in the drainage lymph node (Emery, 1981a; 
Morrison et a l, 1981). Over the next 5-7 days, the proportion of parasitized cells in 
lymphoid tissues increases rapidly as a result of massive uncontrolled proliferation of
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schizont-infected lymphoblasts, in a manner analogous to tumour cells (Jarrett et al., 
1969; Radley et al., 1974; Morrison et al., 1981). Levels of parasitosis of 30% or more 
may be found in the lymphoid tissues at this stage (DeMartini and Moulton, 1973 a; 
Morrison et al., 1981). As infection progresses, the number of nuclei per schizont 
increases (Jarrett et al., 1969), and a proportion of the parasites differentiate to produce 
merozoites which are released following rupture of the host cell and invade erythrocytes 
to form piroplasms, thus completing the parasite life cycle.
In susceptible cattle naturally exposed to infection with T. parva, mortality can reach 
95% (Brocklesby et al., 1961), with death occurring within 2-4 weeks depending on the 
initial parasite dose. The lymphoproliferative phase of the infection is associated with the 
onset of the disease, characterized initially by enlargement of superficial lymph nodes and 
sustained pyrexia. Parasitized lymphoblasts are detected in efferent and thoracic duct 
lymph and in blood during the second week of infection (DeMartini and Moulton, 1973b; 
Morrison et al., 1981; Emery, 1981a). During the later stages of the disease, infected 
cells invade the thymus and bone marrow and infiltrate a variety of nonlymphoid tissues, 
notably the lamina propria of the intestine and the interstitial lung tissue (Irvin and 
Morrison, 1987). The presence of numerous parasitized cells in the lung is associated 
with pulmonary oedema which causes severe respiratory distress, a common feature of 
the terminal stages of the disease. In the later stages of the infection, widespread 
lymphocytolysis occurs, affecting both parasitized and non-parasitized lymphocytes. The 
mechanisms of lymphocytolysis are unclear, but the result is a profound depletion of 
lymphocytes in organised lymphoid tissues and in the recirculating pool (DeMartini and 
Moulton, 1973a,b; Morrison et al., 1981, Emery et al., 1981a). There is also a severe 
leucopenia in the terminal stages of disease, but this follows a gradual decline in blood 
leucocyte counts after the onset of lymphoproliferation, and probably reflects bone 
marrow suppression by the parasite as well as leucocyte destruction (Wilde, 1966; Shatry 
et al., 1981; Morrison et al., 1981). Infiltration and destruction of primary lymphoid 
tissue in the thymus and bone marrow may also contribute to leucopenia by impairment 
of lymphopoiesis. Although up to 50% of erythrocytes may be infected with piroplasms, 
proliferation of piroplasms is minimal, and thus anaemia is normally mild in ECF, in 
contrast to infections with some other Theileria species e.g. T. annulata, where anaemia 
is a prominent feature of the disease (Wilde, 1966; Shatry et al., 1981). Animals that
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recover from ECF are carriers of the infection, but this carrier state is most likely due to 
residual infection of lymphoid cells.
1.1.2. Target cells for infection.
Sporozoites attach to and invade a subpopulation of bovine mononuclear cells; 
development of the schizont is accompanied by a rapid change in the morphology of the 
host cell, which becomes characteristically lymphoblastoid in appearance, with a large 
nucleus containing a prominent nucleolus, extensive cytoplasm and a prominent Golgi 
complex (Stagg et al., 1981; Fawcett et al., 1982c). The first clue as to the identity of 
the target cells came from experiments in which infected cell lines and parasitized cells 
from infected cattle were shown to be negative for surface or intracellular 
immunoglobulin, suggesting that the parasite preferentially infected T lymphocytes 
(Duffus etal., 1978; Emery, 1981a).
More detailed analysis of the phenotype of infected cells was permitted by the develop­
ment of techniques for infecting lymphocytes with sporozoites in vitro (Brown et al., 
1973), and the characterization of monoclonal antibodies specific for differentiation 
antigens on bovine lymphocytes (summarized by Howard et al., 1991). Various 
subpopulations of bovine lymphocytes were purified by flow cytometry and incubated 
with sporozoites at limiting dilutions in vitro. These studies demonstrated that a/p  T 
cells (both CD4+ and CD8+), y/5 T cells and B cells can all be infected with similar 
frequencies, and establish cell lines with distinct cell surface phenotypes. Cell lines were 
not established from monocytes or granulocytes (Lalor et al., 1986; Baldwin et al., 1988; 
Spooner etal., 1989).
Studies using electron microscopy to examine the processes of parasite invasion of host 
cells in vitro have shown that sporozoites enter lymphocytes by an energy-dependent 
process of receptor-mediated endocytosis (Fawcett et al., 1982c; Shaw et al., 1991). 
This technique has also been applied to investigate the range of host cells that are 
susceptible to infection with sporozoites of T. parva (Shaw et al., 1993). In this study, 
sporozoites were observed to bind to and invade afferent lymph veiled cells (dendritic
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cells) and, to a lesser extent, monocytes and macrophages, as well as lymphocytes. 
However, transformed cell lines could not be derived from veiled cells or 
monocytes/macrophages. Sporozoite binding and internalization by granulocytes and 
fibroblasts was very rare. These observations suggest that sporozoites bind to specific 
receptors expressed on a limited range of host cells, but that only lymphocytes possess 
the cellular components necessary for transformation, and are therefore the only cell type 
that is permissive for parasite multiplication and differentiation following invasion. The 
molecular nature of the parasite-host cell interaction that determines the cell tropism of 
the sporozoite is not known. Monoclonal antibodies reactive with common determinants 
on bovine class I MHC molecules and with p2-niicroglobulin have been shown to inhibit 
sporozoite binding and entry into lymphocytes (Shaw et al., 1991). In addition, using 
bovine deletion mutant cell lines from which expression of one or both MHC class I 
haplotypes has been lost, it was demonstrated that sporozoite binding and entry 
correlated with the level of class I surface expression (Shaw et al., 1995). However, the 
specificity of sporozoites for a restricted range of cells must involve additional parasite 
host-cell interactions, since MHC class I molecules are expressed on the surface of 
virtually all nucleated cells.
Despite the fact that I  parva infections can be established in all the major 
subpopulations of bovine lymphocytes at similar frequencies in vitro, most bulk cell lines 
and clones derived from in vitro infection of PBMC or from infected animals have been 
shown to possess cell surface markers indicative of T cell origin (Baldwin et al., 1988; 
Emery et al., 1988; Spooner el al., 1989). In addition, the vast majority of parasitized 
lymphoblasts isolated from the efferent lymph of cattle undergoing lethal infections with 
71 parva were found to express the T lymphocyte markers CD2, CD4 or CD8 (Emery et 
al., 1988). However, examination of the phenotype of recently established cultures of 
infected PBMC revealed that large numbers of parasitized B cells were present after 7 
days, but by day 14, the percentage of B cells in the cultures had declined markedly 
(Morrison et al., 1996). Similarly, Baldwin et al. (1988) observed that although bulk cell 
lines derived from the drainage lymph node of an infected animal were clearly of T cell 
origin, clones of 71 /?arva-transformed cells established from the same organ were 
negative for T cell markers, and therefore most likely derived from infected B cells.
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These observations suggest that, in most cases, infected T cells overgrow infected B cells 
in culture, either through a difference in the replication rate of the two cell types, or by 
suppression of B cell growth by parasitized T cells.
The pathogenicity of the different infected cell types in vivo has been examined by 
sorting PBMC into CD2+, CD4+, CD8+ and B cell (surface Ig+) subpopulations, and 
incubating the cells in vitro with sporozoites before inoculation of susceptible cattle with 
the purified populations. While the T cell subpopulations produced severe clinical 
reactions with high levels of parasitosis, infected B cells gave rise to mild self-limiting 
infections with low numbers of parasites, even when a ten-fold higher dose of cells was 
administered (Morrison et al., 1996). The explanation for the reduced pathogenicity of 
parasitized B cells is unknown, but may reflect either the inability of this cell type to 
sustain high levels of parasite replication, or increased susceptiblity of infected B cells to 
host immune responses.
1.1.3. Characteristics of infected lymphocytes.
Lymphocytes undergo extensive phenotypic changes following infection with T. parva. 
Phenotypic analysis of cell lines derived from different lymphocyte populations in vitro 
showed that, while a/(3 T cells retain expression of differentiation antigens such as CD2, 
CD4 and CD8, most B cells downregulate expression of surface immunoglobulin 
following continued subculture and do not express T cell differentiation antigens (Lalor 
et al., 1986; Baldwin et al., 1988). Infected y/5 T cell lines continue to express high 
levels of the lineage-specific marker WC1 and usually acquire expression of CD2 and/or 
CD8, but not CD4. Some parasitized cell lines and clones derived from PBMC express 
both CD4 and CD8, although CD8 is expressed only on a proportion of the CD4+ cells 
and at variable levels (Baldwin et al., 1988; Emery et al., 1988; Spooner et al., 1988). In 
cattle infected with T. parva, CD4+CD8+ T lymphoblasts are also found in large numbers 
in efferent lymph during the second week of infection, and a high proportion of these 
cells are parasitized (Emery et al., 1988). This phenotype is considered to arise as a 
result of de novo expression of CD8 on parasitized CD4+ T cells, since CD4+ T cells 
infected in vitro frequently acquire expression of CD8, while infected CD8+ T cells
7
remain negative for CD4 (Baldwin et al., 1988; Emery et al., 1988). Studies with 
monoclonal antibodies that react with different determinants on the a  and (3 chains of 
bovine CD8 suggest that, on CD4+CD8+ Theileria-\nfected cell lines, the CD8 molecule 
is expressed as a homodimer of the a  chain (MacHugh et al., 1991). Induction of CD8 
expression on infected CD4+ cells probably reflects the activated state of parasitized 
cells, since it has previously been demonstrated that CD8 is expressed on a proportion of 
human and rat CD4+ T cells activated by mitogens or alloantigens (Blue et al., 1985; 
Bevan and Chisholm, 1986), and that human CD4+ T cell clones stimulated in the 
presence of IL-4 upregulate expression of CD8 (Paliard et al., 1988).
Following transformation, parasitized lymphocytes acquire additional differentiation 
antigens typical of activated lymphocytes (Naessens et al., 1985; Lalor et al., 1986). 
MHC class II antigens are constitutively expressed on infected cell lines derived from T 
cells, as well as on B cell lines; however, the proportion of positive cells and the levels of 
expression may be variable, particularly in newly established cultures (Lalor et al., 1986; 
Spooner et al., 1988). Expression of MHC class II molecules has previously been 
demonstrated on rat T cells activated by mitogens or alloantigens, but expression is 
transient (Bevan and Chisholm, 1986). Induction of MHC class II expression was also 
observed on bovine T cells cultured with mitogen (DeMartini et al., 1993). Interestingly, 
when MHC class II expression was monitored in PBMC and lymph node cells of cattle 
undergoing lethal infections with T. parva, MHC class II-negative parasitized cells 
progressively outnumbered those expressing MHC class II (DeMartini et al., 1993).This 
suggests that, in vivo, MHC class II-positive parasitized cells are selectively destroyed or 
sequestered, or that differentiation of parasitized cells in vivo results in downregulation 
of expression of MHC class II molecules. Lymphocytes infected in vitro and in vivo 
retain expression of MHC class I molecules, and their pattern of reactivity with 
serological class I typing reagents remains similar to that of cells of the donor animal 
(Spooner and Brown, 1980).
Other activation markers which are expressed on almost all activated and proliferating 
leucocytes are the transferrin receptor (Trowbridge and Omary, 1981) and the high- 
affinity IL-2 receptor (EL-2R) (Lipkowitz et al., 1984). Recently, a monoclonal antibody
has been characterized that detects expression of the bovine transferrin receptor on bone 
marrow erythroid cells and proliferating lymphocytes (Naessens et al., 1996). Expression 
of the molecule was also demonstrated on all T. /?ara?-transformed cell lines that were 
tested, including both B cell- and T cell-derived lines. Expression of the a  chain (CD25; 
formerly designated Tac antigen) of the bovine EL-2R has also been demonstrated at the 
messenger RNA (mRNA) and protein level in all T. parva-infected cell lines of either T 
cell or B cell origin (Coquerelle et al., 1989; Dobbelaere et al., 1990). The a  chain is an 
essential component of the high affinity IL-2 receptor expressed on activated 
lymphocytes (Kondo et al., 1986). In parasitized cell lines expression of biologically 
functional IL-2R was shown to be constitutive, in contrast to the transient expression 
normally detected on activated T cells (Coquerelle et al., 1989; Dobbelaere et al., 1990).
The phenotypic changes described above indicate that lymphocytes infected with T. 
parva become constitutively activated, and acquire many characteristics of leukaemia cell 
lines. They proliferate continuously in culture independently of exogenous growth factors 
or feeder cells, can be cloned by limiting dilution or in soft agar (Nelson and Hirumi, 
1981), and cause invasive tumours when injected into irradiated athymic mice (Irvin et 
al., 1975). However, the lymphoblastoid transformation caused by T. parva is 
completely reversible; treatment of cultures with theilericidal drugs based on derivatives 
of naphthoquinone results in elimination of schizonts from infected cells and reversion of 
the cells to the morphology of resting lymphocytes, leading to growth arrest (Pinder et 
al., 1981; Dobbelaere et al., 1988).
The mechanisms by which the parasite induces and maintains the transformed state of 
host lymphocytes are not known. The observation that parasitized cells constitutively 
express high-affinity IL-2R and respond to T cell growth factors (TCGF) or human 
recombinant IL-2 (hurIL-2) with increased proliferation led to the proposal that 
continued growth of parasitized cells might be maintained by a IL-2/IL-2R autocrine 
loop (Brown and Logan, 1986; Dobbelaere et al., 1988). In support of this hypothesis, 
low levels of TCGF activity have been detected in the supernatants of some parasitized 
cell lines (Brown and Logan, 1986; Dobbelaere et al., 1991). Constitutive expression of 
mRNA for DL-2 was also demonstrated in all T. parva-infected cell lines that were
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examined, including two B cell lines (Heussler et al., 1992); however, the levels of 
expression were low compared with the amount of IL-2 mRNA found in concanavalin A 
(ConA) stimulated lymphocytes, and in a number of lines transcripts could only be 
detected following amplification in the polymerase chain reaction (PCR). In addition, 
while anti-IL-2 antibodies caused significant inhibition of the growth of some cell lines, 
other cell lines were unaffected or only marginally inhibited, and proliferation was never 
completely eliminated (Dobbelaere et al., 1991; Heussler et al., 1992). Thus although IL- 
2 may play an important role in stimulating growth of parasitized cells, it is clearly not 
the sole mechanism responsible for maintaining proliferation of infected cells in vitro.
Other cytokines produced by T. parva-infected cells may also have growth factor activity 
that contributes to proliferation. There is evidence that bovine T cell lines transformed by 
T. parva secrete IFNy (Entrican et al., 1991; Ahmed et al., 1993), and transcripts for 
other cytokines including TNFa, IL-6 and IL-10 have been detected in a range of cell 
lines examined by multiplex PCR (McKeever et al., 1997). The effects of some of these 
cytokines on the establishment of infection in bovine lymphocytes and on the 
proliferation of schizont-infected cell lines have been examined in two studies, with 
somewhat contradictory results. Thus, while DeMartini and Baldwin (1991) reported 
that addition of bovine recombinant IFNy (borlFNy) and borIL-2 to the culture medium 
marginally enhanced the establishment of parasitized cell lines, Preston et al. (1992) 
concluded that borEFNy, borTNFa, huIFNa, hurIL-2 and hurIL-6 significantly inhibited 
the development of the parasite in freshly infected cells. It is not easy to explain this 
discrepancy in view of the different methods employed by the investigators to assess the 
development of infected cell lines. For example, the effects noted by DeMartini and 
Baldwin were most apparent when infected cells were plated at limiting dilutions of 1000 
to 4000 cells/well, while in the study of Preston et al. cell inputs of 5 x 105 cells/well 
were used in all experiments, making direct comparison of the results difficult. Although 
IL-2 (and to a lesser extent, borTNFa) enhanced the proliferation of established T. 
parva-infected cell lines and clones, IFNy neither inhibited nor stimulated the 
proliferation of parasitized cells. This is in contrast to infections with other intracellular 
protozoa, such as Leishmania (Liew et al., 1990), Plasmodium (Schofield et al., 1987)
1 0
and Toxoplasma (Suzuki et al., 1988), where IFNy has been shown to inhibit 
intracellular multiplication of the organisms within macrophages or hepatocytes.
In addition to cytokines, cell-cell contact has also been demonstrated to play an 
important role in maintaining proliferation of parasitized cells. Dobbelaere et al. (1991) 
found that proliferation of highly diluted T. parva-infected cells could be restored in a 
dose-dependent manner by the addition of autologous glutaraldehyde-fixed stimulator 
cells, or membrane preparations from infected cells. Uninfected allogeneic lymphoblasts 
and alveolar macrophages were as effective as autologous infected cells in stimulating 
proliferation, and the response was not inhibited by the addition of anti-MHC class I or 
class II monoclonal antibodies to the culture. These findings suggest that interactions of 
costimulatory molecules on the surfaces of parasitized cells help to maintain continuous 
proliferation. Normally, signals provided by costimulatory molecules (for example, CD28 
bound by B7) are necessary for the expression of proliferative responses and cytokine 
production in T cells activated by engagement of the T cell receptor (TCR) with its 
ligand. However 77ze//ma-infected cells may be able to respond to costimulatory signals 
alone, in the absence of an antigen-specific stimulus through the TCR.
The TCR signal transduction pathway involves a complex series of biochemical 
reactions, culminating in activation of transcription factors, such as NF-kB. NF-kB is a 
transcriptional activator, which is involved in the regulation of IL-2 and EL-2R 
expression, and can be found in the activated form in the nuclei of T. parva-infected cells 
(Ivanov et al., 1989). The similarities between T. parva-infected cells and activated T 
cells suggest that the parasite may induce a state of constitutive activation in bovine 
lymphocytes by interaction or interference with the antigen receptor signalling cascade. 
In support of this hypothesis, two protein tyrosine kinases involved in TCR signal 
transduction, p56,ck and p59^n, were also shown to be activated in infected cells 
(Eichhom and Dobbelaere, 1994). However, the nature of the interaction between 
parasite molecules and constituents of the signalling pathway is unknown at present.
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1.1.4. Immunity to Theileria parva.
1.1.4.1. Methods of immunization.
Control of East Coast fever currently relies on the regular application of acaricides to 
susceptible cattle to prevent tick infestation. However, cattle that recover spontaneously 
from infection demonstrate solid long-lasting immunity to the disease, and considerable 
efforts have been directed towards developing a method of vaccination suitable for 
application in the field. Successful immunization of cattle against ECF has been achieved 
by “infection and treatment” strategies or inoculation of live macroschizont-infected 
cells. The former technique is based on the finding that administration of tetracyclines 
during the prepatent period of the infection resulted in self-limiting infections and 
subsequent immunity. Practical application of this immunization strategy became possible 
following the development of methods to extract and cryopreserve sporozoite 
suspensions (stabilates) from infected ticks (Cunningham et al., 1973). Titration of this 
material resulted in a graded series of responses in cattle, permitting induction of 
reproducible experimental infections with predictable kinetics (Cunningham et al., 1974; 
Radley et al., 1974; Dolan et al., 1984a). Simultaneous inoculation of an infective tick 
stabilate and treatment with a long-acting formulation of oxytetracycline is effective in 
inducing immunity to challenge with the homologous parasite stock (Radley, 1981). An 
alternative method of immunization involves treatment of infected animals at the onset of 
clinical signs with a theilericidal drug such as parvaquone (Dolan et al., 1984b). These 
vaccination strategies have a number of drawbacks that may limit their practical 
application. First, the use of live parasites requires facilities for transport and storage of 
cryopreserved stabilate in liquid nitrogen. Second, immunization with one parasite stock 
may not provide protection against challenge with heterologous stocks, due to strain 
variation among different isolates of T. parva (Radley et al., 1975). However, this 
problem can be overcome by combining different stocks for immunization. Third, a 
prolonged carrier state has been demonstrated in immunized cattle, so that these animals 
can maintain infection in the tick population, and may transmit vaccine strains of the 
parasite to susceptible individuals (Kariuki et al., 1995). Nevertheless, this immunization 
strategy has been successfully implemented in the field, using locally isolated stocks of T. 
parva.
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A vaccine based on live macro schizont-infected cells, attenuated by prolonged culture in 
vitro, has been successfully applied in the field to protect against infection with T. 
annulata (Pipano, 1981). Inoculation of susceptible cattle with varying numbers of 
autologous T. parva-infected cells demonstrated that only 102 cells were required to 
induce immunity, while doses of 106 or more cells produced lethal infections (Biischer et 
al., 1984; Dolan et al., 1984c). However, 108 or more infected allogeneic cells were 
required to obtain reproducible immunity to T. parva (Pirie et al., 1970; Biischer et al., 
1984), which renders this approach uneconomic as a strategy for field immunization. 
With allogeneic cells, induction of immunity is dependent on establishment of an active 
infection in the cells of the recipient animal (Emery et al., 1981a). Transfer of T. parva 
between cells is a rare event, but occurs more readily with T. annulata, with the result 
that 105 or less allogeneic infected cells are sufficient to induce immunity against the 
latter species.
1.1.4.2. The role of humoral immune mechanisms.
Following immunization or recovery from ECF, cattle produce antibodies to schizont 
and piroplasm antigens, initially detectable at the time of elimination of infection (Wagner 
et al., 1975). This response does not appear to contribute to immunity against the 
disease. Cattle immunized with semi-purified schizont antigens or killed schizont- 
infected cells are fully susceptible to challenge with T. parva, despite developing titres of 
anti-schizont antibody comparable to those in immune cattle (Wagner et al., 1974; 
Emery e ta l ,  1981a). In addition, transfer of serum or concentrated gammaglobulin from 
immune to naive animals produced no protective effect against experimental challenge 
(Muhammed et al., 1975).
After immunization of cattle with T. parva by infection and treatment, a weak anti- 
sporozoite antibody response is observed which, on subsequent challenge, fails to 
prevent the infection becoming established in host lymphocytes. Thus, responses to 
sporozoites were initially not considered to play an important role in protective 
immunity. However, immunized cattle subjected to repeated challenge with infected ticks 
develop high titres of antibodies that neutralize the infectivity of sporozoites in vitro 
(Musoke et al., 1982). Sera and monoclonal antibodies raised against T. parva
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sporozoites neutralize the infectivity of several parasite stocks that do not cross-protect 
in vivo (Musoke et al., 1984; Dobbelaere et al., 1984). Neutralizing antibodies have been 
shown to react with a 67 kDa sporozoite-specific surface antigen (p67), which has been 
investigated as a possible candidate antigen for inclusion in a subunit vaccine, because of 
its potential for stimulating cross-protective immunity to all strains of T. parva. The gene 
encoding p67 has been cloned and was shown to be identical in sequence in five different 
cattle-derived parasite stocks; the protein encoded by a buffalo-derived parasite was also 
very similar in sequence but contained a short insert (Nene et al., 1992,1996). 
Recombinant p67 has been expressed in E. coli as a fusion protein with part of a non- 
structural protein (NS1) of influenza virus A. Repeated inoculations of cattle with the 
purified fusion protein emulsified in saponin resulted in high levels of antibody and 
induced protective immunity in a proportion of the immunized cattle (Musoke et al., 
1992). However, the effectiveness of this immunization procedure in inducing protection 
against a high-dose challenge or field challenge has not yet been evaluated.
1.1.4.3. The role of cell-mediated immune mechanisms.
The failure to demonstrate a role for antibody responses in protection against T. parva 
suggested that immunity was mediated by cellular immune responses. Following 
homologous challenge of immunized cattle, small numbers of parasitized cells are often 
transiently detectable in the drainage lymph node, indicating that immunity does not 
prevent infection but operates at the level of the schizont-infected cell (Eugui and Emery, 
1981). Cattle immunized by infection and treatment are protected against challenge with 
parasitized cells, and immunization with autologous or allogeneic infected cell lines 
renders animals resistant to challenge with sporozoites (Pirie et al., 1970; Emery et al., 
1982; Biischer et al., 1984). Further confirmation of the importance of cell-mediated 
immune mechanisms came from experiments in which adoptive transfer of thoracic duct 
lymphocytes from immune to naive chimaeric twin calves was shown to confer 
protection against challenge with T. parva (Emery, 1981b).
A role for cytotoxic cells in the immune response to T. parva was first proposed by 
Pearson et al. (1979), who demonstrated that cytotoxic cells could be induced in PBMC 
of immune animals following co-culture with autologous Theileria-infected cell lines. In
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cattle undergoing lethal infections with T. parva, cytotoxic cells capable of killing 
allogeneic, but not autologous, infected cell lines and a mouse tumour cell line were 
detected in the peripheral blood during the later stages of the infection (Emery et al., 
1981b). In contrast, in cattle recovering from primary infections, or in immunized 
animals undergoing challenge infection, cytotoxic cells are transiently detected in the 
peripheral blood at about the same time as schizonts disappear from the drainage lymph 
node (Emery et al., 1981b; Eugui and Emery, 1981; Morrison et al., 1987). These 
cytotoxic cells kill autologous parasitized cells but not uninfected lymphoblasts or 
allogeneic cell lines infected with the same parasite. The effector cells are confined to the 
CD8+ fraction of PBMC and lymphatic lymphocytes, are specific for parasitized cells and 
are class I MHC-restricted (Goddeeris et al., 1986a; Morrison et al., 1987; McKeever et 
al., 1994). Parasite-specific cytotoxic T cell (CTL) clones can be generated and 
maintained in vitro following repeated stimulation of PBMC from immune animals with 
autologous parasitized cells (Goddeeris et al., 1986b). Application of limiting dilution 
analysis has permitted estimation of the frequency of T. parva-specific CTL precursors 
(CTLp) in the peripheral blood of immune cattle. In animals immunized 6-8 weeks 
earlier, frequencies of CTLp ranging from 1:5300 to 1:3600 were found, and a similar 
range of frequencies was demonstrated up to 6 months after immunization (Taracha et 
al., 1992).
Direct evidence for the role of cytotoxic CD8+ T cells in mediating immune responses to 
T. parva has come from experiments involving adoptive transfer of lymphocytes enriched 
for CD8+ cells from immune to naive monozygotic twins (McKeever et al., 1994). The 
immune twins were challenged, and 9-12 days later, lymphocytes were collected from the 
efferent duct of the lymph node draining the site of challenge. The cells were enriched for 
CD8+ T cells by complement-mediated lysis of the other lymphocyte populations, and 
transferred to the naive twins 6-9 days after infection with a lethal dose of T. parva. In 
two sets of twins, the animals receiving the CD8+ enriched population controlled the 
infection. In another set of twins, CD8+ T cells were also depleted and a contaminating 
population of lymphocytes expressing CD2 and CD6 was transferred. The recipient in 
this case underwent a severe infection comparable to that in the challenge control. These 
results indicate that CD8+ cells are required to mediate protective responses.
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When PBMC from immune animals were restimulated at weekly intervals with 
autologous parasitized cells, a large proportion of the proliferating cells were shown to 
be CD4+CD8' lymphocytes (Goddeeris et al., 1986a; Baldwin et al., 1987). Clones 
derived from these cells exhibit a parasite-specific proliferative response, restricted by 
MHC class II molecules, when stimulated with autologous parastized cells or extracts of 
parasitized cells presented by conventional accessory cells (Baldwin et al., 1987; Brown 
et al., 1989). The clones have characteristics of helper T cells in that the antigen-specific 
proliferative responses occurs in the absence of exogenous growth factors, and the 
responding cells produce T cell growth factor activity. Although cytolytic activity was 
demonstrated in some clones (Baldwin et al., 1992), the functional significance of these 
cells in protective immune responses is unknown.
1.1.4.4. Parasite strain specificity of cytotoxic T cell responses.
Heterogeneity of T. parva parasites has been demonstrated in a number of in vitro 
assays. A panel of monoclonal antibodies to schizont antigens detected polymorphisms 
among different stocks of the parasite (Minami et al., 1983). Most of these antibodies 
react with a single antigen expressed by schizonts and sporozoites, referred to as the 
polymorphic immunodominant molecule (PIM). In addition to the expression of 
polymorphic epitopes, the PIM associated with different parasite strains exhibits 
variation in molecular weight (Toye et al., 1991). Genomic diversity in different parasite 
stocks has also been demonstrated by using parasite-specific probes based on repetitive 
genomic sequences to detect restriction fragment length polymorphisms (RFLP) in 
Southern blots of parasite DNA (Conrad et al., 1987a; Allsopp and Allsopp, 1988). In 
addition, the use of these techniques has revealed that various stocks of cattle- and 
buffalo- derived parasites contain a mixture of parasite populations (Conrad et al., 
1987b, 1989a,b; Allsopp and Allsopp, 1988; Toye et al., 1991).
Studies of the strain specificity of CTL responses to T. parva have focussed on two 
selected stocks of the parasite, Muguga and Marikebuni. In cross-protection 
experiments, cattle immunized with the Marikebuni stock were consistently immune to 
challenge with the Muguga stock, while a proportion of cattle immunized with Muguga 
were susceptible when challenged with Marikebuni (Irvin et al., 1983). Initial studies of
16
CTL reponses in cattle immunized with the Muguga stock showed that in some instances 
the response was parasite strain-specific i.e. CTL specifically lysed Muguga-infected 
target cells but not cells infected with Marikebuni. In other animals, cross-reactive CTL 
were induced that could kill cells infected with either stock of the parasite (Goddeeris et 
al., 1986a; Morrison et al., 1987). However, study of the relationship between cross­
protection and the strain specificity of CTL responses was complicated by the discovery 
that the Marikebuni stock contains a heterogeneous mixture of parasite strains (Conrad 
et al., 1989b; Toye etal., 1991). To overcome this problem, a cloned parasite population 
has been isolated from the Marikebuni stock (Marikebuni 3219) which shows a uniform 
profile with parasite-specific monoclonal antibodies and probes (Taracha et al., 1995a). 
Two groups of cattle were immunized either with the Muguga stock or with Marikebuni 
3219, and the specificity of the CTL responses was analysed in a limiting dilution assay. 
In both groups, the CTL responses were specific for the immunizing strain in a 
proportion of animals, whereas the CTL in the remaining animals recognized both 
parasites. There was a close correlation between the specificity of the responses and 
susceptibility to challenge with the heterologous parasite. Animals with cross-reactive 
CTL were immune, whereas those showing strain-specific CTL responses developed 
severe clinical reactions but recovered from the infection. These experiments provide 
further evidence for the importance of CTL responses in mediating immunity to T. parva.
Early studies on the MHC restriction of CTL responses to T. parva in cattle 
heterozygous at the bovine lymphocyte antigen (BoLA)-A locus demonstrated a bias in 
the response to one or other BoLA specificity (Morrison et al., 1987). These 
observations have subsequently been confirmed in more detailed investigations of the 
relationship between strain specificity of CTL responses and MHC phenotype (Goddeeris 
et al., 1990; Taracha et al., 1995b). The CTL responses in most cattle were shown to be 
restricted entirely by the products of one MHC haplotype, and there was a hierarchy in 
dominance among the haplotypes examined, with a consistent bias to some haplotypes in 
preference to others. One of the dominant haplotypes carries the genes encoding the 
serological specificities A10 and KN104. The majority of Muguga-immunized animals 
carrying this haplotype exhibit strain-specific CTL responses restricted entirely by the 
KN104 class I molecule. However, when animals carrying the A10, KN104 haplotype 
were immunized with Marikebuni 3219, they produced CTL responses that were either
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AlO-restricted and specific for Marikebuni or KN104-restricted and cross-reactive 
(Taracha et al., 1995b). These differences were also observed in sets of identical twins 
where one of each pair had been immunized with Muguga and the other with 
Marikebuni. This is in agreement with previous studies which demonstrated that CTL 
clones with different MHC restriction specificities generated from a single animal 
recognized distinct parasite strains (Goddeeris et al., 1990). Taken together, these 
findings provide evidence that the parasite strain used for immunization can influence the 
MHC restriction and/or the parasite specificity of the CTL response.
1.1.4.5. Immune responses to primary infections.
The very high mortality rate following infection of susceptible cattle with T. parva 
demonstrates the failure of the immune system to mount an effective response to the 
parasite. Rapid replication of the parasitized cells is thought to outpace the development 
of cellular immune responses. However, at the time when schizonts are first detected at 
very low levels in the lymph node draining the site of inoculation, there is a massive 
increase in the cellularity of the node (Morrison et al., 1981). At about the same time, 
uninfected T lymphoblasts form a significant proportion (up to 25%) of cells in the 
efferent lymph draining the node, while less than 2% of the cells are parasitized (Emery, 
1988). Subsequently, there is a rapid increase in the numbers of parasitized cells in the 
lymph node and efferent lymph, such that during the second week of infection over 95% 
of blasts in the efferent lymph were found to contain schizonts (Emery, 1981a). These 
observations suggest that the initial increased cellularity of the drainage lymph node is 
due, at least in part, to a T cell response to parasitized cells occurring within the node. 
However, there is no evidence that the early T cell response has any inhibitory effect on 
the course of the infection. Parasite-specific cytotoxic cells are not detected at any stage 
during lethal infections with T. parva (Emery et al., 1981b) and CTLp cannot be 
detected in the peripheral blood of naive cattle by limiting dilution analysis (Taracha et 
al., 1992). Nevertheless, parasitized cells stimulate potent proliferative responses in 
PBMC from naive as well as immune animals (Pearson et al., 1982; Goddeeris and 
Morrison, 1987). However, when PBMC from naive cattle were repeatedly stimulated in 
vitro, low levels of cytotoxicity were found in only a proportion of lines, and the 
responses were not MHC-restricted (Goddeeris et al., 1986a). The responding cells
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recognise cell surface determinants on infected cells, because glutaraldehyde-fixed 
stimulator cells can also stimulate a proliferative response, and supernatants from 
cultures of infected cells do not stimulate proliferation (Goddeeris and Morrison, 1987). 
The early T cell lymphoblast response in the drainage lymph node may reflect a similar 
process of non-specific T cell activation occurring in vivo.
1.1.4.6. Potential role of primary immune responses in pathogenesis of the 
infection.
Some of the observations made on the characteristics of parasitized cells during in vitro 
studies may be of relevance when considering the pathogenesis of the infection in vivo. 
Infected lymphocytes of all phenotypes constitutively express high-affinity IL-2 receptors 
(Dobbelaere et al., 1990). Although parasitized cell lines can be maintained in vitro 
without exogenous growth factors, they fail to proliferate at cell densities of less than 2 x 
102 cells/ml. However, addition of exogenous IL-2 significantly enhances the growth of 
infected cells seeded at suboptimal densities (Dobbelaere et al., 1988). Thus IL-2, and 
possibly other cytokines, have the potential to stimulate the growth of parasitized cells in 
vivo. Stimulation of PBMC from both naive and immune cattle in vitro with autologous 
parasitized cells induces proliferative responses of similar magnitude and kinetics 
(Goddeeris and Morrison, 1987). Similarly, cells isolated from the lymphoid organs of 
infected cattle stimulate proliferative responses in autologous PBMC, even when the 
percentage of schizont-infected cells is very low (Emery and Morrison, 1980). If 
parasitized cells are able to induce comparable responses in vivo, cytokines produced by 
the responding cells could enhance the proliferation of parasitized cells and thus 
contribute to the pathogenesis of the disease.
Parasitized cells have the characteristics of constitutively activated lymphoblasts, and 
thus they may also be able to influence the development of immune responses by the 
host. The infected cells express MHC class II molecules and probably costimulatory 
molecules, and may therefore be able to present parasite antigens and induce activation 
of uninfected lymphocytes. Infected cell lines have been found to express mRNA for a 
variety of cytokines, and secretion of IL-2 and IFNy has been detected using bioassays
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(Brown and Logan, 1986; Entrican et al., 1991; McKeever et al., 1997). It has been 
clearly shown that cytokines present in the local microenvironment during priming of 
naive CD4+ T cells have an important influence on their subsequent differentiation into 
Thl- or Th2-type effectors. Thl-type CD4+ cells produce IL-2, IFNy and TNFP and 
induce cell-mediated immune responses (e.g. delayed-type hypersensitivity reactions, 
macrophage activation) that are effective against intracellular pathogens. Th2-type 
responses are induced by extracellular pathogens and allergens, and are characterized by 
the production of IL-4, EL-5 and IL-10, which promote differentiation of B cells to 
antibody producing cells and recruitment and activation of mast cells and eosinophils 
(Mosmann and Coffman, 1989). Inappropriate induction of Th2-type responses in 
BALB/c mice infected with Leishmania major is associated with progressive 
disseminated infections due to failure to control parasite replication (Heinzel et al., 
1991). The induction of Th2-type responses is dependent on the presence of IL-4 during 
priming of naive CD4+ precursors, while differentiation into Thl-type effectors is 
promoted by IL-12 (Hsieh et al., 1992; Seder et al., 1993; Mattner et al., 1996). These 
cytokines also inhibit differentiation of the reciprocal Th subset. Thus the relative 
amounts of different cytokines present during priming of T cell responses may have a 
significant effect on the outcome of infection.
Parasitized cells may also produce cytokines or other soluble factors that have an 
immunosuppressive effect on host immune responses. Supernatants from infected T cell 
lines grown at high cell densities have a marked inhibitory effect on allogeneic mixed 
leucocyte reactions (MLR), but supernatants from parasitized B cell lines have no 
suppressive activity (Goddeeris and Morrison, 1987). It is possible that parasitized T 
cells may also produce such suppressive factors in vivo, resulting in inhibition of 
parasite-specific immune responses. However, these observations in vitro suggest that 
immune suppression might only be significant when high levels of parasitosis are reached.
The finding that T. parva-infected cells can induce potent in vitro proliferative responses 
in PBMC from naive cattle suggests that the parasite may possess a mechanism for non­
specific lymphocyte activation. As discussed above, triggering of a similar response in 
vivo could benefit the parasite by producing cytokines that promote proliferation of
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schizont-infected lymphocytes while failing to generate parasite-specific effector cells 
capable of eliminating the infection. The large number of T lymphoblasts detected in the 
drainage lymph node at the time when parasites are first detected is evidence that such a 
response may be occurring. One possible mechanism by which the parasite could trigger 
non-specific activation of large numbers of T cells is by expression of a superantigen. 
Unlike conventional antigens, superantigens interact only with the Vp element of the 
TCR, and activate all T cells expressing a restricted subset of VP regions. In order to 
determine whether a superantigen is responsible for T cell activation during T. parva 
infections, an important aim of this project was to examine the TCR VP repertoire 
expressed by T cells participating in the response to the parasite in vivo. Thus, to provide 
the background to this investigation, the remainder of the introduction will focus on the 
T cell receptor and the properties of superantigens.
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1.2. The T Cell Receptor.
An essential feature of the immune system of vertebrates is the ability to mount highly 
specific responses against a vast array of foreign antigens, and to discriminate between 
these and self-antigens derived from the host cell proteins. The cells responsible for the 
specificity of the response are B and T lymphocytes, and the basis for their specificity lies 
in the expression of polymorphic antigen receptors on the cell surface. For B cells these 
receptors are immunoglobulin molecules, which recognise conformational determinants 
on protein and non-protein molecules. The T cell antigen receptor (TCR) recognizes 
peptide fragments of foreign antigens in association with MHC molecules on the surface 
of antigen presenting cells. Peptides are generated by enzymatic degradation of proteins 
by cytosolic proteosomes or lysosomal enzymes. Fragments of cytosolic proteins are 
translocated into the endoplasmic reticulum, where they form stable complexes with 
MHC class I heavy chains and (32-microglobulin that are exported and expressed on the 
cell surface (this is termed the endogenous pathway of antigen processing). Before being 
expressed at the cell surface, newly synthesized MHC class II molecules are targeted to a 
specialized compartment of the endosomal-lysosomal system, where they bind fragments 
of proteins that have been internalized by phagocytosis or endocytosis and degraded by 
lysosomal proteases (the exogenous pathway of antigen processing). In both MHC class 
I and MHC class II molecules, the peptides are bound in a groove formed by two a- 
helices in the membrane-distal domains of the molecule. The T cell receptor recognizes 
determinants on both the antigenic peptide and the associated MHC molecule. The 
affinity of the interaction between the TCR and peptide/MHC complex is low, but is 
stabilized in part by coreceptors expressed on T cells that interact with non-polymorphic 
determinants on the MHC molecules. CD4 molecules are expressed by helper T cells and 
bind to MHC class II molecules, while CD8 molecules are expressed on cytotoxic T cells 
and bind to MHC class I molecules. Further stabilization of the ternary complex of TCR, 
MHC molecule and peptide is provided by the interactions of a number of cell surface 
molecules on T cells with their specific ligands on antigen presenting cells, for example, 
CD28/B7, CD2/LFA-3, LFA-l/ICAM-1. In addition to their role in cell-cell adhesion, 
these molecules are also involved in the transduction of signals essential for T cell 
activation; for this reason, they are commonly referred to as costimulatory molecules.
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1.2.1. Structure and diversity of the T cell receptor.
The T cell antigen receptor was initially characterized using clonotypic monoclonal 
antibodies that could either block or stimulate the activation of T cell clones and 
immunoprecipitate polymorphic disulphide-linked heterodimeric molecules (Kappler et 
al., 1983). Subsequently, isolation and sequencing of complementary DNA clones 
encoding these polypeptides revealed that they contained sequences homologous to 
those of immunoglobulins, encoding a variable and a constant domain (Hedrick et a l,  
1984; Sim et al., 1984). The heterodimers were composed of a  and P chains in the 
majority of T cells in the mouse; however a second type of TCR, composed of y and 6 
chains was also identified (Brenner et al., 1986). Transfer of the genes encoding the 
a  and P chains of the TCR was shown to transfer both antigen and MHC specificity 
between T cells (Dembic et al., 1986). Both ot/p and y/S heterodimers are expressed at 
the cell surface in association with a complex of non-polymorphic polypeptides, 
collectively termed CD3. The CD3 complex contains at least five proteins, termed 
y, 8, e, and rj, which are involved in signal transduction from the antigen receptor to 
the interior of the cell. These invariant chains are also necessary for the assembly and 
transport of the TCR complex to the cell surface.
1.2.1.1. Genomic organization of the TCR genes.
Sequence analysis of cDNA clones encoding the four TCR polypeptides 
(a, p, y, 8) showed that the molecules contained sequences homologous to the variable 
(V), diversity (D), junctional (J) and constant (C) gene segments of immunoglobulins. 
The genomic organization of the TCR genes is also very similar to that of the 
immunoglobulin loci; i.e. tandem arrays of V, D, J  and C gene segments are arranged 
over a considerable length of chromosomal DNA. For example, the human TCR P chain 
locus covers almost 700kb of DNA and encodes eight trypsinogen genes in addition to 
the TCR gene segments (Rowen et al., 1996). Specific V, D  (P and 8 chains only) and J  
segments are joined by a process of somatic recombination to form a complete V region- 
coding exon immediately 5’ to a C gene segment. As for immunoglobulin gene 
rearrangements, recombination is controlled by conserved recombination signal
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sequences (RSS) that flank the V, D  and J  gene segments (Toyonaga et al., 1985; 
Yoshikai et al., 1985). The RSS consist of conserved heptamer and nonamer sequences 
separated by non-conserved spacer regions of either 12 or 23 nucleotides. An RSS with a 
12 base pair (bp) spacer may recombine only with one containing a 23 bp spacer and vice 
versa, thus the arrangements of RSSs flanking the various gene segments determines 
which gene combinations are possible. The mechanisms for rearrangement of gene 
segments involve both looping-out and deletion and inversion, depending on the 
orientation of the sequences being joined. The products of two homologous 
recombination activating genes, RAG-1 and RAG-2, are essential for the rearrangement 
of antigen receptor genes in B and T cells, although their exact function is unknown 
(Schatz et al., 1989; Shinkai et al., 1992).
The TCR a , (3, y, and 8 chains are encoded by TCRA, TCRB, TCRG and TCRD genetic 
loci respectively. The TCRA locus is unique among antigen receptor loci in that it 
contains the entire TCRD locus within the region encompassing the AV  and A J  gene 
segments. There is considerable variation between the different TCR loci in both the 
numbers of gene segments and the overall organization of genes. Figure 1.1 gives a 
schematic representation of the TCRA and TCRB loci in humans. In mice and humans, 
the TCRB locus contains two very similar (and functionally equivalent) TCRBC gene 
segments, each of which is associated with a single TCRBD gene segment and a cluster 
of TCRBJ gene segments located 5’ to the BC  gene. In the mouse, the two TCRBJ 
clusters (BJJ and BJ2) each contain six functional gene segments and one pseudogene. 
The human locus contains six BJ1 gene segments and seven BJ2 gene segments, all of 
which are functional. Most of the TCRBV gene segments are located 5’ to the BD-BJ-BC 
gene clusters. The DNA sequence for the entire human TCRB locus on chromosome 7 
has recently been published (Rowen et al., 1996). A cluster of six non-functional TCRBV 
genes (designated orphon genes) has also been identified on chromosome 9 (Robinson et 
al., 1993). Sixty-five TCRBV gene segments were identified, of which 46 appeared to be 
functional. These gene segments are grouped into 30 subfamilies, whose members share 
at least 75% nucleotide sequence identity. The criterion of 75% similiarity for subfamily 
members derives from studies in which the numbers of TCRAV and TCRBV genes were 
estimated from the number of bands hybridizing to V region-specific probes in Southern
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blots of genomic DNA (Barth et al., 1985; Kimura et al., 1987), nucleotide sequence 
homologies of about 75% or greater being required for cross-hybridization. Members of 
24 human TCRBV subfamilies are expressed, and some also contain pseudogenes; the 
other subfamilies contain only pseudogenes. Most of the subfamilies contain multiple 
members, with the largest subfamilies being BV5 (7 members), BV6 (9 members), BV8 (5 
members), and BVJ3 (8 members). In contrast, most of the 25 murine TCRBV 
subfamilies contain a single member, the exceptions being BV5 and BV8, which each 
have three members (Arden et al., 1995b). Five subfamilies contain pseudogenes (Louie 
et al., 1989), so that the number of functional TCRBV gene segments in the mouse is 
estimated at twenty-two. A summary of the numbers of different TCRB gene segments in 
mice and humans is given in Table 1.1.
Comparison of the sequences of different TCRBV subfamilies within a species reveals 
that, on average, they display less than 40% identity at the amino acid level. However, 
when the deduced protein sequences of human and mouse TCRBV gene segments were 
compared, 14 murine subfamilies were shown to display >60% similarity to their human 
homologues (Clark et al., 1995). Genome mapping of TCRBV gene segments has 
revealed that the relative order of the homologous TCRBV subfamilies is highly 
conserved in mice and humans (Lai et al., 1988). In humans, multi-membered TCRBV 
subfamilies have arisen as a result of internal duplications and subsequent divergence 
within the TCRB locus (Rowen et al., 1996). In some cases, the duplications have 
increased the size of individual BV  subfamily gene clusters, e.g. BV8 (Sui et al., 1986), 
while in others, tandem duplication of BV  gene segments from different subfamilies has 
resulted in interspersion of clusters o f BV  genes unrelated by homology, for example, 
members of the BV5, BV6 and BV13 subfamilies (Li etal., 1991).
The organization of the TCRA locus is also very similar in humans and mice. Both 
species have a single TCRAC gene segment separated from the upstream A V region by an 
extended cluster of TCRAJ gene segments, containing 61 functional elements in humans, 
and 50 in mice. The TCRDV gene segments are interspersed among the TCRAV 
segments, and a limited number of V gene segments are used in both a  and 6 chains. 
Human A V gene segments are grouped into 32 subfamilies, the majority of which contain
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a single member (Arden et al., 1995a). In contrast, 88 AV  gene segments have been 
identified in mice, which fall into 20 subfamilies, most of which have multiple members 
(Arden et al., 1995b). A summary of the TCRA genes of mice and humans is presented in 
Table 1.1. As described for the human TCRB locus, members of the different murine and 
human TCRA V subfamilies are interspersed on the chromosome.
Table 1.1. Summary of the numbers of TCRA and TCRB gene segments in humans
and mice.
Gene segments Human Mouse
TCRA TCRB TCRA TCRB
TCRC 1 2 1 2
TCRJ 61 13 50 12
TCRD - 2 - 2
TCRV 40a 65b 88a 29a
Multi-membered AVI (5) BV5 (7) AVI (8) BV5 (3)
TCRV subfamilies AV2 (3) BV6 (9) A V2 (9) BV8 (3)
(number of A V 4( 2) BV7 (3) AV 3( 8)
members)3 AV7(2)  
AVI4 (2)
BV8 (5) 
BV9 (2) 
BV12 (3) 
BVJ3 (8) 
BV21 (3)
AV4(  11) 
A VS (3) 
A V7 (2) 
AVS (15) 
AV9(  2) 
AV10 (8) 
AVI I (7) 
AVI3 (2) 
AVJ4(  2) 
AVI6 (2) 
AV17(3) 
AVI8 (2)
Notes: a) These figures are derived from the classification of Arden et al. (1995a,b) and 
include non-functional TCRVgene segments (pseudogenes) 
b) This figure is derived from the sequence of the entire human TCRB locus 
published by Rowen et al. (1996).
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Figure 1.1. The organization of the human TCRA (A) and TCRB (B) gene loci. 
L = leader sequence, V, D, J and C stand for variable, diversity, joining, and 
constant gene segments respectively. See text for full explanation.
Although the genomic organization of bovine TCR genes has not been investigated, 
cDNA clones encoding the bovine TCR a , (3, y, and 8 chains have been isolated and 
sequenced (Ishiguro et al., 1990; Tanaka et al., 1990; Takeuchi et al., 1992). Clones 
containing TCRA and TCRB sequences were isolated from a cDNA library prepared from 
bovine peripheral blood lymphocytes. Seven full-length TCRA V sequences were grouped 
into five subfamilies, and eighteen different TCRAJ segments were identified (Ishiguro et 
al., 1990). Thirteen distinct TCRBV gene segments representing nine different 
subfamilies were identified in clones containing functional TCRB transcripts, and twelve 
different TCRBJ gene segments were also found (Tanaka et al., 1990). Probing of 
Southern blots of genomic DNA with AC- and 2?C-specific probes confirmed that, in 
common with most other species, cattle possess one TCRAC gene segment and two 
TCRBC segments. Southern blots of genomic DNA from four bovine breeds were also 
hybridized with eight 2?F-specific probes and two different £C-specific probes. This 
analysis failed to detect any restriction fragment length polymorphisms (RFLP) with the 
enzymes Pst I and Eco RI and, furthermore, the 2? L-specific probes hybridized with a 
limited number of bands, suggesting that bovine TCRBV subfamilies have relatively few 
members (Tanaka et al., 1990). However, four RFLP alleles were subsequently detected 
in bovine genomic DNA digested with Taq I, using an uncharacterized BV-specific probe 
(Lunden etal., 1991).
Comparison of the bovine TCRBV sequences with those of homologous human TCRBV 
subfamilies revealed sequence similarities of at least 63% at the protein level, while the 
amino acid similarity between BV  genes from the different bovine subfamilies ranged 
from 18% to 53% (Tanaka et al., 1990). This is in agreement with the results obtained 
from comparison of mouse and human TCRBV sequences (see above). In fact, when the 
analysis was extended to subfamilies within the TCR A/D and G families, sequences in 
almost every murine subfamily were found to have closer homology to a human V gene 
segment than to a member of another mouse subfamily (Clark et al., 1995). Although 
extensive sequence comparisons have not been possible in other species, the limited data 
available suggests that this general principle holds true in, for example, rabbits and horses 
(Isono et al., 1994; Schrenzel et al., 1994; Schrenzel and Ferrick, 1995). The degree of 
conservation varies between different subfamilies; for example, some members of the
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TCRBV6 subfamily have been extensively conserved between different mammalian 
groups (Buitkamp et al., 1993). These observations suggest that a set of ancestral V gene 
segments has been retained during the evolution of species, but that different 
diversification strategies involving gene duplication and/or deletion have modified the 
repertoire as the species diverged.
I.2.I.2. Nomenclature for TCR gene segments.
Historically, the V gene segments and subfamilies have been named according to their 
order of discovery. According to this arbitrary numerical nomenclature, members of the 
same subfamily share the first digit and differ in the second, for example, V(38.1, VJ38.2 
and V(38.3 are all members of the V08 subfamily. A standardized system of 
nomenclature for TCR gene segments suitable for application in all species has recently 
been devised by the WHO-IUIS Nomenclature Sub-Committee on TCR Designation 
(Williams et al., 1993). The names for the genetic loci (A, B, G, D) and gene segments 
(V, D, J, C) are self-explanatory and have been used so far in this discussion. S  refers to 
gene segments and is used to enumerate and distinguish subfamily members. Based on 
these principles, a revised nomenclature has been proposed, following detailed analysis of 
all the available human and mouse TCR variable gene sequences (Arden et al., 1995a,b). 
However, the traditional numbering of V gene segments in the order of their discovery 
was preserved, except where there was conflict with the names of other segments. Thus, 
murine homologues of human V gene segments do not have the same subfamily 
designation. In other species a convention of numbering TCRV gene segments according 
to the human TCRV subfamilies to which they showed closest sequence homology has 
generally been adopted (Tanaka et al., 1990; Isono et al., 1994; Schrenzel et al., 1994).
Following the publication of the complete genomic sequence of the human TCRB locus 
by Rowen et al. (1996), these workers proposed that V subfamilies should be assigned 
consecutive numbers, starting at the 5’ end of the locus. Individual subfamily members 
would then be numbered sequentially after the subfamily designation. However, this 
system has not been adopted as yet and, if it is to be applied to all TCRV gene segments, 
will require complete mapping or sequencing of all the TCR loci.
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1.2.1.3. Generation of diversity in T cell receptors.
The basis for the diverse repertoire of B cell and T cell receptor specificities lies in the 
organization of the IG (encoding immunoglobulins) and TCR genetic loci. Most of the 
antigen receptor diversity is generated during the rearrangement of V, (D) and J  gene 
segments to form the exon encoding the V region. Although most of the genetic 
mechanisms for the generation of diversity are common to both B and T cells, their 
relative contribution varies, with the result that variability is concentrated in different 
parts of the binding sites of immunoglobulins and TCR.
Combinatorial diversity in both immunoglobulins and TCRs is generated by the random 
association of different F, D and J  elements during gene rearrangements. The number of 
potential combinations is a function of the numbers of different gene segments encoded 
in the germline. The repertoire of V gene segments used by the TCR is small in 
comparison to that of immunoglobulins; for example, approximately 20 B V  and 100 AV  
gene segments are employed by the murine a/p TCR, compared to the 250-1000 VH or 
VK gene segments available to immunoglobulins. Thus, assuming that there is random 
association of TCR a  and P chains, the estimated number of Va x VP combinations is 
only 2000, while the immunoglobulins can generate up to 250000 different V region 
combinations (Davis and Bjorkman, 1988). However, the diversity at the V-J junction of 
TCRs greatly exceeds that of immunoglobulins. Junctional diversity is generated by a 
number of mechanisms. A relatively large number of J  gene segments (in mice, 50 A J  and 
12 BJ) are used by TCRs compared to the 4 J  elements found in mouse IGH  and IGK 
loci. The boundaries of the gene segments to be joined are cleaved by exonucleases, 
which also remove a variable number of nucleotides from the ends of the V (3’), D  (5’ 
and 3’) and J  (5’) elements (Rowen et al., 1996). Non-germline (N) nucleotides are then 
added to the junctions between gene segments by the enzyme terminal deoxynucleotidyl 
transferase (TdT). N region diversification is found in all four TCR polypeptides, but is 
confined to the heavy chains of immunoglobulins. In addition, the D gene segments of 
TCR p and 5 chains can be translated in all three reading frames, a rare event in 
immunoglobulin heavy chains (Abergal and Claverie, 1991). When these mechanisms are 
taken into account, an estimated 1015 different junctional combinations can be predicted
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for murine cx/p T cells, compared to only 10u combinations for immunoglobulins (Davis 
and Bjorkman, 1988).
Further diversification of immunoglobulins occurs by a process of somatic hypermutation 
during B cell differentiation into antibody-producing cells following stimulation by 
specific antigen. Although one report provided preliminary evidence for somatic 
hypermutation of TCR V a regions in germinal centres (Zheng et a l 1994), these 
findings have not subsequently been confirmed, and it is unlikely that this mechanism 
contributes to TCR diversity.
1.2.1.4. The structure of the a/p T cell receptor.
The similarities between the deduced primary sequences of the TCR a  and P polypeptide 
chains and those of immunoglobulins suggested that the molecules would also have a 
similar three-dimensional structure. Both molecules are part of the immunoglobulin 
superfamily which includes many proteins involved in cell recognition in the immune 
system, e.g. MHC class I and class II molecules, p2-microglobulin, CD2, CD4 and CD8. 
The extracellular portion of members of this superfamily is composed of a variable 
number of discrete domains, each of which has a characteristic tertiary structure known 
as the immunoglobulin fold. The basic features of the immunoglobulin fold have been 
elucidated by X-ray analysis of crystallized antibodies. Each domain is approximately 110 
amino acids long, and comprises two P-sheets consisting of 3-4 anti-parallel P strands. 
The p-sheets are stabilized by interactions between hydrophobic amino acids and by an 
intrachain disulphide bond. Pairs of domains on separate chains can fold together in turn 
to create a functional quaternary structure as, for example, in V l-V h  and C l-C h pairing 
to form functional immunoglobulins.
Calculations of variability, defined as the number of different amino acids occurring at a 
given position divided by the frequency of the most common amino acid at that position 
(the Wu-Kabat coefficient of variability), have demonstrated that immunoglobulin V 
regions have three distinct hypervariable regions (HVRs) separated by relatively 
conserved framework regions. The first two HVRs are located within the V gene
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segment, while the third occurs at the V-J or V-D-J junction. In X-ray crystallographic 
studies of the structure of antibodies, it was demonstrated that the HVRs in V H and Vl 
domains are brought together by pairing of heavy and light chains to form a cluster of 
loops at the tip of the Fab arm of the molecule, which corresponds to the antigen-binding 
site. Since the HVRs are responsible for antigen binding, they are also commonly 
referred to as complementarity-determining regions (CDRs). When the combining site of 
an immunoglobulin molecule is viewed from above, the first and second CDRs on Vl are 
separate from their counterparts on Vh, and the space between them is occupied by the 
two CDR3 regions.
Although the overall sequence homology between immunoglobulin and TCR 
polypeptides is relatively low, residues that are responsible for the conserved structure of 
the domain framework are identical or very similar in both sets of molecules (Patten et 
al., 1984). From an analysis of immunoglobulins of known structure, Chothia et al. 
(1988) identified 40 sites crucial for the conserved structure of the variable domains. The 
sites responsible for the conserved framework are buried between the domain P-sheets, 
or on the loops between the strands. In addition, the residues that determine the way in 
which the Vl and VH domains pack together, and residues in Vh that form contacts with 
conserved residues in the ChI domain, were identified. When the sequences of V a and 
Vp regions were examined, they were found to contain the same or very similar residues 
at sites homologous to the 40 conserved residues in immunoglobulin V domains. Based 
on these results, it was predicted that the oc/p TCR would have a framework structure 
very close to that found in immunoglobulins, and that the Va and VP domains would 
pack together with a geometry close to that of Vl and Vh domains. To facilitate 
comparison of the protein sequences of immunoglobulins and TCRs, a common 
numbering system for the amino acid residues was proposed by Kabat et al. (1991), 
based on the alignment of functionally conserved residues, and has been widely used in 
studies of TCR structure.
Computation of the Wu-Kabat coefficient of variability for amino acid positions in V a or 
VP regions demonstrates a much broader distribution of variability throughout the V 
region, rather than the three distinct hypervariable regions found in immunoglobulins.
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Nevertheless, three hypervariable regions can be distinguished that are similar in size and 
position to the antibody CDRs, with the greatest variability being concentrated in the 
third HVR (Concannon et al., 1986; Jores et al., 1990). Thus, in the predicted structure 
of the a/(3 TCR, these hypervariable loops are arranged in a manner similar to that found 
in the antigen-binding site of immunoglobulins (see Figure 1.1.). A fourth hypervariable 
region (HVR4), which is located between CDR2 and CDR3, has been identified in the 
TCR P-chain; in the predicted three-dimensional structure of the molecule this region 
formed a loop that lay in close proximity to CDRip and CDR2p (Jores et al., 1990), as 
shown in Figure 1.1.
Recently, the crystal structure of the complete extracellular fragment of a glycosylated 
a/p  TCR has been resolved by X-ray diffraction studies (Garcia et al., 1996). The TCR 
was derived from a murine cytotoxic T cell clone with specificity for a self-peptide bound 
to MHC class I H-2Kb molecules. The results of this analysis showed that the the TCR 
a  and P chains fold into a quaternary structure that resembles the antigen binding region 
(Fab) of antibodies, and confirmed the predictions of the earlier models of TCR 
structure. The structure determined by Garcia et al. is illustrated in Figure 1.2, with the 
CDRs and the HVR4 region of the p-chain highlighted in colour.
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Figure 1.2. Three-dimensional structure o f  the a  (3 1 C'R plotted from the co-ordinates 
deposited in the Biookhaven Database by Garcia et al. (1996). A. Side view o f  the 
TCR with the a -cha in  on the left and the p-chain on the right. B. The TCR rotated 90° 
towards the viewer, looking directly down on the antigen/M HC binding site. The 
C D R 1 loops are shown in red, the CDR2s in blue and the C'DR3s in green. The 11 \  R4 
loop on the P-chain, which has been implicated in superantigcn binding, is show n in 
yellow.
The TCR V a and VP regions can be further classified into various subgroups, which 
have certain framework residues in common. These variations in certain residues are 
predicted to produce small and local differences in the framework structure of different 
subgroups (Chothia et al., 1988). TCR Vp sequences were first divided into two 
subgroups by Schiffer et al. (1986), based on the presence of paired residues that can 
form a salt bridge. Salt bridges have been detected in all immunoglobulin molecules 
examined by X-ray crystallography, suggesting that they may be an important feature of 
the protein structure. The majority of sequences in subgroup I are capable of forming a 
salt bridge between an aspartate residue (Asp) at postion 86 and an arginine (Arg), lysine 
(Lys) or histidine (His) at position 64. The residues that form salt bridges in 
immunoglobulins are found at similar locations. In contrast, subgroup II sequences have 
glycine (Gly) at position 63 and glutamine (Gin) at position 86 and are therefore 
incapable of forming a salt bridge. In addition, all subgroup I sequences have a 
phenylalanine (Phe) at position 65 and serine (Ser) at position 87, while subgroup II 
sequences have a tyrosine (Tyr) at position 65, and most have a threonine (Thr) at 
position 87.
As greater numbers of sequences became available, the subgroup classification was 
extended by Chothia et al. (1988), who proposed six V a and five V(3 subgroups. In this 
system, subgroups consist of sequences whose protein sequences are >50% identical if 
they are from the same species, or >40% identical if they are from different species. The 
Vp subgroups I-III correspond to Schiffer’s subgroup I, in that they contain an invariant 
Phe at position 65 and other conserved residues capable of forming a salt bridge. 
Subgroup IV sequences have an invariant Tyr at position 65 (as in Schiffer’s subgroup 
II). Subgroup V contains only two sequences, one murine and one human, which both 
contain a leucine (Leu) at position 65. Subsequently, the discovery of human and murine 
sequences that do not fit into this classification has led to the proposal of further 
subgroups (Robinson, 1991). So far, the subgroup classification has not been extended 
to species other than humans, mice and rabbits.
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I.2.I.5. Interaction of the a/p  TCR with peptide/MHC.
X-ray crystal structures of MHC class I and class II molecules have shown that peptide 
fragments of antigens are located in a specific binding groove, formed by the outer 
domains of the molecules and comprising a p-pleated sheet bounded on either side by a- 
helices (Bjorkman et al., 1987). From these structures it has also become apparent that 
many of the polymorphic residues of MHC molecules are focused on interactions with 
peptides. Based on the predicted similarities in structure between the cc/p TCR and 
immunoglobulins, a model for TCR interaction with peptide/MHC was put forward 
(Davis and Bjorkman, 1988; Chothia et al., 1988). This model proposed that the CDR1 
and CDR2 loops on V a and Vp contact relatively conserved residues on the a-helices of 
the MHC molecule, while the highly diverse CDR3 loops are principally responsible for 
peptide contact. Support for this hypothesis has come from studies in which mutation of 
residues in the CDRs of TCR a  and p chains has been shown to affect T cell recognition, 
with certain substitutions resulting in complete abolition of the T cell response (Nalefski 
et al. 1992; Bellio et al., 1994). However, attempts to transfer peptide or MHC 
specificity by exchanging the CDR loops of one TCR p-chain for those of another have 
been unsuccessful (Patten et al., 1993).
In an attempt to identify V a and Vp elements or junctional sequences involved in 
recognition of antigen/MHC, numerous studies have related the primary structure of 
TCR a  and P chains from T cell clones to their fine specificity for a defined 
peptide/MHC combination. In some cases, the majority of clones specific for a particular 
peptide/MHC complex express the same TCRAV and BV  gene segments and have 
conserved junctional sequences (CDR3) in the a -  and/or p-chain (Hedrick et al., 1988; 
Urban et al., 1988; Casanova et al., 1992). For example, most murine T cell clones 
specific for the carboxyl-terminal fragment of pigeon cytochrome c (pcc) presented by 
the MHC class II molecule I-Ek express V a l l . l  and Vp3, and show striking 
conservation of the P-chain junctional sequence encoding CDR3, although the response 
is clearly polyclonal (Hedrick et al., 1988). In particular, an asparagine residue, partly 
encoded by N-region nucleotides, is found at position 100 in almost every clone. 
Mutation of this residue resulted either in abolition of the response or in altered antigen
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fine specificity, confirming its importance in antigen recognition (Engel and Hedrick, 
1988). Similar patterns of conservation of the V elements and junctional sequences have 
also been found in human CTL clones specific for influenza A virus matrix protein or 
nucleoprotein peptides presented by the MHC class I molecules HLA-A0201 and HLA- 
B27, respectively (Moss et al., 1991; Bowness et al., 1993; Lehner et al., 1995). 
However, there are many other examples of both MHC class I and class II restricted 
responses, in which the responding T cells exhibit diverse TCR gene usage, or 
VP conservation alone (Taylor et al., 1990; Casanova et al., 1991; Boitel et al., 1992). 
These results suggest that contacts between the TCR and MHC/peptide complex can be 
made in a number of different ways. In fact, in studies using MHC molecules mutated at 
residues predicted to interact with the TCR, it has been shown that very limited changes 
in either a CDR3 loop of the TCR or in a contact residue of the antigenic peptide can 
have a profound effect on relatively distant TCR/MHC interactions (Ehrich et al., 1993). 
Thus the same TCR can contact an MHC molecule in different ways depending on the 
interaction with peptide residues.
The X-ray structure of a crystallized ternary complex of a TCR, MHC class I molecule 
and peptide has recently been determined (Garcia et al., 1996). The Va and VP CDR3s, 
as predicted, were located over the central part of the peptide and appeared to play a 
prominent role in peptide interaction. CDRs 1 and 2 contacted the a-helices of the MHC 
molecule; however, the CDRal and CDRpi loops also contacted residues at the amino 
and carboxyl terminals of the peptides respectively. Thus, although previous models were 
derived for TCR/MHC class II systems, the predictions they make are largely in 
agreement with the results of structural analysis.
1.2.2. Factors influencing the T cell receptor repertoire.
As discussed already, T cells have the potential to express a vast array of different 
antigen receptors, generated by the recombination of large numbers of different V, (D) 
and J  gene segments and mechanisms for introducing junctional diversity. However, the 
TCR repertoire expressed by mature T cells in the periphery is more limited than that 
which would be predicted by completely random association of gene segments. The
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major influences on the TCR repertoire are genetic polymorphisms within the TCR loci, 
and the processes of positive and negative selection during thymocyte maturation.
In the mouse, germline deletions within the TCRB locus, involving up to half the TCRBV 
gene segments, have been found both in inbred laboratory strains and in wild mice 
(Behlke et al., 1986; Pullen et al., 1990a). In one laboratory strain (NZW) a deletion 
containing TCRBCl, TCRBD2 and the BJ2 cluster has also been identified (Kotzin et al., 
1985). At least two such deletions have also been found in the TCRB locus in humans 
(Seboun et al., 1989), one of which involves two functional TCRBV gene segments 
(Zhao et al., 1994). Although mice with massive deletions within the TCRB locus appear 
healthy and phenotypically normal, their ability to respond to certain antigens is impaired, 
indicating that there are limits to the redundancy of the TCR repertoire (Nanda et al., 
1991; Kumar and Sercarz, 1994).
The extent of the expressed TCR repertoire is also influenced by allelic polymorphisms 
within the coding regions of TCRV genes. Restriction fragment length polymorphism 
(RFLP) analyses have suggested the existence of a small number of alleles for most 
TCRV genes in mice and humans (Klotz et al., 1989; Charmley et al., 1990; Posnett, 
1990). However, direct sequence analysis of V gene segments isolated from genomic 
DNA demonstrated that, in most cases, polymorphisms within the coding regions of 
different alleles were confined to a limited number of nucleotide substitutions (usually 
less than five), some of which were silent (Robinson, 1989; Smith et al., 1990; Li et al., 
1990; Comelis et al., 1993; Reybum et al., 1993). Some of the coding substitutions may 
influence interactions with peptide/MHC; a single amino acid substitution in the 
predicted CDR1 of murine V]33 was shown to alter dramatically the TCR a/p repertoire 
used in an antigen-specific, MHC-restricted immune response (Gahm et al., 1991). 
However, allelic polymorphism may also limit the expressed TCR repertoire through the 
introduction of point mutations which produce stop codons (Wade et al., 1988; 
Charmley et al., 1993) or substitution of functionally important residues (Luyrink et al., 
1993). Surprisingly, the resultant null alleles were maintained at relatively high 
frequencies in the human populations studied (Charmley et al., 1993; Barron and 
Robinson, 1994). Polymorphisms located in the non-coding regions of V genes may also
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influence the level of expression of certain gene segments; for example, an allele of the 
human BV3 gene that differs only by a single nucleotide substitution in the 23bp spacer 
of the RSS is expressed at very low levels, presumably due to an alteration in the 
recombination process (Posnett et al., 1994). Mapping of polymorphic loci in different 
individuals has demonstrated that multiple distinct TCRB haplotypes result from frequent 
recombination between these loci (Comelis et al., 1993; Day et al., 1994).
The peripheral a/p  TCR repertoire is also profoundly influenced by the processes of 
positive and negative selection to which thymocytes are exposed during thymic 
maturation. The thymus is colonized by stem cells migrating from the bone marrow, 
which are negative for T cell markers. These cells undergo expansion and differentiation 
over a period of about three weeks to produce mature immunocompetent T cells, 
expressing functional a/p  TCRs and T cell differentiation antigens, including either CD4 
or CD8 (Shortman, 1992). Only a small proportion of thymocytes (<5%) differentiate 
fully to produce mature T cells that are exported to the periphery; the majority die within 
the thymus as a result of selection processes or the failure to express a functional TCR. 
The TCRB locus is rearranged first, and expression of a productively rearranged P-chain 
inhibits further recombination at this locus, a phenomenon known as allelic exclusion 
(Uematsu et al., 1988). Expression of a functional p-chain as part of the pre-TCR also 
promotes survival and expansion of the immature CD4'CD8‘ thymocytes, permitting 
differentiation to the next developmental stage, the double positive (CD4+CD8+) 
thymocyte (Mombaerts et al., 1992; Groettrup and von Boehmer, 1993). This involves 
rearrangement of the TCRA genes, and a/p TCRs are initially expressed at low levels by 
double positive (DP) thymocytes. DP thymocytes expressing functional TCRs are then 
selected based on the interaction of their TCRs with self-MHC molecules expressed by 
thymic stromal cells; cells bearing TCRs that do not recognize self-MHC molecules 
undergo apoptosis. Low affinity interactions between the TCR and self-MHC/ peptide 
promote survival of immature thymocytes and differentiation into mature thymocytes 
that express either CD4 or CD8 (positive selection) (von Boehmer, 1994). DP 
thymocytes expressing TCRs with high affinity for self MHC/peptide combinations, i.e. 
potentially self-reactive cells, are eliminated by a deletional mechanism (negative 
selection) (Nossal, 1994). The TCR repertoire of those cells that survive thymic selection
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and are exported to the periphery is therefore determined both by the MHC phenotype of 
the individual and by the products of “background” polymorphic genes that generate 
some of the self peptides complexed to MHC molecules in the thymus (Vukusic et al., 
1995).
The influence of MHC genes on the peripheral TCR repertoire has been demonstrated in 
MHC disparate strains of mice (Bill et al., 1988), and in studies of large human families, 
HLA-identical sibs had more similar patterns of V  segment frequencies than mismatched 
or haploidentical sibs (Akolkar et al., 1993). In addition, significant biases in the 
expression of certain V gene segments towards either the CD4+ or the CD8+ subset of T 
cells have been observed, which may reflect a differential effect of MHC class II and 
class I molecules on positive selection of thymocytes (Singer et al., 1990; Akolkar et al., 
1993). Although evidence has been presented for the involvement of polymorphic non- 
MHC genes in thymic selection, few have actually been characterized (Fry et al., 1989). 
An exception are the Mtv loci in mice (formerly designated Mis), which correspond to 
endogenous retroviruses (mouse mammary tumour viruses) integrated into the genome. 
These loci encode superantigens which mediate intrathymic deletion of the majority of T 
cells expressing specific Vp elements, and can therefore significantly alter the peripheral 
TCR repertoire (Vacchio and Hodes, 1989). There is no evidence for similar 
superantigen-mediated Vp deletions in humans (Baccala et al., 1991).
Despite considerable inter-individual variation, the peripheral TCR repertoire has a 
similar overall pattern o f BV  and BJ  gene usage even in individuals of differing MHC 
phenotype, in that some gene segments are frequently expressed while others are rarely 
utilised (Okada and Weissman, 1989; Rosenberg et al., 1992; Malhotra et al., 1992). 
This variation is independent of thymic selection, as examination of the TCR repertoire 
of unselected thymocytes reveals similar biases in the use of certain gene segments 
(Okada and Weissman, 1989; Baccala et al., 1991; Jores and Meo, 1993). The cause of 
differential expression of B V  genes is unknown, but presumably reflects their relative 
ability to undergo recombination. However, there is no obvious correlation between the 
order of murine B V  gene segments on the genome and their relative levels of expression
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(Okada and Weissman, 1989), and human BV  subfamily members expressed at different 
levels have conserved promoter and RSS sequences (Rowen et al., 1996).
Environmental factors, such as exposure to infectious agents, superantigens or mitogens, 
may also play a role in shaping the TCR repertoire. In normal human subjects, the 
TCRBV repertoire of circulating CD8+ T cells is frequently altered as a result of the 
oligoclonal expansion of CD8+ subsets (Hingorani et al., 1993). These expanded subsets 
have a ‘memory’ phenotype and presumably arise initially in response to infection, but in 
some cases have been shown to persist for months or even years.
1.3. Superantigens.
The term ‘superantigen’ was coined to describe molecules capable of stimulating a 
strong proliferative response in unprimed T cells, comparable to that induced by 
mitogens. It was used initially to describe certain soluble bacterial toxins, such as the 
staphylococcal enterotoxins, which stimulate potent T cell proliferative responses in vitro 
(Choi et al., 1989). These proteins were found to be capable of stimulating T cells that 
express a specific set of TCRBV gene segments, regardless of the other variable 
components of the TCR (Kappler et al., 1989). At about the same time, different groups 
of investigators observed that, in mice expressing the proteins encoded by the Mls-Ja 
genes, T cell subsets bearing specific V(5 elements were deleted from the pool of 
immature thymocytes (Kappler et al., 1988; MacDonald et al., 1988). Furthermore, a 
high frequency of T cells or T cell hybridomas expressing these V|3 elements proliferated 
in vitro in response to stimulation with splenocytes from M ls-la mice. Thus it appeared 
that the bacterial superantigens and the product of the Mls-Ja gene might interact with 
the TCR in a similar manner. The Mis loci were originally described by Festenstein 
(1973), who found that vigorous mixed leukocyte reactions (MLR) could be initiated 
between MHC-identical strains of mice. The polymorphic genetic loci controlling the 
response mapped outside the MHC, and their products were named minor lymphocyte 
stimulating (Mis) antigens. Genetic studies showed that the Mis antigens were encoded 
by a number of unlinked biallelic loci, and that only one allele from each Mis locus is
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stimulatory in an MLR. However, the nature and function of the Mis antigens remained 
obscure until comparatively recently.
The nature of the antigens encoded by the Mis loci became clearer following the 
discovery of a genetic linkage between expression of the Mis antigens and the presence 
of endogenous mouse mammary tumour viruses (MMTV) integrated into the host 
genome (Dyson et al., 1991; Frankel et al., 1991). Infection of neonatal mice with 
exogenous MMTVs transmitted in milk was also shown to result in VP-specific deletion 
of subsets of T cells (Ignatowicz et al., 1992). Subsequently, it was demonstrated that 
mice transgenic for the MMTV(GR) genome or the open reading frame {orf) within the 
3’ long terminal repeat (LTR) of the virus, deleted V pl4+ T cells from their peripheral 
repertoire (Acha-Orbea et al., 1991). In addition, transfection of the orf sequence into a 
B cell line conferred the ability to stimulate V pl4+ T cells and hybridomas in vitro (Choi 
et al., 1991). These findings provided definitive proof that an MMTV gene encoded a 
protein with M/s-like properties. Accordingly, the Mis loci are now more commonly 
referred to as Mtv loci.
1.3.1. Properties of superantigens.
As outlined above, superantigens interacting with T lymphocytes through the Vp domain 
of the TCR are able either to activate a high proportion of unprimed mature T cells, or 
delete immature thymocytes. Since there is a relatively small number of TCRBV genes, 
the estimated frequency of precursors responding to Mis antigens in limiting dilution 
analyses is in the range 1:30 to 1:10 (MacPhail et al., 1985). In contrast, T cell 
recognition of a conventional foreign peptide/MHC complex, involves all the variable 
components of the TCR (Va, Ja, Vp, Dp, Jp, and non-templated junctional residues) 
and, accordingly, the estimated frequencies of precursors in unprimed populations are of 
the order of 1:106 to 1:104.
Although MHC class II molecules are required for the presentation of superantigens to T 
cells, presentation differs from that of conventional antigens in several ways. There does 
not appear to be a requirement for antigen processing, since fixed antigen-presenting
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cells are capable of presenting staphlyococcal enterotoxins (SE) to T cells (Yagi et al., 
1988). In addition, the T cell response is not restricted to antigen-presenting cells bearing 
autologous MHC molecules; superantigens can be also be recognized in the context of 
multiple MHC class II alleles and isotypes, including xenogeneic class II molecules 
(Fleischer et al., 1989; Mollick et al., 1989). Conventional MHC class II-restricted T cell 
responses are confined to the CD4+ subset; however, superantigens bound to class II 
molecules can activate both CD4+ and CD8+ T cells.
1.3.1.1. Structure of superantigens.
The staphylococcal enterotoxins and toxic shock syndrome toxin-1 (TSST-1) are the 
most intensively studied of the bacterial superantigens. The X-ray crystallographic 
structures for SEB and TSST-1 have been determined (Swaminathan et al., 1992; Prasad 
et al., 1993). They are globular basic proteins, with a similar general structure consisting 
of two closely packed domains. Mutagenesis studies of SEB have identified two MHC- 
binding sites widely separated on one face of the molecule, and TCR contact residues in 
the groove formed by the domain interface (Kappler et al., 1992).
In contrast, much less is known about the protein structure of the superantigens of 
MMTV, partly due to low levels of expression. In vitro translation experiments have 
demonstrated that the orf gene in the 3’ LTR (also referred to as the sag gene) has the 
potential to produce a Type II transmembrane glycoprotein with a short amino (NH2) 
terminal cytoplasmic tail and a large extracellular carboxyl (COOH) terminus (Korman et 
al., 1992; Choi et al., 1992). Comparison of the sequences of the MMTV and Mtv 
superantigens reveals approximately 85% overall amino acid homology, with most of the 
differences concentrated in a stretch of highly polymorphic amino acids at the COOH- 
terminus. The sag genes can be grouped into seven families of homologous sequences 
that correlate with the TCR Vp specificities of the gene products (SAGs) (Acha-Orbea 
and MacDonald, 1995). When chimeric SAGs were tested for activity, it was found that 
only the polymorphic COOH-terminus was required to confer Vp specificity 
(Yazdanbakhsh et al., 1993). A monoclonal antibody (mAb) raised against a COOH- 
terminal SAG peptide can detect low levels of expression on the surface of activated B
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cells, and block T cell responses. Immunoprecipitation studies with the same mAh 
revealed a 45 kDa glycosylated protein as the predominant intracellular form of the 
molecule; however, an 18 kDa fragment was expressed at the cell surface (Winslow et 
al., 1992). Proteolytic processing of the 45 kDa precursor is required for superantigen 
activity, and the 18 kDa product has been shown to bind to MHC class II molecules 
(Winslow et al., 1994; Park et al., 1995).
1.3.1.2. Interactions of superantigens with MHC molecules and T cell receptors.
The discovery that bacterial exotoxins did not require processing for presentation by 
MHC class II molecules (Yagi et al., 1990), and could be shown to bind directly to 
MHC class II molecules, independently of allotype or isotype (Scholl et al., 1989; 
Mollick et al., 1989), suggested that they bound to relatively non-polymorphic residues 
on the MHC molecule and not in the peptide binding groove. This was confirmed by 
Dellabona et a l,  (1990) who showed that mutation of the residues in one of the a- 
helices forming the antigen-binding groove of a class II MHC molecule could abolish 
presentation of conventional peptide antigens but had negligible effects on superantigen 
presentation. However, individual MHC class II molecules vary in their effectiveness at 
presenting bacterial superantigens to T cells, reflecting preferential binding to certain 
class II isotypes. In general, the bacterial toxins bind HLA-DR molecules better than 
HLA-DQ and have little affinity for HLA-DP proteins (Scholl et al., 1989; Herrmann et 
al., 1989).
It appears that the superantigenic toxins have slightly different, but overlapping, binding 
sites on the MHC class II molecule. SEA has two separate MHC binding sites, one of 
which binds with high affinity and involves a histidine residue at position 81 on the DRP 
chain, while the other mediates a low-affinity interaction with the DRa chain, permitting 
cross-linking of MHC class II molecules by the toxin (Hudson et al., 1995). The 
structure of SEB bound to HLA-DR1 has been determined by X-ray crystallography 
(Jardetzky et al., 1994). The MHC-binding face of this interacts with residues of the a l  
domain of DR1 outside the peptide-binding site, as predicted by mutagenesis studies. 
Using chimeric a - and P-chains of DR and DP, it has been shown that the a l  domain of
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DR is also essential for high affinity binding of TSST-1 (Karp et al., 1990). Recently it 
has been found that the peptides bound by MHC class II molecules have an influence on 
the binding of SEA and TSST-1, and that a restricted subset of peptides are able to 
promote the presentation of these SAGs (Wen et al., 1996).
The association of Mtv superantigens with MHC class II molecules is less well defined; 
however, indirect evidence suggests that class II molecules are also essential for 
presentation of MMTV SAgs. For many Mtv SAGs, expression of the mouse MHC class 
II I-E molecules (the murine homologue of DR) is crucial for induction of clonal 
deletion, whereas others can also be presented with varying efficiency by different I-A 
alleles (the murine homologue of DQ) (Kappler et al., 1988; MacDonald et al., 1989). 
Similarly, the SAGs encoded by exogenous MMTVs are most efficiently presented by I- 
E molecules (Held et al., 1994b). In addition, an 18 kDa fragment of the Mtv-7 SAG 
generated by proteolytic processing of a precursor protein has been shown to bind to 
MHC class II molecules (Winslow et al., 1994). As for bacterial SAgs, the product of 
Mtv-7 can also be presented to mouse T cells by human MHC class II DR molecules 
(Subramanyam et al., 1993). However, HLA-DR molecules that had been mutated at the 
residues responsible for binding SEA, SEB and TSST-1 were still able to present Mtv 
SAGs, indicating the two types of superantigens have different binding sites on class II 
molecules (Thibodeau et al., 1994).
The first insight into the elements of the TCR that interact with Mtv superantigens came 
from analyses of wild mice that expressed alleles of V(38.2 which differed by a few amino 
acids. One allele conferred M ls-la (Mtv-7) reactivity to T cells, while the others did not 
(Pullen et al., 1990a). Analysis of the amino acid differences, and subsequent 
mutagenesis experiments, identified three residues that were responsible for interaction 
with the SAG (Pullen et al., 1990b). One of these residues was located in the putative 
CDR1 while the others were found in the fourth hypervariable region (HVR4) and in the 
predicted three-dimensional structure of the TCR the residues were clustered in close 
proximity to one another on the lateral solvent-exposed face of the VP domain. Similarly, 
T cells bearing the human Vpl3.2 element respond to the toxin SEC2, whereas those 
expressing VP13.1 do not. Introduction of ten amino acid residues at positions 67-77 of
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VP13.2 into VP13.1 conferred reactivity to SEC2 on the mosaic molecule. This is the 
same region of the Vp domain that was implicated in the binding of M ls-la (Choi et al., 
1990a). In addition, mutation of residues in the Vp CDR1 has been shown to affect 
recognition of staphylococcal toxins (Bellio et al., 1994), and in mutagenesis studies 
involving the transfer of CDR loops from VP3 onto a Vpi framework, transfer of CDR1 
and CDR2 could confer reactivity to SEB and SEA (Patten et al., 1993). The crystal 
structures of a TCR P-chain complexed with SEC2 and SEC3 have been determined, and 
confirmed that these SAGs contacted residues in CDR1, CDR2, HVR4, as well as 
neighbouring framework residues (Fields et al., 1996).
In the X-ray crystal structure of SEB bound to HLA-DR1, the TCR binding site of the 
toxin is positioned above and to the side of the MHC peptide-binding groove. The 
alignment of these residues with the HVR4 of a TCR VP domain leads to a model of the 
MHC/SAG/TCR complex in which the CDRs of the TCR are oriented over the peptide- 
binding site, and the V a domain is above the class II pi domain. This model is consistent 
with a role for both TCR a-chain and MHC polymorphism in modulating superantigen 
stimulation through direct TCR-MHC interactions (Jardetzky et al., 1994). In fact, it has 
been shown that for certain SAG-TCR interactions the V a or DP-Jp regions and the 
MHC haplotype of the presenting cell may influence superantigen recognition (Woodland 
et al., 1993; Waanders et al., 1993; Borrero et al., 1995). It was proposed that when a 
superantigen has relatively weak affinity for the MHC or VP, the TCR-MHC contacts 
may play an important role in stabilising the trimolecular complex. However, if the 
affinity of the SAG for both MHC and TCR is strong, the TCR-MHC interaction is 
irrelevant, and T cells expressing the relevant Vp element will be activated irrespective of 
the paired V a domain or presenting MHC class II molecule (Woodland and Blackman, 
1993). A schematic representation of the interaction of a superantigen with an MHC 
class II molecule and a TCR is shown in Figure 1.3.
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Figure 1.3. Schematic diagram illustrating the interaction of an exogenous 
superantigen, e.g. staphylococal enterotoxin B, with an MHC class II molecule 
and a T cell receptor (TCR). Conventional peptide antigens are bound in a groove 
formed by the membrane-distal domains of the a  and (3 chains of the MHC molecule, 
and interact with determinants of both the V a  and V(3 domains of the TCR. In 
contrast, the superantigen binds to the a  chain of the MHC class II molecule outside 
the peptide-binding groove, and interacts with the lateral surface of the TCR V(3 
domain.
1.3.1.3. Superantigen-mediated T cell activation and tolerance.
The responses of T cells to superantigens and conventional peptide antigens appear very 
similar, with either stimulus capable of triggering proliferation, cytokine production and 
effector functions such as cytotoxicity (Fischer et al., 1990; Bette et al., 1993; Herrmann 
et al., 1990). However, there is evidence that T cell activation by superantigens is 
mediated by pathways that are distinct from those used in responses to conventional 
antigens (reviewed by Webb and Gascoigne, 1994). Superantigen stimulation of T cell 
clones with Mtv antigens or SEB failed to trigger phosphatidylinositol hydrolysis or a rise 
in the intracellular free calcium ion concentration, changes that accompany T cell 
activation by conventional antigens, despite inducing comparable proliferative responses 
and IL-2 production (Liu et al., 1991; Oyaizu et al., 1992). The differences in T cell 
activation induced by conventional peptide antigens and superantigens, and by different 
superantigens, may reflect the different modes of interaction of these molecules with the 
TCR ligand, leading to activation of functionally distinct signalling pathways, and/or a 
differential contribution from accessory molecules.
In addition to specific engagement of the TCR by a peptide/MHC complex, normal T cell 
responses are dependent on costimulatory signals mediated by accessory molecules on T 
cells and antigen presenting cells for full expression of the activated phenotype. The CD4 
and CD8 coreceptors are also believed to play a role in TCR signal transduction through 
an associated cytoplasmic tyrosine kinase (p59,ck). In contrast, the requirements for co­
stimulation and engagement of coreceptors during T cell activation by superantigens 
appear to be less strict. Anti-CD4 MAbs can inhibit proliferation and IL-2 production of 
CD4+ T cell clones in response to a specific peptide, but have no inhibitory effect on the 
response of the same clones to stimulation with SEB (Oyaizu et al., 1992). CD8+ T cells 
bearing the appropriate TCR Vp region respond to superantigens presented by MHC 
class II molecules, in contrast to conventional peptide antigens which must be presented 
on MHC class I molecules for recognition by CD8+ T cells. SAG-stimulated CD8+ T 
cells lyse class II+ target cells in the presence of the SAG, and lysis is not inhibited by 
anti-CD8 mAbs (Herrmann et al., 1990). These findings suggest that binding of the CD4 
and CD8 coreceptors to MHC class II and class I molecules is not required for T cell
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recognition of superantigens. This may be explained by the much higher affinity binding 
of the TCR to SAG/MHC class II complexes than to MHC /peptide combinations (Seth 
el al., 1994), or by a higher density of SAG/MHC complexes on antigen presenting cells.
Costimulatory signals for T cell activation can be delivered by the interaction of a 
number of cell surface molecules with their ligands on antigen-presenting cells. These 
receptor-ligand pairs include CD2/LFA-3, LFA-l/ICAM-1 or ICAM-2 and CD28/B7. 
The differential effect of these costimulatory molecules on T cells is not well understood; 
however, the interaction of CD28 and B7 molecules provides one of the most potent 
costimulatory pathways for activation of resting T cells. The requirement for 
costimulation in T cell responses to superantigens is controversial. In the absence of 
antigen-presenting cells, a soluble mAb to CD28 was able to synergize with SEB to 
produce a proliferative CD4+ T cell response in vitro (Goldbach-Mansky et al., 1992). 
However, proliferative responses of T cells to SEA and SEB presented by IFNy-treated 
keratinocytes (which express MHC class II molecules, ICAM-1 and B7) were inhibited 
by mAbs against LFA-1 or ICAM-1, but not by mAbs against the B7 ligands of CD28 
(Nickoloff et al., 1993). These in vitro findings have been confirmed in studies using 
mice with targeted disruption of the genes encoding certain adhesion molecules. Mice 
deficient in ICAM-1 are unable to mount a proliferative response of S AG-reactive 
splenic T cells following injection of SEB (Gonzalo et al., 1995). In contrast, in adult 
mice deficient in CD28 expression, VP-specific expansion of SAG-reactive T cells still 
occurs following infection with MMTV, although the response is reduced in comparison 
to that of wild-type mice (Palmer et al., 1996). These studies suggest that the requisite 
costimulatory signals for conventional antigens and superantigen are different. The 
CD28/B7 costimulatory pathway is not essential for T cell activation by SAGs, but 
appears to increase the sensitivity of T cells to SAG stimulation (Muraille et al., 1995).
In adult mice injected with SEB or cells expressing Mtv SAGs, there is a marked T cell 
proliferative response followed by clonal deletion or anergy (antigen-specific non­
responsiveness) of SAG-reactive cells (Webb et al., 1990; MacDonald et al., 1991). 
Although both CD4+ and CD8+ T cells bearing the appropriate VP element are expanded 
in the initial proliferative response to SEB, clonal deletion and anergy induction seem to
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affect mainly CD4+ T cells (Kawabe and Ochi, 1990,1991; Herrmann et al., 1992). SAG- 
reactive T cells appear to be eliminated by apoptotic cell death, and there is evidence that 
proliferation is required for clonal deletion in vivo (Kawabe and Ochi, 1991; Renno et 
al., 1995). This agrees with a study of T cell responses to Mtv SAGs, in which the 
degree of clonal deletion correlated with the extent of the initial T cell proliferative 
response, and was influenced by various factors including the MHC haplotype of the 
host, the VP element examined and the particular Mtv SAG studied (Webb et al., 1994). 
However, repeated administration of very low doses of SEA to mice resulted in almost 
complete elimination of VP3+ T cells without detectable prior expansion of this 
population, suggesting that a massive proliferative response is not an essential 
prerequisite for SAG-mediated T cell deletion (McCormack et al., 1993).
SAG-reactive T cells that escape clonal deletion in vivo appear to be rendered anergic; 
that is, when restimulated in vitro with the SAG used for priming, they fail to proliferate 
and have a defect in IL-2 production (Rammensee et al., 1989; Kawabe and Ochi, 1990; 
MacDonald et al., 1991). However, it seems that the state of apparent anergy observed 
in vitro is not reflected in unresponsiveness of SAG-primed T cells in vivo. Upon 
challenge of SE-primed mice with the homologous toxin, SAG-reactive CD8+ cells 
display cytolytic activity and produce normal levels of IFNy (Kawabe and Ochi, 1990; 
Sundstedt et al., 1994). In addition, although SAG-reactive CD4+ T cells are not clonally 
expanded following restimulation, they also appear to retain effector functions such as 
cytokine production and help for B cell differentiation (Bandeira et al., 1991; Gaus et al., 
1994; Heeg et al., 1995). Thus the state of anergy is reversible, perhaps reflecting 
different activation signals that operate during in vivo but not in vitro stimulation.
1.3.2. The role of superantigens in the pathogenesis of disease.
Although the properties of superantigens and their interactions with cells of the immune 
system have been the subject of detailed investigation and are now quite well understood, 
less is known about their role in the host-pathogen interactions occurring during 
infectious diseases. In addition to the MMTV SAGs and staphylococcal exotoxins, 
superantigen activity has been associated with a range of pathogenic organisms including
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streptococci (Marrack and Kappler, 1990; Tomai et al., 1990), Mycoplasma arthriditis 
(Cole and Atkin, 1991), Mycobacterium tuberculosis (Ohmen et al., 1994), rabies virus 
(Lafon et al., 1992) and Epstein-Barr virus (EBV) (Sutkowski et al., 1996). The 
discovery that a large proportion of patients infected with the human immunodeficiency 
virus (HIV) show selective anergy of V(38+ T cells has fuelled speculation that a 
superantigen may play a role in the pathogenesis of the acquired immunodeficiency 
syndrome (AIDS), although this is still a controversial theory (Dadaglio et al., 1994; 
Westby et al., 1996).
The infection of mice with exogenous MMTVs provides the most completely understood 
example of the important role that superantigens can play in the life cycle of an infectious 
organism (reviewed by Acha-Orbea and MacDonald, 1995). Exogenous MMTVs are 
transmitted from mother to pups in milk and enter the Peyer’s patches through the gut 
epithelium. Infection is lifelong, and the major target cells for virus replication are 
epithelial cells of the mammary gland. Transmission of infection from the gut to the 
mammary gland is dependent on an intact immune system. Transgenic mice expressing 
high levels of a MMTV SAG showed specific deletion of V pi4+ T cells and failed to 
transmit the homologous virus when infected by the natural route, suggesting that SAG- 
reactive T cells are required for the virus to complete its life cycle (Golovkina et al., 
1992). The inoculation of an exogenous MMTV into the footpad of mice produces initial 
marked expansion of SAG-reactive CD4+ T cells in the drainage lymph nodes, followed 
by deletion of these cells (Held et al., 1992), and this model has been used to dissect the 
role of superantigens in the life cycle of the virus. It appears that the initial targets for 
infection are B cells, which present the virus-encoded SAG to CD4+ T cells following 
integration of the MMTV genome. The expansion of SAG-reactive CD4+ T cells is 
paralleled by an increase in the numbers of IgG-secreting B cells, as a result of T cell- 
dependent activation and differentiation of infected cells (Held et al., 1993a, 1994a). 
When SAG-reactive T cells are absent as a result of deletion by endogenous SAGs or 
expression of a transgenic TCR p chain that does not react with the viral SAG, MMTV 
transmission does not occur (Held et al., 1993b). Thus, it appears that expression of the 
viral superantigen is necessary for clonal expansion of the infected B cell population, 
permitting efficient transmission of virus to the mammary gland. In neonatal mice
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infected by the oral route, expansion of SAG-reactive CD4+ T cells can be detected in 
the intestinal Peyer’s patches within 5 days of infection, suggesting that the experimental 
model also reflects events occurring during natural infection (Karapetian et al., 1994).
The role of superantigens in bacterial infections is less clear. The staphylococcal 
enterotoxins are associated with food poisoning in humans, producing acute, self-limiting 
attacks of vomiting and diarrhoea. The relevance of superantigenic T cell activation in 
the production of these symptoms has not been addressed. There is evidence that other 
bacterial exotoxins may be associated with the shock-like symptoms observed during 
certain staphylococci and streptococcal infections. Toxic shock syndrome is one such 
disease, characterized by fever and shock, and associated with infection by strains of 
Staphylococcus aureus that produce TSST-1. The majority of human T cells stimulated 
in vitro with TSST-1 specifically express V(32, and in a group of patients with toxic 
shock syndrome, most individuals were found to have marked expansions of Vp2+ T 
cells (CD4+ and CD8+) in the peripheral blood (Choi et al., 1989,1990b). However, there 
was no evidence for deletion or anergy of the Vp2+ population following infection. In a 
murine model of toxic shock syndrome, T cells were shown to be essential for the 
development of lethal shock following injection of TSST-1. The pathogenesis of lethal 
shock appears to be mediated principally by TNF produced by T cells and activated 
macrophages (Miethke et al., 1992; Bette et al., 1993). However, under natural 
conditions the induction of shock by toxin-producing bacteria is a relatively rare event, 
and it is not clear how superantigen production benefits the bacteria.
It has been suggested that bacterial superantigens may contribute to the development of 
various autoimmune disorders by activation of potentially autoreactive T cells which are 
normally tolerant to self-antigens (reviewed by Renno and Acha-Orbea, 1996). For 
example, comparison of the TCRBV repertoire expressed by T cells infiltrating the joints 
of patients with rheumatoid arthritis with that of peripheral blood revealed oligoclonal 
expansion of T cells bearing a restricted subset of BV  genes, including BV3, BV14 and 
BV17 (Paliard et al., 1991; Howell et al., 1991). There is high sequence similiarity 
among these B V  genes, especially in the HVR4 region. This led to the proposal that, 
following T cell activation by a microbial superantigen, a few cross-reactive cells specific
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for self-antigens may home to the joints and initiate an inflammatory response. This 
theory is supported by experiments with a number of different rodent models but, as yet, 
there is no definitive proof that SAGs are involved in human autoimmune diseases 
(Renno and Acha-Orbea, 1996).
A number of protozoan parasites, including Plasmodium falciparum and Trypanosoma 
cruzi have been shown to stimulate strong in vitro proliferative responses in T cells from 
non-immune individuals, leading to speculation that these organisms may also produce 
superantigens (Good et al., 1987; Piuvezam et al., 1993). The response of human PBMC 
from unexposed donors to stimulation with a P. falciparum schizont lysate or whole 
parasitized erythrocytes has been studied in some detail. The responding cells are 
predominantly ‘memory’ (i.e. CD45RO+) CD4+ a/p  T cells and Vy9/V82 T cells (Jones 
et al., 1990; Goodier et al., 1992; Currier et al., 1992). However, the response is 
dependent on antigen-processing, and CD4+ T cell clones generated from the responding 
population exhibit MHC-restricted responses to malaria parasites. The clones are also 
cross-reactive with a variety of different environmental organisms, and express a diverse 
array of TCR Vp elements (Currier et al., 1995; Fell et al., 1996). Similarly, the 
proliferative response of human T cells to T. cruzi is also dependent on antigen- 
processing, and the responding cells display heterogeneous TCRBV usage (Piuvezam et 
al., 1993). These findings are inconsistent with superantigen-mediated T cell stimulation 
of the responses.
Recent studies by Denkers et al. (1994,1996) have provided evidence that there is a 
superantigen associated with Toxoplasma gondii. Non-immune mouse splenocytes 
stimulated in vitro with intact tachyzoites or soluble tachyzoite antigen show strong 
proliferative responses and produce IFNy. The response was blocked by anti-MHC class 
II MAbs, but was not MHC-restricted, and cellular processing of the soluble antigen was 
not required for presentation. Among the proliferating cells, there was a preferential 
expansion of CD8+VP5+ T cells. In addition, selective expansion of both CD4+ and CD8+ 
VP5+ T cells was observed during the acute phase of T. gondii infection of mice, and 
VP5+ T cells from chronically infected or vaccinated animals were unresponsive to in 
vitro stimulation with a plate-bound VP-specific MAb. The induction of IFNy production
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by a parasite SAG might be expected to benefit the host, since IFNy is crucial in 
controlling parasite infection. However, overproduction of IFNy could also contribute to 
disease pathogenesis by stimulating high systemic levels of proinflammatory cytokines 
such as TNFa and IL-1. Early induction of IFNy maY be beneficial in reducing parasite 
numbers to levels that are not harmful to the host, while non-responsiveness of SAG- 
reactive T cells in the later stages of infection could prevent immune-mediated 
pathology, resulting in an optimal balance for survival of both pathogen and host.
Thus, although superantigen activity has been associated with a wide variety of 
pathogens, in many cases the potential advantage of this activity for survival of the 
organism is unclear. However, it is possible to speculate that the VP-specific activation 
of T cells with a wide variety of mostly irrelevant antigen specificities provides an 
important mechanism for evading protective immune responses. In addition, clonal 
deletion or tolerance induction of SAG-reactive cells may also limit the capacity of the 
immune system to mount an effective response.
1.4. Aims of the project.
Theileria parva preferentially infects bovine lymphocytes and induces a state of 
constitutive activation in the parasitized cells. Immune responses to the parasite in cattle 
are directed against the schizont-infected lymphocytes, and CD8+ cytotoxic T cells have 
been demonstrated to play an important role in protective immunity. In susceptible cattle, 
however, MHC-restricted parasite-specific cytotoxic T cell responses are not detected, 
and it has been assumed that parasite replication outpaces the capacity of the immune 
system to respond to the infection. However, the presence of large numbers of 
lymphoblasts in the lymph nodes draining the site of inoculation, at a time when parasite 
numbers are very low, suggests that the host does mount a primary immune response 
which is ineffective in controlling the infection. The massive increase in the cellularity of 
the lymph node is evidence that the parasite is capable of stimulating a potent response. 
In line with this observation, parasitized cells induce strong in vitro proliferative 
responses in autologous PBMC from naive cattle. The large numbers of responding cells
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in the absence of detectable effector function suggests that the parasite may induce non­
specific activation of lymphocytes. The ability to stimulate a strong immune response in 
vivo may paradoxically be of benefit to the parasite. The cytokines produced by the 
uninfected lymphoblasts could potentiate the growth of parasitized cells, which express 
functional IL-2 receptors. The action of a parasite-derived superantigen is one possible 
mechanism for non-specific activation of a high proportion of T lymphocytes in an 
unexposed individual.
The aim of the current study was to examine the nature of the primary immune response 
to infection with T. parva and, in particular, to determine whether a superantigen may be 
responsible for inducing lymphocyte activation in the drainage lymph node in vivo, and 
stimulating the strong proliferative responses generated by parasitized cells in vitro. The 
initial objective was to perform a detailed analysis of the phenotype of the responding 
cells in the drainage lymph nodes of cattle during the early stages of infection with T. 
parva. The cellular changes in the drainage lymph node were examined histologically, 
using immunocytochemistry. The expression of cytokines in the lymph nodes of infected 
cattle was also investigated. Phenotypic analysis of the responding cells in cultures of 
PBMC from naive animals with autologous parasitized cells was carried out to determine 
whether this system could be used to model events in the lymph node.
The potential involvement of a superantigen in stimulating the T cell response in the 
drainage lymph nodes of animals infected with T. parva was assessed by analysis of 
TCRBV expression of uninfected lymphoblasts purified from lymph node suspensions. T 
cells responding to superantigens express a restricted subset of TCRBV genes, regardless 
of the MHC phenotype of the host. Since the extent of the bovine TCRBV repertoire has 
not been established, it was necessary initially to establish the background TCRBV 
repertoire in a normal lymph node as a basis for comparison, using the anchored PCR to 
permit inclusion of bovine TCRBV gene segments that had not been previously identified.
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CHAPTER TWO
MATERIALS AND METHODS
2.1. Experimental Infections.
Calves used for experimental infections with Theileria parva were assumed to be naive, 
as the parasite does not occur in the UK. In each experiment, pairs of calves were 
infected by subcutaneous inoculation with a lethal dose of infective tick stabilate, half the 
dose being given on either side of the neck. The stabilate was generously provided by 
Professor C. G. D. Brown, Centre for Tropical Veterinary Medicine, University of 
Edinburgh, and was prepared from ticks infected with the Muguga stock of T. parva, 
according to the method described by Cunningham et al. (1973). The course of the 
infection was monitored daily by taking the rectal temperature, by assessment of lymph 
node size, and by staining smears obtained by needle biopsy of the prescapular lymph 
nodes for the presence of schizonts from day 5 of infection. Calves were either treated by 
intramuscular injection of buparvaquone (Butalex®; Coopers) at a dose of 20mg/kg on 
day 11 of infection, or were euthanased at different times after infection for collection of 
the prescapular lymph nodes.
2.1.1. Staining of lymph node biopsies for detection of schizonts.
Small numbers of lymph node cells were obtained by needle biopsy of the prescapular 
lymph node, and used to make smears on clean microscope slides. The smears were air- 
dried, then fixed in acetone for 10s, and washed with cold phosphate buffered saline 
(PBS -  A.1). A few drops of a monoclonal antibody (MAb5) specific for the 
polymorphic immunodominant antigen (PIM) expressed by T. parva schizonts (ascitic 
fluid diluted 1:400 in culture medium) were added to the smears, and the slides were 
incubated in a humidified box for 30min at room temperature. They were then washed 
twice in cold PBS, and a few drops of fluorescein isothiocyanate (FITC)-conjugated goat 
anti-mouse IgG monoclonal antibody (Southern Biotechnology Associates Inc., 
Birmingham, Alabama, USA), diluted 1:40 in PBS, were added before incubating for a 
further 30min at room temperature in a humidified box. The slides were again washed 
twice in cold PBS, then a coverslip was placed over the smear for examination under
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ultra-violet light on the microscope. A number of fields were examined under x40 power, 
the percentage of parasitized cells calculated from the number of schizonts counted per 
2000 lymphoid cells. The schizont index is defined as the number of schizonts, both 
intracellular and extracellular, per 100 cell nuclei.
2.2. Techniques in cellular immunology. 
2.2.1. Isolation of leucocytes.
2.2.1.1. Isolation of peripheral blood mononuclear cells (PBMC).
Blood was collected from calves by jugular venupuncture, using sodium heparin (Leo, 
Bucks., UK) at lOU/ml as anti-coagulant. The blood was diluted with an equal volume of 
sterile PBS in a 50ml Blue Max polypropylene tube (Falcon, Oxford, UK) and carefully 
underlaid with Histopaque (density 1.083; Sigma Chemicals Co. Ltd., Poole, Dorset, 
UK), then centrifuged at 1200xg for 30min. Separated leucocytes were harvested at the 
interface, washed three times in sterile PBS, counted and resuspended at the appropriate 
cell concentration in sterile culture medium (A.3) or PBS.
In experiments carried out at the International Livestock Research Institute (ILRI), 
Nairobi, Kenya, the procedure for isolating PBMC was slightly different. Blood was 
collected by jugular venupuncture into an equal volume of sterile Alsever’s solution 
(A.2), which contains sodium citrate as anti-coagulant. This mixture was carefully 
underlaid with Ficoll-Paque (Pharmacia Biotech, St. Albans, Herts., UK), then 
centrifuged as above. The harvested leucocytes were washed three times in sterile 
Alsever’s solution.
2.2.1.2. Collection of lymph node cells by needle biopsy.
Lymph node cells were collected into culture medium containing lOU/ml sodium heparin 
(Leo) at selected time points during the infection, by aspiration with a 21G needle and 
syringe. The cell suspension was made up to 5ml with sterile PBS and carefully underlaid 
with 4ml Histopaque in a 15ml Blue Max Jr. polypropylene tube (Falcon). Mononuclear 
cells were separated by centrifugation at 1200xg for 30min, harvested from the interface, 
and washed twice with sterile PBS by centrifugation at 200xg for 5min (4°C). The cells
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were then resuspended at 5 x 106 cells/ml in PBS containing 0.1% w/v sodium azide 
(PBS/azide) and distributed at 5 x 105 cells/well in a 96-well U well microtitre plate 
(Sterilin, Stone, Staffs., UK) for staining with monoclonal antibodies. Alternatively, cells 
to be sorted were resuspended in sterile culture medium containing ImM EDTA.
2.2.1.3. Isolation of leucocytes from lymph nodes.
Prescapular lymph nodes were removed from the calves immediately following 
euthanasia. Using sterile instuments, samples of the lymph nodes were teased apart in 
sterile Petri dishes (Sterilin) containing sterile PBS, and small pieces were gently 
disrupted by passing through a fine-meshed steel sieve. The resulting cell suspension was 
transferred to a 50ml Blue Max tube and left for a few minutes to allow large particles to 
settle. The supernatant was transferred to a fresh Blue Max tube and centrifuged at 
200xg for 5min to pellet the cells. The cells were resuspended in PBS, counted and 
diluted to 107 cells/ml. Gradients were set up by carefully underlaying 10ml of cell 
suspension with 4ml Histopaque, and centrifuging at 1200xg for 30min. The cells 
harvested from the interface were pooled, washed twice with PBS and counted.
2.2.2. Flow cytometry and cell sorting.
2.2.2.I. Phenotypic analysis of leucocytes by immunofluorescent staining.
Monoclonal antibodies (mAbs) used in the phenotypic analysis of lymphocytes and cell 
lines are listed in Table 2.1. Antibodies derived from culture supernatants were used at a 
dilution of 1:10 for single staining and 1:5 for two-colour staining, while those derived 
from ascitic fluid were diluted 1:1000 for single staining or 1:500 for two-colour 
staining. The fluorochrome-labelled secondary antibodies mentioned below were 
supplied by Southern Biotechnology Associates, Inc., Birmingham, Alabama, and diluted 
1:400 or 1:200 before use.
Cells distributed at 2-5 x 105 cells/well in a 96-well U well plate were resuspended in 
25 pi of primary antibody (for single staining) or 25 pi each of two primary antibodies of 
different Ig isotypes (for two-colour staining). The cells were incubated either at room 
temperature for lOmin or at 4°C for 30min, and then washed 3 times in lOOpl PBS/azide
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by spinning the plates at 200xg for 2min and discarding the supernatant. They were then 
resuspended in 25 pi of the appropriate isotype-specific secondary antibodies, conjugated 
either to fluorescein isothiocyanate (FITC) or phycoerythrin (PE). Incubation conditions 
were as above, and the cells were again washed three times in PBS/azide, then 
resuspended in lOOpl PBS/azide and diluted in 0.5ml sheath fluid (A.5) before 
examination on a FACScan analyser (Becton Dickinson, Mountain View, CA, U.S.A.). 
Negative controls were incubated with irrelevant antibodies of the same isotype as the 
test antibodies, and either the FITC- or PE-conjugated secondary antibodies. For two- 
colour staining the compensation was set using two controls, each stained with a test 
mAb and either the FITC- or PE-conjugated secondary antibodies.
2.2.2.2. Three-colour immunofluorescent staining.
5 x 105 cells from each animal were stained first with IL-A43 (anti-CD2; IgG2a) and 
GB21A (anti-y5TCR; IgG2b) mAbs by incubation with 25pi of each antibody (diluted as 
above) for 30min at 4°C. The cells were washed twice with PBS/azide and incubated 
with 25pl each of PE-conjugated goat anti-mouse IgG2a and FITC-conjugated goat anti­
mouse IgG2b for lOmin at room temperature. After one wash in PBS/azide, the cells 
were incubated for lOmin at room temperature with 25pi PBS/azide containing 10% v/v 
normal mouse serum to block non-specific binding of the third mAb by the secondary 
monoclonals. The cells were washed again, then incubated with biotinylated CC63 (anti- 
CD8; diluted 1:2000) for lOmin at room temperature, washed twice and incubated with 
Streptavidin-Cy-Chrome complex (Pharmingen, San Diego, CA, USA; diluted 1:25 in 
PBS/azide) as before. Two final washes were performed and the cells were resuspended 
in PBS/azide before analysis on the FACScan as above. Negative controls consisted of 
cells stained with irrelevant IgG2a and IgG2b mAbs and the appropriate FITC- and PE- 
conjugated isotype-specific secondary antibodies, and cells incubated with an irrelevant 
biotinylated mAb and Streptavidin-Cy-Chrome. The compensation circuits were set using 
three controls incubated with the test mAbs and FITC- or PE-conjugated secondary 
mAbs or Streptavidin-Cy-Chrome.
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Table 2.1. Monoclonal antibodies used in phenotypic analysis and purification of
bovine leucocytes.
Monoclonal
antibody
Isotype Specificity Cell distribution
IL-A433 G2a CD2 T cells
CC423 G1 CD2 As above
CHI 28 A3 G1 CD2 As above
IL-A453 G2b CD2 As above
MMlAb G1 CD3 T cells
CC30C G1 CD4 Class II restricted T cells
CC8C G2a CD4 As above
IL-A12C G2a CD4 As above
CC63d G2a CD 8a chain Class I restricted T cells
CACT80Cd G1 CD8a chain As above
IL-A105 G2a CD8 As above
LL-A51d G1 CD 8a chain As above
CC58e G1 CD8|3 chain As above
GB21Af G2b ySTCR All yS T cells
CC15g G2a WC1 Peripheral y8 T cells
IL-A298 G1 WC1 As above
EL-A58h G2a Ig light chain B cells
IL-A301 G1 IgM As above
CC21k G1 CD21 As above
CC-G331 G1 CD14 Monocytes/macrophages
CC94m G1 C D llb As above
IL-A24n G1 MyD-1 Monocytes/macrophages/DC
CC149" G2b MyD-1 As above
IL-A21 G2a MHC class II As above
IL-A1110 G1 CD25 Activated lymphocytes
CACTI 08 A0 G2a CD25 As above
NCL-Ki67-MM1P G1 Ki67 Proliferating cells
MAb5q - PIM T. parva-infected lymphocytes
AV29 G2b Chicken CD4 -
TRT3r G2a G surface 
glycoprotein of 
turkey rhinotracheitis 
virus
TRTT G1 As above -
Notes: References defining the specificity of mAbs: Davis and Splitter, (1991)a, Davis et al. (1993)b, 
Bensaid and Hadam, (1991)°, MacHugh and Sopp, (1991)d, MacHugh et al. (1991)e, Davis et al. (1996)f| 
Morrison and Davis, (1991)8, Williams et al. (1990)h, Naessens et al. (1988)', Sopp (1996)k, Sopp et al. 
(1996)', Hall et al. (1993)m, Brooke and Howard, (1996)", MacHugh et al. (1993)°, Gerdes et al. (1984)p, 
Toye et al. (1991)q, Cook et al. (1993)r.
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2.2.2.3. Staining procedures for purification of lymphocyte subpopulations.
Lymph node cells obtained from infected animals on days 9 or 10 of infection were 
sorted by flow cytometry to obtain a purified population of CD2‘CD8+ cells. The primary 
and secondary mAbs were diluted to the appropriate working dilution in sterile culture 
medium as described above, and passed through a 0.2pm syringe filter (Acrodisc, 
Gelman Sciences, Ann Arbor, MI, U.S.A.). 108-109 lymph node cells were incubated 
with primary mAbs against CD2 (CC42; IgGl) and CD8 (CC63; IgG2a), in a volume of 
25pi diluted antibody/106 cells, for lOmin at room temperature, then washed three times 
in 10ml sterile culture medium by centrifugation at 200xg for 5min. Then the cells were 
resuspended in 10ml each of isotype-specific secondary antibodies (FITC-conjugated 
goat anti-mouse IgGl and PE-conjugated goat anti-mouse IgG2a), diluted to 1:200, and 
incubated as above. The washing steps were repeated three times as above, and the 
labelled cells were resuspended in 1.5ml sterile culture medium for sorting on a FACStar 
Plus fluorescence-activated cell sorter (Becton Dickinson).
In some experiments the cells were enriched for CD8+ cells prior to sorting on the 
FACStar by staining with magnetic beads and separation on MACS VS+ Separation 
Columns (Miltenyi Biotec, 51429 Bergisch Gladbach, Germany). In these experiments 
the primary monoclonals used were IL-A43 (CD2; IgG2a) and CACT80C (CD8; IgGl). 
The staining procedure was essentially the same as described above, except that the 
washing steps were performed using FACSFlow (FF) medium (Becton Dickinson - 
composition not disclosed) containing 0.5% w/v bovine serum albumin (BSA; Sigma) 
and filtered through a 0.2pm syringe filter. Following the final wash, the cells were 
incubated with MACS beads coupled to an anti-FITC monoclonal antibody (Miltenyi 
Biotec) for lOmin at room temperature (in a volume of lOpl beads/107cells), before 
washing three times as above and resuspension in 2ml FACSFlow medium. The cell 
suspension was applied to the magnetic separation column and allowed to flow through, 
CD8+ cells being retained on the column. The column was washed twice with 2ml 
FACSFlow containing 0.5% BSA (FF/BSA), then removed from the magnet and the 
cells eluted in 1.5ml FF/BSA. An equal volume of sterile culture medium was added 
before sorting on the FACStar.
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2.2.2.4. Sorting T cell subpopulations using magnetic beads.
Lymphocytes were isolated from the prescapular lymph nodes of infected and control 
calves as described in Section 2.2.1.3. The mAbs used for sorting were CC8, to isolate 
CD4+ T lymphocytes, and CC63, to isolate CD8+ T lymphocytes. Both antibodies were 
available as culture supernatants of hybridomas and were used diluted 1:10 in sterile 
culture medium. 108 cells were resuspended in 2.5ml of each diluted antibody and 
incubated for lOmin at room temperature. The cells were then washed three times in 
10ml FF/BSA, by centrifugation at 200xg for 5min. They were resuspended with 100pi 
MACS beads coupled to an anti-mouse IgG mAb (Miltenyi Biotec) and incubated at 
room temperature for lOmin. A further three washes in FF/BSA were performed as 
above and the cells resuspended in 1.5ml FF/BSA. Positive cells were separated on a 
MiniMACS magnetic column (Miltenyi Biotec). The column was pre-wet with 0.5ml 
FF/BSA before adding the cell suspension, allowing it to flow through under gravity. The 
column was washed three times with 0.5ml FF/BSA, before removing it from the magnet 
and eluting the retained cells in 1ml FF/BSA. 25pi of the eluted cell suspension was 
mixed with 25pi FITC-conjugated goat anti-mouse IgG (Southern Biotechnology 
Associates) diluted 1:200 in PBS, and incubated for lOmin at room temperature before 
washing and analysing on the FACScan to assess the purity of the sorted population.
2.2.3. Generation of parasitized cell lines.
2.2.3.1. Preparation of sporozoite suspensions.
Suspensions of infective sporozoites were prepared from adult Rhipicephalus 
appendiculatus ticks which had been infected with the Muguga stock of Theileria parva 
by feeding on infected cattle. This material was provided by Prof. Duncan Brown and 
colleagues at the Centre for Tropical Veterinary Medicine, University of Edinburgh. 
Briefly, 80 ticks infected with T. parva (Muguga) were fed on the ears of a rabbit. After 
4 days all the ticks were still attached and were removed for preparation of sporozoite 
suspensions. Sterile suspensions of sporozoites were prepared as described by Brown 
(1983). In the experiment carried out at ILRI, sporozoites were isolated from infected 
tick salivary glands supplied by the ILRI Tick Unit. These were dissected from ticks 
infected with T. parva (Muguga) and pre-fed on rabbit ears for 4 days, as above. The
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estimated number of infected acini was 1500. The salivary glands were crushed in a 
sterile homogeniser in about 1ml of cold sterile culture medium, to release the 
sporozoites. The suspension was centrifuged at 200xg for 5min at 4°C, and the 
supernatant containing the sporozoites was recovered.
2.2.3.2. In vitro infection of bovine PBMC with Theileria parva sporozoites.
Cell lines from a number of different animals were established by in vitro infection of 
PBMC with T. parva (Muguga) sporozoites. The PBMC were resuspended in sterile 
medium at 2 x 106 cells/ml and an equal volume of the sporozoite suspension was added. 
The cells were then incubated at room temperature for 4h, before washing with fresh 
medium to remove potentially toxic tick material, and resuspending at 4 x 106 cells/ml in 
standard culture medium.
In the experiment carried out at ILRI, 2 x 107 PBMC were isolated from two animals 
(AT 107 and ATI 13) as described above, and pelleted by centrifugation at 200xg for 
5min. The cell pellets were resuspended in 0.5ml of the sporozoite suspension 
(containing the equivalent of 750 infected acini) and incubated for lh  at 37°C, with 
gentle mixing at lOmin intervals. Culture medium was added to a final volume of 5ml, 
and the cells were pelleted by centrifugation as above. The pellet was resuspended in 
10ml culture medium, and the cells were divided between two 50ml polystyrene tissue 
culture flasks (Falcon, Oxford, UK), and incubated at 38°C in a humidified atmosphere 
of 5% CO2 in air. The cells were examined daily for signs of transformation: when there 
were significant numbers of blasts in the cultures (after 3 days) the cells were irradiated 
and used as stimulators in the autologous Theileria mixed leucocyte reaction.
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2.2.3.3. Establishment and maintenance of parasitized cell lines.
Three different culture conditions were used in the initial establishment of cell lines. Cells 
were distributed at 4 x 106 cells/well into 24 well cluster plates (Nunc, Roskilde, 
Denmark) and cultured in a total volume of 2ml of culture medium with:
a) 10% T-cell growth factors (TCGF)
b) 10% TCGF and a bovine fibroblast feeder layer
c) a bovine fibroblast feeder layer.
The TCGF consisted of conditioned medium from PBMC stimulated for 18h with 
2.5pg/ml concanavilin A (ConA), prepared as described by Goddeeris and Morrison 
(1988), and containing 0.05% w/v a-methyl mannoside (Sigma). Bovine fibroblasts were 
established in the wells at 3 x 104 cells/well 2 days before the addition of infected PBMC, 
in order to provide a confluent monolayer.
The plates were incubated at 38°C in a humidified atmosphere of 5% CO2 in air and inspected 
daily for signs of cell transformation. Every three days 0.5-1.0 ml of medium was removed 
from each well and replaced with an equal volume of fresh medium, supplemented with 
TCGF where necessary in accordance with the initial culture conditions. Once cell 
transformation was established, the medium was changed every 2-3 days. When transformed 
cells covered >50% of the surface of the plate, the cells were split and passed into fresh wells. 
Cells grown with feeder layers were seeded on to fresh feeder layers on the first passage, but 
TCGF was no longer added to the medium. Once the growth of transformed cells was well 
established, they were subcultured and maintained as continually growing cell lines in culture 
medium without additional growth factors. The phenotype of the cell lines was established by 
immunofluorescent staining with a panel of mAbs against lymphocyte differentiation antigens, 
including IL-A58 (immunoglobulin light chain), MM1A (CD3), CC42 (CD2), CC8 (CD4), 
CC63 (CD8), GB21A (y/8 TCR), and CC15 (WC1), as described above.
2.2.3.4. Cryopreservation of parasitized cell lines.
Once cell lines were growing vigorously, aliquots of cells were stored in liquid nitrogen for 
future use. Cells in logarithmic phase growth were pooled, counted, pelleted by centrifugation 
at 200xg for 8min (at 4°C), and the supernatant discarded. The cells were resuspended at 2 x 
106 cells/ml in 90% heat-inactivated FBS and 10% dimethylsulphoxide (DMSO; Sigma) and
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lml aliquots were transferred into polypropylene cryovials (Greiner Labortechnik Ltd., 
Dursley, Glous., UK). These were frozen overnight to -70°C and transferred to liquid 
nitrogen the following day.
2.2.4. Proliferation assays.
Proliferation assays were performed using a variety of different stimuli, responder cells, 
and incubation times; the details of each particular assay are outlined in the relevant 
chapters. Cultures were established in 96 well flat-bottomed (Coming, NY, USA) or 
round-bottomed plates (Nunc). Parasitized stimulator cells used in the autologous 
Theileria mixed leucocyte reaction, and PBMC or lymph node mononuclear cells used as 
filler cells, were exposed to gamma-radiation from a 137Cs source (Gammacell 1000 
Elite; Nordion International Inc., Kanata, Ontario, Canada). Parasitized cells received a 
radiation dose of 50 Grays (Gy), while filler cells were exposed to 20 Gy. Culture 
medium incorporating 2-mercaptoethanol (Sigma) was used for proliferation assays 
(A.4). The cultures were incubated at 38°C in a humidified atmosphere of 5% CO2 in air. 
Proliferation of responding cells was measured by the incorporation of tritiated [3H] 
thymidine (NEN Life Science Products, Stevenage, Herts., UK) or [125I] 
iododeoxyuridine (Amersham International, Bucks., UK ), added at 0.037MBq/well 
during the final 8h of culture. Cells were harvested onto glass microfibre filters (Wallac, 
Turku, Finland), using a Skatron cell harvester (Skatron Ltd., Newmarket, Suffolk, UK) 
and allowed to dry. For cultures incubated with [3H], the filters were sealed in plastic 
covers, and 10ml Optiphase scintillant (LKB Ltd., Loughborough, Leics., UK) was 
added. The amount of incorporated radioactivity was measured by liquid scintillation 
counting on a Wallac 1205 beta-scintillation counter. For cultures incubated with [125I] 
iododeoxyuridine, the filter mat discs from each well harvested were placed in 4ml 
polypropylene tubes (Falcon) and counted on a gamma counter (Gamma 5500, 
Beckman).
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2.3. Techniques for histology.
2.3.1. Preparation of tissue blocks from lymph nodes.
Blocks of 5-10mm thickness were cut from the prescapular lymph nodes immediately 
following their removal from the animal. Since the animals received half the dose of 
stabilate on either side of the neck, the lymph nodes used for preparation of material for 
histology were those that had not been sampled by needle biopsy. Tissues were fixed by 
immersion in either neutral buffered formalin (NBF -  B. 1.1) for in situ hybridization or 
in mercuric formalin (B.1.2) for haematoxylin and eosin (H&E) staining. The blocks 
were then embedded in paraffin wax. Frozen tissues for use in immunocytochemistry 
were prepared by embedding blocks in OCT compound (Miles Inc., Elkhart, IN, U.S.A.) 
and freezing rapidly in liquid nitrogen. They were then stored either at -70°C or in liquid 
nitrogen.
2.3.2. Haematoxylin and eosin (H&E) staining.
Paraffin blocks were cut in sections 3 jam thick using a 2030 rotary microtome (Reichert- 
Jung, Nussloch, Germany) and incubated overnight at 37°C. H&E staining was carried 
out using a Shandon automatic Stainer (Varistain 24-3, Shandon Scientific Ltd., Bucks., 
UK) according to the standard staining protocol for paraffin sections (Stevens, 1982), 
except that xylene was substituted with Safeclear (Chemix UK Ltd., Wigan, Lancs., 
UK). Briefly, sections were dewaxed in Safeclear, hydrated through a graded series of 
alcohols to water, then stained with haematoxylin (Surgipath, St. Neots, Cambs., UK) 
for 3.5min, washed in tap water, differentiated with acid alcohol (0.5% hydrochloric acid 
in 70% alcohol), blued in 1% borax solution and washed in water. Sections were then 
stained with 0.5% eosin (BDH Chemicals Ltd., Poole, Dorset, UK) in distilled water for 
lmin, washed in tap water, dehydrated through a graded series of alcohols, cleared in 
Safeclear and mounted in Safemount (Chemix UK Ltd.).
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2.3.3. Immunocytochemistry.
Immunocytochemistry was performed on cryostat sections. Lymph node blocks frozen in 
OCT compound were warmed to -20°C and cut in sections 5 pm thick using a Frigocut E 
2800 microtome (Reichert-Jung). The mAbs used for immunocytochemistry were 
MM1A, CC42, CC63, GB21A, CC149 and CC94, the T. /?arva-specific mAb, and NCL- 
Ki67-MM1, a mAb reactive with the Ki67 nuclear antigen expressed on proliferating 
cells (Novocastra Laboratories Ltd., Newcastle upon Tyne, UK). Most of these 
antibodies are listed in Table 2.1. Two mAbs, AV29 and TRT1 with irrelevant 
specificities and the isotypes IgG2b and IgGl were used as controls to check the level of 
non-specific binding of mouse IgG to Fc receptors on monocytes/macrophages.
The cryostat sections were fixed for lOmin in acetone, then washed with PBS. They 
were incubated for 30min in methanol containing 0.3% H2O2 to quench endogenous 
tissue peroxidases. The sections were washed three times with PBS over a period of 10- 
15 min, and then incubated with diluted normal horse serum in a humidified container for 
20min at room temperature. Excess serum was tipped off the slides and the sections were 
covered with the primary mAb , then incubated for a further 30min at room temperature. 
CC42, CC63, CC149 and CC94 were available as culture supernatants from hybridomas 
and were used undiluted. Purified MM1A was diluted to a final concentration of 5pg/ml 
in PBS. GB21A, AV29, TRT1 and the T. parva-specific mAb (MAb5) were in ascitic 
fluid from mice, and were diluted 1/250 in PBS before use. Lyophilized NCL-Ki67-MM1 
was reconstituted in distilled water according to the manufacturer’s instructions and used 
at a working dilution of 1:100. Following incubation with the primary antibodies, the 
sections were washed three times in PBS. 100-150pl biotinylated horse anti-mouse IgG, 
diluted according to the manufacturer’s instructions (Vectastain ABC Kit, Vector 
Laboratories, Peterborough, UK) was added to each section, and they were again 
incubated in a humidified container for 30min at room temperature. Following a further 
three washes in PBS, 100-150pl Vectastain ABC reagent (a solution containing a 
complex of Avidin DH and biotinylated horseradish peroxidase H) was applied to each 
section, before another 30min incubation as above. The enzyme substrate was prepared 
by dissolving 150mg diaminobenzidine (Sigma) in 300ml PBS containing 0.02% w/v
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sodium azide and adding 6% w/v H2O2 to give a final concentration of 0.01%. The 
sections were washed three times in PBS before being transferred to the substrate 
solution, in which they were incubated for 10 min. They were then washed once with 
PBS before counter-staining in Harris haematoxylin (diluted 1/3) for 10-30s, and rinsing 
with tap water. The sections were dehydrated by immersion in gradually increasing 
concentrations of ethanol followed by Safeclear. After air-drying, they were mounted 
using Safeclear mounting fluid.
2.3.4. Staining for acid phosphatase.
Staining for the lysosomal enzyme acid phosphatase was performed on lymph node 
cryostat sections, essentially according to the method outlined by Bancroft (1982).
2.3.5. In situ hybridization.
2.3.5.1. Preparation of riboprobes.
Riboprobes to bovine IL-10 were synthesized and labelled with digoxigenin-ll-UTP at 
IAH, Compton, by Wallace Bulimo, using a commercial in vitro transcription/labelling 
system (DIG RNA Labeling Kit [SP6/T7]; Boehringer Mannheim UK, Lewes, East 
Sussex, UK)
2.3.5.2. Unmasking of nucleic acids.
Sections of lymph nodes 3 pm thick were cut using a microtome and placed on coated 
ribonuclease-free slides (Superfrost Plus; BDH Chemicals Ltd.). The lymph node 
sections were dewaxed by incubating for 5 min in xylene, then hydrated by sequential 
transfer through a graded series of alcohols to diethyl pyrocarbonate (DEPC)-treated 
water (B.2.1). Nucleic acids were unmasked by digestion with proteinase K (Sigma) at 
O.lmg/ml in buffer 2 (B.2.4) at 37°C for 15min. As for all incubations described below, 
the slides were placed in Terasaki plates (Nunc) containing TE buffer, pH8.0 (C.2.1), to 
prevent the sections drying out. The slides were then washed in DEPC-treated water, 
immersed in 100% ethanol, and air-dried.
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2.3.5.3. Denaturation and hybridization of riboprobe to section.
The DIG-labelled probes were thawed at 65°C for 5min, and incorporated in a 
hybridization mixture for each tissue section as follows:
DIG-labelled riboprobe xpl
Hybridization buffer (B. 2.7) 3 5 pi
Salmon sperm DNA (lOmg/ml; freshly
denatured -  B.2.6) 2pl
TE buffer, pH8.0 ypl
Total volume 50pl
The hybridization mixtures were applied to the sections and covered carefully with a 
coverslip. The slides were incubated in Terasaki plates at 80°C for 30min to denature the 
probes, before hybridization at 55°C for 2h. Negative controls consisted of sections 
incubated with the DIG-labelled sense probe in the same hybridization mix.
2.3.5.4. Post-hybridization washing.
The coverslips were gently washed off with 4X SSC (B.2.2), and the slides washed twice 
for 5min in 4X SSC, twice for 5min in 2X SSC, and finally for 15min at 55°C in 0.1X 
SSC. The sections were then incubated in blocking buffer (B.2.8) at room temperature 
for 30min, to block non-specific binding of the antibody to the sections.
2.3.5.5. Detection of hybridized riboprobe.
Sheep anti-digoxigenin Fab’ fragments conjugated to alkaline phosphatase (750U/ml; 
Boehringer Mannheim) were diluted 1/500 in 3% BSA solution and applied to the tissue 
sections. The sections were incubated at room temperature for 30min, washed twice for 
5min in buffer 1 (B.2.3), and equilibrated for 2min in buffer 3 (B.2.5). The substrate 
solution consisted of 0.33mg/ml nitroblue tetrazolium salt (NBT; Promega UK Ltd., 
Southampton, Hants., UK) and 0.17mg/ml 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP; Promega) in buffer 3. The sections were immersed in the substrate solution, and 
incubated in darkness until a strong colour reaction had developed in the samples 
hybridized with the anti sense probe, while there was still minimal staining in the negative
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controls (typically about 4h). The reaction was stopped by washing the slides in distilled 
water, and allowing them to air-dry. The sections were counterstained with 1% methyl 
green, washed and air-dried before mounting in a gelatin mountant (see B.2.9).
2.4. Techniques for molecular biology.
2.4.1. Isolation of total RNA.
Isolation of total RNA from lymphocytes was performed using the Ultraspec RNA 
Isolation Kit (Biotecx, AMS Biotechnology UK Ltd., Witney, Oxon, UK), essentially 
according to the protocol recommended by the manufacturers. This technique allows 
single-step extraction of RNA based on the guanidium-isothiocyanate method 
(Chomczynski and Sacchi, 1987). The cells were pelleted by centrifugation at 200xg for 
5min and all the supernatant carefully removed. Cells were lysed by addition of the 
Ultraspec reagent (1ml per 5 x 106 cells), a solution containing guanidine salts and urea 
with phenol and other detergents (precise composition not disclosed). 1ml aliquots of the 
homogenate were transferred to 1.5ml microcentrifuge tubes and placed on ice for 5min 
to allow complete dissociation of nucleoprotein complexes. RNA was extracted by 
addition of 0.2ml chloroform to each tube, followed by vigorous mixing and incubation 
on ice for 5min, then centrifugation at 12000xg for 15min at 4°C. The upper aqueous 
phase was carefully transferred to a fresh tube, mixed with an equal volume of 
isopropanol, and placed on ice for lOmin, before centrifugation at 12000xg for 15min at 
4°C to precipitate the RNA. The RNA pellet was washed twice with 75% ethanol, air- 
dried and dissolved in lOpl DEPC-treated water.
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2.4.2. Measurement of RNA concentration.
The amount of total RNA in solution was estimated by measurement of the absorbance 
of light from a deuterium source at wavelengths 260nm(A26o) and 280nm(A2g0). Samples 
were diluted in DEPC-treated water (see Appendix) and transferred to quartz cuvettes 
for measurement of the absorbance in a calibrated spectrophotometer (Ultrospec ID, 
Pharmacia, Uppsala, Sweden). The concentration of RNA in the sample was calculated 
based on the assumption that an A26o value of 1.0 corresponds to an RNA concentration 
of 40(ig/ml (Sambrook et a l,  1989). The ratio of A26o:A2go was calculated to give an 
indication of the quality of the RNA preparation: values between 1.8 and 2.0 were 
regarded as optimal, whereas a ratio of <1.7 indicates the presence of contaminants such 
as protein or phenol in the RNA solution (Sambrook et a l,  1989).
2.4.3. Complementary DNA (cDNA) synthesis.
First strand complementary DNA (cDNA) was synthesized from 5 jig total RNA using 
avian myeloblastoma virus reverse transcriptase (AMV-RT; supplied with the Reverse 
Transcription System, Promega), according to the manufacturer’s instructions. The 
reaction components listed below were combined on ice, then incubated at 42°C for 
15min, before heating to 95°C for 5min to inactivate the enzyme. The cDNA was stored 
at -20°C prior to use as template in the polymerase chain reaction.
10XRT buffer (C. 1.1) 
25mM MgCl2
lOmM dNTP (C.1.7) 
oligo(dT)i5 (0.5[ig/pl)
2 pi 
4pl 
2pl 
lpl
Recombinant ribonuclease
inhibitor (rRNasin® - 39U/pl) 
AMV-RT (25U/pl)
Total RNA (5pg) 
DEPC-treated water 
Total volume
0.5pl
0.75pl
xpl
104!
20nl
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2.4.4. Polymerase chain reaction for detection of bovine cytokine mRNA.
2.4.4.1. Synthesis of oligonucleotide primers.
Oligonucleotide primers were produced at the IAH by Miss K. Mawditt using the 
phosphoramidite method of synthesis on an Applied Biosystem DNA Synthesizer (Model 
381 A). The oligonucleotides were cleaved from glass column supports by four complete 
column washes with concentrated ammonium hydroxide solution (15min each) and 
incubated at 55°C for 16h to remove the base protecting groups. The ammonia was 
recovered by lyophilization in a Univap (UniScience) particle concentrator and the 
oligonucleotides resuspended in 0.5ml sterile double distilled water (DDW). The 
concentration of oligonucleotide in solution was estimated by measurement of the 
absorbance at 260nm as for RNA. The concentration was calculated based on the 
assumption that an A260 of 1.0 is equivalent to 20pg/ml of single-stranded 
oligonucleotide. The concentration in pmol/pl is given by the formula A26o/0.01xN, 
where N is the number of bases in the oligonucleotide.
2.4.4.2. PCR amplification of cDNA.
Amplification of cDNA was performed on a programmable thermal cycler (PTC-100;
M.J. Research Inc., Watertown, Mass., U.S.A.) using Taq DNA polymerase (Amersham 
International pic, Bucks., U.K.) in the reaction buffer supplied by the manufacturers 
(composition not supplied). The cytokine-specific primers used for amplification were 
designed based on the published sequences of bovine cytokines (Collins et al., 1996), and 
are listed in Table 2.2. A “hot-start” PCR method was used; that is, the reaction 
components apart from the enzyme (see below) were assembled on ice, overlaid with a 
drop of mineral oil and heated to 94°C for 5min, then held at 80°C while lp l of Taq 
DNA polymerase (diluted to lU/p.1) was added. Amplification then proceeded using the 
following conditions: denaturation (94°C for lmin), annealing (55°C for lmin), extension 
(72°C for lmin) for 30 cycles, with a final extension for 7min at 72°C. Each set of 
reactions incorporated a negative control with cDNA replaced by DDW, and a positive 
control containing cDNA prepared from PBMC stimulated in culture with 5pg/ml ConA 
for 24h. Samples were stored at -20°C until the products could be analysed by agarose 
gel electrophoresis.
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1 OX reaction buffer 2.5 pi
25mM MgCl2 2pl
5mM dNTP lpl
Sense primer (1 Opmol/pl) 1 pi
Antisense primer (1 Opmol/pl) 1 pi
cDNA 2pl
DDW 14.5pl
Total volume 25pi
Table 2.2. Primers for the detection of bovine cytokines.
Cytokine Primers PCR product size 
(base pairs)
IL-2 5’-TGCTGCTGGATTTACAGTTGC 
3 ’-GAGGCACTTAGTGATCAAGCT
373
IL-4 5 ’-GTCTC ACCTACC AGCTGATC 
3’-TCAGCGTACTTGTGCTCGTC
348
EL-6 5 ’-AGGC AGACTACTTCTGACC AC 
3 ’-C AGCTACTTC ATCCGAATAGC
505
IL-10 5 ACAGCTCAGCACTGCTCTGTT 
3 ’-CGTTGTC AT GT AGGATT CT AT G
518
IFNy 5 ’-GCAAGTAGCCCAGATGTAGC 
35 -GGT GAC AGGT C ATT CAT C AC
316
TNFa 5’-ACTCAGGTCATCTTCTCAAGCC 
3 ’ -AT GATCCC AAAGT AGACCT GCC
464
(3-actin 5 ’-CC AGAC AGC ACT GT GTT GGC 
3 ’-GAGAAGCTGTGCTACGTCGC
270
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2.4.4.3. Agarose gel electrophoresis of DNA.
PCR products were analysed by agarose gel electrophoresis using a midi-gel system 
(Hybaid, Teddington, Middlesex, UK) for the rapid analysis of DNA fragments in the 
0.5-1.0 Kb size range. Aliquots (7pl) of the completed PCR reactions were diluted in 3 pi 
IX loading buffer (C.3.2) and examined on 1% agarose gels incorporating 0.4pg/ml 
ethidium bromide and prepared using 0.5X Tris-borate (TBE) buffer (C.3.1). 
Electrophoresis was carried out at 100V for 30min with 0.5X TBE as running buffer, 
and PCR products were visualized using a ultra-violet (UV) light source and 
photographed with a Polaroid MP4 camera or a UVP GDS500 digital camera 
(Mitsubushi). Gels were calibrated with 0.5pg of molecular weight DNA markers (100 
bp DNA ladder; Gibco BRL, Life Technologies, Paisley, Scotland.) diluted in loading 
buffer and DDW to give a final volume of lOpl.
2.4.4.4. Recovery of DNA from agarose gels.
The bands containing PCR products of the predicted size were excised and the DNA 
recovered using the GENECLEAN II Kit (BIO 101, Vista, CA, USA) according to the 
manufacturer’s instructions. The gel slices were weighed and dissolved in 2-3 volumes 
(assuming that lg = 1ml) of a saturated (6M) sodium iodide (Nal) solution and lOOpl 
TBE modifier at 45°C for 30min. The DNA was adhered to an aliquot of GLASSMILK 
(crystalline silica) suspension (5 pi for up to 5pg DNA) by mixing at 4°C for 10-30min, 
and separated by centrifugation at 9000xg for 2min. The pellet was washed three times in 
NEW Wash buffer (composition not disclosed) by resuspension and centrifugation. The 
DNA was eluted from the silica by the addition of lOpl TE buffer, pH8.0 (C.2.1) and 
incubation at 55°C for lOmin, followed by centrifugation at 9000xg for lmin and 
recovery of the supernatant.
2.4.4.5. Restriction endonuclease (RE) digestion of cytokine PCR products.
The sequence of the cytokine PCR products was confirmed by digestion with different 
restriction endonucleases (RE). The enzymes were selected on the basis of the published 
sequences, such that each PCR product was cleaved once at a specific site, yielding two 
fragments that could be detected by agarose gel electrophoresis. Failure to detect 
fragments of the predicted sizes following RE digestion would indicate that the primers
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had not amplified the correct specific product. The restriction enzymes used and the 
predicted sizes of the fragments generated are shown in Table 3.7. (Chapter 3). 5pl of 
amplified DNA recovered from the agarose gel was combined with 5U of the appropriate 
RE in the buffer recommended by the manufacturer, made up to a final volume of lOpl 
with sterile DDW and incubated at 37°C for lh. The products of the digestion were 
analysed by agarose gel electrophoresis as described above.
2.4.5. Anchored polymerase chain reaction.
Synthesis of complementary DNA by reverse transcription (RT), homopolymer tailing and 
amplification by polymerase chain reaction (PCR) were performed using the 5' RACE System 
Kit, manufactured by Gibco BRL. The protocols used were those recommended by the 
manufacturer, unless otherwise stated. Oligonucleotide primers were designed based on 
bovine T cell receptor sequences published by Tanaka et al. (1990). When designing the 
primers, estimates of the annealing temperature (Tm) were made using the formula:
Tm =Td -  5°C
where Ta = 4 x (G + C) + 2 x (A + T) (in °C)
The dissociation temperature, Ta, is defined as the temperature at which 50% of the hybrids 
formed between oligonucleotides (14-20 bases long) and immobilized DNA show decreased 
stability and dissociate from the hybrid (Thein and Wallace, 1986). The letters represent the 
numbers of each deoxynucleotide base in the primer sequence.
First strand cDNA synthesis was primed using an antisense gene-specific primer (PBC1) 
complementary to a conserved region near the 5' end of the TCR p chain constant region 
gene segments (TCRBC). A “nested” primer (PBC2) located 5' to PBC1 on TCRBC was 
used with the anchor primer for amplification of C-tailed cDNA. An “internal” primer 
(PBV2) is complementary to a conserved region at the 5' end of the bovine TCRBV2 gene 
family, and was used with PBC2 in positive controls to check the yield of cDNA from first 
strand synthesis and purification procedures. The primer sequences are listed in Table 2.3, and 
the locations and orientations of the primers are illustrated in Figure 5.1. The anchor primer
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was supplied as part of the 5' RACE System kit and a similar primer based on this design was 
synthesized at IAH, Compton.
Table 2.3. Primers used for amplification and sequencing of bovine TCRBV region
sequences.
Primer Sequence
PBV2 5-CCTCTGTGACCATCGAGTG
PBC2 5-GTTCGAACACAGCCACCTTG
PBC1 5-GAGATCTCTGCTTCCGAGG
Anchor primer 5'-GGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG
Modified anchor primer 5'-ACTACTACAAGCTTGGGIIGGGIIGGGIIG
P6 5’ GCTTCCGGCTCGTATGTTGTGG
P7 (5’ biotinylated) 5’ AAAGGGGGATGTGCTGCAAGGCG
5' Sequencing primer 5-AGCTCGGATCCACTAGTAAC
3’ Sequencing primer 5-TCTAGATGCATGCTCGAGCG
2.4.5.1. First strand cDNA synthesis.
lpg  total RNA was combined with 2.5pmol of the primer PBC1 and brought to a final 
volume of 15pi with DEPC-treated water, then incubated at 70°C for 5-10min to 
denature the RNA, and chilled on ice for lmin. The remaining reaction components were 
added as follows:
10X buffer (C. 1.2) 2.5pl
25mMMgCl2 3.0pl
lOmM dNTP (C. 1.7) l.Opl
0.1M dithiothreitol (DTT) 2.5pi
Total volume 24pl
The mixture was incubated at 42°C for 2min before addition of lpl Superscript RT II 
(containing 200U/pl Moloney Murine Leukaemia Virus reverse transcriptase); incubation
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at 42°C was then continued for a further 30min. The reaction mix was heated to 65°C for 
15min to inactivate the enzyme, then cooled to 55°C before addition of lpl E. coli 
ribonuclease H (20U/|_il) and incubation for a further lOmin at 55°C. A control reaction 
without reverse transcriptase was run in parallel to check for contamination of RNA with 
genomic DNA.
2.4.5.2. Purification of first strand cDNA.
Efficient purification of first strand cDNA is essential to ensure that excess dNTPs and 
first strand primer are not present during the tailing reaction. Purification was carried out 
using the GLASSMax Spin Cartridge Kit (Gibco). 120pl 6M Nal solution was added to 
the cDNA reaction, and then transferred to a spin cartridge and centrifuged at llOOOxg 
for 20-3 Os. The cDNA is retained on the membrane of the spin column. The column was 
washed three times with 0.4ml of cold (4°C) dilute wash buffer (composition not 
disclosed) and three times with 0.4 ml of cold 70% ethanol, by centrifugation at llOOOxg 
for 20-3 Os. The cDNA was eluted into a fresh tube in 50pl DDW equilibrated to 65°C, 
by centrifugation as before.
2.4.5.3. Homopolymer tailing of purified cDNA.
The following components of the reaction mix were combined and heated to 94°C for 
3 min:
10X buffer (C. 1.2) 2.5pl
25mM MgCl2 1.5pl
2mM dCTP 2.5pl
Purified cDNA lO.Opl
DDW 7.5 pi
Total volume 24pl
The reaction was then chilled on ice before addition of lpl terminal deoxynucleotidyl 
transferase (TdT-lOU/pl), and incubation at 37°C for lOmin, followed by lOmin at 65°C 
to inactivate the enzyme. A control reaction that omitted TdT was run in parallel to 
check for non-specific annealing of the anchor primer.
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2.4.5.4. Amplification of tailed cDNA.
The following components were combined in a 0.5ml microcentrifiige tube:
10X buffer (C.1.2) 5.0pl
3 .0p l
l.Opl
2 .0p l
2 .0p l
5.0pl
31 .0u l
49 .0p l
25 mM MgCl2 
lOmMdNTP
Anchor primer (lOpmol/pl) 
PBC2 (lOpmol/pl)
Tailed cDNA 
DDW
Total volume
The reactions were overlaid with a drop of mineral oil, placed in a thermal cycler (PTC- 
100; M.J. Research, Inc., Watertown, Mass., U.S.A.) and heated to 94°C for 5min, then 
held at 80°C. lpl Taq DNA polymerase (diluted to 2.5U/pl) was added to each reaction, 
and amplification was performed over 35 cycles of denaturation (94°C for lmin), 
annealing (55°C for 30s) and extension (72°C for lmin), with a final extension step of 
72°C for lOmin. In later experiments this protocol was modified by inclusion of Taq 
Extender (Stratagene) so that the final reaction composition was altered to: 5pi tailed 
cDNA, 5pi 10X Taq Extender buffer (C.1.3), 1.2pl 50mM MgCl2, lp l lOmM dNTPs, 
20pmol each primer, 5U Taq Extender and 5U Taq DNA polymerase, in a total volume 
of 50pl. The cycling conditions were also changed to 94°C for 45s, 57°C for 30s and 
72°C for 2min. PCR products were analysed by agarose gel electrophoresis as described 
in Section 2.4.4.3.
2.4.6. Cloning of anchored PCR products using the TA Cloning System™.
The anchored PCR product was recovered from the agarose gel as described in Section
2.4.4.4, and cloned into the /?CR™II plasmid vector supplied with the TA Cloning Kit 
(Invitrogen, R&D Systems, Abingdon ,Oxon, U.K.), which allows direct non-directional 
cloning of PCR products without prior purification or digestion. This system takes 
advantage of the non-template-dependent activity of Taq DNA polymerase that adds a
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single deoxyadenosine residue to the 3 ’ ends of double stranded DNA molecules. These 
3’ A overhangs are used to insert the PCR product into the /?CR™H vector, which 
contains single 3’ T overhangs at the insertion site. When Taq Extender was included in 
the PCR reactions, the products generated lacked the single-base 35 A overhangs. These 
products were incubated with Taq DNA polymerase as follows, to allow addition of 
adenine bases: lOpl PCR product (recovered from agarose gel) was combined with 1.5pi 
10X buffer (C.1.2), 0.4pl lOmM dATP, 1.25U Taq DNA polymerase (Gibco) and DDW 
to a final volume of 15 pi, and incubated at 72°C for 20-3 Omin.
2.4.6.1. Ligation reactions.
Ligation reactions were set up as follows, and incubated for 16h at 12°C:
Sterile water yjil
10X ligation buffer (C. 1.5) 1 id
pCR™n (25ng/|il) 2|il
PCR product (75ng) xpl
T4 DNAligase (4U/pl) I p !
Total volume 10pl
2.4.6.2. Transformation of competent E . coli.
The ligated plasmid/inserts were transformed into OneShot ENVaF’ competent E. coli 
(Invitrogen; C.4.1) according to the manufacturer’s protocol. A 50pl aliquot of 
competent cells was thawed on ice and 2pl of 0.5M (3-mercaptoethanol was added, lpl 
of the completed ligation reaction was added to the cells which were placed on ice for 
3 Omin, before heat shocking at 42°C for 30s and returning immediately to ice for 2min. 
450pl SOC medium (C.4.4) was then added and the cells were incubated at 37°C for lh 
on a rotary shaking incubator (225 rpm). 50pl or lOOpl aliquots of the contents of the 
vial were spread on Luria-Bertani (LB) agar plates (C.4.3) and incubated overnight at 
37°C. The agar plates contained lOOpg/ml ampicillin and were spread with 25 pi X-gal 
(40mg/ml 5-bromo-4-chloro-3-indoyl-p-D-galactosidase in dimethylformamide) to allow 
blue/white selection of colonies containing inserts.
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2.4.6.3. Preparation of frozen stocks of bacterial clones.
A large number of white colonies (>100) were picked from the plates spread with 
transformed E. coli. Each individual colony was inoculated into 3ml of LB medium 
(C.4.2) containing lOOpg/ml ampicillin, and incubated for 16h at 37°C on a rotary 
shaker. Aliquots of 0.7ml from each culture were mixed with 0.7ml 30% glycerol, and 
stored at -70°C. Prior to examination of the inserts, the bacterial clones were thawed, 
streaked onto LB agar plates containing 100p.g/ml ampicillin and incubated overnight at 
37°C to allow growth of colonies.
2.4.7. Preparation of DNA template for sequencing.
2.4.7.1. Small scale preparation of plasmid DNA.
Method A for the preparation of plasmid DNA using Qiagen columns.
Plasmid DNA was prepared using Qiagen resin tips (Tip 20; Qiagen Ltd., Dorking, 
Surrey, UK) according to the manufacturer’s instructions. Single colonies were selected 
from bacterial clones and inoculated into 5ml LB broth containing 100|ig/ml ampicillin, 
then incubated for 15h on a rotary shaker at 37°C. Cells were centrifuged at lOOOxg for 
15min at 4°C, the supernatant was discarded and the pellet resuspended in 3 0 0 j j J  of 
buffer PI (C.5.1). The cells were lysed by addition of 300pl of buffer P2 (C.5.3) and left 
at room temperature for 5min. Cellular debris and chromosomal DNA were precipitated 
by addition of 300jil of chilled neutralization buffer P3 (C.5.4) and incubation on ice for 
lOmin, with occasional gentle mixing. The tubes were then centrifuged at 12000xg for 
15min in a bench-top microfuge, and the supernatant was passed through a Qiagen resin 
tip (Tip 20) which had been equilibrated with 1ml of QBT buffer (C.5.6). The resin was 
washed four times with 1ml of QC buffer (C.5.7) and DNA eluted in 0.8ml of QF buffer 
(C.5.8). The plasmid DNA was precipitated with 0.7 volumes of isopropanol by 
centrifugation at 12000xg for 3Omin. The pellet was washed with 1ml 70% ethanol, air- 
dried and dissolved in 20pl of TE buffer, pH 8.0.
Method B for the preparation of plasmid DNA.
Small scale preparation of plasmid DNA was also performed according to a protocol 
recommended by Applied Biosystems, Inc. (ABI), Warrington, Cheshire, UK. Cultures
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were prepared as described above. The cells were pelleted by centrifugation at 2000xg 
for 15min at 4°C, then resuspended in 200pl GTE buffer (C.5.2), before adding 300pl of 
lysis buffer (C.5.3). The tubes were placed on ice for 5min, then 300|il of neutralization 
buffer (C.5.5) was added, followed by a further 5min incubation on ice. The cellular 
debris was pelleted by centrifugation at 12000xg for lOmin, and the supernatant was 
incubated at 37°C for 20min in the presence of 20pg/ml ribonuclease A to remove 
contaminating cellular RNA. The plasmid DNA was extracted twice with chloroform, 
and precipitated by adding an equal volume of isopropanol and centrifuging at 12000xg 
for lOmin at room temperature. The pellets were washed once with 70% ethanol and air- 
dried before dissolving in 32pl DDW. Precipitation of plasmid DNA was repeated by 
addition of 8pl 4M NaCl and 40pl 13% polyethylene glycol (PEG) 8000 (Sigma), 
incubation on ice for 20min and centrifugation at 12000xg for 15min at 4°C. The pellet 
was again washed with 70% ethanol, air-dried and dissolved in 20jil TE buffer, pH8.0.
2.4.7.2. RE digestion of plasmid DNA.
The presence of inserts of the correct size (about 600bp) was confirmed by digestion 
with a restriction endonuclease (Nsil; Stratagene Ltd.,Cambridge, U.K.) that cuts vector 
sequences flanking the insert. The reactions were set up as follows and incubated at 37°C 
for lh. The products of RE digestion were analysed by agarose gel electrophoresis, as 
described for PCR products (see Section 2.4.4.3).
DNA (l-2pg) xpl
Reaction buffer (10X; see C. 1.6) ini
DDW yixl
Nsil (16U/pl) 0.5fil
Total volume lOpl
2.4.7.3. Measurement of DNA concentration.
The yield and purity of plasmid DNA from the miniprep procedures was assessed by 
measurement of the absorbance of the solution at wavelengths 260nm (A26o) and 280nm 
(A28o). The measurements were performed on a Ultrospec III spectrophotometer 
(Pharmacia) as described for RNA in Section 2.4.2. The DNA concentration was
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calculated based on the assumption that an A26o value of 1.0 is equivalent to 50pg/ml of 
double-stranded DNA (Sambrook et a l, 1989). The quality of the DNA was assessed by 
calculation of the ratio A26o:A28o - a value of 1.7 - 2.0 indicated that the plasmid 
preparation was sufficiently pure for sequencing.
2.4.7.4. Preparation of sequencing template using magnetic beads (Dynabeads®).
Single-stranded DNA for solid-phase DNA sequencing was prepared using the Template 
Preparation Kit (Dynal A. S., Oslo, Norway). PCR amplification of the cloned insert was 
carried out using primers complementary to vector sequences flanking the cloning site, 
one of which is labelled with biotin at the 5’ end. This generated PCR products that 
contain one biotinylated and one non-biotinylated strand. Biotin-labelled PCR products 
were immobilized on 2.8nm superparamagnetic styrene beads coated with chemically 
bound streptavidin (Dynabeads® M-280 Streptavidin). The non-biotinylated strand was 
eluted leaving single-stranded DNA bound to the beads which was used as the 
sequencing template.
The sequences of the oligonucleotides used as primers in the PCR reaction are given in 
Table 2.3. These primers were supplied by Dynal as components of the Template 
Preparation Kit. Additional supplies of the 5’-biotinylated oligonucleotide were obtained 
from Oswel DNA Service, Southampton, Hants., UK. Vent® DNA polymerase (New 
England Biolabs Inc., Beverly, MA, USA) was used to amplify the inserts as this enzyme 
contains 3’ to 5’ proof-reading exonuclease activity, and therefore has a lower error rate 
than Taq DNA polymerase. Single colonies were picked from bacterial clones and 
resuspended in 10pl of sterile DDW, then heated to 96°C for 5min to lyse the bacteria. 
5 pi of the bacterial lysate were combined with the following components on ice:
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DDW 34pl
10X Thermopol buffer (C. 1.4) 5 pi
100mMMgSO4 2 pi
lOmMdNTP lpl
P6 (lOpmol/pl) 2pl
P7 (5pmol/pl) lpl
Total volume 49 pi
The reactions were overlaid with a drop of mineral oil, placed in a thermal cycler (MTC- 
100) and heated to 96°C for 5min, then held at 80°C while lpl Vent® DNA polymerase 
(0.5U/pl) was added. The reaction then proceeded through 25 cycles of denaturation 
(96°C for 30s), annealing (65°C for lmin) and extension (72°C for 2min), followed by a 
final extension at 72°C for 5min. Aliquots of the completed reactions were analysed by 
agarose gel electrophoresis to check the yield of the PCR product and the size of the 
insert (expected size of bands ~850bp).
The biotinylated PCR products were bound to 200pg Dynabeads® M-280 Streptavidin. 
The suspension of Dynabeads was placed in a magnetic particle concentrator (MPC-E; 
Dynal) to collect the beads, the supernatant was removed, and the beads were washed 
once with 20pi of Binding and Washing buffer (BW buffer -  C.2.2) using the same 
procedure. The beads were then resuspended in 40pl BW buffer, and 40pl of the PCR 
reaction mix was added, followed by incubation at room temperature for 15min to allow 
binding of the biotinylated DNA to the Dynabeads. The Dynabead/template complex was 
washed with 40pl BW buffer, then resuspended in lOpl 0.1M NaOH solution and 
incubated for 10 min at room temperature to elute the non-biotinylated DNA strand. The 
Dynabead/template complex was then washed three times as follows: once with 50pl 
0.1M NaOH, once with 50pl BW buffer, and once with 50pl TE buffer, pH7.5. The 
beads were resuspended in 10-20pl DDW before inclusion in the sequencing reaction.
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2.4.8. DNA sequencing.
Sequencing was carried out using two methods adapted from Sanger’s dideoxy chain 
termination reaction (Sanger et al., 1977).
2.4.8.1. Cycle sequencing using fluorescent dye terminators.
DNA sequencing was carried out using the ABI PRISM™ Dye Terminator Cycle 
Sequencing Ready Reaction Kit, and an updated version of the kit incorporating 
AmpliTaq® DNA polymerase, FS (ABI). The reaction produces chain terminated 
fragments from unlabelled primers extended by AmpliTaq® DNA polymerase. Each of 
the dideoxynucleotides are labelled with a different fluorescent dye, to allow 
performance of all four base reactions simultaneously in the same tube. The kit supplies a 
Terminator Premix containing the dye-labelled dideoxynucleotides, deoxynucleotides 
(dATP, dCTP, dTTP, dITP) and AmpliTaq® DNA polymerase (C.6.1). Sequencing 
primers (SP f and SPr) designed to anneal to plasmid sequences flanking the cloning site 
were used to allow sequencing of both strands of the insert (see Table 2.3). The reaction 
components were assembled on ice as follows:
The reactions were overlaid with a drop of mineral oil and placed in a thermal cycler 
preheated to 96°C. Thermal cycling proceeded through 25 cycles of denaturation (96°C 
for 30s), annealing (50°C for 15 s) and extension (60°C for 4min) with a rapid thermal 
ramp between each step. The completed reactions were placed on ice. Extension 
products were purified by phenol/chloroform extraction to remove unincorporated dye 
terminators. Briefly, 80|il DDW and lOOpl chloroform were added to each reaction 
before extraction with 100pi phenol:chloroform:water reagent (ABI) by vortexing
Original kit Kit with AmpliTaq® FS
Terminator premix 
Template (0.75-1 pg) 
Primer (1 Opmol/ pi) 
DDW
Total volume
9pl
xp l
lp l
ail
20nl
8 pi 
xp l 
lp l  
ypl 
20  pi
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thoroughly and centrifugation at 12000xg for lmin. The upper aqueous phase was 
transferred to a fresh tube and the phenol/chloroform extraction step was repeated. The 
DNA was precipitated by addition of 15(il of 2M sodium acetate, pH4.5 and 300pi of 
absolute ethanol and centrifugation at 12000xg for 15min at room temperature. The 
pellet was washed with 70% ethanol and dried under vacuum. In the updated version of 
the kit AmpliTaq® DNA polymerase has been replaced with a mutant form of Taq DNA 
polymerase (AmpliTaq® DNA polymerase FS) which has a greatly reduced 
discrimination against incorporation of dideoxynucleotides. This permits the use of much 
lower levels of dye labelled terminators in the reaction and removes the need for 
phenol/chloroform extraction to purify the extension products. For sequencing reactions 
performed with this enzyme, excess terminators were removed by ethanol precipitation. 
The entire 20pl contents of the reaction tubes were transferred to tubes containing 3 pi of 
2M sodium acetate, pH4.6 and 50pl of 95% ethanol, placed on ice for lOmin, then 
centrifuged at 12000xg for 3 Omin at room temperature. The pellets were washed with 
70% ethanol and dried under vacuum. For each reaction, a mixture of 5 pi deionised 
formamide and lpl 50mM EDTA, pH8.0 was prepared and the pellet was redissolved in 
4pl of this mixture. The samples were denatured by heating to 90°C for 2min just before 
loading on the gel.
2.4.8.2. DNA sequencing using Sequenase® T7 DNA polymerase.
Sequencing was also performed using the Sequenase® version 2.0 DNA sequencing kit 
(United States Biochemical, Cleveland, Ohio, U.S.A.). Double-stranded plasmid DNA 
was alkaline denatured by adding 0.1 volumes of 2M sodium hydroxide, 2mM EDTA 
and incubating at 37°C for 3Omin. The mixture was neutralized by adding 0.1 volume of 
3M sodium acetate, pH5.5 and the DNA precipitated with 2 to 4 volumes of absolute 
ethanol, placing the sample at -70°C for 15min. After pelleting the DNA by 
centrifugation at lOOOOxg for lOmin, the pellet was washed once with 70% ethanol, air- 
dried and dissolved in lOpl DDW. Denatured DNA (3-5pg) was mixed with 2pl of 
Sequenase® reaction buffer (C.6.2.1), lpl of primer (SP r or SPf; lOpmol/pl) and DDW 
to a final volume of lOpl. The template/primer mixture was heated to 65°C for 2min and 
left to cool slowly to <35°C to allow annealing of the primer, and then placed on ice. The
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Sequenase® enzyme was diluted to a concentration of 1.6U/pl in glycerol enzyme 
dilution buffer (C.6.2.5). The following components of the labelling reaction were added:
DTT(O.IM) lpl
Labelling mix -  diluted 1:5 (C.6.2.2) 2pl
[<x-35S]dATP (0.37MBq/pl;
NEN Life Science Products) 0.5pi
Diluted Sequenase® 2pl
T otal volume 15.5 pi
The extension reaction was allowed to proceed for 5min at room temperature. To 
terminate the reactions, 3.5pi aliquots of the labelling reactions were added to each of 
four 0.5ml eppendorf tubes containing 2.5pl of each termination mixture (C.6.2.3) and 
prewarmed to 37°C. The reactions were incubated at 37°C for a further 5min, and 
stopped by the addition of 4pl of stop solution (C.6.2.4). The samples were either 
analysed immediately by denaturing gel electrophoresis, or stored at -20°C. Immediately 
before loading the samples on the gel they were heated to 70°C for 2min, then placed on 
ice.
2.4.9. Denaturing gel electrophoresis.
2.4.9.1. Electrophoresis of dye-terminated extension products.
A 6% polyacrylamide gel solution was prepared by dissolving 25g urea (Gibco) in 7.5ml 
of a 40% w/v acrylamide/bis solution (Bio-Rad Laboratories, Hemel Hempstead, Herts., 
UK), 5ml of 10X TBE (C.3.1) and DDW to a final volume of 50ml. The solution was 
deionised by addition of lg  of Amberlite monobed resin (BDH) and stirring for 5min, 
before being filtered through a Nalgene disposable filter (Techmate Ltd., Milton Keynes, 
Bucks., UK). The gel solution was polymerized by addition of 250pl of freshly prepared 
10% w/v ammonium persulphate (10% APS) solution and 25pl of TEMED (N,N,N’,N’- 
tetramethylethylenediamine -  Bio-Rad), and poured immediately. The gel was poured at 
least 2h before the sequencing run was started. The sequencing gel was run in a 3 73A 
DNA Sequencer (ABI) at 2500V for 14h using IX TBE as running buffer. The sequence
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data was collected on a Macintosh computer running the 3 73A Sequence Data 
Collection Programme (ABI) and analysed using the 3 73A Sequence Analysis 
Programme (ABI).
2.4.9.2. Electrophoresis of 35S-IabeIIed extension products.
The products of sequencing reactions performed using Sequenase® were analysed using 
the Sequi-Gen™ nucleic acid sequencing cell apparatus (Bio-Rad). The glass 
electrophoresis plates were washed in detergent (Labdet 100, Don Whitley Scientific 
Ltd., Shipley, West Yorks., UK) and rinsed with DDW and ethanol. The upper plate was 
coated with Sigmacote™ (chlorinated organopolysiloxane; Sigma) and the plates were 
clamped together, separated by two 0.4mm plastic spacers along each edge. The bottom 
of the sequencing cell was sealed by clamping it in a casting tray containing a paper strip 
soaked in 10ml of 6% acrylamide gel solution to which 125pl of 10% APS and 50pl 
TEMED had been added. The 6% acrylamide gel solution was prepared essentially as 
described in section 2.4.9.1. above, except that 20X glycerol tolerant electrophoresis 
buffer (C.6.2.6) was substituted for 10X TBE, and the solution was neither deionised nor 
filtered. The solution was polymerized by the addition of 0.5ml 10% APS and 20pl 
TEMED and poured using a 50ml syringe. A 24-well sharks-tooth comb was inverted 
and placed in the top of the gel until it had set. The sequencing cell was assembled using 
IX glycerol tolerant buffer as the running buffer and pre-run at 1500V for 20-3Omin. 
The comb was inserted and urea leaching from the gel was flushed out of the wells with a 
pasteur pipette before loading the samples. Electrophoresis was carried out at 1500V for 
4-5h.
After electrophoresis, the upper siliconised plate was removed and the gel, still attached 
to the lower plate, was immersed in 5% acetic acid, 5% methanol (v/v) for 15-20min to 
remove the urea. The gel was transferred to a piece of 3MM chromatography paper 
(Whatman Scientific Ltd., Maidstone, Kent, UK), covered in Saran wrap, and dried on a 
vacuum drier (Bio-Rad) connected to a refrigerated solvent trap for lh at 80°C. The 
dried gel was then exposed directly to radiographic film (Fuji RX Medical X-ray film) 
and developed after 1-4 days using an automatic developing machine (Xenograph). The 
sequence was read directly from the autoradiograph on a light box and entered into the
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VAX 750 mainframe computer. The data was analysed using a number of programmes 
from the University of Wisconsin Genetics Computing Group (GCG) package (Devereux 
et al., 1984).
86
CHAPTER THREE
THE CELLULAR IMMUNE RESPONSE IN THE REGIONAL LYMPH NODES 
OF CATTLE UNDERGOING PRIMARY INFECTION WITH THEILERIA
PARVA.
3.1. Introduction.
In susceptible cattle infected with Theileria parva, the outcome of the infection is 
invariably fatal, demonstrating the failure of the immune system to mount an effective 
response. However, animals that recover from the infection, and cattle immunized by 
infection and simultaneous treatment with long-acting oxytetracycline, are resistant to 
challenge with a lethal dose of T. parva. Immunity is associated with cell-mediated 
immune responses, in particular with the generation of parasite-specific MHC class I- 
restricted CD8+ cytotoxic cells (CTL), which are detected in the efferent lymph and 
peripheral blood of immune animals undergoing challenge (Eugui and Emery, 1981; 
Morrison et al., 1987; McKeever et al., 1994). In contrast, parasite-specific CTL are not 
generated at any stage during lethal infections with T. parva, and CTL precursors cannot 
be detected in the peripheral blood of naive cattle (Eugui and Emery, 1981; Taracha et 
al., 1992). However, a massive increase in the cellularity of the lymph node draining the 
site of inoculation has been observed in these animals, at a time when schizont-infected 
cells are detected at very low levels (<1%) (Morrison et al., 1981). Uninfected T 
lymphoblasts, comprising both CD4+ and CD8+ cells, form a significant proportion of 
cells (20-30%) in the efferent lymph at this time (Emery et al., 1988). These findings 
suggest that naive animals mount a T cell response to T. parva in the drainage lymph 
node, but the subsequent rapid expansion of parasitized lymphoblasts indicates that this 
response is ineffective in controlling the infection.
The failure of naive cattle to control infections with T. parva may be attributable to 
strategies evolved by the parasite for evasion of host immune effector mechanisms. 
Strategies for immune evasion have been demonstrated in other parasitic infections, and 
involve interactions with a number of different components of the immune system. 
Induction by T. parva of an inappropriate host response would allow the parasite to
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escape elimination, resulting in uncontrolled proliferation of schizont-infected cells. In 
Leishmania infections of mice and humans, susceptibility to disseminated progressive 
infections has been associated with inappropriate induction of CD4+ T cells expressing 
Th2-type cytokines (IL-4, EL-5, IL-10), while individuals able to control the infection 
mount a Thl-type CD4 response characterized by the production of IFNy (Heinzel et 
al., 1991). The differentiation of naive CD4+ T cells towards the Thl- or Th2-type 
phenotype is influenced by the cytokine environment in which initial priming occurs 
(Hsieh et al., 1992; Seder et al., 1993).
Development of T. parva macroschizonts takes place within lymphocytes, resulting in 
activation and proliferation of the infected cells. Studies with schizont-infected cell lines 
maintained in vitro have shown that they can produce IFNy and low levels of IL-2 
(Entrican et al., 1991; Heussler et al., 1992; Ahmed et al., 1993). In addition, parasitized 
cells constitutively express functional EL-2 receptors (Coquerelle et al., 1989; 
Dobbelaere et al., 1990), and respond to IL-2 with increased proliferation, particularly at 
low cell densities (Dobbelaere et al., 1988). Thus, it is possible that during the primary 
infection in vivo, cytokines secreted by responding T lymphoblasts could potentiate the 
growth of parasitized cells, and cytokines secreted by the infected lymphocytes may also 
be capable of modulating host immune reponses. Since both natural and experimental 
infections with T. parva are initiated by subcutaneous inoculation of sporozoites, 
immune responses will be generated initially in the local lymph node draining the site of 
inoculation. Indeed, the presence of large numbers of uninfected lymphoblasts in the 
drainage lymph nodes of cattle in the early stages of T. parva infection is evidence of an 
immune response to the parasite. The object of this chapter, therefore, was to determine 
the phenotype of the cells involved in the lymph node response to the parasite, and to 
examine the expression of a variety of cytokines in the drainage lymph node during 
primary infections with T. parva.
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3.2. Materials and Methods.
3.2.1. Experimental infections.
The calves used in the experiments at Compton were castrated male Holstein-Friesians 
or Channel Island breeds. The Holstein-Friesians were bred at the Institute for Animal 
Health, Compton, and selected on the basis of their differing MHC phenotypes (see 
Table 3.1). The Channel Island calves were purchased from different local farms, and 
their MHC phenotypes were not determined. Most animals were 3 to 6 months old at the 
time of infection; in one experiment a 14 month old animal (3327) was used.
In initial experiments, pairs of calves were infected by subcutaneous inoculation with 
infective tick stabilate as described in Section 2.1. Samples of cells from the prescapular 
lymph node were obtained by needle biopsy at different times during the infection for 
detection of parasites and phenotypic analysis of the cells by flow cytometry. Four 
animals were euthanased at specified times after infection and the prescapular lymph 
nodes collected to provide larger numbers of cells for cell sorting. The remaining animals 
were treated on day 10 of infection by intramuscular injection of buparvaquone 
(Butalex®) at a dose of 20mg/kg.
In a later experiment, a group of six Channel Island calves were infected as before, and 
euthanased in pairs on days 5, 7 and 9 post-infection. The prescapular lymph nodes were 
removed to provide material for phenotypic analysis, histological examination, cell 
sorting and RNA isolation. Two uninfected calves of a similar age were used as controls.
The animal used for the infection and cannulation experiment carried out at ELRI was a 
14 month old Boran X N ’Dama heifer, which had been kept indoors under tick-free 
conditions. Five days after subcutaneous inoculation with infective tick stabilate, the 
efferent lymph duct draining the right prescapular lymph node was surgically cannulated 
with a dual-lumen cannula that permitted continuous infusion of Alsever’s solution to the 
proximal tip of the cannula. Efferent lymph flowing down the lumen of the larger cannula 
was collected aseptically each day and the cells were separated for phenotypic analysis.
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On day 15 post-infection, the cannula was removed and the animal was treated with 
buparvaquone, as above.
Table 3.1. MHC Phenotypes of Calves Used in Experiments.
Calf number MHC Phenotype
3327 A10/A12
4282 A14/A11
4260 A10/A18
4291 A12/A31
5158 A18/CC1
5178 A11/A31
Serological typing for MHC class I antigens was carried out by Dr. M. Stear, 
Department of Veterinary Medicine, University of Glasgow, using specific alloantisera in 
a complement-mediated microlymphocytotoxicity test.
3.2.2. Immunofluorescent staining of lymph node cells for phenotypic analysis.
Mononuclear cells (MNC) were isolated from lymph node aspirates and from prescapular 
lymph nodes as described in Sections 2.2.1.2 and 2.2.1.3. The monoclonal antibodies 
(mAbs) used for single staining were MM1A (CD3), CC42 (CD2), CC30 (CD4), CC63 
(CD8), GB21A (ySTCR), IL-A58 (surface Ig), CC-G33 (CD14) and IL-A24 (bovine 
monocyte/dendritic cell marker). Two-colour immunofluorescent staining was performed 
using the combinations of mAbs listed in Table 3.2. Three-colour immunofluorescent 
staining using a combination of IL-A43 (CD2), GB21A (ySTCR) and biotinylated CC63 
(CD8) was carried out on lymph node cells isolated on day 9 post-infection from two 
animals. In some animals, PBMC were examined by single and two-colour fluorescent 
antibody staining using the same panel of monoclonal antibodies. Details of all 
monoclonal antibodies used and the staining procedures are given in Table 2.1 and 
Section 2.2.2.
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Some of the monoclonal antibodies used in the phenotypic analysis of efferent lymph 
lymphocytes (ELL) were different from those described above. CHI28A (CD2),
IL-A12 (CD4), IL-A105 (CD8), EL-A51 (CD8) and EL-A30 (IgM) were substituted, 
where appropriate, in single and two-colour fluorescent antibody staining. The two- 
colour analysis of phenotype was extended by using CH128A and IL-A29 (WC1) in 
separate combinations with GB21A (y/8 TCR).
The samples were analysed on a FACScan (Becton Dickinson). 5000 events (single 
staining), 10000 events (two-colour staining) or 15000 events (three-colour staining) 
were recorded. Statistical analysis of the data was carried out using PC LYSYS II 
software (Becton Dickinson).
Table 3.2. Combinations of monoclonal antibodies used in two-colour 
immunofluorescence analysis.
Target molecules Monoclonal antibodies Isotypes
CD3/CD8 MM1A/CC63 IgGl/IgG2a
CD2/CD8 CC42/CC63 IgGl/IgG2a
CD2/CD4 CC42/CC8 IgGl/IgG2a
y/5TCR/CD8 GB21A/CC63 IgG2b/IgG2a
CD4/CD8 CC30/CC63 IgGl/IgG2a
CD8p/CD8a CC58/CC63 IgGl/IgG2a
CD3/MHC class II MM1A/IL-A21 IgGl/IgG2a
CD3/CD25 MM1 A/CACTI 08 A IgGl/IgG2a
y/5TCR/CD25 GB21 A/C ACT 108C IgG2bAgG2a
CD25/CD8 IL-A111/CC63 IgGl/IgG2a
CD25/CD4 EL-A111/CC8 IgGl/IgG2a
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3.2.3. Isolation and culture of CD2'CD8+ T cells from the drainage lymph node.
3.2.3.1. Purification of CD2'CD8+T cells by flow cytometry.
Lymph node cells obtained from infected animals were sorted by flow cytometry to 
obtain a purified population of CD2'CD8+ T cells. The cells were stained with the 
primary mAbs CC42 (CD2; IgGl) and CC63 (CD8; IgG2a) followed by fluorescein 
isothiocyanate (FITC)-conjugated goat anti-mouse IgGl and phycoerythrin (PE)- 
conjugated goat anti-mouse IgG2a, as described in Section 2.2.2.3, and sorted on a 
FACStar Plus cell sorter (Becton Dickinson). In some experiments, the cells were 
enriched for CD8+ T cells prior to sorting by incubation with magnetic beads and 
separation on MACS VS+ Separation Columns (Miltenyi Biotec); the details of the 
protocol are given in Section 2.2.2.3. The primary mAbs were IL-A43 (CD2; IgG2a) and 
CACT80C (CD8; IgGl) and the secondary mAbs were goat anti-mouse IgG2a-PE and 
goat anti-mouse IgGl-FITC, allowing positive selection of CD8+ cells using MACS 
beads coupled to an anti-FITC monoclonal antibody. Cells were selected for sorting by 
setting a gate on the live cells, which were distinguished from dead cells by light 
scattering characteristics, and gating on the CD2‘CD8+ cell population (and the 
CD2+CD8+ population in some experiments) according to the fluorescence parameters. 
An example of the gates set for sorting is illustrated in Figure 3.1.
As contamination of the sorted population with y/8 T cells had proved to be a problem 
during early experiments, the protocol for cell sorting was later modified to specifically 
exclude y/5 T cells. This involved staining with three primary mAbs; GB21A (y/5TCR; 
IgG2b), IL-A45 (CD2; IgG2b) and CACT80C (CD8; IgGl). The secondary mAbs were 
goat anti-mouse IgGl-FITC and goat anti-mouse IgG2b-PE, and the CD8+ population 
was first enriched as before, by MACS sorting with magnetic beads coupled to an anti- 
FITC mAb. Since both the CD2- and y8TCR-specific mAbs were of the IgG2b isotype, 
the y/5TCR+ cells were included in the population of cells stained by the PE-conjugated 
secondary antibody, and excluded from the CD2'CD8+ population gated for sorting.
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Figure 3.1. Gates to select CD2CD8 T cells Mononuclear cells isolated from the 
prescapular lymph node o f animal 5158 on day 9 of infection with T. pan’a, were stained 
with mAbs against CD2 (IL-A43; IgG2a) and CD8 (CACT80C; IgGl). The secondary 
mAbs were fluorescein isothiocvanate (FITC)-conjugated goat anti-mouse IgGl and 
phycoerythrin (PE)-conjugated goat anti-mouse IgG2a. CD8 cells were enriched to 
>95% purity' by incubating with anti-FITC MACS microbeads (Miltenyi Biotec) and 
sorting using a MidiMACS VS separation column (Miltenyi). The CD2CD8 cells were 
sorted to >99% purity on a FACStar Plus cell sorter (Becton Dickinson) using two sort 
gates: A -  forward scatter (FSC) v side scatter (SSC) gate used to distinguish live cells 
from dead cells and subcellular debris. B -  gate set on CD2 CD8 cells in a FITC (CD8) 
fluorescence (x-axis) v PE (CD2) fluorescence (y-axis) dot plot display.
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3.2.3.2. Culture of sorted CD2'CD8+ T cells.
Various stimulation protocols were tried in an attempt to establish cell lines and/or 
clones from the sorted CD2CD8" T cells. Cultures were established in 96-well round- 
bottomed microculture plates with the sorted cells being titrated by threefold dilution at 
cell concentrations ranging from 300 to 0.3 cells/well. 2 x 104 irradiated (20Gy) 
autologous PBMC were added to each well as filler cells. The stimulators were irradiated 
(50Gy) autologous T. parva-infected leucocytes added at 5 x 103 cells/well. The culture 
medium was supplemented with either 10% T cell growth factors (TCGF) or lOU/ml 
recombinant bovine IL-2 (rboIL-2). TCGF was prepared from supernatants of cultured 
PBMC stimulated with ConA, essentially as described by Goddeeris and Morrison 
(1988), and the recombinant IL-2 was generously provided by Dr. R. A. Collins, IAH 
Compton. The cultures were incubated at 38°C, and regularly examined microscopically 
for the outgrowth of the cells.
Further experiments using a variety of stimulation protocols were carried out in an 
attempt to culture the CD2 CD8" T cells. Preliminary experiments were carried out to 
determine optimal conditions for stimulation of purified resting CD8+ T cells from 
uninfected animals. CD8+ T cells were sorted from the PBMC of two animals using 
magnetic beads (see Section 2.2.2.4), distributed in 96 well round-bottomed plates at 105 
cells/well, and cultured in medium supplemented with 10% TCGF under the following 
stimulation conditions:
a) Concanavilin A (ConA) at 5 jig/ml.
b) ConA (5(j.g/ml) and 2 x 104 irradiated (20Gy) autologous PBMC/well.
c) Phorbol myristate acetate (PMA) at 50ng/ml and ionomycin at l(j,g/ml.
The cultures were pulsed with tritiated thymidine and harvested after 3, 5 and 7 days to 
assess the level of proliferation, as described in Section 2.2.4.
In subsequent experiments, the sorted CD2*CD8+cells were distributed at 104 cells/well, 
cultured in medium supplemented with 10% TCGF or rboIL-2, and stimulated with
a) ConA (5p,g/ml) in the presence of 2 x 104 irradiated (20Gy) filler cells,
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b) phorbol myristate acetate (PMA; 50ng/ml) and ionomycin (1 jig/ml) in the 
presence or absence of 104 irradiated (20Gy) autologous lymph node cells as 
fillers, or
c) 2 x 104 irradiated (50Gy) MHC-matched T. parva-infected cells.
Proliferation was evaluated either by microscopic examination for outgrowth of the cells 
or by measuring [3H] thymidine incorporation after 4 days in culture.
3.2.4. Histological examination of lymph node sections.
For this experiment, a group of eight Channel Island calves were used. Two control 
calves were killed on day 0; the other six calves were infected with T. parva, and pairs of 
calves were killed on days 5, 7 and 9 post-infection. The right prescapular lymph nodes 
were removed, and blocks cut from the nodes were fixed in formalin or mercuric 
formalin, or snap-frozen embedded in OCT compound, as described in Section 2.3.1. 
Sections cut from the blocks fixed with mercuric formalin were stained with 
haematoxylin and eosin for examination of the lymph node morphology (see Section 
2.3.2).
Immunocytochemistry was performed on cryostat sections from the frozen lymph node 
blocks using the monoclonal antibodies MM1A (CD3), CC42 (CD2), GB21A (ySTCR), 
CC149 (MyD-1), CC94 (CDlib), MoAb5 (T. parva schizonts) and NCL-Ki67-MM1. 
Two mouse monoclonal antibodies with irrelevant specificities, AV29 (IgG2b) and TRT1 
(IgGl), were used as isotype controls. Details of the monoclonal antibodies and the 
staining procedure are given in Section 2.3.3 and Table 2.1. In addition, selected cryostat 
sections were stained for detection of the lysosomal enzyme acid phosphatase (Section 
2.3.4).
Sections cut from lymph node blocks fixed with formalin were used for in situ 
hybridization with a digoxigenin (DIG)-labelled EL-10-specific riboprobe to detect 
expression of EL-10 mRNA, as described in Section 2.3.5.
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3.2.5. Analysis of cytokine mRNA expression by polymerase chain reaction.
The expression of cytokines in the drainage lymph node during primary infection with T. 
parva was examined in the series of animals killed on days 5, 7 and 9 post-infection. 
Total RNA was isolated from the whole lymph node MNC population and from CD4+ 
and CD8+ T cell subpopulations separated using magnetic beads, as described in Section
2.4.1. First strand cDNA synthesis was performed on total RNA using the Reverse 
Transcription System (Promega) as described in Section 2.4.3, and used directly as a 
template for the polymerase chain reaction (PCR). Specific primers for p-actin, IL-2, 
IFNy, TNFa, IL-4, IL-6 and IL-10 were used to amplify the cDNA encoding these 
molecules in the PCR (see Section 2.4.4). The sequences of the cytokine primers are 
given in Table 2.2. PCR products were analysed by electrophoresis in 1% agarose gels. 
Products of the predicted size were recovered from the gel and digested with restriction 
enzymes to verify the specificity of the PCR reaction.
3.2.6. Effect of lymph plasma from T. /Hzrva-infected animals on the growth of 
parasitized cell lines seeded at limiting dilutions.
In an experiments carried out at ILRI, a naive animal (AT 115) was infected with T. 
parva, and the efferent lymphatic duct of the left prescapular lymph node was 
subsequently cannulated, allowing daily collection of efferent lymph over the early course 
of the infection. Mononuclear leucocytes were separated from efferent lymph by density 
gradient centrifugation; the remaining lymph plasma was removed separately and stored 
at -20°C. To remove the Alsever’s solution used as anti-coagulant, which can inhibit 
immune responses, lymph plasma collected on day 7 and day 11 of infection was dialysed 
against RPMI 1640 medium for 18h with three changes of medium. The dialysed plasma 
was centrifuged at 500xg for 10 min to remove clots. As a control, normal lymph was 
collected by cannulation of the efferent prescapular lymphatic duct of second animal, and 
the lymph plasma was collected and treated in the same way as above.
A T. pamz-infected cell line was harvested in the logarithmic growth phase. In initial 
experiments to determine the cell density at which continued cell growth was inhibited,
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cells were seeded in 96 well round-bottomed plates at 1 x 104 cells/well, and titrated in 
two-fold dilutions to 3 x 102 cells/well. Triplicate dilutions of two cell lines were 
incubated for either 48h or 72h at 38°C in a humidified atmosphere of 5% CO2 in air. 
Proliferation was measured by the incorporation of [125I] iododeoxyuridine.
To determine the effect of lymph plasma from the T. parva-infected animal on 
proliferation of parasitized cells plated at limiting dilutions, cell lines were titrated as 
above in a series of two-fold dilutions from 5 x 103 cells/well to 3 x 102 cells/well. The 
dilution series were incubated in triplicate in medium containing 0%, 2.5%, 5%, 10% and 
20% dialysed lymph plasma from the uninfected control animal and from an infected 
animal, as above. After 72h, proliferation of the cells was measured as before, by the 
incorporation of [125I] iododeoxyuridine.
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3.3. Results.
3.3.1. Kinetics of experimental infections with Theileria parva.
The progress of experimental infections with Theileria parva in 8 calves was followed by 
monitoring the rectal temperature, lymph node size and the number of schizonts present 
in smears of lymph node needle biopsies from infected animals. A rectal temperature 
(RT) of 39.5°C or greater was considered to indicate pyrexia. The schizont index (SI) 
was estimated by calculating the number of schizonts per 100 cells in lymph node smears, 
as described in Section 2.1.1. This information is summarized in Table 3.3. In general, 
the response to the stabilate was consistent in all eight animals, with only slight individual 
variation. Schizonts were first detected at 6-8 days post-infection, and in all but one 
animal the percentage of parasitized cells was 1% or less by day 8 of infection. By day 9 
post-infection, the percentage of schizont-infected cells had risen above 3% in only two 
animals. In one calf (5178), schizonts were not detected at any point during the infection; 
however this was probably due to the poor quality of the lymph node smear obtained on 
day 8 post-infection, since in all other respects this calf appeared to be infected. There 
was a dramatic increase in lymph node size from day 6 of infection, so that the lymph 
nodes were markedly enlarged by day 8. The onset of fever was more variable, ranging 
from 7 to 9 days, and in two animals fever was not detected within the time-course of the 
experiment.
The kinetics of the infection in the animal (ATI 15) used in the cannulation experiment at 
ILRI were different, because a different stabilate was used. Schizonts were not detected 
in the drainage lymph node until day 9 post-infection, and the SI remained below 5% at 
day 12. Fever was not detected in this animal until day 13 post-infection; from days 9 to 
12 of infection the rectal temperature was between 39°C and 39.5°C.
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Table 3.3. Summary of the kinetics of primary infection with T. parva in
experimental calves.
Days post-infection 0 3 6 7 8 9 10
Calf no.
4260 RT (°C) 39.8 39.8 38.6 40.1 40.9 40.6 42.0
SI - - - <1% <1% 1% 6%
LN size - + ++ +++ +++ +++ +++
4282 RT (°C) 39.1 38.9 38.2 38.8 39.1 38.9 39.3
SI - - - - <1% <1% 5%
LN size - + ++ ++ +++ +++ +++
4291 RT (°C) 39.0 38.6 39.1 39.2 39.3 ND
SI - - - - 1% 4%
3327 RT (°C) 38.9 38.2 38.3 40.2 40.1 ND
SI - - - - <1% 5%
5158 RT (°C) 38.9 38.8 39.2 38.6 39.2 39.6
SI - - - - <1% 2%
5178 RT (°C) 38.3 38.9 38.9 39.2 39.5
SI - - - - ND
776 RT (°C) 38.5 38.5 39.3 39.8 39.9 40.0
SI - - - <1% <1% 1%
LN size - + ++ +++ +++ +++
782 RT (°C) 38.8 38.7 40.2 39.5 40.4 40.1
SI - - <1% 1% 1-2% 1-2%
LN size - + ++ +++ +++ +-H-
Notes: RT = rectal temperature; SI = schizont index; LN = lymph node; ND = not done. 
Lymph node size was estimated by external palpation: + = 5-10mm diameter (cross- 
sectional area), ++ = 10-20mm diameter, +++ = 20-3 0mm diameter.
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3.3.2. Changes in the phenotype of lymph node cells during primary infections with 
Theileria parva.
3.3.2.1. Indirect immunofluorescent staining using single monoclonal antibodies.
Lymph node cells were collected by needle biopsy immediately before infection, on day 
3, and daily from day 6 post-infection with T. parva. Changes in the major 
subpopulations of lymphocytes during the course of the infection were monitored by 
flow cytometric analysis with mAbs against CD2, CD3, CD4, CD8, y8 T-cell receptor (T 
cells), surface immunoglobulin (B cells), CD 14 and the monocyte marker recognised by 
IL-A24. The results of this analysis for 5 calves (4260, 4282, 4291, 5158 and 5178) are 
summarized in a table in Appendix D). For the T and B lymphocyte populations, defined 
by expression of CD3 and surface Ig respectively, no consistent trends were detected. In 
some animals, an early increase in the percentage of B cells was observed from day 3 to 
day 6 of infection, with a corresponding decrease in the proportion of T cells. There was 
also a tendency for the proportion of T cells to increase between days 6 and 8 post­
infection. In some animals, an increase in the percentage of cells expressing the monocyte 
markers recognized by CC-G33 and IL-A24 was seen on days 9-10 of infection.
The changes in the CD4+ and CD8+ T cell subpopulations during the course of infection 
with T. parva in four animals are illustrated in Figure 3.2. To minimize the effect of 
fluctuations in the proportions of B cells or monocytes on the percentages of CD4+ and 
CD8+ T cells, they were expressed as a percentage of the total T cell population (CD3+) 
rather than the total mononuclear cell population. The most consistent change in T cell 
subpopulations was an increase in the percentage of CD8+ T cells, peaking on days 8 to 
10 post-infection. This is demonstrated by a reversal in the CD4:CD8 ratio between day 
0 and day 8 post-infection for most animals. Changes in the CD4+ T cell subpopulation 
were more variable, but in some animals there was a small increase in the percentage of 
positive cells by days 6 or 7 post-infection, followed by a gradual decline. In one animal 
(5178), there was a marked increase in the percentage of CD4+ T cells by day 6 and the 
proportion of positive cells remained elevated at day 8 post-infection. Changes in the y8 
T cell subpopulation were also variable; the proportion of these cells tended to remain 
low throughout the observed period of the infection, and no distinct trends emerged.
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Figure 3.2. Changes in T cell subsets in the prescapular lymph nodes o f four animals 
infected with T. parva. The proportions of CD4 T cells (solid bars) and CD8 T cells 
(open bars) are expressed as a percentage of the total T cell population i.e. the 
proportion of the lymph node mononuclear cell population that express CD3. The 
CD4:CD8 ratio is shown for each time point. When the CD4:CD8 ratios of day 0 and 
day 8 were compared using the Mann-Whitney U test, they were found to be 
significantly different (p<0.05). A non-parametric test was used because there were 
insufficient data points to determine whether the values fall into a normal distribution.
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3.3.2.2. Two-colour immunofluorescent staining.
An example of the results of two-colour analysis of the CD8+ lymphocyte population 
from animal 4282 are illustrated in Figure 3.3. The results of the analysis over the course 
of the infection in this animal and four others are summarised in Table 3.4. The most 
notable change was the emergence of a population of CD2'CD8+ T cells (Figure 3.3; C) 
which appeared initially on day 7 or 8 of infection. In the majority of the animals 
examined the appearance of this population coincided with the time at which schizonts 
were first detected in the drainage lymph node, and with the reversal of the CD4:CD8 
ratio. For example, for animal 4291, in which schizonts were detected initally on day 8 
post-infection, the CD4:CD8 ratio at this time was 0.5 (compared to 0.9 on the previous 
day, and 1.3 on day 0) and the percentage of CD2CD8+ cells was 17% (compared to 2% 
on the previous day). The CD2CD8+ cells expressed CD3 (Figure 3.3; B), indicating that 
they express T cell receptors. There was a small increase in the percentage of y8TCR+ T 
cells co-expressing CD8 (Figure 3.3; D), which may also be CD2'; however, the 
proportion of these cells at day 8 was 7% of the total lymph node population compared 
to the CD2CD8+ T cells which comprised 30% of the population at this time. This 
suggests that the majority of the CD2'CD8+ T cells express the oc/p TCR. This was 
supported by three-colour fluorescent antibody staining on day 9 of infection, with 
antibodies to CD2 (IL-A43), ySTCR (GB21A) and CD8 (CC63), as illustrated in Figure
3.4. After gating on the CD8+ cells, the expression of CD2 and y8TCR was analysed. In 
animals 4282 and 4260, only 3% and 2% respectively of the total lymph node population 
was y8TCR+CD2CD8+, compared to 19% (4282) and 10% (4260) with the phenotype 
y8TCR’CD2CD8+.
On the vast majority of the CD8+ T lymphocytes the CD8 molecule was expressed as the 
ap  heterodimeric form of the molecule, as demonstrated by staining with mAbs specific 
for the a  and P chains (Figure 3.3; E). The percentage of T cells co-expressing CD4 and 
CD8 (Figure 3.3; F) remained very low during the first 9 days of the infection, but a 
small increase was observed on day 10 in animals 4260 and 4282 (see Table 3.4). 
Examination of CD4+ T lymphocytes by two-colour immunofluorescent staining for CD2 
and CD4 showed no evidence for the emergence of a CD2'CD4+ population during 
infection, as illustrated in Figure 3.5.
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Two-colour staining with antibodies against T cell-specific antigens and CD25 (the a  
chain of the IL-2 receptor) was performed to assess the extent of T cell activation in the 
lymph node. The results were disappointing, due to low fluorescence intensity of staining 
on less than 5% of lymph node cells with both the monoclonals to CD25 (IL-A111 and 
CACTI 08 A) on days 8-10 of infection, when there was a significant blast response in the 
node. However, during infection there was significant up-regulation of MHC class II 
expression (another indicator of T cell activation) on CD3+ cells in the lymph node, as 
shown in Figure 3.6. In the resting lymph node, 3% of the cells co-expressed CD3 and 
MHC class II molecules, while on day 8 post-infection 16% of the total lymph node 
population and 21% of the blast cell population were CD3+MHC class II+.
To focus on the cells participating in the immune response to T. parva, gates were set on 
the larger cells, i.e. those with high forward scatter (FSCW), as shown in Figure 3.3 in the 
right-hand column. Since lymphoblasts are much larger than resting lymphocytes, this 
population contains most of the activated cells. Figure 3.7 illustrates the composition of 
this population in 3 animals (4260, 4282 and 4291) on day 8 of infection. The majority of 
cells falling within the high forward scatter gate were CD8+ T cells (61%-85%), and in 
each animal more than half of these lacked expression of CD2. The percentage of yS T 
cells in the blast cell population was low (8%-ll%); however most of the activated 
yS T cells co-expressed CD8 (see Figure 3.3; D). The proportions of activated CD4+ T 
cells and B cells were also low, ranging from 10% to 19% and 10% to 13% of the FSC1” 
population respectively.
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Table 3.4. Results of two-colour immmunofluorescent staining of CD8+ cells in 
lymph nodes of calves infected with T. parva.
Phenotype Calf
number
Days post-infection
0 6 7 8 9 10
Percentage positive cells
CD3+CD8+ 4260 ND ND 29 36 29 30
4282 33 ND 33 52 45 59
4291 22 36 36 45 ND -
5158 11 23 14 13 18 -
5178 15 20 26 30 - -
CD2+CD8+ 4260 ND ND 22 26 18 19
4282 31 ND 32 27 26 29
4291 20 36 33 28 21 -
5158 8 12 15 9 9 -
5178 12 19 20 25 - -
CD2'CD8+ 4260 ND ND 10 11 9 13
4282 3 ND 2 25 20 30
4291 2 2 2 17 6 -
5158 3 0 1 4 6 -
5178 1 1 5 2 - -
y5TCR+CD8+ 4260 ND ND 2 3 ND 5
4282 2 ND 1 5 ND 7
4291 2 2 2 3 5 -
5158 1 1 2 1 1 -
5178 1 2 ND 2 - -
CD8a+CD8p+ 4260 ND ND 27 ND 26 22
4282 31 ND 31 48 43 51
4291 ND 33 33 39 26 -
5158 11 14 ND 13 2 -
5178 9 18 ND 29 - -
CD4+CD8+ 4260 ND ND 1 2 2 6
4282 2 ND 1 3 2 4
4291 ND 1 1 3 3 -
5158 1 ND 1 2 2 -
5178 2 ND 1 2 "
Notes: ND = not done
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Figure 3.3. Changes in the phenotype of CD8^ T lymphocytes in the drainage lymph 
node of calf 4282 during primary infection with T. parva. A: dot-plots showing forward 
scatter (x-axis) against side scatter (y-axis) and the gates set for analysis. B-F:dot plots 
showing the expression of CD3 (B), CD2 (C), y8TCR (D), CD8 [3-chain (E), and CD4 
(F) (x-axes), on cells expressing the CD8 a-chain (y-axes). The figures indicate the 
percentage of positive cells within each quadrant.
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Figure 3.4. Three-colour immunofluorescent staining of CD8+ T cells isolated 
from the prescapular lymph nodes of animals 4260 and 4282 on day 9 post­
infection. mAbs against CD2 (IL-A43; IgG2a) and y/5TCR (GB21A, IgG2b) were 
used in combination with a biotinylated anti-CD8 mAb (CC63). The secondary 
mAbs were fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG2b 
and phycoerythrin (PE)-conjugated goat anti-mouse IgG2a. The biotinylated mAb 
was revealed by staining with Streptavidin-Cy-Chrome™ (Pharmingen). A: a gate 
was set on the CD8+ cells; the percentage of lymph node cells falling within the 
gate is indicated. B. dot-plots showing the distribution of cells expressing CD2 and 
ydTCR within the CD8" population. The figures in each quadrant indicate the 
percentage of the total lymph node population falling within those quadrants.
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Figure 3.5. Expression of CD2 on CD4f lymphocytes is unaltered during primary 
infection with T. parva. The dot-plots show the results of two-colour staining with 
antibodies against CD2 (x-axes) and CD4 (y-axes) of drainage lymph node cells 
from calf 4282 on days 0 and 8 post-infection.
Day 0 Day 8 Day 8 (blasts)
MHC 
class II f  .
15
'J C q S T ; ' ,  
: .
3
67
----1—rTTmi
rn
o
<=>
u  . > 16
■
W
2 i
10
m 2'
66
r i r r r i n
CD3
Figure 3.6. Upregulation of activation markers on T lymphocytes during primary 
infection with T. parva. The dot-plots show the results of two-colour staining with 
antibodies against CD3 (x-axes) and MHC class II molecules (y-axes) on drainage 
lymph node cells from animal 4282 on days 0 and 8 post-infection. The blasting cells 
on day 8 of infection were selected by gating on the cells with high forward scatter. 
The cell populations and gates are identical to those illustrated in Figure 3.3.
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Figure 3.7. Surface phenotype of the lymphoblast population in the prescapular lymph 
nodes of three animals (4260, 4282 and 4291) on day 8 of infection with T. parva. 
Mononuclear cells isolated from lymph node suspensions were stained with mAbs to the 
lymphocyte surface markers indicated, and fluorochrome-conjugated isotype-specific 
goat anti-mouse IgG secondary mAbs. The samples were analysed on a FAC Scan 
(Becton Dickinson) and statistical analysis was performed using PC Lysys II software 
The blasting cells were selected by gating on cells with high forward light scatter as 
illustrated in Fieure 3 .3.
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3.3.2.3. Phenotypic analysis of efferent lymph lymphocytes during primary 
infection with T. parva.
To determine whether the changes in phenotype of the drainage lymph node cells were 
reflected in efferent lymph lymphocytes, cannulation of the prescapular efferent 
lymphatic duct was performed in an animal (AT 115) undergoing primary infection with 
T. parva. B cells (surface Ig+) and monocytes (IL-A24+) formed a very low proportion of 
ELL (less than 2% respectively) from days 7 to 13 post-infection. The major changes in 
T cell subpopulations are illustrated in Figure 3.8. The percentage of CD8+ T cells 
increased from 22% on day 7 post-infection to 72% of ELL on day 12. CD2'CD8+ T 
cells were initially detected on day 10, and formed 23% of ELL on day 11, thereafter 
their numbers declined rapidly. In this animal, there was also a significant increase in the 
proportion of y/5 T cells that co-expressed CD8; this became obvious a day after the 
increase in the CD2'CD8+ population. The percentage of y5TCR+CD8+ cells peaked at 
16% on day 12 post-infection, when the total percentage of y/5 T cells was 19%; thus 
CD8 was expressed on the majority of y/5 T cells at this time. The proportion of 
y5TCR+CD2+ cells was 9% on day 12 so, assuming that y8TCR+CD2+ cells also express 
CD8, approximately 38% of the CD2'CD8+ T cells were y8TCR+ at this time.
3.3.2.4. Phenotypic analysis of PBMC during primary infection with T. parva.
In three animals, the phenotype of the PBMC during infection was examined using the 
same panel of monoclonal antibodies for single and two-colour immunofluorescence 
analysis. The results for the different mononuclear cell subpopulations (CD4+ T cells, 
CD8+ T cells, y/5 T cells, B cells, and monocytes) are summarized in a table in Appendix 
E. The changes in the proportions of T cells (CD3+), B cells and monocytes are 
illustrated in Figure 3.9. From day 0 to day 7 of infection there was little change in the 
composition of the PBMC population, apart from a moderate increase in the proportion 
of y/5 T cells in two animals (4260 and 4282); thereafter the proportion of T cells 
(CD3+) gradually decreased, accompanied by an increase in the percentage of 
monocytes. As total and differential WBC counts were not performed, it is unclear 
whether this reflects an increase in the absolute numbers of monocytes, or selective 
depletion of T lymphocytes. At no point during the infection were CD2"CD8+ T cells 
detected in the peripheral blood.
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Figure 3.8. Changes in T cell subsets in the efferent lymph draining the prescapular 
lymph node of an animal (ATI 15) infected with T. parva. Mononuclear cells isolated 
from efferent lymph were stained with mAbs against CD4, CD8, y5 TCR and fluorescein 
(FITC)-conjugated goat anti-mouse IgG. Two colour staining was performed with 
combinations of mAbs against CD2 and CD8 or yS TCR and CD8 followed by FITC- 
and phycoerythrin-coupled isotype-specific goat anti-mouse IgG mAbs. The samples 
were analysed on a FACScan. The proportions of the different T cell subsets are 
expressed as a percentage of the total efferent lymph lymphocyte population
1 1 0
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Figure 3.9. Changes in the phenotype of PBMC in three animals (4260, 4282, 4291) 
during infection with T. parva. Mononuclear cells isolated from peripheral blood were 
stained with mAbs against CD3 (T cell marker), surface immunoglobulin (B cell marker) 
and a molecule expressed on monocytes (recognized by 1L-A24), and secondary 
fluorescein isothiocyanate- or phycoerythrin-conjugated isotype-specific goat anti-mouse 
IgG mAbs. The samples were analysed on a FACScan and the results are expressed as 
the percentage of positively staining cells in the whole population.
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3.3.3. In vitro culture of sorted CD2'CD8+ T lymphocytes.
As relatively low numbers of CD2'CD8+ T cells could be obtained from the drainage 
lymph node by cell sorting, attempts were made to expand and maintain this population 
in vitro, with the aim of generating cell lines or clones that could be used in functional 
assays.
Initially, the sorted cells were cultured at limiting dilution with irradiated autologous 
parasitized cells as stimulators, in medium supplemented with TCGF or rboIL-2. 
Although proliferation was observed in the wells containing 100-300 cells, phenotypic 
analysis of cells derived from two such wells showed that one population consisted of y5 
T cells and the other of CD2‘CD3‘CD8+ cells. They were therefore considered to 
represent outgrowth of contaminating cells in the sorted population.
Subsequently, other stimuli, i.e. ConA and PMA/ionomycin, were used in addition to 
autologous parasitized cells. In preliminary experiments, these mitogens, in combination 
with TCGF, were shown to stimulate proliferation of resting CD8+ T cells sorted from 
PBMC of uninfected animals (see Figure 3.10). However, there was no significant 
proliferation of the sorted CD2'CD8+ T cells, as assessed by microscopic examination of 
the cultures. Quantitative analysis of the proliferative response by measurement of the 
incorporation of tritiated thymidine was precluded by the small numbers of cells that 
were available in this experiment.
The apparent unresponsiveness of the CD2'CD8+ T cells to in vitro stimulation was 
subsequently confirmed in an experiment in which proliferation was assayed by 
incorporation of [3H]-labelled thymidine. Lymph node cells isolated from a calf on day 8 
post-infection with T. parva were sorted into two CD8+ populations one of which was 
y/5TCRCD2' and the other y/8TCR+ and/or CD2+ (see section 3.2.3.1), and cultured in 
the presence of PMA and ionomycin, in combination with irradiated lymph node filler 
cells from the same calf and/or rboEL-2. Normal CD8+ T cells sorted from the peripheral 
blood of an uninfected animal were cultured under identical conditions as an additional 
control. The results are illustrated in Figure 3.11. There was no significant proliferative
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response of the CD2‘CD8+ a/p  T cells to PMA/ionomycin under any of the different 
culture conditions. In contrast, both the CD2+CD8+ lymph node cells (containing a/p and 
y/5 T cells) and the peripheral blood CD8+ T cells showed proliferative responses, 
although much stronger proliferation was induced in the latter population. The presence 
of filler cells and/or rboIL-2 did not significantly enhance the proliferative responses of 
these two populations to PMA/ionomycin.
The results indicate that the CD2'CD8+ population of cells do not proliferate in response 
to stimuli that elicit a strong proliferative response in resting CD8+ T cells. The lack of 
growth of CD2'CD8+ T cells also indicates that this population does not contain 
parasitized cells, which in the presence of IL-2 would be expected eventually to 
overgrow the cultures.
113
o
w
B
Clo
350
300
250
200
150
100
3 5 7
Key:
♦ ConA 
-■— ConA + fillers 
PMA/iono 
—•— Medium
Days in culture
Figure 3.10. Proliferative responses of CD8 T cells. CD8‘ T cells were isolated from 
peripheral blood mononuclear cells (PBM) at >95% purity by positive selection with an 
anti-CD8 mAb (CC63, IgG2a), incubation with anti-mouse IgG MACS microbeads 
(Miltenyi Biotec), and separation on a MiniMACS column (Miltenyi). The sorted cells 
were distributed at 10" cells/well in a 96 well flat-bottomed plate and stimulated either 
with concanavalin A (ConA) at 5pg/ml in the presence or absence of 104 irradiated 
autologous PBM as fillers, or phorbol myristate acetate (PMA) and ionomycin (iono) at 
50ng/ml and lpg/ml respectively. The cultures were incubated at 38°C and proliferation 
was assessed by the incorporation of tritiated thymidine after 3, 5 and 7 days in culture. 
The results are expressed as counts per minute (cpm) and the values represent the mean 
of triplicate wells
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Figure 3.11. CD2CD8 y/5TCR cells isolated from the prescapular lymph node of an 
animal (6294) infected with T. parva do not proliferate in response to stimulation with 
phorbol myristate acetate and ionomycin (PMA/iono). Mononuclear cells isolated from a 
lymph node suspension (LNC) were stained with mAbs against CD2 (IL-A45; IgG2b), 
y/5 TCR (GB21A; IgG2b) and CD8 (CACT80C; IgGl). The secondary mAbs were 
fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgGl and phycoerythrin 
(PE)-conjugated goat anti-mouse IgG2b. CD8 cells were enriched to >95% purity by 
incubating with anti-FITC MACS microbeads (Miltenyi Biotec) and sorting on a MACS 
VS separation column (Miltenyi). The CD8 cells were sorted into CD2y/8TCR" and 
CD2 and/or y/5TCR populations to >99% purity on a FACStar Plus cell sorter (Becton 
Dickinson). CD8 T cells were isolated at >95% purity from peripheral blood 
mononuclear cells (PBM) of an uninfected animal by positive selection with an anti-CD8 
mAb (CC63; IgG2a), incubation with anti-mouse IgG MACS beads (Miltenyi) and 
sorting on a MiniMACS column (Miltenyi). Cells from the three populations were 
distributed at 104 cells/well and stimulated with PMA (50ng/ml) and ionomycin (lpg/ml) 
in the presence or absence of 104 filler cells (irradiated LNC) and/or recombinant bovine 
IL-2 (lOU/ml). Proliferation was measured after incubation of the cultures at 38°C for 4 
days by incorporation of tritiated thymidine. The results are expressed as counts per 
minute (cpm) and represent the mean values of triplicate cultures.
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3.3.4. Histological examination of lymph node sections.
Blocks cut from the prescapular lymph nodes of calves infected with T. parva, and from 
uninfected control calves were used to prepare sections for examination of changes in 
cellular composition and cytokine expression during infection, in relation to the 
histological appearance of the lymph node.
3.3.4.1. Histological examination of sections stained with haematoxylin and eosin.
The morphological features of normal lymph nodes obtained from two uninfected control 
animals are illustrated in Figure 3.12. The cortex and paracortex contained mainly small 
resting lymphocytes, with the occasional isolated lymphoblast (Figure 3.12.A). A 
proportion of the B cell follicles contained active germinal centres. These secondary 
follicles had an outer narrow rim of small resting lymphocytes, surrounding the large 
activated lymphoblasts of the germinal centre. The lymphoblasts had large pale nuclei 
with prominent nucleoli, and mitotic figures were frequently observed. Mature germinal 
centres were divided into light and dark zones; the latter containing more actively 
proliferating cells (Figure 3.12.D). The medullary cords were populated by resting 
lymphocytes with some lymphoblasts, and the sinuses contained relatively few cells, most 
of which were small lymphocytes. (Figure 3.12.F). Small foci of polymorphonuclear cells 
were seen occasionally in the paracortex, at the cortico-medullary junction and in the 
medullary cords. On day 5 of infection, the morphology of the lymph node cortex and 
paracortex was essentially the same as in the resting node. In one animal, there were 
numerous large secondary B cell follicles. In both animals, there was a notable increase in 
the cellularity of the medulla, with expansion of the medullary cords and much greater 
numbers of cells in the sinuses. The frequency of lymphoblasts was increased, especially 
within the sinuses, and mitotic figures were occasionally observed.
On day 7 of infection, there was a marked increase in the number of activated cells within 
the medulla, particularly in the sinuses. There were many large dark-staining 
lymphoblasts (Figure 3.12.G). Lymphoblasts were also found within the medullary cords 
and at the cortico-medullary junction. In one animal (786), increased numbers of blasts 
were also noted in some areas of the paracortex (Figure 3.12.B).
116
By day 9 of infection, lymphocyte activation was widespread throughout the lymph node. 
This was particularly notable in one of the animals (782), in which lymphoblasts were 
predominant in the cortex, paracortex, and medulla, with numerous mitotic figures 
visible (Figure 3.12.C,H). In this animal, significant numbers of polymorphonuclear cells 
were also observed in all regions. Although B cell follicles could still be distinguished, 
germinal centres were not seen in the lymph nodes at this stage of the infection (Figure 
3.12.E).
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A. Paracortex -  normal prescapular lymph node. There are numerous small resting 
lymphocytes. A high endothelial venule (HEV) is present on the right of the picture. 
xl28.
B. Paracortex -  prescapular lymph node (calf 786); 7 days post-infection with Theileria 
parva . There are a number of large lymphoblasts present (arrowed), which can be 
distinguished by the pale staining nuclei containing prominent nucleoli. x310.
C. Paracortex -  prescapular lymph node (calf 782); 9 days post-infection with T. parva. 
There are numerous lymphoblasts present. A primary B cell follicle, containing 
predominantly small resting lymphocytes, is present on the right of the picture. x80.
Figure 3.12. Sections of bovine lymph node stained with haematoxylin and eosin.
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D. Dark zone of a germinal centre -  normal prescapular lymph node (calf 784). The rim 
of the germinal centre (GC) is indicated by filled arrows. The dark zone of the GC 
contains numerous lymphoblasts and mitotic figures (open arrows), indicating active 
cell division. xl28.
E. Primary follicle and paracortex -  prescapular lymph node (calf 776); 9 days post­
infection with T. parva. The paracortex contains numerous lymphoblasts, while the B 
cell follicle at the top of the picture is composed mainly of small resting lymphocytes. 
x!28.
Figure 3.12. (cont) Sections of bovine lymph node stained with haematoxylin and
eosin
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F. Medulla -  normal prescapular lymph node. The majority of the cells forming the 
medullary cords (C) or present within the sinuses (S) have the morphology of small 
resting lymphocytes. x80.
G. Medulla -  prescapular lymph node (calf 783); 7 days post-infection with T. parva. 
There are numerous large lymphoblasts with darkly stained cytoplasm in the medullary 
sinus. A few lymphoblasts are also seen within the medullary cords. x80.
H. Medulla -  prescapular lymph node (calf 782); 9 days post-infection with T parva. 
There are numerous lymphoblasts in the medullary sinuses and cords. x80.
Figure 3.12. (cont) Sections o f bovine lymph node stained with haematoxylin and
eosin.
FG
H.
3.3.4.2. Examination of lymph node sections by immunocytochemistry.
To obtain direct quantitative confirmation of the presence of actively proliferating cells 
within the lymph node, cryostat sections were stained with a monoclonal antibody 
against Ki67, a nuclear antigen expressed by proliferating cells in the late G l, S, M and 
G2 phases of the cell cycle (Gerdes et al., 1984). The pattern of cell activation was 
compared with the distribution of the parasite within the lymph node, revealed by 
staining with a mAb specific for a schizont antigen of T. parva. A quantitative estimate 
of the numbers of positive cells in different parts of the lymph node was made by 
counting the positive cells in five different fields for each region, using an eyepiece 
graticule. These results are summarized in Tables 3.5. and 3.6., and the staining patterns 
are illustrated in Figure 3.13.
The results obtained by staining with the anti-Ki67 monoclonal antibody reflect the 
observations made on the H&E-stained sections. An increase in the numbers of activated 
cells was found initially within the medullary cords and sinuses, and at the cortico- 
medullary junction on days 5 and 7 post-infection, and by day 9 there was a substantial 
increase of Ki67-positive cells in the cortex and paracortex (Figure 3.13.I.B). Isolated 
schizonts were detected initially within the medullary cords on day 5 post-infection, and 
by day 7 could be seen in low numbers in all regions of the lymph node. On day 9, there 
was a dramatic increase in the number of schizonts, correlating with the increased 
numbers of activated cells. With the exception of the B cell follicles, which contained 
very few parasites, this increase in parasitized cells occurred throughout the lymph node, 
as shown in Figure 3.13.n.A,B. However, the individual schizonts were scattered, rather 
than occurring in clusters, suggesting that the increase in parasitized cells was due to 
continual migration into the node. Alternatively, the parasitized cells may rapidly become 
separated following cell division.
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Table 3.5. The numbers and distribution of Ki67-positive cells in the drainage 
lymph node during primary infection with T. parva.
Stage of infection Day 0 Day 5 Day 7 Day 9
Calf number 781 784 788 789 783 786 776 782
Primary follicles - 8(7) 29(14) 25(5) 23(7) 7(5) 26(15) 22(8)
Outer cortex 15(4) 25(8) 23(9) 17(6) 54(25) 25(11) 70(28) 57(5)
Paracortex 17(3) 20(9) 17(1) 23(6) 42(12) 31(3) 73(14) 79(15)
C-M junction 13(3) 16(7) 33(13) 55(22) 57(19) 35(8) 52(11) 75(5)
Medullary cords 5(3) 4(2) 20(11) 34(35) 27(7) 23(4) 30(16) 24(16)
Medullary sinuses HD 0 7(4) 11(3) 19(10) 42(7) 6(6) 10(11)
Table 3.6. The numbers and distribution of schizonts in the drainage lymph node 
during primary infection with T. parva.
Stage of infection Day 5 Day 7 Day 9
Calf number 788 789 783 786 776 782
Primary follicles 0 0 <1 <1 3(2) 3(2)
Outer cortex 0 0 0 2 27(17) 14(4)
Paracortex 0 0 1 2 23(6) 20(7)
C-M junction 0 0 1 1 23(10) 29(7)
Medullary cords <1 0 1 3 19(6) 26(6)
Medullary sinuses 0 0 0 1 12(5) 16(1)
Notes: The figures are the average o f the numbers of positively-stained cells counted in 5 
fields from each region of the lymph node, using an eyepiece graticule and the 
X25 objective. Figures in parentheses are the standard deviations.
C-M = cortico-medullary
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A Paracortex -  normal prescapular lymph node (784). Cells positive for the Ki67 
antigen are found in small numbers throughout the paracortex. x80
■  • - 44 
4 t
V • • ••
B Cortex -  prescapular lymph node (782), 9 days post-infection with T. parva Large
numbers of positive cells are found throughout the paracortex. The primary follicles (F)
on the right and left of the picture contain only a few positive cells. x32
Figure 3.13. I. Sections o f  bovine lymph node stained by immunoperoxidase with the
monoclonal antibody NCL-Ki67-MM1 (anti-Ki67).
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cC Medulla -  normal prescapular lymph node (784). Very small numbers o f cells 
positive for Ki67 are scattered in the medullary cords (C) and sinuses (S). x80
D <r> ^ 4 *  *
D Medulla -  prescapular lymph node (782); 9 days post-infection with T. pcin>ct Large 
numbers of cells expressing Ki67 are found in both the medullary cords (C) and sinuses
(S). x80.
Figure 3.13. I. (cont.) Sections o f  bovine lymph node stained by immunoperoxidase
with the monoclonal antibody NCL-Ki67-MM1 (anti-Ki67).
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A. Cortex -  prescapular lymph node (782); 9 days post-infection with T. parva. 
Individual schizonts are clearly visible scattered throughout the paracortex; a few 
schizonts are also present in the primary follicle (F). x32.
B. Medulla -  prescapular lymph node (782); 9 days post-infection with T. parva. 
Parasitized cells are present within the medullary cords (C) and sinuses (S). x80.
Figure 3.13. EL Sections of bovine lymph node stained by immunoperoxidase with 
MAb5 (against the polymorphic immunodominant molecule of T. parva).
'  * .
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In control animals, large numbers of CD3+ and CD8+ T cells were found in the 
paracortex, with smaller numbers scattered in the medullary cords and a few positive 
cells within the medullary sinuses (Figure 3.14.A,B). By day 7 post-infection, the 
distribution of CD3+ and CD8+ cells within the paracortex was very similar to the 
controls; however, large numbers of CD3+ cells and smaller numbers of CD8+ T cells 
were also found in the medullary cords and sinuses (Figure 3.14.C,D). Similar patterns of 
staining with these T cell-specific mAbs were observed on day 9 post-infection. These 
findings suggest that many of the lymphoblasts in the medulla on days 7 and 9 post­
infection are T cells, but not all of them express CD8.
The cryostat sections were also stained with two antibodies specific for molecules 
expressed on bovine myeloid cells: CC149 which binds to MyD-1, a molecule expressed 
on a subset of dendritic cells and monocytes, and CC94 which binds to C D llb  
(expressed on monocytes and a small subset of B cells). In the resting node, small 
numbers of cells that stained with CC149 were found in the paracortex (Figure 3.15.A). 
CC94 did not stain cells within the cortex or paracortex, but there were foci of positive 
cells near the cortico-medullary junction. Both antibodies stained small numbers of cells 
within the medullary cords and sinuses (Figure 3.15.B). By day 5 post-infection, there 
was little change in the numbers and distribution of cells stained by CC149 and CC94. 
However on day 7, there was an increased numbers of cells staining with CC149 and 
CC94 in the cortex and large numbers of cells positive for both markers within the 
medullary cords and sinuses. These changes were particularly marked in calf 786 (see 
Figure 3.15.C,D). By day 9 post-infection, numerous cells within the cortex and 
paracortex stained with both antibodies (Figure 3.15.E,F) and occasional positive cells 
were seen in B cell follicles. To determine whether the increased numbers of cells 
recognized by both CC149 and CC94 represent monocytes/macrophages, cryostat 
sections were stained for the lysosomal enzyme, acid phosphatase. In the lymph nodes of 
uninfected animals, positive cells were largely confined to the medulla; very few were 
seen in the paracortex, as shown in Figure 3.16.A,B. From day 7 to day 9 of infection 
there was a progressive increase in positive cells the paracortex (Figure 3.16.,C). These 
changes parallel the findings with CC149 and CC94 and indicate that the cells identified 
by these monoclonal antibodies have a well-developed lysosomal system, suggesting that 
they are macrophages.
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A Medulla -  normal prescapular lymph node stained with MM1A Small numbers of 
positive cells are found, mainly within the medullary cords (C). x80.
B. Medulla -normal prescapular lymph node stained with CC63. The appearance is 
similar to that of the section stained with MM1 A, with small numbers of positive cells 
located in the medullary cords. x80.
Figure 3.14. Sections o f bovine lymph node stained by immunoperoxidase with MM1A
(anti-CD3) and CC63 (anti-CD8).
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C Medulla -  prescapular lymph node (calf 783) stained with MM1 A; 7 days post­
infection with / ’. parva. There are large numbers of positively stained cells within the 
medullary cords and sinuses. x80
D. Medulla -  prescapular lymph node (calf 783) stained with CC63; 7 days post­
infection with T. pan>a. CD8 cells are less numerous than CD3 cells in the medullary
cords. x80.
Figure 3.14. (cont.) Sections o f bovine lymph node stained by immunoperoxidase with
MM1A (anti-CD3) and CC63 (anti-CD8)
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A Paracortex -  normal prescapular lymph node (784) stained with CC149 Small foci 
o f  positively staining cells were found scattered in the paracortex. x80.
B
B. Medulla -  normal prescapular lymph node (784) stained with CC94 Small numbers 
of positively staining cells were found in the medullary cords (C). x80.
Figure 3.15. Sections o f bovine lymph node stained by immunoperoxidase with CC94
(anti-CD 1 lb) and CC149 (anti-MyD-1).
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cC. Cortex -  prescapular lymph node (calf 786) stained with CC149, 7 days post­
infection with T. parva Large numbers of positive cells are found throughout the 
paracortex, but not within the primary follicles (F). x32.
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D Medulla -  prescapular lymph node (calf 786) stained with CC149; 7 days post­
infection with T. parva. Large numbers of positive cells are present within the 
medullary cords (C) and sinuses (S). x80.
Figure 3.15. (cont) Sections o f bovine lymph node stained by immunoperoxidase with
CC94 (anti-CD 1 lb) and CC149 (anti-MyD-1)
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E. Paracortex -  prescapular lymph node (calf 776) stained with CC94; 9 days post­
infection with T. pcin'ci. Large numbers of positively staining cells are found throughout 
the paracortex. x80.
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F. Medulla -  prescapular lymph node (calf 776) stained with CC94; 9 days post­
infection with T. parva. Positively stained cells are located mainly within the medullary 
cords (C). x80.
Figure 3.15. (cont.) Sections o f bovine lymph node stained by immunoperoxidase with
CC94 (anti-CD 1 lb) and CC149 (anti-MyD-1)
A. Medulla -  normal prescapular lymph node (calf 784). Positively staining cells (pink) 
are confined mainly to the medullary sinuses (S). Counter-stained with methyl green. 
x80.
B. Cortex — normal prescapular lymph node (calf 784). A few small positively stained 
cells are scattered in the paracortex. x80.
C. Cortex -  prescapular lymph node (calf 5158); day 9 post-infection with T. parva. 
Numerous large positively stained cells are present throughout the paracortex, but not 
within the primary follicle (F) on the left of the picture. x80.
Figure 3.16. Sections of bovine lymph node stained for acid phosphatase.
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3.3.5. Cytokine expression in the drainage lymph node during primary infection 
with T. parva,
3.3.5.I. Detection of cytokine transcripts by RT-PCR.
To identify the cytokines expressed in the lymph node during infection with T. parva, 
RNA was extracted from freshly isolated lymph node cells (the whole MNC population 
and sorted CD4~ and CD8+ subpopulations) at different time points and used as a 
template for RT-PCR. Amplification using bovine P-actin-specific primers was 
performed in each case to verify the efficiency of cDNA synthesis by reverse 
transcription (Figure 3.18). The specificity of the cytokine PCR products was checked by 
digestion with restriction endonucleases to produce fragments of the sizes predicted from 
published sequences of bovine cytokines (see Table 3.7 and Figure 3.17).
Transcripts for EL-2, EFNy, TNFa and EL-10 were detected in both the whole lymph 
node MNC population and the CD4+ and CD8+ T cell subpopulations of the control 
animals; no transcripts for EL-4 and IL-6 were found in these samples. Transcripts for all 
six cytokines are present in the whole MNC population and CD4" T cells on days 5, 7 
and 9 of infection with T. parva. There was insufficient RNA from the CD8+ T cells to 
perform RT-PCR at each time point; however at day 7 transcripts for all cytokines 
except IL-4 were detected. Figure 3.18 illustrates the results of RT-PCR on the whole 
lymph node MNC population; these are also representative of the results obtained from 
sorted CD4+ T cells.
Table 3.7. Predicted sizes of fragments generated by restriction enzyme digestion of
cytokine PCR products.
Cytokine PCR product size 
(bp)
Restriction
enzyme
Sizes of fragments 
(bp)
IL-2 373 X b a l 149, 224
EFNy 316 Eco RV 164, 152
TNFa 464 Bgl I 355,109
EL-4 348 Pst I 141,207
IL-6 505 Bgl n 352, 153
IL-10 518 Bst Eli 223, 295
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Lane 1 lOObp DNA ladder
Lane 2 IL-2 Lane 8: IL-4
Lane 3 IL-2IXba I Lane 9: [L-4/Pst I
Lane 4 IFNy Lane 10: IL-6
Lane 5 IFNy/Eco RV Lane 11: IL-6//?#/ II
Lane 6 TNFa Lane 12: IL-10
Lane 7 TN Fa//?#/1 Lane 13: \L-\0/Bst Eli
Figure 3.17. Verification of the specificity of cytokine-specific primers by restriction 
enzyme digestion of the PCR products. cDNA from ConA-stimulated peripheral blood 
mononuclear cells was the substrate for amplification. The sizes of the fragments 
generated by digestion with restriction enzymes were predicted from the published 
sequences of bovine cytokines and are shown in Table 3.7.
2 3 4 5 6
(3 actin
IL-2
IFNy
TNFa
IL-4
IL-6
1L-10
Key
Lane 1: postive control, cDNA
derived from Con A blasts
Lane 2: negative control; no cDNA
Lane 3: uninfected control
Lane 4: day 5 post-infection
Lane 5: day 7 post-infection
Lane 6: day 9 post-infection
Figure 3.18. Cytokine transcripts detected by RT-PCR in the mononuclear cell (MNC) 
population of the drainage lymph node during primary infection with TheHeria parva.
3.3.5.2. Expression of EL-10 mRNA in the drainage lymph node of infected calves.
Examination of cytokine mRNA expression by in situ hybridization (ISH) can provide 
more useful information than RT-PCR alone, as ISH allows direct assessment of the 
numbers of cells expressing the cytokine and their anatomical location. Digoxigenin- 
labelled antisense and sense riboprobes specific for bovine IL-10 were available at the 
time these experiments were performed, and were used to examine the expression of 
IL-10 mRNA in the drainage lymph nodes of T. /?arva-infected animals. Expression of 
this cytokine was detected in the lymph node of one of the control animals (784); a few 
strongly positive cells were observed within the medullary sinuses (Figure 3.19.A). In the 
other uninfected calf, 781, the appearance of the sections stained with the antisense 
probe was not significantly different from that of the negative control which was 
hybridized with the sense probe. At day 5 post-infection, the pattern of expression of IL- 
10 mRNA was not significantly altered. By day 7 post-infection, there was a marked 
increase in IL-10 mRNA expression which was confined almost exclusively to cells 
within the medulla (Figure 3.19.B,C). In the medulla, large numbers of positive cells 
were found predominantly within the sinuses. The flattened cells lining the sinuses were 
also positive for IL-10 mRNA. The pattern of mRNA expression on day 9 post-infection 
was essentially the same as at day 7, with the majority of positively staining cells 
confined to the medulla (Figure 3.19.D,E). There was considerable cell-to-cell variation 
in the intensity of the staining, with the most strongly staining cells located in the sinuses. 
No positive cells were seen in the outer cortex, paracortex, follicles and germinal centres, 
or within the subcapsular sinus or trabecular sinuses at day 7 or day 9 post-infection.
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Figure 3.19. Sections of bovine lymph node stained by in situ hybridization with a 
digoxigenin-labelled riboprobe to bovine IL-10.
A. Medulla -  normal prescapular lymph node (calf 784), stained with the antisense IL- 
10 probe. A very small number of positive cells are present in the medullary sinuses. 
x80.
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B. Medulla -  prescapular lymph node (calf 783) stained with the antisense IL-10 probe, 
7 days post-infection with T. parva. Large numbers of intensely stained cells are present 
within the medullary sinuses, but are much less numerous in the medullary cords. x80.
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C. Medulla -  prescapular lymph node (calf 783) stained with the sense IL-10 probe; 7 
days post-infection with T. parva. This is taken from the same region as the section 
shown above to serve as a control for the specific binding of the IL-10 riboprobe. x80.
Figure 3.19. (cont.) Sections of bovine lymph node stained by in situ hybridization 
with a digoxigenin-labelled riboprobe to bovine IL-10.
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D. Medulla -  prescapular lymph node (calf 776) stained with the IL-10 anti-sense 
probe, day 9 post-infection with T. pan’a Large numbers of positively stained cells are 
present within the medullary sinuses, and the flattened cells lining the sinuses are also 
stained (open arrows). Small numbers of positive cells are also present in the medullary 
cords. x80.
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E. Medulla -  prescapular lymph node (calf 776) stained with the IL-10 sense probe; day 
9 post-infection with T. pan’a. This is taken from the same region as the section shown 
above. x80.
Figure 3.19. (cont.) Sections of bovine lymph node stained by in situ hybridization 
with a digoxigenin-labelled riboprobe to bovine IL-10.
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3.3.6. Effect of lymph plasma from a T. parva-infected animal on the growth of 
parasitized cell lines seeded at limiting dilutions.
The immune response provoked during primary infections with T. parva may benefit the 
parasite by secretion of cytokines from activated lymphocytes which could act as growth 
factors for parasitized cells, enhancing their proliferation. To test whether substances 
capable of enhancing proliferation of T. parva-infected cells were produced during 
infection, plasma was separated from efferent lymph draining from the prescapular lymph 
node of an infected calf (ATI 15) on days 7 and 11 of infection. At day 7 in this animal, 
no response was evident, while at day 11 approximately 30% of efferent lymph 
lymphocytes were blasting, and the proportion of CD2'CD8+ T cells reached its peak 
(23%). The percentage of parasitized cells in the efferent lymph was <2% at day 11. 
Different concentrations of lymph plasma were included in the culture medium of a T. 
parar-infected cell line over a range of cell concentrations that had been shown to be 
suboptimal for maintenance of proliferation (see Figure 3.20). As illustrated in Figure 
3.21, lymph plasma isolated from an uninfected animal had no effect on the proliferation 
of the cell line. However, day 7 lymph plasma from the infected animal produced a dose- 
dependent enhancement in the proliferation of parasitized cells seeded at 2.5 x 103 and 5 
x 103 cells/well. Lymph plasma isolated on day 11 of infection produced even greater 
enhancement of proliferation at the same cell concentrations; however this effect was 
more marked with the lower concentrations of lymph (2.5% and 5%), and least 
pronounced when lymph formed 20% of the culture medium.
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Figure 3.20. Titration of T. /?arva-infected cell lines to determine the cell density that is 
critical for maintenance o f cell proliferation. Two cell lines, AT107 (circles) and ATI 12 
(squares), were seeded at doubling dilutions from lxlO4 to 3xl02 cells/well, and 
incubated at 38°C for 48h (closed symbols) or 72h (open symbols). Proliferation was 
assessed by the incorporation of [125I] iododeoxyuridine. The results are expressed as 
counts per minute (cpm), and represent the mean values of triplicate cultures.
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Figure 3.21. The effect of lymph plasma from an animal (ATI 15) infected with T. parva 
on the proliferation of a parasitized cell line seeded at limiting dilution. Cell-free lymph 
plasma was prepared from efferent lymph draining the prescapular lymph node on days 7 
and 11 post-infection, and dialysed to remove Alsever’s solution used as anticoagulant. 
The lymph plasma was included in the culture medium of parasitized cells seeded at 
doubling dilutions from 5x10' to 3xl02 cells/well, at concentrations of 20%, 10%, 5% 
and 2.5% (v/v). The cultures were incubated at 38°C for 3 days and proliferation was 
assessed by the incorporation of [125I]iododeoxyuridine. The results are expressed in 
counts per minute (cpm) and represent the mean values of triplicate cultures.
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3.4. Discussion.
The results presented in this chapter indicate that a major T cell response, principally 
involving CD8+ T cells, occurs in the drainage lymph nodes of calves undergoing primary 
infections with Theileria parva. The response coincides with the initial detection of 
parasites within the lymph node, and occurs at a time when parasite numbers are 
increasing rapidly. In previous studies, T cell responses have been shown to play an 
important role in immunity to T. parva. After immunization or challenge of animals with 
T. parva, MHC class I-restricted CD8+ cytotoxic T cells (CTL) were detected in PBMC 
and ELL, and CTL precursors (CTLp) could be detected in the PBMC of immune 
animals by limiting dilution analysis (Eugui and Emery, 1981; Morrison et al., 1987; 
Taracha et al., 1992). In contrast, CTLp were undetectable in the PBMC of naive 
animals, and CTL capable of killing autologous infected targets were not detected during 
the course of lethal primary infections, although cytotoxic activity against allogeneic 
infected cells and xenogeneic targets was observed in the late stages of the infection 
(Eugui and Emery, 1981; Taracha et al., 1992). CD2'CD8+ and CD2+CD8+ cells sorted 
from the efferent lymph of animals undergoing lethal infections, and tested for cytotoxic 
activity in a limiting dilution assay had a very low frequency of CTLp (less than 1:20000) 
(Taracha, 1991). The response involving CD8+ T cells in the drainage lymph node during 
primary infections may thus represent a host immune response which is ineffective in 
controlling parasite replication. The failure to clear the infection may be the result of a 
strategy employed by the parasite to evade the host immune response, for example, non­
specific T cell activation, which would promote parasite survival.
The unusual phenotype (CD2‘CD3+CD8+) of a large proportion of the T cells involved in 
the primary response to the parasite, and the failure to detect parasite-specific cytotoxic 
activity at this stage of the infection, suggests that these are not conventional CTL. 
Theileria- specific CTL clones have been shown to express both CD2 and CD 8 
(Morrison et al., 1988). Almost all mature T cells in the periphery, with the exception of 
y/5 T cells, express CD2. However, analysis of the CD2'CD8+ population by three-colour 
fluorescent antibody staining revealed that the majority of these cells are negative for the 
y/5 TCR, and since they are CD3+, they are assumed to express an a/p  TCR. In the
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infected animals examined, these cells reach a maximal percentage ranging from 5% to 
30% of the total lymph node cell population, compared to 3% or less in resting nodes. 
The histological and immunocytochemical examination of lymph node sections from 
infected animals provided evidence that these cells are probably accumulating in the 
medulla or corticomedullary junction regions.
The CD2 CD3+CD8+ population may arise as a result of downregulation of CD2 
expression on the surface of activated CD8+ lymphocytes, or from expansion of a small 
pre-existing population of T lymphocytes with this phenotype. The division of the CD8+ 
T cells of infected animals into distinct CD2-negative and CD2-positive subpopulations 
argues against the downregulation of CD2 expression at the cell surface, as this might be 
expected to produce a gradation of mean fluorescence intensity such as occurs during 
modulation of CD2 expression by monoclonal antibodies (Giickel et al., 1991). On the 
other hand, the possibility that the parasite has evolved a mechanism to rapidly block 
expression of CD2 on CD8 T cells cannot be discounted. CD2 appears to have important 
functions in the activation and expression of effector functions in CD8+ cytotoxic cells 
(de Waal-Malefyt et al., 1993); therefore loss of CD2 from these cells could confer a 
survival advantage on the parasite by preventing expression of cytolytic activity against 
parasitized lymphocytes. However CD2'CD4+ T cells were not detected during the 
infection, and it is difficult to conceive how CD2 could be selectively down-regulated on 
CD8 T cells and not on activated CD4 T cells. Therefore, it seems more likely that the 
appearance of CD2'CD3+CD8+ T cells represents expansion of a small pre-existing 
population of these cells. CD2’CD8+ can form 1-3% of the MNC population in the 
normal resting lymph node, but are not detected in peripheral blood. Some of these cells 
in the resting node may be y/5 T lymphocytes, as small numbers of y5TCR CD8+ cells are 
also found.
The existence of a minor subpopulation of bovine CD2’CD3+CD8+ (assumed apTCR ) 
lymphocytes that can be selectively activated during infection has not been previously 
reported. Cells with this phenotype have not been described in peripheral lymphoid 
compartments of other species, although a subset of cx/pTCR+CD2'CD8+ intestinal 
intraepithelial lymphocytes (IEL) has been noted in mice. (Van Houten et al., 1993). In
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man CD2'CD3+a(3TCR+ T cells were shown to comprise less than 1% of PBMC in 
adults; however phenotypic analysis of a small number of clones derived from this 
population showed that they expressed CD4 rather than CD8 (Kabelitz et al., 1989). The 
functions of these cells and their stimulatory requirements are thus unknown, and 
attempts to address these questions in the present study by culturing the cells in vitro 
were unsuccessful. Although a variety of stimuli, including autologous parasitized 
stimulators, PMA and ionomycin, and ConA were used, the cells appeared refractory and 
failed to demonstrate significant proliferative responses. This may reflect a requirement 
for CD2-mediated costimulation of the CD3/TCR signalling pathway. There is evidence 
that in addition to acting as a cell adhesion molecule, CD2 can play an important role in 
T cell activation. CD2' mutants of the human Jurkat leukaemia cell line stimulated via 
CD3/TCR produce much less IL-2 than the parental cells; transfection of CD2 restored 
IL-2 production (Makni et al., 1991). In addition, down-regulation of CD2 expression in 
vivo by injection of mice with an anti-CD2 monoclonal antibody has been shown to result 
in profound inhibition of T cell-mediated immune responses (Giickel et al., 1991). The 
CD2aPTCR+ subset of murine intestinal intraepithelial lymphocytes show greatly 
reduced proliferative responses to PMA/ionomycin and anti-CD3 monoclonal antibody in 
comparison with their CD2+ counterparts (Van Houten et al., 1993). Recently it has been 
shown that interaction between CD2 and its ligand CD58 is required for optimal 
stimulation of T cell proliferation by IL-12 (Gollob et al., 1995,1996). However, for the 
CD2'CD8+ T cells to be expanded during infection with T. parva, they must be activated 
in vivo by a CD2-independent mechanism. The inclusion of exogenous EL-2 in the 
cultures would be expected to replace the need for co-stimulation of the CD3/TCR 
signalling pathway. It may be that in vivo these cells have stimulatory requirements 
distinct from those of conventional CD8+apTCR+ T cells, which are not adequately 
reproduced by the in vitro culture conditions used. Alternatively, since most of the 
sorted CD2'CD8+ T cells have already been activated in vivo, it is possible that the 
activation process has rendered them anergic, or that further stimulation induces 
programmed cell death. It has been shown in several systems that the same stimuli which 
activate resting T cells can trigger apoptosis in activated T cells (Wesselborg et a l, 
1993; Pohl et al., 1995). Interestingly, apoptosis and anergy are commonly observed 
following in vivo T cell activation by superantigens (Webb et al., 1990; MacDonald et
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al., 1991). However, in the experiments that were carried out in the current study, 
insufficient numbers of the purified cells were obtained to test for the induction of 
apoptosis.
The expansion of lymphocyte subsets of unusual phenotype has been demonstrated 
during some chronic infections. In mice infected with the cestode parasite Mesocestoides 
corti, increased numbers of cells with the morphology of large granular lymphocytes 
were found in the liver and spleen. These cells expressed Thy-1 and low levels of CD4, 
but were negative for CD3 and other T and B cell markers. Cell lines with this phenotype 
produced by in vitro stimulation of splenocytes by M. corti hsp70 produced IL-6 
constitutively and could be induced to secrete IL-2; however no cytolytic activity was 
detected (Estes et al., 1993). An atypical subset of human CD8+a|3TCR+ T cells is 
significantly expanded in HIV-infected individuals (Lewis et al., 1985), CMV-infected 
patients (Wang et al., 1993a) and transplant recipients. These cells, which are also found 
in low numbers in the blood of normal donors, are CD28' and express CD57, a molecule 
also found on human NK cells; they express levels of CD2 equivalent to those found on 
the cell surface of CD8+CD28+CD57‘ T cells (Azuma et al., 1993). They show poor 
proliferative responses to a variety of stimuli (Ruthlein et al., 1988; Azuma et al., 1993), 
and mediate suppression of humoral and cellular immune responses, including cytotoxic 
T cell responses (Clement et al., 1984; Wang et al., 1994). In addition, this population 
appears more susceptible to apoptosis when cultured ex vivo (Lewis et al., 1994). In 
both these examples, the effector function of these unusual cells in vivo is unknown.
Although the cytotoxic potential of the novel CD2"CD8+ population was not directly 
tested, their expression of CD3 makes it unlikely that they represent natural killer (NK) 
cells, which do not express a TCR. Bovine NK cells are poorly characterized in terms of 
phenotype, however non-specific cytotoxic activity of bovine PBMC against virus- 
infected and tumour cell targets has been demonstrated following treatment with IL-2 
(Campos et al., 1992). Two cloned cell lines derived from the PBMC of an animal 
immunized with T. parva by stimulation with TCGF and irradiated parasitized cells 
displayed non-MHC-restricted cytotoxic activity against infected and uninfected 
lymphoblasts (Goddeeris et al., 1991). Phenotypic characterization of these clones
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showed that neither expressed CD3 mRNA; one expressed CD2 only and the other 
expressed homodimeric CD8a. Attempts to identify the cell in bovine PBMC that 
mediates non-specific EL-2-activated killing of tumour cells demonstrated that most of 
this activity resided in a non-adherent population of CD2+CD4'CD8' lymphocytes 
(Campos et al., 1992). In contrast, a population of bovine lymphocytes with NK activity 
against virus-infected and non-infected embryonic kidney cells were shown to be 
negative for CD2, CD4, CD8 and WC1, but expressed CD3, CD45 and Fc receptors; 
this population may represent a subset of y/8 T cells (Amadori et al., 1992).
The role of T cell-derived cytokines in determining the outcome of parasitic infections of 
mice has been well documented. The polarization of CD4+ T cell responses towards 
dominance of cells producing either Thl-type (IL-2, IFNy) or Th2-type (IL-4, IL-5) 
cytokines appears to be influenced by the conditions under which initial priming of naive 
CD4+ T cells occurs. Studies using CD4+ T cells from TCR transgenic mice established 
the importance of certain cytokines in the local microenvironment for promoting Th 
subset differentiation in vitro (Hsieh et al., 1992; Seder et al., 1993). The influence of 
cytokines on the differentiation of Th subsets during in vivo infection with an 
intracellular pathogen has been extensively studied using the model of Leishmania major 
infection in mice. In susceptible BALB/c mice, IL-4 plays a key role in initiating a T in ­
type response which fails to clear the infection, while the induction of EL-12 in resistant 
strains of mice is essential for the development of protective Thl-type responses 
(Mattner et al., 1996). Intracellular pathogens that have evolved mechanisms capable of 
diverting the CD4+ T cell response towards a Th2-type phenotype would be expected to 
have a selective advantage due to their ability to evade elimination by the host. However, 
examination of cytokine mRNA expression in the drainage lymph nodes of naive cattle 
infected with T. parva revealed no bias in the expression of Thl- or Th2-type cytokines 
by CD4+ T cells, with transcripts for IL-2, IFNy, EL-4, IL-6, EL-10 and TNFa 
consistently detected at days 5, 7 and 9 post-infection. This is perhaps not surprising in 
view of the evidence that, during the first few days after infection with L. major, CD4+ T 
cells in the drainage lymph nodes of both susceptible and resistant mice express EL-2, EL- 
4 and IFNy at the mRNA and protein level (Morris et al., 1992; Reiner et al., 1994). In 
the present study, the relative levels of expression of the different cytokines were not
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quantified and it is therefore difficult to draw any conclusions about the potential role of 
cytokines in promoting a bias towards a either a Thl- or Th2-type response in primary 
infections with T. parva. Interpretation of the results of RT-PCR was also made difficult 
by the finding that transcripts for IL-2, IFNy, EL-10 and TNFawere expressed in the 
lymph nodes of both uninfected control animals. This reflects the sensitivity of the RT- 
PCR technique, and presumably is the result of background immunological activity in the 
lymph nodes.
Examination of the distribution of cells expressing IL-10 mRNA in the drainage lymph 
nodes of infected calves found that the most intensely staining cells on days 7 and 9 post­
infection were concentrated within the medullary sinuses, although numerous cells in the 
medullary cords were also postively stained. It is likely that IL-10 is being expressed by 
T cells and/or macrophages/monocytes, as these form the predominant cell types within 
the medulla at this time. These findings alone do not provide any direct information 
about the role of EL-10 in the primary immune response to T. parva. EL-10 was initially 
recognized as a soluble factor produced by murine CD4+ Th2-type clones that selectively 
inhibited cytokine synthesis (EL-2 and IFNy) of Thl-type clones (Fiorentino et al., 1989). 
In humans and cattle, IL-10 is produced by ThO-, Thl- and Th2-type clones and down- 
regulates proliferation of all subsets indirectly, by inhibition of the costimulatory function 
of macrophages (Del Prete et al., 1993; Brown et al., 1994; Ding et al., 1993). Human 
recombinant EL-10 was also shown to directly inhibit proliferation of a bovine CD8+ 
clone (Brown et al., 1994). In addition, IL-10 down-regulates the functions of activated 
human and murine macrophages by inhibiting the synthesis of pro-inflammatory 
cytokines such as EL-12, EL-1, TNFa and IL-6, and production of reactive oxygen and 
nitrogen intermediates (de Waal Malefyt et al., 1991; Gazzinelli et al., 1992a). In mice, 
IL-10 has been shown to play a role in the transient down-regulation of T cell responses 
that occurs during the acute phase of Toxoplasma gondii infection (Khan et al., 1995). 
Transient immunosuppression is a common feature of the acute phase of many parasitic 
infections, and is thought to benefit the parasite by allowing it to evade host immune 
responses and establish persistent infections. However, since many parasites induce 
strong cell-mediated responses, the immunosuppression may also benefit the host by 
protecting against the deleterious effects of excessive production of pro-inflammatory
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cytokines. The influence of IL-10 on the outcome of infection depends on complex 
interactions with other components of the immune reponse and cannot be predicted from 
examination of the level of expression of this cytokine alone.
The role of cytokines in the pathogenesis of Theileria parva infections is further 
complicated by the fact that the parasite invades lymphocytes and results in their 
activation, such that these cells are responsive to cytokines and can themselves produce 
certain cytokines. In vitro studies have established that T. parva-infected cell lines 
constitutively express high-affinity IL-2 receptors, and that cell lines seeded at low 
densities proliferate in response to exogenous IL-2 (Coquerelle et al., 1989; Dobbelaere 
et al., 1990,1991). Thus, in vivo, IL-2 produced by T cells activated in the primary 
response may contribute to parasite survival by promoting proliferation of infected cells. 
To determine whether soluble growth factors for parasitized cells were produced during 
the in vivo response to T. parva, lymph plasma obtained from an infected animal was 
included in the culture medium of a parasitized cell line seeded at limiting dilution. 
Enhanced proliferation, proportional to the concentration of lymph in the culture 
medium, was observed at cell densities greater than 6.25 x 103 cells/ml with lymph 
collected on day 7 post-infection. With lymph collected on day 11, the greatest 
enhancement in proliferation was found with the lower concentrations of lymph plasma. 
This may be due to a tendency of the lymph plasma to form clots in the cultures at higher 
concentrations, which was observed with day 11 lymph, or may reflect the presence of 
molecules that inhibit growth of parasitized cells at higher concentrations. These 
preliminary results suggest that soluble growth factors for parasitized lymphocytes are 
produced in the drainage lymph node during primary infections with T. parva. However, 
since this experiment was carried out using only one animal, confirmation of this 
observation is required, and further studies will be needed to establish the precise nature 
of the stimulatory factors and whether they play a role in the pathogenesis of the 
infection. Previous studies have examined the influence of recombinant cytokines, 
including IL-1, IL-2, IFNy, IFNa and TNFa, on the establishment and proliferation of T. 
parva-infected cell lines. EL-2 was the only cytokine that consistently enhanced the 
proliferation of established cell lines; none of the cytokines tested had an inhibitory effect 
(DeMartini and Baldwin, 1991; Preston et al., 1992).
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Another notable feature of the lymph node response to T. parva was the appearance 
between days 7 and 9 post-infection of large numbers of cells expressing the myeloid 
lineage markers recognized by the monoclonal antibodies CC149 and CC94. Staining for 
the enzyme acid phosphatase revealed that these cells contained a well-developed 
lysosomal system, suggesting that they are activated monocytes/macrophages. The 
results of immunocytochemistry are supported by the flow cytometric analysis, which 
revealed increased proportions of monocytes in the drainage lymph nodes and PBMC of 
some animals at this stage of the infection. A transient increase in monocytes/ 
macrophages in PBMC and lymph nodes of calves undergoing lethal infections with T. 
parva was previously reported by Emery et al. (1988). Similar observations were made 
in a recent study of the lymph node response to Theileria annulata, 8 days post-infection 
large numbers of monocytes/macrophages were found throughout the cortex and 
medulla (Campbell et al., 1995). However, these may represent parasitized cells, since T. 
annulata is known to preferentially infect monocytes, and large numbers of schizonts 
were also present at this time. T. parva does not infect monocytes; in this case the 
appearance of these cells in the drainage lymph node is likely to reflect recruitment in 
response to the infection. Recruitment of monocytes from peripheral blood into tissues 
usually involves the release of chemokines e.g. M IP-la, MCP-1, from a variety of cells, 
including activated lymphocytes, at the site of infection or inflammation (Strieter et al., 
1996).
Macrophages, activated via IFNy produced by CD4+ and CD8+ T lymphocytes and NK 
cells, are an important component of cell-mediated immune responses against a variety of 
intracellular pathogens (Suzuki et al., 1988; Gazzinelli et al., 1992b). In mice, much of 
the microbicidal activity of macrophages is mediated by the production of toxic oxidative 
metabolites such as nitric oxide (NO) (Liew et al., 1990). PBMC isolated from naive 
cattle during the course of infections with T. parva and T. annulata were shown to 
synthesize NO spontaneously in vitro, and NO appeared to inhibit the establishment of 
schizont-infected cell lines (Visser et al., 1995). Thus, activation of macrophages may 
play a role in the response to primary infections with T. parva. The expansion of CD2‘ 
CD8+ T cells within the drainage lymph node coincides with the detection of increased 
numbers of monocytes/macrophages, and it is possible that this population plays a role in
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the recruitment and activation of monocytes from peripheral blood. Unfortunately the 
pattern of cytokine expression in the CD2'CD8+apTCR+ population was not established, 
although expression of transcripts for EFNy was detected in the whole CD8+ population.
In summary, the primary response to T. parva in the drainage lymph node is 
characterized by the expansion of CD8+ T cells, a large proportion of which have the 
unusual phenotype CD2'CD3+CD8+, and by the appearance of large numbers 
monocytes/macrophages, at a time when parasite numbers are increasing rapidly. The 
function of the CD2'CD8+ population remains obscure, but the fact that their emergence 
coincides with the increase in monocytes/macrophages suggests that they may have a 
role in recruitment and activation of these cells. There is no direct evidence that this 
response contributes to the pathogenesis of the infection, but these observations suggest 
a number of areas that deserve further investigation. It would be interesting to try to 
establish the stimulus that triggers activation of the CD2'CD8+a(ITCR+ cells, and also to 
investigate which cytokines they express, and if they are capable of inducing activation of 
monocytes. Activated monocytes/macrophages might be expected to have an inhibitory 
effect on parasite growth; however excessive stimulation of these cells could also have 
deleterious effects for the host. Further studies are required to investigate the ability of 
monocytes/macrophages to influence parasite growth and modulate host immune 
responses.
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CHAPTER FOUR
ANALYSIS OF IN VITRO RESPONSES TO THEILERIA PARVA.
4.1. Introduction.
The ability to produce continuously growing schizont-infected cell lines by in vitro 
incubation of bovine PBMC with sporozoites from infected ticks has played an important 
role in the elucidation of immune responses to Theileria parva. These T. /?arva-infected 
cell lines are capable of stimulating potent proliferative responses in autologous PBMC 
from immune or naive animals, a response referred to as the autologous Theileria mixed 
leucocyte reaction (MLR) (Goddeeris and Morrison, 1987). The responding populations 
from immune animals have been shown to contain both MHC class I restricted, parasite- 
specific, CD8+ cytotoxic T cells, and parasite-specific CD4+ Th cells (Goddeeris et al., 
1986a,b; Baldwin et al., 1987). However, cytotoxic T cells are not generated when 
PBMC from naive animals are stimulated by autologous parasitized cell lines, despite 
proliferative responses of similar magnitude to those of immune animals. The phenotype 
of the responding cells has not been examined in detail; however, using a mAb against 
immunoglobulin as a marker for B cells and peanut agglutinin (PNA) as a marker for T 
cells, the majority of the responding population were found to be negative for both 
markers (Pearson et al., 1982). The proliferative response of naive PBMC is maintained 
even when the stimulator cells are glutaraldehyde-fixed, suggesting that they are 
responding to a specific cell surface component of the parasitized cells, and not to 
soluble mitogens or growth factors secreted by the infected cells. In addition, culture 
supernatants from parasitized cell lines do not produce proliferative responses in normal 
PBMC; in fact, when they are grown at high cell densities, the supernatants from infected 
T cell lines suppress proliferation in autologous and allogeneic mixed lymphocyte 
reactions (MLR) (Goddeeris and Morrison, 1987).
In primary T cell responses to conventional antigens, the frequency of responding cells is 
normally too low to be detected in antigen-specific T cell proliferative assays. The strong 
proliferative response to T. /?ara?-infected cells of PBMC from naive individuals 
suggests that these cells have received a stimulus which results in activation of a high
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proportion of the population. This could be due to a cross-reactive memory T cell 
subset, or the action of a mitogen or superantigen. Limiting dilution analysis of the 
response to the Mis superantigen (encoded by an endogenous mouse mammary tumour 
virus) estimated the frequency of precursors at between 1 in 30 and 1 in 20, while the 
frequency of cells responding to a mitogen such as ConA was between 1:10 and 1:3 
(MacPhail et al., 1985). The frequency of ‘memory’ cells responding to recall antigens 
such as tetanus toxin is lower, of the order of 1:5000 (Merkenschlager et al., 1988).
The strong proliferative responses of PBMC from naive cattle stimulated by autologous 
parasitized cells in vitro may parallel the marked T cell response observed in the lymph 
nodes of infected cattle at the time of initial detection of parasites. The aim of the work 
described in this chapter was to examine the phenotype of the responding cells in vitro 
and, by comparison with the in vivo response, to determine whether the autologous 
Theileria MLR could be used to model events occurring in the lymph node. In particular, 
it was hoped that if CD2'CD8+ a/p T cells were also generated during the in vitro 
response, this might be a more convenient approach for the further characterization of 
this unusual subset of T cells.
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4.2. Materials and Methods.
4.2.1. Autologous Theileria mixed leucocyte cultures.
4.2.1.1. Establishing the kinetics of the response.
Autologous Theileria mixed leucocyte cultures were established essentially as described 
by Goddeeris and Morrison (1987). The cultures were established in 96 well flat- 
bottomed microculture plates with 4 x 105 PBMC per well as responder cells and a 
variable number of irradiated autologous T. /?arva-infected leucocytes as stimulator cells. 
The parasitized stimulator cells were harvested from cultures during logarithmic growth 
and exposed to 50 Gy of gamma-radiation prior to use. The stimulator cells were titrated 
into the culture by two-fold dilution, starting at 4 x 105 cells/well. Each series of cultures 
was set up in triplicate or duplicate. Controls included PBMC cultured with medium 
alone, and dilutions of stimulators cultured alone. The cultures were incubated at 38°C in 
a humidified atmosphere of 5% CO2 in air for 3-7 days. Proliferation of cells was 
measured by the incorporation of tritiated thymidine as described in Section 2.2.4.
4.2.1.2. Bulk cultures.
Once optimal conditions for the responder: stimulator ratio and length of culture had been 
established, bulk cultures were set up to examine the phenotype of the blasting cells at 
the peak of the response. The cultures were established in 24 well cluster plates with 4 x 
106 PBMC per well as responders, and a responder: stimulator ratio of 10:1. Parallel 
cultures were established in triplicate in 96 well flat-bottomed plates with 4 x 105 PBMC 
per well as responders, to confirm that a proliferative response was occurring by 
measurement of incorporation of [3H]thymidine or [125I]iododeoxyuridine as above. 
Control wells containing responders or stimulators cultured alone were also included on 
the 96 well plate. The cultures were incubated for 5 days.
4.2.1.3. Phenotyping responding cells in the autologous Theileria M LR
Cells from the bulk cultures were resuspended, and the live cells were separated by 
density gradient centrifugation using Histopaque or Ficoll-Paque. The cells were washed 
once with PBS and distributed at 2 x 105 cells/well in a 96 well round-bottomed 
microtitre plate. The cells were incubated either with single monoclonal antibodies to
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CD2 (CC42 or CH128A), CD3 (MM1A), CD4 (CC30 or IL-A12), CD8 (CC63 or IL- 
A105), y/5 TCR (GB21A), WC1 (CC15 or IL-A29), surface Ig (IL-A58 or IL-A30) and 
the monocyte marker recognized by IL-A24, or different combinations of two of these 
antibodies, as shown in Table 4.1. Details of monoclonal antibodies and the protocols 
used for single staining and two-colour indirect immunofluorescent staining are given in 
Table 2.1 and Section 2.2.2.1. The samples were analysed on a FACScan (Becton 
Dickinson) and 5000 (single staining) or 10000 (two-colour staining) events were 
recorded. Statistical analysis of the data was carried out using PC LYSYS II software 
(Becton Dickinson).
Table 4.1. Antibodies used in two-colour staining of responding lymphocytes in the
autologous Theileria MLR.
Target molecules Monoclonal antibodies Isotypes
Isotype control TRT1/TRT3 IgGl/IgG2a
CD2/CD8 CC42/CC63 or 
CHI 28A/IL-A105
IgGl/IgG2a
CD3/CD8 MM1A/CC63 or 
MM1A/EL-A105
IgGl/IgG2a
y/5TCR/CD8 GB21A/CC63 or 
GB21A/IL-A51
IgG2b/IgG2a
IgGl/IgG2b
y/STCR/CD2 GB21A/CH128A IgG2b/IgGl
CD8p/CD8a CC58/CC63 IgGl/IgG2a
CD4/CD8 CC30/CC63 IgGl/IgG2a
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4.2.2. Phenotyping responding cells in cultures of lymph node cells stimulated by 
mitogens.
Mononuclear leucocytes were isolated from the prefemoral lymph node of a healthy five 
month old Channel Island calf, as described in Section 2.2.1.3. The cells were 
resuspended in standard culture medium and distributed at 4 x 106 cells/well in a 24 well 
cluster plate. The mitogens used to stimulate proliferation were:
a) ConAat 5pg/ml
b) Pokeweed mitogen (PWM) at 5pg/ml
c) Phorbol myristate acetate (PMA) at 50ng/ml and ionomycin at lpg/ml.
The cultures were incubated at 38°C as above for 3 days. To confirm that a proliferative 
response was occurring, cultures with identical stimuli were also established in triplicate 
in 96 well flat-bottomed plates with 4 x 105 responder cells/well, and the incorporation of 
tritiated thymidine was measured on day 3.
Cells harvested from the bulk cultures were treated in the same way as those harvested 
from the autologous Theileria mixed leucocyte cultures. A more limited panel of 
monoclonal antibodies was used to analyse the phenotype of the responding cells. Single 
staining was performed using monoclonal antibodies recognizing CD3 (MM1A), CD4 
(CC8), CD21 (CC21), and a monocyte marker (IL-A24). Two colour staining was 
carried out by combining the anti-CD8 mAb, CC63, with either GB21A (y/5 TCR) or 
CC42 (CD2). The cells were analysed on a FACScan as described above.
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4.3. Results.
4.3.1. Determination of the kinetics of the in vitro response to Theileria parva.
To ensure that autologous Theileria mixed leucocyte cultures were harvested when the 
response was at its peak, the kinetics of the response were examined. In initial 
experiments, cultures were established in 96 well plates with varying numbers of 
irradiated stimulator cells, and incubated for different lengths of time before proliferation 
was measured by incorporation of tritiated thymidine. After 5 days in culture, maximal 
proliferation was observed at responder:stimulator ratios of 8:1 to 16:1, with 
proliferative responses of lower magnitude being observed at higher ratios (see Figure
4.1.A). The time at which maximum proliferation occurred was more variable, but the 
peak response was usually found between days 4 and 6 of culture (Figure 4. l.B). Thus a 
responder:stimulator ratio of 10:1 and a culture period of 5 days were adopted in 
subsequent experiments as the conditions most likely to provide optimal stimulation of 
PBMC by autologous T. parva-infected cell lines.
4.3.2. Phenotypic analysis of responses of PBMC to T. parva-inftcted cells.
4.3.2.1. Responses of PBMC from naive cattle.
PBMC from two animals (3225 and 4197) naive to infection with T. parva were cultured 
for five days with irradiated autologous T. parva-infected cells. The cell surface 
phenotype of the stimulator cells is shown in Table 4.2. The phenotype of the cultured 
cells was examined by flow cytometry using antibodies to CD2, CD3, CD4, CD8, 
y/STCR, WC1 (y/5 T cell marker), surface immunoglobulin and the monocyte marker 
recognized by IL-A24. Gates for analysis were set on all viable cells and on the cells with 
high forward scatter (FSC1*), which comprise mainly blasting cells (Figure 4.2). The 
results are shown in Table 4.3. For both animals, there was a marked increase in the 
percentage of y/5 T cells, which formed more than 50% of the total viable cell population 
after 5 days in culture. The majority of the y/5TCR+ cells expressed WC1, a high 
molecular weight surface marker of ruminant y/5 T cells. There was also evidence that 
CD8+ T cells were involved in the response, as their percentage increased from 6% to
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23% of the total population in 4197; and they formed a substantial proportion (23%) of 
the blast cell population from 3225. The involvement of CD4+ T cells was more difficult 
to assess; there was a marked decrease in the proportion of this subpopulation in 3225, 
while a moderate increase in the percentage of CD4+ cells was seen in 4197. B cells and 
monocytes did not appear to participate in the proliferative response, as the proportions 
of these cells showed a marked decrease during the culture period.
Two-colour immunofluorescent staining of the CD8+ cells in the responding population 
revealed that a significant response involving CD2‘CD8+ a/p  T cells did not occur in 
vitro. As illustrated in Figure 4.3, a small percentage of the CD2' population expressed 
low levels of CD8 (representing 8% of the total population for 3225, and 2% for 4197), 
but this subset was not enriched within the blasting population. The percentage of 
y/8TCR+CD8+ cells (11% of the total population for 3225 and 6% for 4197) exceeded 
the percentage of CD2*CD8+ cells in both cases. This suggests that the majority of cells 
in the CD2'CD8+ subset may be y/5 T cells; however three-colour cytofluorometry was 
not performed to confirm this possiblity.
4.3.2.2. Comparison of the reponses of PBMC from naive and immune cattle.
In one experiment, the response of PBMC from a naive animal (4197) was compared 
with that of an immune animal (4198). These animals were twins, homozygous at the 
MHC, and therefore were stimulated using the same irradiated T. parva-infected cell line, 
originally derived from 4197. The results of flow cytometric analysis of the phenotype of 
the responding populations for each animal are shown in Table 4.3. There were no 
obvious differences between the responses of the immune and naive twin; in both 
animals, y/8 T cells formed the largest proportion of the blast cell population after 5 days 
in culture. In both animals, the percentage of CD8+ T cells in the total population was 
also expanded at day 5, and a small increase in the proportion of CD4+ T cells was also 
found. Two-colour immunofluorescent staining of the CD8+ subpopulation during the 
response of the immune twin also gave results very similar to those found in the naive 
twin (see Figure 4.3). Thus, at the level of the phenotype of the responding cells, it was 
not possible to distinguish between the responses of the PBMC from immune and naive 
twins following stimulation in vitro with a T. /?arva-infected cell line.
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Figure 4.1. Kinetics of the autologous Theileria mixed leucocyte reaction. Proliferation 
was assessed by the incorporation of tritiated thymidine, and values are expressed as 
counts per minute (cpm) and represent the mean of duplicate or triplicate cultures. A: the 
effect of varying the ratio o f responder cells (PBMC) to stimulator cells (irradiated 
autologous T. parva-infected cells) was measured for 4 animals (3474, 4222, 3225, 
4197) after 5 days in culture. The background counts for PBMC cultured alone were 
2095, 540, 7732, and 6058 cpm, respectively. B: the magnitude o f the proliferative 
response was measured for 2 animals from day 3 to day 7 of culture. PBMC from 3474 
and 3327 were cultured at responder:stimulator ratios of 8:1 and 16:1 respectively 
(closed symbols). The background counts for PBMC cultured alone are also shown 
(open symbols).
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Table 4.2. Phenotype of parasitized cell lines used as stimulators in the autologous
Theileria MLR.
Calf number 3225 4197
Phenotype
CD3 + +
CD4 +/- +
CD8 +/- +
sig - -
WC1 - -
Notes: + = majority of cells in the cell line were positive for this marker; +/- = distinct 
populations of positive and negative cells; - = majority of cells were negative for this 
marker.
Table 4.3. Changes in leucocyte subpopulations following culture of PBMC with
autologous T. pamz-infected cells.
Calf 3225 4197 4198
number Day 0 Day 5 Day 0 Day 5 Day 0 Day 5
Total Total FSChi Total Total FSChi Total Total FSChi
Phenotype (%) (%) (%) (%) (%) (%) (%) (%) (%)
CD2 46 36 37 29 48 58 30 43 54
CD3 54 88 82 56 89 76 62 87 74
CD4 20 13 9 20 22 28 14 15 18
CD8 20 19 23 6 23 28 11 24 30
y/5TCR 26 66 66 31 54 42 ND 57 45
WC1 17 58 59 28 47 40 36 47 39
B cells 34 13 16 21 5 5 23 10 14
Monocytes 12 <1 <1 31 <1 <1 16 <1 <1
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Figure 4.2. Gates set for flow cytometric analysis of responding cells in the autologous 
Theileria mixed leucocyte reaction. PBMC isolated from animals 3225 and 4197 were 
cultured with irradiated (50 Grays) autologous parasitized cells at a responder: stimulator 
ratio of 10:1. After 5 days, the viable cells were separated by density gradient 
centrifugation, stained with monoclonal antibodies and analysed on a FACScan (Becton 
Dickinson). The dot-plots show forward light scatter (x-axis) against side scatter (y- 
axis). Gates for analysis were set by comparison with day 0 PBMC (A) to focus either on 
the entire population of viable lymphocytes (B) or on cells with high forward scatter 
(FSChl -  C), which comprise mainly blast cells.
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Figure 4.3. Two-colour immunofluorescent staining of CD8 T cells in the autologous 
Theileria mixed leucocyte reaction. PBMC from animals 3225 and 4197 were cultured 
for 5 days in the presence of irradiated (50 Gy) autologous parasitized cells at a 
responder: stimulator ratio of 10:1. The viable cells were separated by density gradient 
centrifugation and stained with either CC42 (CD2; IgG l) or GB21A (y/5 TCR; IgG2b) in 
combination with CC63 (CD8; IgG2a). The secondary mAbs were fluorescein 
isothiocyanate (FITC)-conjugated goat anti-mouse IgGl or FITC-conjugated goat anti­
mouse IgG2b with phycoerythrin (PE)-conjugated goat anti-mouse IgG2a. The samples 
were analysed on a FACScan (Becton Dickinson). The dot-plots show the patterns of 
staining for cells falling within the gate set on the total live cell population (see Figure
4.2.A). The CD8 cells are shown on the y-axes and the CD2T cells (A) and y/5 TCR" 
cells (B) on the x-axes. The figures on the dot-plots are the percentages of gated cells 
that fall within each quadrant.
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4.3.3. Effect of different T. parva-infected stimulator populations on the phenotype 
of responding cells.
The continuous growth of T. pczraz-infected cell lines in vitro probably involves the 
selective outgrowth of the most rapidly proliferating cells and, following numerous 
passages, the phenotype of the cells may be significantly different from that of freshly 
infected lymphocytes. To investigate whether the nature of the stimulator cell population 
can influence the in vitro response to T. parva, the phenotype of cells responding either 
to freshly infected PBMC or to established cell lines was compared. PBMC from two 
naive animals (ATI 13 and AT 107) were incubated with large numbers of sporozoites 
prepared from infected tick salivary glands, as described in Section 2.2.4.2. The cell 
cultures were examined microscopically every day until a significant blast population was 
observed (after 3 days), indicating that the infected cells were undergoing transformation 
and beginning to proliferate. The cells were harvested, irradiated and used as stimulators 
in autologous Theileria MLC, while parallel cultures were set up using established T. 
pomz-infected cell lines from the same animals as stimulators. For simplicity, the freshly- 
infected PBMC and the established cell lines are referred to as stimulator populations A 
and B, respectively.
The phenotype of the stimulator populations was determined using a panel of 
monoclonal antibodies to CD2, CD3, CD4, CD8, y/STCR, surface Ig, and the monocyte 
marker recognized by EL-A24. The results are shown in Table 4.4. For both animals, the 
phenotypes of the stimulator cells were quite different. In freshly-infected PBMC from 
both individuals, all the major lymphocyte subsets were represented among the blasting 
(infected) cell population, including B cells and y/5 T cells. The long-term parasitized cell 
line established from AT 107 was negative for all the leucocyte differentiation antigens, 
apart from small numbers of cells expressing very low levels of surface Ig and the 
monocyte marker. This phenotype is found in cell lines derived from infected B 
lymphocytes, but is unusual in bulk cell lines derived from unfractionated PBMC. The 
majority of cells in the parasitized line established from ATI 13 expressed the T cell 
markers CD2, CD3 and CD4.
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Despite the differences in the phenotypes of the stimulator populations, the responses 
they provoked in autologous PBMC were remarkably similar. As shown in Table 4.5, the 
response of PBMC from ATI 13 and AT 107 to both stimulator populations was 
dominated by y/5 T cells, which constituted at least 45% of the total viable population 
after 5 days in culture. In addition, y/5 T cells were enriched in the blast cell population 
(high FSC) of three of the four cultures, the proportion being approximately 10% greater 
than in the total population in cultures stimulated with AT 107A, ATI 13A and AT113B. 
Increases in the percentage of CD8+ T cells in the total and blast cell populations were 
most marked in the cultures stimulated with freshly infected PBMC. In cultures 
stimulated with AT 107A and ATI 13A, CD8+ T cells were expanded from 16% of 
PBMC in both animals at day 0 to 36% and 22%, respectively, of the total viable cell 
population at day 5. CD8+ T cells were also enriched in the blast cell populations of these 
cultures, forming 51% (AT 107 A) and 28% (ATI 13 A) of blasts at day 5. The percentage 
of CD4+ T cells in the total population was decreased after 5 days in culture in 
comparison to the starting population; however CD4+ T cells formed a significant 
proportion (34%) of the blast cell population in the culture stimulated with AT107B.
As in the previous experiments, two-colour flow cytometric analysis of the CD8+ T cells 
in these cultures provided no evidence for the involvement of CD2'CD8+ a/p  T cells in 
the in vitro response of PBMC to T. parva. The results are illustrated in Figure 4.4. For 
both animals, regardless of the stimulator population used, all CD8+ T cells in the 
responding populations also expressed CD2. Expression of CD2 and CD8 on y/5TCR+ 
cells was also examined (Figure 4.5). CD2 was expressed on approximately 40% of y/5 
TCR+ cells in resting PBMC from both animals, while CD8 was expressed on 30% and 
20% of y/5TCR+ cells from AT 107 and ATI 13, respectively. Increased percentages of 
y/5TCR+CD2+ and y/5TCR+CD8+ cells were found in the total viable cell populations of 
day 5 cultures, as would be expected from the general increase in the proportion of y/5 T 
cells. The percentages of these subsets were higher in the blast cell populations than in 
the total population in all cultures except that stimulated by ATI 13A. In all cases, the 
proportion of y/5 T cells co-expressing CD2 exceeded the proportion that co-expressed 
CD8.
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Table 4.4. The phenotype of T. /wrva-infected cell populations used to stimulate
PBMC from AT107 and ATI 13.
Calf number AT107 ATI 13
Stimulator population A B A B
Phenotype (%) (%) (%) (%)
CD2 56 0 59 91
CD3 64 0 65 90
CD4 32 0 42 75
CD8 12 0 11 1
y/5TCR 10 0 7 0
Surface Ig 23 1 27 0
Monocytes . 7 7 5 0
Table 4.5. Effect of different stimulator populations on the phenotype of 
responding cells in the autologous Theileria MLR.
Calf
number AT107 AT113
Stimulator
population Day 0 Day 5 -A Day 5 - B Day 0 Day 5 -A Dav 5 -B
Total FSCW Total FSCbi Total FSChi Total FSChl
Phenotype <%) (%) (%) (%) (%) (%) (%) (%) (%) (%)
CD2 59 53 62 41 60 55 55 58 49 48
CD3 56 75 85 83 90 61 84 85 82 78
CD4 28 11 15 19 34 33 16 14 20 20
CD8 16 36 51 15 20 16 22 28 17 20
y/STCR 24 45 53 58 58 14 58 67 50 60
Surface Ig 21 10 10 7 8 14 9 10 13 17
Monocyte 5 2 4 1 1 13 2 3 3 5
Notes: PBMC from AT107 and ATI 13 were cultured with two different stimulator cell 
populations; recently-infected PBMC (stimulator population A) or T. parva-infected cell 
lines after multiple passages (stimulator population B).
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Figure 4.4. Two-colour immunofluorescent staining for CD2 and CD8 on responding 
cells in the autologous Theileria MLR. PBMC from animals A TI07 and ATI 13 were 
cultured for 5 days in the presence of two different stimulator cell populations; an 
established autologous parasitized cell line (B) or PBMC infected three days previously 
with T. parva sporozoites (C). Cells harvested from the cultures were stained with the 
mAbs CC42 (CD2; IgG l) and CC63 (CD8; IgG2a) followed by phycoerythrin (PE)- 
conjugated goat anti-mouse IgGl and fluorescein-isothiocyanate (FITC)-conjugated 
goat anti-mouse IgG2a, and analysed on a FACScan. Gates were set on the live cells as 
they were analysed, and the gated populations are illustrated in A. The dot-plots show 
the pattern of staining for CD2 (y-axes) and CD8 (x-axes) within these populations. The 
percentages of cells that fall within each quadrant are shown.
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Figure 4.5. Two-colour immunofluorescent staining of y/5 T cells in the autologous 
Theileria MLR. The cultures were set up as described in the legend to Figure 4.4. 
Acutely infected autologous PBMC were used as the stimulator cells for AT 107, and an 
established autologous parasitized cell line provided the stimulator dells for ATI 13. Cells 
harvested from the cultures were stained either with CH I28A (CD2, IgG l) or IL-A51 
(CD8; IgG l) in combination with GB21A (y/5 TCR, IgG2b). The secondary mAbs were 
fluorescein isothiocyanate (FlTC)-conjugated goat anti-mouse IgG2b and phycoerythrin 
(PE)-conjugated goat anti-mouse IgGl. The samples were analysed on a FACScan and 
live cells were gated for analysis as illustrated in Figure 4.4. The dot-plots show the 
pattern of staining of CD8 (A) and CD2 (B) (y-axes) on y/5 TCR cells (x-axes). The 
percentages of cells falling within each quadrant are shown on the dot-plots.
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4.3.4. Phenotype of lymph node cells responding to mitogenic stimulation.
One possible explanation for the failure to observe expansion of CD2'CD8+ oe/p T cells 
during the in vitro response to T. parva may be that the precursors of this subset are not 
found in peripheral blood, but are localized in the lymph nodes. To investigate this 
possibility, mononuclear leucocytes isolated from the prescapular lymph node of a 
healthy calf were cultured in the presence of different mitogens. The stimuli used were 
Concanavalin A (ConA), pokeweed mitogen (PWM) and phorbol myristate acetate in 
combination with ionomycin (PMA/iono). The phenotypes of the total viable cell 
populations after 3 days in culture are shown in Table 4.6. With each of the stimuli, the 
vast majority of cells in the cultures at this stage were T cells, predominantly CD4+ and 
CD8+ a/p T cells, y/5 T cells were also expanded at day 3, but did not exceed 17% of the 
total population in any of the cultures. CD2'CD8+ T cells were not found in lymph node 
cells before stimulation; however, a very small percentage of cells (1-3%) with this 
phenotype were detected in cultures stimulated with all three mitogens, as shown in 
Table 4.6. These could be equivalent to the subset observed in the drainage lymph node 
during the in vivo response to T. parva but, lacking a parasite-specific stimulus, they may 
not be expanded to the same extent. However, the possibility that they are y/5TCR+CD2' 
CD8+ cells cannot be excluded without three-colour cytofluorometric analysis. 
Unfortunately, an autologous T. /?arva-infected cell line was not available for this animal, 
so the effect of stimulation with parasitized cells could not be assessed.
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Table 4.6. Phenotype of lymph node cells responding to stimulation with various
mitogens.
Phenotype Day 0 (%) Day 3 (%)
ConA PWM PMA/iono
CD2 75 83 88 84
CD3 78 92 88 86
CD4 45 49 47 42
CD8 25 39 42 44
y/5TCR 9 17 10 17
CD21 23 16 15 5
Monocyte 6 7 5 2
CD2'CD8+ 0. 1 2 3
y/5TCR+CD8+ 5 9 6 12
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4.4. Discussion.
The results presented in this chapter show that, following in vitro stimulation of PBMC 
from naive cattle with autologous T. parva-infected cell lines, a large percentage of the 
responding population were y/5 T cells. This was a consistent finding, regardless of the 
phenotype of the stimulator cells. Although CD8+ T cells were also moderately expanded 
in the cultures, there was no evidence for the emergence of the CD2‘CD8+ a/p  T cell 
subset found during the in vivo response to T. parva.
A similar response was observed when PBMC from unexposed cattle were cultured with 
cell lines infected with Theileria annulata (Collins et al., 1996). The majority of the 
responding population after five days in culture was y/5 T cells. CD8+ T cells also formed 
a significant proportion of the blasting population, but the percentage of responding 
CD4+ T cells was low, in contrast to the present study, where in some cases CD4+ T cells 
formed 20% or more of the blast cell population. However, highly purified y/8 T cells 
could not respond to T. anrrulata-mfected cells in the absence of exogenous IL-2, 
suggesting that cooperation with CD4+ T cells may be necessary for this response to 
occur. Strong in vitro proliferative responses of PBMC from naive individuals to other 
parasites, including Plasmodium falciparum (Jones et a l , 1990), Trypanosoma cruzi 
(Piuvezam et al., 1993) and Borrelia burgdorferi (Roessner et al., 1994), have also been 
reported. The response of human PBMC to P. falciparum has been studied in some 
detail. Responding cells from individuals not previously exposed to malaria are confined 
to the subset of PBMC that express CD45RO, a cell surface marker associated with 
memory cells (Jones et al., 1990; Currier et al., 1992). The strong proliferative response 
is thought to be due to activation of cross-reactive memory T cells which have arisen as 
a result of exposure to environmental organisms (Currier et al., 1995). However, y/8 T 
cells bearing the Vy9/VS2 TCR also form a substantial proportion of the responding 
population (Goodier et al., 1992; Behr and Dubois, 1992). The response of the y/8 T 
cells is dependent on the presence of CD4+ T cells, but this requirement can be overcome 
by addition of exogenous IL-2, IL-4 or IL-5 (Elloso et al., 1996). Thus the in vitro 
response of human PBMC to P. falciparum-m£QcXed erythrocytes shares some 
similiarities with the response of bovine PBMC to T. annulata (Collins et al., 1996). The
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nature of the stimulatory component(s) of these parasites for y/8 T cells has not yet been 
identified. Reported ligands for the y/8 TCR include classical and non-classical MHC 
class I and class II molecules (Kronenberg, 1994). However, human Vy9/V82TCR+ cells 
that respond to mycobacteria have been shown to be stimulated by low molecular weight 
non-peptide ligands independently of MHC molecules. The most potent of these 
molecules are phosphorylated thymidine- and uridine-containing compounds and prenyl 
pyrophosphate derivatives e.g. isopentenyl pyrophosphate (Porcelli etal., 1996).
In one experiment, PBMC from a pair of MHC-identical twins, one of which had been 
immunized against T. parva, were stimulated with a parasitized line derived from animal 
4197. The responses were indistinguishable based on the phenotype of the responding 
cells, with y/8 T cells forming the majority of the blast cell population in the immune as 
well as the naive animal. The effector function of the responding cells was not examined 
in the present study; however it has previously been established that repeated stimulation 
of PBMC from immune animals results in enrichment of MHC class I restricted CD8+ 
cytotoxic T cells and MHC class II restricted CD4+ T cells with specificity for parasite 
antigens (Goddeeris et al., 1986a; Baldwin et al., 1987). In contrast, the levels of 
cytotoxicity generated in PBMC from naive cattle were lower and the effectors were not 
MHC restricted. In some instances, no cytotoxic activity was observed or the culture 
failed to proliferate following the primary stimulation (Goddeeris et al., 1986a). Thus, 
although in the present study the cultures from immune and naive animals were 
phenotypically identical after primary stimulation, these previous studies indicate that 
they differ at the functional level. The enhancement of MHC class I restricted 
cytotoxicity following repeated stimulation of immune PBMC may reflect selective 
outgrowth of parasite-specific CD8+ T cells at the expense of the y/8 T cells.
The potent proliferative response of PBMC to stimulation with T. parva-infected cells in 
vitro clearly does not reflect the processes leading to widespread lymphocyte activation 
in the drainage lymph nodes of infected cattle. Although there was a small increase in the 
proportion of y/8 T cells between days 8 and 12 of infection in some animals, they did 
not form the majority of the responding population as they did in the in vitro cultures. 
Also, the CD2'CD8+ a/p T cell subset that was consistently found among the responding
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population in vivo did not appear in the in vitro cultures. There are several possible 
reasons for these differences. Under in vitro culture conditions, the bovine y/5 T cells 
may have an increased sensitivity to activation signals. The majority of y/5 T cells in the 
peripheral blood of cattle and sheep express WC1, a polymorphic glycoprotein that 
belongs to a family of molecules which includes the macrophage type 1 scavenger 
receptor, CD5 and CD6 (Wijngaard et al., 1992,1994). The function of this molecule in 
vivo is unknown; however, recent studies have demonstrated that mAbs to WC1 inhibit 
the proliferation of ovine and bovine IL-2-dependent y/8 T cell lines in vitro, causing cell 
cycle arrest in G0/G1 phase. The growth arrest could be reversed by signalling through 
the TCR in the presence of IL-2 (Takamatsu et al., 1997). In view of these findings in 
vitro, it is tempting to speculate that, in vivo, WC1 may function to inhibit non-specific 
activation of y/8 T cells. The ligand for WC1 in vivo has not been identified; however, if 
the ligand were absent under in vitro culture conditions, the removal of inhibition might 
result in increased sensitivity of y/S T cells to non-specific stimuli. The failure to activate 
CD2*CD8+ T cells during in vitro stimulation may reflect a lack of precursors for these 
cells in peripheral blood. However, when mononuclear leucocytes isolated from a 
peripheral lymph node were stimulated in vitro with a number of different mitogens, only 
very low numbers of CD2'CD8+ (2-3%) cells were found among the responding cells. 
This may reflect the need for a parasite-specific stimulus to preferentially activate or 
expand this particular cell type.
Another possible reason for the differences observed between the in vitro and in vivo 
responses may occur at the level of the antigen presenting cells, and cell-cell interactions 
involved in the initiation of the responses. Following infection with T. parva, 
lymphocytes undergo a number of phenotypic changes; T lymphocytes acquire 
expression of MHC class II molecules, B lymphocytes modulate surface expression of 
immunoglobulin and both subsets upregulate molecules associated with activated T cells 
(Naessens et al., 1985; Baldwin et al., 1988). Parasitized cell lines maintained in vitro 
secrete IFNy and low levels of IL-2 (Brown and Logan, 1986; Entrican et al., 1991) and 
express mRNA for various cytokines, including IL-2, IL-6, IL-10, IFNy, and TNFa 
(Heussler et al., 1992; McKeever et al., 1997). In humans, activated T cells have been 
shown to express costimulatory molecules such as B7 (CD80/CD86) and are capable of
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presenting antigen to other T cells (Lanzavecchia et al., 1988; Azuma et al., 1993b). 
Thus in autologous Theileria mixed lymphocyte cultures, parasite antigens may be 
presented by the parasitized cells themselves or by monocytes present in PBMC. 
However, continuously growing cell lines represent the outgrowth of the most rapidly 
proliferating cells and thus may become modified during prolonged culture in vitro, so 
that they differ in their stimulatory properties from the parasitized cells responsible for 
initiating the primary immune response in vivo. Indeed, susceptible cattle infected with 
autologous parasitized cell lines after multiple passages in vitro, show mild or inapparent 
clinical reactions indicating that prolonged culture produces changes that result in 
reduced pathogenicity of the infected cells (Morrison et al., 1996). For this reason, 
PBMC from naive cattle were stimulated with freshly infected lymphocytes, which is 
more likely to reflect the situation in vivo if such cells were responsible for initiating the 
lymph node response. The responses were indistinguishable from those provoked by 
long-term parasitized cell lines, suggesting that the differences between the in vitro and 
in vivo responses do not simply reflect modification of the cultured stimulator cells, but 
that signals or cytokines from other cell types in the lymph node environment are not 
being provided in vitro.
Although cells expressing MHC class II molecules, including B cells, macrophages and 
dendritic cells, can all function as accessory cells during T cell activation, a number of 
studies have indicated that dendritic cells may be the major antigen-presenting cell 
involved in initiating responses of naive resting T cells (Inaba et al., 1990). In vitro 
studies of the cellular targets for T. parva infections have shown that parasitized cell 
lines can be established from purified populations of B lymphocytes and both y/5 and cx/p 
T lymphocytes, but not monocytes (Baldwin et al., 1988). However there is evidence 
that both macrophages and afferent lymph veiled cells (equivalent to dendritic cells) can 
be infected by sporozoites in vitro but do not become “transformed” i.e. undergo 
continuous replication, perhaps because they are not permissive for parasite 
differentiation (Shaw et al., 1993; D. McKeever, personal communication). In addition, 
sporozoites are phagocytosed by macrophages (Fawcett and Stagg, 1986). However, it 
is not known to what extent macrophages and dendritic cells are infected in vivo, and 
whether such cells contribute to initiation of the immune response. Parasitized
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lymphocytes can provide adequate signals for the activation of memory T cells, as shown 
by the generation of parasite-specific cytotoxic and T helper cells when PBMC from 
immune animals are stimulated in vitro with autologous infected cell lines (Goddeeris et 
al., 1986a; Baldwin et al., 1987). They are also capable of inducing T cell proliferative 
responses in PBMC from naive animals, although CTLs are not generated, perhaps due 
to the low frequency of precursors (Goddeeris and Morrison, 1987). Thus it is 
reasonable to assume that schizont-infected lymphocytes can also function as antigen- 
presenting cells in vivo. However, they may not provide appropriate stimuli for 
activation of parasite-specific effector function in naive T cells. This could be due to lack 
of co-stimulatory function and/or secretion of appropriate cytokines. For example, it has 
been demonstrated in mice that presentation of antigen by either resting or activated B 
cells induces tolerance in naive T cells, but results in activation of memory T cells (Fuchs 
and Matzinger, 1992).
In summary, in vitro stimulation of PBMC with I  /?orar-infected cell lines produces a 
responding population which is phenotypically distinct from the blast cell population in 
the drainage lymph node during the primary in vivo response. The inability to detect 
CD2'CD8+ T cells among the responding population in vitro prohibited further studies to 
determine the stimulatory requirements and function of these cells in vitro. In future 
work, it would be useful to investigate which cells are responsible for initiation of the 
immune response in vivo. Further in vitro studies using lymph node cells rather than 
PBMC may yield more information about the CD2‘CD8+ subset.
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CHAPTER FIVE
CLONING, SEQUENCING AND CLASSIFICATION OF BOVINE TCRBV
GENES.
5.1. Introduction.
The T cell antigen receptor consists of a polymorphic, disulphide-linked heterodimer 
associated with a complex of invariant CD3 molecules. The function of the heterodimer 
is antigen recognition, while the components of CD3 are involved in signal transduction. 
The a  and P (or y and 5) chains that make up the heterodimer are encoded by separate 
variable (V), diversity (D - p and 5 chains only), joining (J) and constant (C) gene 
segments which are assembled by somatic recombination, as for immunoglobulin heavy 
and light chains, during T cell differentiation. The V regions of the TCR polypeptides 
contain three regions of relatively greater variability which correspond to 
immunoglobulin hypervariable regions (complementarity determining regions or CDRs), 
and which are brought together by protein folding and V domain packing to form the site 
which interacts with antigenic peptides bound to MHC molecules. Compared to 
immunoglobulins, the number of different A V and BV  genes used by the TCR is relatively 
small; however, there is potential for enormous diversity in the junctional region 
comprising CDR3. Various models of the interactions between the a/p  TCR and 
peptide/MHC complexes predicted that CDR1 and CDR2 of V a and Vp would contact 
residues on the cti and a .2 domains of the MHC molecule, while the CDR3 loops would 
interact with the bound peptide (Davis and Bjorkman, 1988; Chothia et al., 1988). This 
model has recently been confirmed by structural analysis of a crystallized ternary 
complex of TCR, MHC class I molecule and peptide (Garcia et al., 1996).
The specificity of the TCRs on T cells is determined by the combination of V a and Vp 
elements. Studies with T cell clones that react with a defined peptide/MHC combination 
have shown that in some cases the TCRs express a limited repertoire of V and J  gene 
segments and restricted junctional sequences (Hedrick et al., 1988; Moss et al., 1991), 
while in others a diverse repertoire of TCRV and J  genes are used, with no apparent
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conservation of junctional sequences (Taylor et a l, 1990; Casanova et al., 1991). In 
contrast, T cell responses to superantigens are characterized by polyclonal activation of 
T cells bearing a restricted subset of Vp elements and diverse junctional sequences, 
irrespective of the paired V a domain or the MHC molecule involved in antigen 
presentation (Kappler et al., 1989; Mollick et al., 1989). The explanation for this is that 
superantigens are not degraded into peptide fragments which are presented in the 
antigen-binding groove of MHC molecules (Yagi et a l,  1988); instead, they bind directly 
to a number of different MHC class II molecules, and make contact only with residues on 
the solvent-exposed lateral face of the TCR Vp domain (Scholl et al., 1989; Choi et al., 
1990a).
One of the major aims of this project was to examine the repertoire of TCRBV genes 
expressed by T cells participating in the primary immune response to Theileria parva 
infection in cattle, to determine whether a superantigen could be driving the response. 
The Vp-specific expansion of T cells without clonal restriction or conserved CDR3 
motifs, in individuals of differing MHC phenotypes, is evidence of stimulation by a 
superantigen.
The extent of the bovine TCRBV repertoire has not yet been determined. In mice and 
humans, the repertoire of TCRBV gene segments was predicted to be limited in 
comparison to that of immunoglobulins, based on the numbers of sequences isolated 
from cDNA libraries and the number of bands hybridizing to 5  F-specific probes in 
Southern blots of genomic DNA (Barth et al., 1985; Behlke et a l,  1985; Kimura et a l, 
1987). Mapping and sequencing of germline BV  segments has confirmed that previous 
estimates of the size of the repertoire were accurate. In humans, 65 unique TCRBV gene 
segments have been identified following sequencing of the entire TCRB locus, of which 
46 appear to be functional (Rowen et al., 1996). Based on the requirement of greater 
than 75% nucleotide sequence homology for cross-hybridization, B V  sequences have 
been divided into subfamilies of sequences that share greater that 75% identity at the 
nucleotide level. In humans, thirty-four subfamilies have been defined, of which twenty- 
four contain functional gene segments, while in the mouse, twenty-five subfamilies have 
been identified at the genomic level but only twenty contain functional TCRBV genes.
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Several of the human TCRBV subfamilies contain multiple members, but most of the 
murine TCRBV subfamilies have only a single member. In both species, the V gene 
segments show limited polymorphism, with alleles usually differing by less than five 
nucleotides (Arden etal., 1995a,b).
Tanaka et al. (1990) identified twelve distinct TCRBV sequences in clones from a cDNA 
library derived from bovine PBMC. They classified the sequences into nine subfamilies, 
each of which was shown to have significant homology at the nucleotide and protein 
level to representative human TCRBV subfamily members. They were unable to 
demonstrate 2?F-associated polymorphisms in Southern blot analysis of genomic DNA; in 
addition, they reported that a limited number of bands were detected on the blots with 
each 2? F-specific probe, suggesting that each bovine TCRBV subfamily contains relatively 
few members.
To facilitate interpretation of the pattern of TCRBV gene usage found in T cells 
responding to T. parva, it was important initially to establish the frequency with which 
different TCRBV subfamilies were expressed in normal individuals. In the absence of 
monoclonal antibodies to specific bovine TCR Vp regions, examination of the expression 
of TCRBV genes was feasible only at the mRNA level. As sequence data for only nine 
bovine TCRBV subfamilies was available, the approach used for repertoire analysis was 
to amplify all TCRBV cDNA transcripts by anchored PCR. This technique permits 
amplification all the TCRBV genes expressed by the T cell population, including those for 
which the sequences are unknown, using a single pair of primers. This approach has 
previously been used in several studies of the human TCR repertoire, in which many new 
V gene segments were identified (Robinson, 1991; Plaza et al., 1991; Ferradini et al., 
1991). In this chapter, the sequences of cDNA clones derived by this technique are 
analysed and classified into different TCRBV subfamilies.
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5.2. Materials and Methods.
5.2.1. Cellular sources of RNA.
To provide material for analysis of the normal T cell receptor repertoire of peripheral 
lymph nodes, a prefemoral lymph node was surgically removed from one experimental 
animal (calf 3327). The mononuclear leucocytes were isolated from the lymph node as 
described in Section 2.2.1.3, and used to prepare total RNA without further 
fractionation. The same animal was later infected with Theileria parva, as described 
previously, and a prescapular lymph node draining the site of inoculation was removed 
after euthanasia on day 9 of infection. Mononuclear leucocytes isolated from the lymph 
node of the infected calf by density gradient centrifugation were stained with monoclonal 
antibodies to CD3 (MM1A) and MHC class II (LL-A21) for sorting on a FACStar cell 
sorter, using the procedure outlined in Section 2.2.3.3. To isolate activated T cells, cells 
were selected for sorting on the basis of their co-expression of both markers. In a 
subsequent experiment, CD2 CD8* T cells were sorted from the drainage lymph node of 
another animal (5158) on day 9 of infection with T. parva, as described in Section
2.2.3.3. Briefly, the separated mononuclear leukocytes were stained with monoclonal 
antibodies to CD2 (IL-A43; IgG2a) and CD8 (CACT80C; IgGl), and secondary goat 
anti-mouse IgG2a-PE and goat anti-mouse IgGl-FITC antibodies. The CD8+ population 
was enriched by staining with an anti-FITC mAb coupled to magnetic beads and 
separation on a MACS VS+ Separation Column. The CD2'CD8+ subset was subsequently 
purified on a FACStar cell sorter. In all cases, total RNA was isolated from the 
lymphocyte populations using the Ultraspec RNA Isolation Kit (Biotecx) as described in 
Section 2.4.1.
5.2.2. Amplification and cloning of bovine TCRBV cDNA transcripts.
The strategy for amplification of bovine TCRBV sequences using the anchored PCR is 
illustrated in Figure 5.1. The details of the protocols are given in Section 2.4.5. Synthesis 
of cDNA was performed by reverse transcription of mRNA using an antisense 
oligonucleotide (PBC1) specific for a conserved region at the 5’ end of the bovine
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BC gene segments. After digestion of mRNA by RNase H, cDNA was purified to 
remove excess primer and dNTPs, before addition of a homopolymer tail of dC 
nucleotides to the 3’ end of the cDNA by the enzyme terminal deoxynucleotidyl 
transferase (TdT). The tailed cDNA was amplified by PCR using a second £C-specific 
primer (PBC2) and an anchor primer complementary to the poly-dC tail. As a positive 
control to verify that TCRBV sequences were present after each step in the procedure, 
PCR amplification was also performed using the .SC-specific primer with an internal 
primer (PBV2), which is complementary to a conserved region near the 5’ end of the 
published sequences for TCRBV2 gene segments (Tanaka et al., 1990). The specificity of 
the primers was checked by performing an amplification reaction using cDNA prepared 
from a bovine y/5 T cell line. As illustrated in Figure 5.2., a distinct band of —350 bp (the 
expected size of the PCR product) was obtained when cDNA from ConA blasts was the 
target for amplification, whereas the primers failed to amplify any sequences from the 
cDNA of y/5 T cells. The sequences of all the oligonucleotide primers are shown in Table
2.3. in Chapter 2.
The products of the anchored PCR were separated by electrophoresis on a 1% agarose 
gel; a band corresponding to the size expected for TCRBV sequences (approximately 
500bp) was excised and the DNA recovered using the GENECLEAN II Kit (BIO 101),
♦ • T V Ias described in Section 2.4.4.4. The purified DNA was cloned directly into the pCK  II 
plasmid vector supplied with the TA Cloning Kit (Invitrogen), products of the ligation 
reaction were transformed into competent E. coli cells (OneShot INVaF’; Invitrogen) 
and the bacteria were plated on LB agar containing 100|ig/ml ampicillin. Details of the 
protocols used for cloning and transformation are given in Section 2.4.6. Large numbers 
of white colonies (>100) were picked from the agar plates from each transformation. 
These clones were grown in liquid LB medium overnight and aliquots of the cultures 
were stored at -70°C in 15% glycerol until required for sequence analysis. Details of the 
reagents and methods used for anchored PCR and cloning are given in Chapter 2. Clones 
derived from the two different animals, 3327 and 5158, were numbered and given the 
prefixes C and D respectively; clones derived from the infected lymph node of 3327 were 
given the prefix IC.
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Figure 5.1. Schematic representation of the strategy used for amplification o f bovine 
TCRBV sequences by anchored polymerase chain reaction (A-PCR). Reverse 
transcription of mRNA was primed with an oligonuleotide (PBCl) complementary to the 
bovine TCRBC genes. A poly-(dC) tail was added to the 3’ end of the cDNA by terminal 
deoxynucleotidyl transferase (TdT). The TCRBV sequences were amplified with the 
anchor primer and a second TO?/?C-specific primer (PBC2) to give a 550 base pair (bp) 
product. To check the efficiency of cDNA synthesis, amplification was also performed 
with PBC2 and a primer complementary to bovine TCRBV2 genes (PBV2), to give a 
350bp product.
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Figure 5.2. Verification of the specificity of the internal control primer PBV2 
(complementary to bovine TCRBV2 subfamily members) for a /p  T cells. cDNA prepared 
from a y/5 T cell line and from Con-A stimulated PBMC were subjected to the same 
amplification protocol using PBV2 and the 1( ’-specific primer PBC2.
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Figure 5.3.
A. Demonstration of the efficiency of reverse transcription by amplification of cDNA 
with the primers PBV2 and PBC2.
B. Demonstration of the specificity of the anchor primer and PBC2 for amplification of 
d(C)-tailed cDNA encoding bovine TC11BV sequences in the anchored PCR
5.2.3. Preparation of DNA template for sequencing.
Two different methods were used to prepare plasmid DNA from bacterial clones for 
sequencing, as outlined in Section 2.4.7.1. However, the DNA from these preparations 
was not consistently of sufficiently high quality for automated cycle sequencing. Thus, 
most cycle sequencing reactions were performed using single stranded DNA immobilized 
on magnetic beads (Dynabeads®), which proved to be a reliable and efficient method for 
generating high quality sequencing template (see Section 2.4.7.4). The template used for 
sequencing reactions with Sequenase® T7 DNA polymerase was alkaline-denatured 
plasmid DNA prepared using Qiagen Tip 20 resin columns (see Section 2.4.7.1). 
Sequencing reactions and denaturing gel electrophoresis of the extension products were 
performed as described in Sections 2.4.8 and 2.4.9.
5.2.4. Analysis of sequence data.
Products of cycle sequencing incorporating fluorescent dye terminators were 
electrophoresed in a 373 A DNA Sequencer (Applied Biosystems, Inc.), and the sequence 
data was collected on a Macintosh computer running the 373A Sequence Data 
Collection Programme (ABI) and analysed using the 373A Sequence Analysis 
Programme (ABI). Sequences were checked and edited using the Seqed or Sequence 
Navigator (ABI) programmes, before being transferred to the VAX 750 mainframe 
computer. Sequence information from reactions performed using Sequenase was read 
directly from autoradiographs and entered into the VAX 750 mainframe computer. The 
sequence data was analysed using the GAP, BESTFIT, FAST A, PILEUP and LINEUP 
programs from the University of Wisconsin Genetic Computing Group (GCG) package 
(Devereux et a l , 1984).
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5.3. Results.
5.3.1. Amplification of TCRBC-sptciTic cDNA.
5.3.1.1. Optimization of the anchored PCR.
The method which was initially adopted for amplification of TCRBV sequences was 
based on that described by Thiesen et al. (1990). This entailed reverse transcription of 
mRNA using an oligo-dT primer, addition of a poly(dG) tail by TdT and PCR 
amplification with a bovine 7Ui?#C-specific 3’ primer and a 5’ primer complementary to 
the homopolymer tail with additional 5’ sequence containing restriction sites for cloning. 
Solvent extraction and ethanol -precipitation of the DNA was necessary after each stage 
in the procedure, to remove excess dNTPs and first-strand synthesis primer before the 
tailing reaction, and to remove the cobalt-containing TdT buffer before amplification. 
The considerable loss of DNA following repeated precipitation and problems with the 
tailing reaction resulted in failure to amplify TCRBV sequences using this method.
The second approach was a simplified protocol based on the 5’ RACE System Kit 
supplied by Gibco. This system represents a considerable improvement over the original 
method for two major reasons. First, the requirement for repeated extraction and 
precipitation of the cDNA is removed by the use of GLASSMax spin columns for 
purification of first strand cDNA, and by performing tailing and amplification reactions in 
the same buffer. Second, the anchor primer is designed with selective placement of 
deoxyinosine residues in the 3’ region to create a melting temperature (Tm) for the 
anchor region which is comparable to that of a typical 20-mer primer with 50% GC 
content. Deoxyinosine has the capacity to base pair with all four nucleotides with varying 
affinities, the most stable conformation being achieved by I:C pairs. This design 
maximizes specific priming from the poly(dC) tail, and establishes a relationship of a 
“balanced” Tm with that of the 3’ TCRBC-specific primer (required for efficient PCR 
amplification). The improved specificity and reduced Tm of this primer removes the need 
for amplification with mixtures of anchor and adapter primers (complementary to the 5’ 
region of the anchor primer), as is the case in most protocols for anchored PCR.
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Some modifications of the protocol recommended by the manufacturers were necessary 
to obtain optimal results using the kit. Initially, problems were encountered with the 
tailing reaction. The magnesium concentration during this reaction is critical; 
concentrations of Mg2'  above 1.5mM inhibit the length of the tail and the percentage of 
molecules tailed. The supplied buffer contained magnesium chloride, and it was found 
that by substituting a Mg2+-ffee buffer and adding MgCk separately (allowing more 
accurate control of the Mg2+ concentration), a product of the expected size (500bp) 
could be generated by the anchored PCR. However, the efficiency of the PCR reaction 
was poor, and a second round of amplification with the anchor primer and a “nested” 
rCftffC-specific primer was necessary to generate sufficient DNA for cloning. 
Sequencing of three clones derived from this product revealed that they contained 
identical BV  gene segments and junctional sequences, strongly suggesting that a bias had 
occurred during amplification. Subsequently, the anchored PCR was performed using a 
modified anchor primer synthesized at IAH, Compton, and generously supplied by Dr. 
Sean McCarthy. This primer had an identical 3’ region (containing deoxyinosine 
residues) to the anchor primer supplied with the kit, but a shorter 5’ region containing 
only one restriction site (compared with 3 restriction sites and a cloning region in the kit 
primer). Thus, the Tm for the whole primer is lower, resulting in more efficient PCR 
amplification. Using this primer, a strong band of 500bp was obtained after a single 
round of amplification (35 cycles), as shown in Figure 5.3. Sequencing of clones derived 
from this PCR product revealed a wide range of different TCRBV genes and diverse 
junctional sequences, with no obvious biases.
5.3.1.2. Analysis of the cloned inserts derived from the anchored PCR.
In initial experiments, restriction enzyme digestion of plasmid DNA followed by analysis 
by agarose gel electrophoresis revealed that the proportion of clones containing inserts of 
~500bp was disappointingly low; only 12 of the 39 clones (31%) examined had full- 
length inserts. In addition, a number of clones contained inserts of approximately 300bp, 
although a band of this molecular weight was not observed following agarose gel 
electrophoresis of the PCR product. Size selection of the PCR product by excision of the 
500bp band from the agarose gel and purification of the DNA prior to ligation into the 
/?CR™13 vector resulted in a marked reduction in the frequency of isolation of clones
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without inserts. Unexpectedly, however, some clones still contained 300bp inserts, the 
proportion varying for different PCR reactions from 0-27%.
Sequence information was obtained from 134 clones containing full-length inserts; these 
clones were derived from the anchor PCR amplification of TCRB chain transcripts from 
the three different lymphocyte populations described in 5.2.1. Seventeen clones 
contained sequences unrelated to TCRB genes and have probably arisen as a result of 
PCR artefact. Sequencing of a small number of the shorter inserts revealed that they also 
contained no TCRB gene segments. One clone contained TCRBC sequence, and another 
contained rearranged BJ-BC gene segments. These are probably the result of 
amplification of germline sequences, or in the case of the rearranged sequence, from a 
BD-BJ-BC transcript. One clone included a full-length TCRBV gene segment but no BD, 
B J  or BC sequences. In three clones, truncated rearranged TCRB sequences including 
between 125bp-250bp of the B V  gene segment were found.
The remaining 111 clones contained rearranged TCRBV-BD-BJ-BC transcripts. Among 
these sequences, nine reoccurred; (i.e., they were identical to another sequence 
throughout the V-D-J region), including three copies of one sequence, and three identical 
pairs. Interestingly, these duplicated sequences were found only in the clones derived 
from the activated T cell populations, which would be more likely to include clonally 
expanded T cells and hence yield more than one copy of the V-D-J rearrangement 
expressed by these cells.
5.3.2. Classification of TCRBV gene segments.
The clones containing rearranged TCRB transcripts were sequenced at least twice. 
Unfortunately, it proved difficult to obtain good quality sequence from the 5’ end of the 
clones using cycle sequencing and the automated sequencer, probably because of 
“slippage” of the Taq DNA polymerase on the homopolymer dC tail. All clones were 
therefore sequenced in one direction (3’-5’), and in many cases this was sufficient to 
obtain sequence for almost the entire TCRBV gene segment. A number of clones 
representing new bovine TCRBV subfamilies or subfamily members were selected and
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sequence from the 5’ end of the V gene was obtained by conventional manual sequencing 
using Sequenase®. The extent of the leader sequence varied between clones; in some 
cases it was truncated while in other clones the translational start codon could be 
identified. Three clones contained deletions or insertions of one or more bases within the 
TCRBV sequences which caused an alteration in the reading frame of the transcript; these 
are probably artefacts that have arisen during the amplification or sequencing reactions.
The remaining 103 sequences were classified into TCRBV families by screening them for 
nucleotide sequence homology to bovine and human TCRBV sequences in the 
GenEMBL database, using the FAST A programme. The sequences were first edited to 
remove leader, BD, B J  and BC  sequences. The 3’ end of the V gene segments were 
assigned as three codons after the conserved cysteine residue at position 92, according to 
convention. Where sequences differed by no more than five nucleotide substitutions, they 
were considered to be products of a single gene locus. This was based on the 
observations of Arden et al. (1995a,b) who, in an extensive analysis of all published 
human and murine TCR sequences derived from genomic or cDNA, noted that alleles of 
V gene segments rarely differ by more than 5 nucleotides, while genes from different loci 
usually differ by at least 10 nucleotides. In the present study the numbers of variant 
sequences in each group were generally too small to distinguish whether nucleotide 
substitutions were genuine allelic differences or had arisen through misincorporation of 
nucleotides by Taq DNA polymerase. However, to minimize the sequence errors 
introduced by Taq DNA polymerase, consensus sequences from at least three different 
clones were derived, where possible, for comparison with other sequences. Sequences 
sharing greater than 75% identity at the nucleotide level are defined as being members of 
the same subfamily. Tanaka et al., (1990) defined nine bovine TCRBV subfamilies based 
on comparison of cDNA sequences with their human counterparts. Their clones, which 
were numbered and had the prefix BTB, are referred to in the text below; the sequence 
comparisons leading to the classification of these clones into subfamilies are shown in 
Table 5.1.
Only nineteen clones contained nucleotide sequences identical or almost identical to the 
published bovine TCRBV sequences. Four clones contained sequences that were almost
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identical to BTB18 (bovine BV1) at the nucleotide level; however, the deduced peptide 
sequences were only 88.6% identical. This was due to a frame-shift between bases 165 
or 170 and base 191 of the nucleotide sequence which caused an alteration in the reading 
frame of the transcript. However, these transcripts were apparently functional, since the 
frame-shift did not result in the introduction of a stop codon or mutation of any 
functionally important conserved residues, as shown in Figure 5.4. Similarly, four clones 
contained sequences identical to BTB4 (bovine BV2) apart from a dinucleotide insertion 
near the 5’ end of the V gene, causing a shift in the reading frame. This resulted in a 
divergence of the deduced peptide sequences over the first 10 amino acid residues of the 
V region, so that the percentage identity of the sequences was only 92.5%.
The remaining eleven clones contained sequences identical, or almost identical to BTB10 
(BV2), BTB91 (BV3), BTB27 (BV7), BTB13 (BV12), BTB22 and BTB45 (both BV15). 
Some sequences differed from the published sequences by one or two nucleotides; 
however, it could not be established whether these differences were genuine or due to 
PCR error because the number of clones that matched each sequence was too low to 
establish consensus sequences. The two clones corresponding to BTB13 contained the 
entire sequence of this V gene; the published sequence of this clone is truncated.
5.3.2.I. New TCRBV subfamily members.
A large number of sequences were identified that, although different from the published 
bovine sequences, shared greater than 75% identity at the nucleotide level, and were 
classified as new subfamily members. Comparisons of the nucleotide and protein 
sequences of all new subfamily members to published human and bovine sequences are 
shown in Table 5.1.
Thirty-seven clones were classified as belonging to the bovine BV1 subfamily, as they 
shared >75% nucleotide sequence similarity with BTB18, including the clones that were 
almost identical (see above). These sequences formed 9 groups of identical or closely 
related sequences and two single sequences that were distinct from these groups, as 
illustrated in Figure 5.4. As shown, alignment of the sequences with BTB18 results in a 
ffameshift in each new sequence as mentioned above, suggesting that the published 
sequence contains an error. This will be discussed more fully later. The results of this
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analysis suggest that the bovine BV1 subfamily contains at least 11 members. The 
nucleotide sequences of the different subfamily members were compared to one another 
and the results of this analysis are presented in Table 5.2. The percentage similarity of the 
nucleotide sequences ranged from 79.3% to 95.4%; however the majority of the 
sequences show 80%-90% nucleotide identity to one another. The amino acid identity 
between different subfamily members ranged from 64.2% to 91.0%. It is interesting that 
many of the differences in the predicted amino acid sequence of the different subfamily 
members are concentrated within the CDR2 region, which is predicted to interact mainly 
with residues on the MHC molecule.
Twenty sequences with >75%* similarity to BTB1, BTB4 and BTB10, including those 
mentioned above, were classified as belonging to the bovine BV2 subfamily. These 
sequences fell into 5 groups of identical or almost identical sequences, with two 
additional distinct single sequences. Alignments of the nucleotide and protein sequences 
of the BV2 subfamily members are illustrated in Figure 5.5. Maximal alignment of the 
nucleotide sequences requires a dinucleotide insertion near the 5’ end of the V gene in 
the published BTB1 and BTB4 sequences, resulting in a marked difference in the amino 
acid sequence of this region to that of BTB10 and all the new sequences identified in this 
study. Again, this probably indicates an error in the published sequences, for reasons that 
will be discussed later. Taking this error into account, V  genes (designated BV2S1 and 
BV2S3 respectively) corresponding to two of the published sequences (BTB4 and 
BTB10) were identified. In addition, the sequence designated BV2S6 differed from the 
published sequence BTB1 by only 5 nucleotides, and therefore could represent an allelic 
variant. The remaining four sequences represent distinct new BV2 subfamily members. 
Comparison of the nucleotide sequences of the BV2 subfamily members with one another 
and with the published sequences revealed that they are much more closely related than 
the members of BV1 (see Table 5.3). The percentage nucleotide identity between the 
different subfamily members is greater than 90% in all cases and ranges from 92.1% to 
98.7%, while the amino acid identity between the different sequences ranges from 84.0 
to 94.6%.
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Leader sequence ► <  Variable region sequence  ►
-20  10 30  
BTB18 CTCCTGGCAGCAGGCCTTGTG GATTCTGAAGTCACCCAAACCCCGAGATACCTGATTAAA
BV1S5  -G ---------------------G----------- C -A ------------------C-
BV1S8   G------------C -A ------------------C-
BV1S9  -C -A G ----------------- C-
BV1S7   G------------C -A ----T----------- C-
BV1S6  -GG------------------ G----------- c - A -----T---------- C-
B V lS3a  ------------ G-------------------G-------------------------------------------- G---------- C -A ------------------- C-
B V lS 3 b   G------------C -A -------1 ---------C-
BV1S11
BTB18
BV1S1
BV1S2
BV1S5
BV1S8
BV1S9
BV1S4
BV1S7
BV1S6
B V lS3a
B V lS 3 b
BV1S10
BV1S11
 G -T  C -A -------------------C------
50  7 0  90
GCAAGAGGACAGCGAGGGACCCTGAGATGCTCCCCTGTCTCTGGACACCTCTCTGTGTCC
T AAC-------A—  C A—  T------------------ T------------C A - -
T--------- AAG--------A— C T------------------ T----------- AA—
T--------- AA----------A— T T------------------ T--------------AG-
T-----------AAG--------A— T— TT---------------- T--------------AA-
T-----------AAG--------A—  T— TA---------------- T--------------AG-
T-----------AAG--------A— T— T a ---------------- T--------------AG-
T--------- AA----------A—  T— T A------------------ T--------------AG-
T--------- AA----------A—  T— TA------------------ T--------------AG-
 AG---------a — T T---------------- T----------C-AA-
T-----------AAG--------A— T— TA---------------- T --------------AA-
 c  A _
 AG-------------- AA-
-----------G— A----- A—
------------------A-----A—
 AGA-------------- A-
 AGA-------------- A-
-----------g — A----- A------
110 1 3 0 1 5 0
BTB18
BV1S1
BV1S2
BV1S5
BV1S8
BV1S9
BV1S4
BV1S7
BV1S6
B V lS3a
B V lS 3 b
BV1S10
BV1S11
TGGTACCAACAGGCCCTGGGCCAGGGCCCCAAGTTCCTCGTTGAGTATTACAGGCAGGAA
—A-------
 g--------------------c _.
------------------------c --------------T A --C --
------------------------- c ---------------TA— C—
— A— A--------T -C -A ------------ A— C—
— A— A— t - T - C - A ------------ A— C—
---------------- T------C -A -------------A— C—
------------------------- C_A------------ a —  C—
 A C  A —
-G  C-CGGAC—
-----------TGATGG-A—
 TTGATGG-A—
----------- T -ATGG-A—
 TT-ATGG-A—
-----------ATGG—c-
 A T G G — C -
 T— aCAGnCa-
 T— ACAC-C—
Figure 5.4. A. Alignment of nucleotide sequences of members of the bovine TCRBV 1 
subfamily. Identical residues are shown as dashes. Letters in lower case indicate bases 
that require further sequencing for confirmation of identity. Gaps have been introduced 
at position 165 in BV1S1, BV1S2, BV1S5 and BV1S8, at position 170 in BV1S9, BVIS4, 
BV1S7, BV1S6, BVlS3a, BVIS3b, BV1S10 and BV1S11, and at position 191 in BTB18 
to maximize the alignment (see over).
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BTB18
BV1S1
BV1S2
BV1S5
BV1S8
BV1S9
BV1S4
BV1S7
BV1S6
B V lS3a
B V lS 3 b
BV1S10
BV1S11
BTB18
BV1S1
BV1S2
BV1S5
BV1S8
BV1S9
BV1S4
BV1S7
BV1S6
B V lS3a
B V lS 3 b
BV1S10
BV1S11
BTB18
BV1S1
BV1S2
BV1S5
BV1S8
BV1S9
BV1S4
BV1S7
BV1S6
B V lS3a
B V lS 3 b
BV1S10
BV1S11
170 190 210
GTGAGATGGAGAAGCACAGCTCCCGGATCGA. TCTCAGTAAAACAGTTTAGTGACTTTCG 
 .  T-----------------------------------------------------------
— T—  . -A  G— A -A -C A -G — A------------ T------------ C--------------A----------------------------
 TATCAA- .  G -A -C A -A T -A  GG------------G------------------- C---------- TGC-GC
 C -tA c A -  . ------- G -A -C A -G — T------------ T---------- GTG----------------C------------- C-------
-A — ATGA— . ------- G -a -C A -G — A----------- T------------ G-------------------------------------------A
-A — ATGA—  . ------- G -A -C A -G — A------------ T------T— GTG------------ C--------------- C -A -
-A-TATGA—  . ------- G -A -C A -A T -A ------------ T---------- G--------------------C------------- C -A -
-A-TATGA—  . ------- G -A -C A -A T -A ------------ G---------- G-------------------- C------------- C -A -
CA— aTG a—  . ------- G -a -C A -A T -A ------------ T---------- G--------------------C------------- C -A -
-A — ATGA—  . ------- G -A -C A -A T -A ------------ T---------- G--------------------C------------- C -A -
2 3 0  2 5 0  2 7 0
CTCCGAGCTGAACTTGAGCTCCTTGGAGCTGACAGACTCAGCCATGTATCTCTGTGCCAG
Figure 5.4. A (cont.). Alignment of nucleotide sequences of members of the bovine 
TCRBV 1 subfamily.
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Leader peptide >  4 Variable region
CDR1
20 40
B V lS3a
B V lS3b
BV1S10
BV1S11
BV1S6
BV1S7
BV1S4
BV1S9
BV1S8
BV1S5
BV1S2
BV1S1
B V lS3a
B V lS 3 b
BV1S10
BV1S11
BV1S6
BV1S7
BV1S4
BV1S9
BV1S8
BV1S5
BV1S2
BV1S1
DS EVTQT PKYLIKS RKQQVILRCS PESGHR SVYWYQQALGQGLQ
- E ----- T--------
— T  ______ ____________________________
---------- Y -S --------T--------P -
G------------------------- N— AT--------
A -G -R G T -G —  
G-RGT--------
-N ----- S
-H----- F
-V ----- L
-V ----- L
Y -S ------------------ P -
— N------------------ P -
---------------------PE
— S------------------ PK
CDR2
60 80
ELIQYYNGAEYEKGNIS D
 F-XQQN------
--------------F - T Q - N -------------------------
 F — K - N ----------------MP
-------------- K-N------- MP
-V — FD-KVRT------MP
-V  D-K V-Q ----------
-V-C-R-Q VSRG E-M P
-V  QKVRGESHLL
-V  RQEVRGEAQLP
-V E — RQEVSGEAQLP
RFSGKQFSDSSSELNLTSLELKDSAVYLCASS
V--------------------------------------t --------------------
 T-----------------
- T  M------------
- T  M------------
- T  M------------
H— L -E -------
-—A-----
 QM— S —
FH---------- S —
-R-QM— S —
AA------ S —  P—
FR---------- S —
-R ---------- S —
FH---------- S —
FR---------- S —
Figure 5.4. B. Alignment of the amino acid sequences of the members of the bovine 
TCRBV 1 subfamily. Identical residues are shown as dashes. The amino acid residues are 
numbered according to the system of Kabat et al. (1991). The complementarity regions 
CDR1 and CDR2, as defined by Chothia et al. (1988), are shown in boxes.
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BTBl
BTB4
BTB10
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
<----------------- Leader sequence  ►
60 - 4 0  - 2 0
AT GAT T T CAC AT AACAGAC AGGAT T C C CT T G GAG C CAC GAGAAA. . . GGCTCTGGGCTTG
-----------------------AC-----------------------------------------------TGG-------------GCA---------------------------
-TGCTGG-G-T-CT-CTG-TTCT-GG-CCCA-------------------------
<----------------- Variable region sequence -----------------►
20  40  60
GGCGCTCTCGTCTCTCAGCAGCCCCGCA. . GCTGT CAGTAAGAGTGGAGCCTCTGTGACCA 
 CG. . ----------------------------------------------------
---------------------------------------------------------------------------------------a — GG------------------
---------------------------------------------------------------------------------------------------- g g ------------------
--------------------------------------------- , -----------------------------------------------------GG------------------
---------------------------------------------------------------------------------------------------- g g ------------------
-------------------------------------------------------------------------------------- g g ------------------ --------------------------------------n ------------------------------------------------------------
---------------------------------------------- gg------------------
---------------------------------------------- gg------------------
80 100 120
TCGAGTGCCGTGCACTGGACTTTCAAGCCTCAAGTATGTTCTGGTACCGTCAGTTCCCAA
 A  G -
---------------------------------------------------------------------- a ----------------------------------------------------g -
---------------------------------------------------------------------- C-G ----------------------------------------------- g-
--------------------------------------------------------------------------------------- 3 G“
---------------------------------------------------------------------------------------------------------------------------- G-
14 0  1 6 0  18 0
AACGAGGC CT C GT GCT GAT GGCAACTT CT AAT GAGGGCACT GAT GCCACATACGAACAAG
-----------------------A-------------------------------------------- T---------- G------------------------------------------
---------------------------------------------------------------------- C---------- G------------------------------------------
,A-------------------------------------------- T-----------G-
----------------------------------------C--------- G'
t ---------- G—
,T --------------------------------A -
Figure 5.5. A. Alignment of the nucleotide sequences of members of the bovine 
TCRBV2 subfamily. Identical residues are shown as dashes. To maximize the alignment, 
gaps have been introduced at positions 29 and 30 in the variable region sequence of 
BTBl, and at positions 31 and 32 in the variable region sequence of BTB4.
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200 220 2 4 0
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
GTTATAACAAGGACAAGTTTCCCATCAGTCAGCCAGACCGAACATTTTCATCTCTGATGG
2 6 0  2 8 0
BT Bl T GATAAGT GT GGAT C CT ACAGACAGCAGC CT CT ACTT CT GCAGT GCT AGA
BTB4  C -C --------------------- G------------------------------------------------- G---T-CAC
BTBIO  C -C ---------------- .— G-----------------------------------------------G-------- C 
BV2S6   C-----------------------------------------------g ------------------------------------------ . —
BV2S4   C G-------------------G-----------------G------------------------------------c  g
BV2S1  C -C --------------------- G-----------------------------------------------G—
BV2S5   C -C ------------------------ G------------------------------------------------- G---A------- C
BV2S7   C -C --------------------- G-----------------------------------------------TG---a — TG
BV2S2   C -C ----------------------- G-----------------G--------------------------------- C— GG
Figure 5.5. A. (cont.) Alignment of nucleotide sequences of members of the bovine 
TCRBV2 subfamily.
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Leader peptide Variable region
CDR1
10 20 30
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
MISHNRQDSLGATRK.ALG LALSSLSSPAAVSKSGASVTIECRALDFQAS
— QH----------------G— Q----
MLVL-LLLGPSSGL G— V-QQPRR--------------------------
-V-QQPHR--------------------------
-V-QQPRR--------------------------
-V-QQPRR--------------------------
-V-QQPRR-----------------------------
V-QQPRR--------------------------
-V-QQPRR--------------------------
-V-QQPRR--------------------------
 T
.A
40
SMFWYRQFPK 
TV----------------
N------------------
TV----------------
TV----------------
TV----------------
TV----------------
 H--------
CDR2
50 60
BTBl
BTB4
BTBIO
BV2S6
BV2S4
BV2S1
BV2S5
BV2S7
BV2S3
BV2S2
70 80 90
GLVLMATSNEGTDATYEQGYNKDKFPISQPDRTFSSLMVISVDPTDSSLYFCSAR
 N
 V
------------ j -------------- L---------- T-TR ------A------------- GVH
------------ j ----------QNL---------- T-TR ------A------------- G—
 V -S —
 A -S  —
 V -S  —
-----V—N.
-T-------------H— L—
 j  NL—
-T--------------H - - L -  —
■— TR-----A— G----------- P -
-T-TR A-------------- G
-— TR-----A--------------- GDS
■T-TR-----A----------------GDM
-T-TR -----A--------------------S
-T-TR -----A— G------------- V
Figure 5.5. B. Alignment of the amino acid sequences of members of the TCRBV2 
subfamily. Identical residues are shown as dashes. The amino acid residues are numbered 
according to the system of Kabat et al., 1991.
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Single new members were identified for the subfamilies BV4, BV6, and BV17, 
represented respectively by clones BTB93, BTB50 and BTB90 of Tanaka et al. The new 
member of BV4 was represented by a single clone (D16), and reliable sequence of the 
entire V gene was not obtained. Comparison of the partial sequence with BTB93 
revealed 90.1% identity at the nucleotide level and 82.7% identity at the amino acid 
level; the differences between the sequences are illustrated in Figure 5.6.
The clones corresponding to BTB50 (BV6S1) contained the entire sequence of the V 
gene and maintained an open reading frame, in contrast to the published sequence which 
is truncated and has a stop codon (TGA) near the 5’ end. Buitkamp et al. (1993), in an 
analysis of germline polymorphisms of artiodactyl TCRBV6 elements, identified and 
partially sequenced another member of the bovine BV6 subfamily, which they named 
Vb6a (BV6S2). The alignments of the sequence identified in this study (designated 
BV6S3) with the nucleotide and protein sequences of BTB50 and Vb6a are illustrated in 
Figure 5.7. There is much closer homology between the sequences of BV6S1 and BV6S3 
(93.5% at the nucleotide level) than between either sequence and BV6S2 (85.1% and 
84.3% nucleotide identity, respectively).
The percentage similarity between the nucleotide sequences of BTB90 and IC46 was less 
than 75% (71.1%); however, when compared with human sequences, both showed 
maximum homology to BV17S1, with percentage nucleotide similarities of 77% and 73% 
respectively. The alignment of the nucleotide and protein sequences of IC46 with BTB90 
is shown in Figure 5.8. The sequences are most divergent near the 5’end of the V gene. 
The subfamily member identified in this study is represented by only two clones (IC46 
and IC85) which were sequenced on one strand (3’-5’). Thus the divergence has 
probably arisen through an error in sequencing in the 5’ region, which could be resolved 
by sequencing on the other strand.
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A.
BTB93
BTB93
BV4S2
BTB93
BV4S2
BTB93
BV4S2
BTB93
BV4S2
BTB93
BV4S2
- 4 0
Leader sequence
- 2 0
ATGTTGACTCTTCTGCTACTTCTCCTGGGACTGGGTTCTGTGTTC GGTACTCTCGTCTCT
20
Variable region sequence
40  60
CAAAAGCCAAGCAGGGCCATCTGTCAACGCGGGACCTCCGTGATGATCGAGTGTCAGGTC
80 100 120
GATAGCCAGGGCAATTTCATGTACTGGTACTGTCAGCTTCCAGGACAGAGCTTGGTGCTG 
---------------- A -T — cC-GG-------------------------- C -A -------------------------------------------------- T—
140 1 6 0 1 8 0
AT GGCT ACTGCCAAT.CAGGGCT C CAAGGCTACTTACGAGAGT GGGTTTACT GACAACAAG 
 G---------------------------------------------------- c — GG-----—
200 220 2 4 0
TTTCCCATTAGCCGCCCAAAGCAGGCGTTCTCAACTCTGACTGTGAGCAACGCGAGCTCC
2 6 0 2 8 0
GAAGACAGCAGCTCTTATTTCTGCAGTGCTAGG 
 T  G G - A
B. Leader peptide
BTB93
BV4S2
BTB93
BV4S2
Variable region 
CDR1
20
MLTLLLLLLGLGSVF GTLVSQKPSRAICQRGTSVMIECQ
 MT H
'/DSQGN 
 VT
40
FMYWYCQLPGQSLVL
CDR2
80
MATANQGSKATYESGFTDNKFPISRPKQAFSTLTVSNASSEDSSSYFCSAR 
—  ED-------- D LE---------------- V------------------------- G
Figure 5.6. Alignment of the partial nucleotide (A) and amino acid (B) sequences of a 
new member of the bovine TCRBV4 subfamily (BV4S2) with the original sequence 
published by Tanaka et al. (1990) (BTB93). Identical residues are shown as dashes. 
Amino acid residues are numbered according to the system of Kabat et al. (1991).
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A. Leader sequence >  < -  Variable region sequence -►
-20 20
BV6S2  CCCTCTGTGTGCTGGGGGTGGGTCATACAA GAGCTGGAGTAGTGTCCCAGTCACCTGGGT 
BV6S3  -C --------------------------C— CA— C
40 60 80
BV6S2  ACAGGGTCGCAGGCAGGGGCCAGACTGTGAATTTCAGGTGTGATCCAATTCCTGGTCACC
BV6S3  --------------T---------- G---------------------------------------C -T -----------------C------------ T---------------TG
BTB50  . - T ---------------TG
100 120 1 4 0
BV6S2  AAGTCCTTTACTGGTACCGACAGATGCTGGGGCAGGGTCTGGAGTACCTGACTTATTTTC
BV6S3  TTTC------------- T---------------------------- CC----------------------- C-CA------- TTT---------------C-------
BTB50 TTTC------------- T---------------------------- CC----------------------------CA-------TTT---------------C-------
1 6 0 1 8 0 200
BV6S2  AGGGCAAGGAGGAAC CAGACAAAT CAGGAAT GCCTAAAAACCGGTTTT CT GCT GAGAGGC
BV6S3  -A A A -G -C C -A -G -A T ------------------------- G------------------------------------------------------------------
BTB50 -A -A -G — C-AC----T-------------------------- G----------------------------------------A------------ A--------
220 2 4 0 2 6 0
BV6S2 CTGAGAGCACGTACTCCTATCTGAAGATCCAGCCAGTGGAGCCCGAGGACTCG 
BV6S3  -------------------- A-------------------------------------------------------------------------G------------ AGCAGTGT
2 8 0
BV6S3
BTB50
AT CT cT GT GCCAGCAGC
B.
BV6S2
BV6S3
BTB50
BV6S2
BV6S3
BTB50
CDR1
20
LCVLGVGHTR AGWSQSPGYRVAGRGQTVNFRCD
A RH--------------------- L—
V*
CDR2
60 80
4 0
P IP  GHQ '/LYWYRQMLGQGLEY LTYFQ
■S—V 
SNS— V
s ------------- T--------P -F
5------------- T--------P -F
GKEEPDKSGM PKNRFSAERPESTYSYLKIQPVEPEDS
---
DEQQL---------- l l I l I K 1 1 1 1 1 * 1 1 1 1 1 1 1 1 1 > 1 1 Q 
C 
1 1
AVYLCASS
Figure 5.7. Alignment of the nucleotide (A) and amino acid (B) sequences of a new 
member of the bovine TCRBV6 subfamily (BV6S3) with the sequences published by 
Tanaka et al. (1990) (BTB50) and Buitkamp et al. (1993) (BV6S2).
197
A .
^ ----------------- Leader sequence  ►
- 4 0  - 2 0
BTB90 ATGGGCAACCAGGTGATCTGCTGCGTGGCCCTTTGTCTCTTTGGAGCAGGCACCGTG
Variable region sequence
2 0  40 60
BTB90 GCTGGTGGGGTCACTCAGACCCCTAAATACCTGCTCAAAAAGGAAGGCGGAGCTGTGACCCTG 
BV1 7S2 -CT-AA-TCT-CCAGATA-G— TT------------ GCTG------- CT------CAG-A---------------------
80  1 0 0  1 2 0
BTB90 GAAT GT GAACAGGAT TTT GAT T AC GACT CAAT GT ACT GGT AC C GACAGGAC C CAGGT CTA
BV1 7S2 — G-------A C-CC-G -G C AGTG-C----------------------------- G------------------------G-AG
1,40 1 6 0  1 8 0
BTB90 GGACTGAGGCAGATCTTCTTCTCGCGAGTTGTAAACAATGTTCAGAAAGAAGACATAGCT
BV1 7S2  — T-------- A— T----- T -A T -A  TACG------------------ GG— A----------- G— G T— T—
2 0 0  2 2 0  2 4 0
BTB90 AAAGGCTACAGCGCCTCTCGTGAAAAGAAGCCTTTCTTTCCTCTTACCGTGACATCAGCA
BV1 7S2 G---------------------T -T ------------- A— G------C— GAGC-G----------------C---------------AG----------T
2 6 0  2 8 0
BTB90 CAGAAGAACCAGAC GGCT CT GT AT CT CT GT GCT GCT GGA
BV1 7S2  — C-CC------------ A— A— CG------C CT GG-CT
B.
BTB90 
BV1 7S2
BTB90 
BV1 7S2
CDR1
20 40
MGNQVICCVALCLFGAGTV AGGVTQTPKYLLKKEGGAVTLECE SMYWYRQDPGL
CDR2
60
AEIYQIRF— AEA-QD----------
80
K-HLG- SA---------------- Q
GLRQIFFS RWNNVQKED 
— K L-YY-T— K DI-RG -
IAKGYSAS REKKPFFPLTVTSAQKNQTALYLCAAG 
LSE V QEL K— HT V SGA
Figure 5.8. Alignment of nucleotide (A) and amino acid (B) sequences of a new member 
of the bovine TCRBV17 subfamily (BV17S2) with the sequence published by Tanaka et 
a l (1990).
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Table 5.1. Comparison of the sequences of new bovine TCRBV subfamily members 
with published bovine and human sequences.
Bovine
subfamily
designation
No. of 
clones
Represent
-tative
clone
Percentage identity with 
published bovine TCRBV 
sequences
Percentage identity with 
human TCRBV sequences
Clone nt aa Segment nt aa
BV1S1 4 IC5 BTB18a 100 100 B v i s r 78 63
BV1S2 4 IC93 BTB18 94.7 81.5 BV1S1 78 67
BV1S3 6 C20 BTB18 82.0 66.0 BV1S1 79 72
BV1S4 4 C12 BTB18 81.1 65.4 BV1S1 79 63
BV1S5 3 C50 BTB18 87.7 75.8 BV1S1 77 66
BV1S6 6 C55 BTB18 80.7 64.8 BV1S1 77 65
BV1S7 3 C125 BTB18 83.8 70.0 BVIS1 81 72
BV1S8 2 C54 BTB18 84.7 73.9 BV1S1 76 64
BV1S9 4 IC58 BTB18 80.9 66.3 BV1S1 77 63
' BV1S10 1 C30 BTB18 80.7 62.5 BV1S1 77 67
BV1S11 1 C47 BTB18 81.6 61.8 BV1S1 76 66
BV2S1 4 IC47 BTB4a 98.9 92.5 BV2S1C 79 66
BV2S2 1 IC14 BTB10a 95.4 88.3 BV2S1 79 65
BV2S3 6 D28 BTB10 99.6 98.9 BV2S1 78 63
BV2S4 3 C23 BTBla 95.4 85.3 BV2S1 78 63
BV2S5 2 C56 BTB1 95.4 83.9 BV2S1 78 63
BV2S6 4 C36 BTB1 97.5 90.4 BV2S1 77 64
BV2S7 1 IC44 BTB10 94.2 86.2 BV2S1 78 66
BV3S1 2 CIO BTB91a 100 100 BV3S1C 77 72
BV4S2 1 D16 BTB93a 90.1 82.7 BV4SJd 80 77
BV6S3 5 D22 BTB503 93.5 84.9 BV6S1- 74-77 62-77
VB6ab 84.3 81.2
BV7S1 2 C25 BTB273 99.0 97.1 BV7S1- 69-77 52-68
S3iil
BV12S1 2 IC61 BTB13a 99.6 98.7 BV12SP 66 55
BV12S2i 65 55
BV15S1 1 D23 BTB22a 98.9 97.8 BV15S1g 83 70
BV15S2 2 C49 BTB453 100 98.9 BV15S1 82 69
BV17S2 2 IC46 BTB903 71.1 55.8 B v n s r 74 64
Notes: nt=nucleotide; aa=amino acid. The sequences used for comparison are contained in the following 
references; GenBank accession numbers are shown in square brackets: Tanaka et al. (1990)a [D90121- 
D90133]; Buitkamp et al. (1993)b [L18952];Concannon et al. (1986)c [M13836, M13842, M13843]; 
Kimura et al. (1986)d [X04934]; Kimura et al. (1987)e [M27383, M27388]; Ferradini et al. (1991)f 
[X58806, X58805, X58813, X58811, X58808]; Tillinghast et al. (1986)g [M14262, M14268, M14269]; 
Santamaria et al. (1993)h [L06887],
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Table 5.2. Comparison of the nucleotide sequences of bovine TCRBV1 subfamily
members.
SI S2 S3 $4 55 S6 S7 S8 S9
■
S ll
SI - 95.4 79.9 82.5 90.2 81.6 85.5 85.9 80.8 82.5 80.3
S2 - 80.2 81.0 89.3 79.3 85.5 84.7 81.0 81.8 79.6
S3 - 84.4 84.4 88.3 91.5 86.5 87.7 93.7 89.6
S4 - 84.8 93.4 89.7 85.6 88.5 86.8 86.3
- 84.4 87.4 88.4 84.6 86.2 82.5
V i | - 93.7 83.5 87.3 89.6 87.9
o / . - 88.1 89.6 92.2 88.3
S8 - - 83.8 85.8 82.9
S9 - 87.3 85.0
S10 - 94.6
S ll -
Table 5.3. Comparison of the nucleotide sequences of bovine TCRBV2 subfamily
members.
SI
95.0 95.6 95.0 96.4 93.5 96.0
96.0 94.6 96.1 95. 96.7
S3 94.594.993.0 96.7
95.1 96.1 94.0
96.1 96.4
S6 93.9
Notes: Pairwise comparisons of the nucleotide sequences of the different subfamily 
members in BV1 and BV2 were performed using the BESTFIT and FASTA programs in 
the GCG package (Devereux et al., 1984). The percentage nucleotide identities between 
the sequences are shown in the above tables. The percentage nucleotide identities of the 
most similar and the least similar members within each subfamily are shown in bold type 
in shaded boxes.
200
5.3.2.2. New TCRBV  subfamilies.
A number of clones contained sequences which had less than 75% nucleotide coding 
region homology with published bovine TCRBV sequences. These were tentatively 
assigned to seven new TCRBV subfamilies and where possible, consensus sequences 
were derived. The sequences were screened against human TCRBV sequences, and the 
new subfamilies were assigned numbers corresponding to the human BV  genes to which 
they showed the closest homology. Comparisons of the new subfamily sequences with 
human TCRBV sequences are shown in Table 5.4.
Two of the new subfamilies, BV10 and BV13, consisted of at least 3 closely related but 
distinct sequences. The alignments of the nucleotide and protein sequences of the three 
members o f B V I0 are shown in Figure 5.9. The nucleotide sequence similarity between 
different members of BV10 ranged from 87.5 to 94.9% and the amino acid identity 
between protein sequences was 79.1-91.3%. Many of the amino acid differences between 
the protein sequences are found within the proposed hypervariable regions (CDRs). One 
sequence is shorter than the other two by one amino acid, due to deletion of a codon at 
position 114, as shown in the alignment. Since this subfamily member is represented by 
two clones from the same PCR reaction, it is possible that the deletion may have been 
introduced during amplification. However, the sequence contains additional differences 
that distinguish it from the other subfamily members, suggesting that it does represent a 
distinct gene segment.
The nucleotide and protein sequences of the three members of BV13 are compared in 
Figure 5.10. The percentage nucleotide similarity between the different members is 88.7- 
95.6%, with 77.2-91.2% identity at the amino acid level. In this subfamily, the coding 
differences between the members are distributed throughout the length of the molecule, 
rather than being concentrated in the CDRs.
Three new subfamilies consisted of a single member, as all the clones assigned to BVI4, 
BV20 and BV24 contained identical or almost identical sequences. Two of the new 
subfamilies, BV9 and BV16, were represented by only one sequence each. These 
sequences and the deduced peptide sequences are shown in Figure 5.11.
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A .
<--------------- Variable region sequence ---------------►
10 3 0  50
BV10S1  GAGGT CAC CCAGAGT CCAGGT CAT CT GGT CAAAGGAAAAGACCAGAAAGCAAAGAT GGAT
BV1 OS 2  --------------------------------------------------------------------------------------------------------------------------------
BV10S3------------------ — T -------------------A---------------- A-------------------------------------- G---------------------------
70  90  1 1 0
BV10 S 1 T GT GT CCCCATAAAAGGACAT GTT CAT GT AT ACT GGT AT CACAAGAAGCCAGAAGGAGCA
B V 10S2 ------------------ G------G------------ C -C -T C  T--------------------- G------------- TG— . . . -----------
BV 10S3  T A -G --------------- C -C -T -C — T-------------------- G---------------- TG--------- A------
1 3 0  1 5 0  1 7 0
BV10S1  TTTGAGTTTTTGGTTTATTTGTGGAATGGAAAAGTTACAGAAGATACAGCCATGTTCAAA
BV10S2  ---------------------------------------------- T-------------------------------------------------------------------------------
BV10S3  ------------------------------------------ TCA C A -G -C A -G -TG  A-------------- TC----------------
1 9 0  2 1 0  2 3 0
BV10S1  CAGCGATTTTCAGCTGAGTGTCCCCAGAACTCACCCTGCAGCCTGGAAATCAACTCCACT
BV10S2  ------------------------------------------C a ---------------------------------------------------------------------C
BV10S3   ------- C— —  A— — — — — — — — — — ------------------ C
2 5 0  2 7 0
BV10S1  GAGGCAGCGGACTCGGCTCTGTATTTCTGTGCCAGCAGC
B V I0S2  -----------------------------------------------------------------------------------
BV10S3 -------- C-------------------
B.
BVI0S1  
BV10S2  
BV10S3
BV10S1 
BV1 OS 2 
BV10S3
CDR1 CDR2
20 40 60
EVTQSP GHLVKGKDQKAKMDCV PIKGHV HVYWYHKKPEGAFEE LVYLWNGKVTEDTAM FK
I I l I w I I H 1 1 1 1 1 V 1 1 1 1 1 1 -K E — AY--------R— L -E -------- ----- FQ-QDMM-N— L —
70 90
QRFSAECPQNSPCSLEINSTEAADSALYFCASS
Figure 5.9. Alignment of the nucleotide (A) and amino acid (B) sequences of the 
members of the bovine TCRBV 10 subfamily. To maximize the alignment, gaps have been 
introduced at positions 114, 115 and 116 of the nucleotide sequence and the 
corresponding amino acid position 41 in the peptide sequence of BV10S2.
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A.
BV13S1
BV13S2
BV13S3
BV13S1
BV13S2
BV13S3
BV13S1
BV13S2
BV13S3
BV13S1
BV13S2
BV13S3
BV13S1
BV13S2
BV13S3
10 30 50
GGTGTCACTCAGGACCCCAGATTCCAGGTCGTGAGGACAGGACAGAACGCGACACTGACA 
— A------------------------------------------------------------------------ G---------------- G----------------------- A -
7 0  90  1 1 0
T GTACT CAGGAT CT GGGT CATAACT CT AT GT ACT GGTACCGACAAGACCT GGGACACGGG 
-------------------------------------------- G— CGC----------------------------------------------------------------------
1 3 0  1 5 0  1 7 0
CTGAGGCTGATCTATTACTCAGCTGGGCCTCCCACCACAGTGAAAGGAGACGTGCCCGAC
-------------------------------------------------------T G T G -G -T -T -G C -A -C C ----------------------------------
------------------------- c --------------------------- TGTG-GGT-T-GC-A-CC---------------------------------
1 9 0  - 2 1 0  2 3 0
GGGTACAGTGTCTCCAGATCAAGCAAAAACCACTTTCCTCTCACTCTGGAGTCCGCCAAC
A-------------------------T----------------- A— C-G -GA-------------------------- A------A---------T-----------
2 5 0  2 7 0
CACT CC CAAACAT CCGT GT ACTT CT GT GC CAGCAGT
-G T  G T-------------------------------------- G-G
B.
BV13S1
BV13S2
BV13S3
CDR1 CDR2
20
GVT Q D P R FQ W R T GQNAT LT CT
-------------------------R— ST AJ
80
40 60
2DLGHN 5MYWYRQDLGHGLRI IYYSAGPPTTVKGDVtPD
---------- VRSSEP--
-H  VRSSEP—
BV13S1  GYSVSRSSKNHFPLTLESANHSQTSVYFCASS
BV13S2  -------------- NTEN---------- K------R-----------------------
BV13S3  R-------F— NTEN----------K R--------------------- G
Figure 5.10. Alignment of the nucleotide (A) and amino acid (B) sequences of the 
members of the bovine TCRBV 13 subfamily.
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A. BV9S1
T AGAAC AT C C T AGAAT GT GAG CAAAAG cT G GAACAT GAT AGTAT GT AT T GGT AT AAG CAG 
* N I  L E C E Q K L E H D S M Y W Y K Q
GACTCCAAGAAATTGCTGAAGGCTATGTTTAGCTACAATAATAAGCTACTCGTTGGAAAT
D S K K L L K A M F S Y N N K L L V G N
GAAACGGTGCCAAGTCGTTTCTCACCGGAGTCTCCTGACAAAGCTCATTTAAACCTTCAC 
E T V P S R F S  P E S P D K A H L N L H
ATCGACTCCCTGGAGCCAGGCGACTCTGCCATGTATTTCTGTGCCAGCAGC 
I D S  L E P G D S A M Y F C A S  S
B. BV14S1
GAG C C CAAGACAC C GCAT CACAGAGAC CAGAAAGAGGGT GACAT T GACT T GT T CT CAGAA 
S P R H R I T E T R K R V T L T C S Q N
TATGAACCATGATGCGATGTACTGGTATCGACAaGACCCAGGGCTGGGTCCAAAGCTGAT
M N H D A M Y W Y R Q D P G L G P K L I
CTACTTTTCAAGGAATGTTGGGTTTATTGAAAATGGAGATATCCCTGATGGATACAcTGC
Y F S R N V G F I E N G D I P D G Y T A
CTCTCGAGAAGAGAAACCAAACTTCCCCCTGACCTTGGAGTTGGCCAGCACCaACCAGAC
S R E E K P N F P L T L E L A S T N Q T
CTCCTTGTACCTCTGTGCCAGCagt
S L Y L C A S S
Figure 5.11. Nucleotide and amino acid sequences of new bovine single-member TCRBV 
subfamilies. A -BV9S1. B -BV14S1.
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C. BV16S1
GAAGT C GC C C AGT C C C C CAG C CAC AG GGT C AT AGAGAAGAAACAG G C T GT GAAT CT GAGT 
E V A Q S  P S H R V I  E K K Q A V N L S
TGTGACCaTATTTCTGGACATGAATcTCTTTTTTGGTACTACCATGCTGTGGGGAAAGAA 
C D H I  S G H E S L F W Y Y H A V G K E
AT GAAACTT CT GATTTACTTCCTAAGAGAGTCTAt GCAGGATGACTCGGGGAT GCCCAAA 
M K L L I Y F L R E S M Q D D S G M P K
GGCCGATTCACAGCAGAAAGGATGGAAGGGACATCtTCtACGCTGAGGGTCCACTCTGCA 
G R F T A E R M E G T S  S T L R V H S A
GAGcT GGGT GACT CAGGAGT GTAT cT C t  GT GCCAGCAGT 
E L G D S G V Y L C A S S
D. BV20S1
ACCATCCATCAGTGGCCATCCACGAGGGTGCAGCCTGCAGGCAGCCCGCTCTCTcTGGAG
T I H Q W P S T R V Q P A G S P L S L E
TGCaCCGTGAAGGGGACATCAAACCCCACCCTGTACTGGTACCGGCAGGAGGCAGGGGGG
C T V K G T S N P T L Y W Y R Q E A G G
AGCCTCCAGCAGCTCTTCTACTCTGTTAGTGCTGGCCAGATAGAACCTAGGGAGTTCCAG 
S L Q Q L F Y S V S A G Q I  E P R E F Q
AACTTCAAAGCTTCCAGGCCCCAGGACGGCCAGTTTACCCTGAGTTCTAAGAAGCTGCAG
N F K A S R P Q D G Q F T L S S K K L Q
CTCAACAACTCTGGCTTcTACTTCTGTGCCTGGAg. 
L N N S  G F Y F C A W X
Figure 5.11. (cont.) Nucleotide and amino acid sequences of new bovine single-member 
TCRBV subfamilies. C -  BV16S1. D -  BV20S1.
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E. BV24S1
AT GgT c  GTT CAGAAC C CAAGAT AC CT GGT t  ACC GGGCT G GGAAAAC CAGT GAC C CT GAGC 
M V V Q N P R Y L V T G L G K P V T L S
T GTT CT CAGAATAT GAAGCAT GAT G C CAT GT ACT GGT AC CAACAGAAGC CAAGC CAAGCA 
C S Q N M K H D A M Y W Y Q Q K P S Q A
C CAAAACT GCT GTT GT ACT ACTAT GATACACAAAT CAC CAAGGAAAAAAACAC CT CT GAA 
P K L L L Y Y Y D T Q I T K E K N T S E
AACTTCCAGTCCAGCCGGCcTAACaCCTCTTTCTGTTCTCTTGACATCCGCTCGGCAGGC 
N F Q S  S F T P N T S  F C S L D I R S A G
CT GGGGGACT CAGCCGTATAT cT CT GT GCCAGCAgC 
L G D S A V Y L C A S  S
Figure 5.11. (cont.) Nucleotide and amino acid sequences of new bovine single-member 
TCRBV subfamilies. E -  BV24SJ.
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Table 5.4. Comparison of the sequences of new bovine TCRBV subfamilies with
human TCRBV  sequences.
Bovine
subfamily
designation
No. of 
clones
Represent
-ative
clone
Percentage identity with human 
TCRBV  sequences
Segment nt aa
BV9S1 1 C68 BV9S1* 84 78
BV10S1 4 C63 BV I0Slh 76 56
BV10S2 2 C21 BV10S1 76 55
BV10S3 3 - D13 BV10S1 77 59
BV13S1 3 IC20 B v is s i - s e ■v 72-76 62-70
BV13S2 2 C48 BV13S1-S6 72-77 62-65
BV13S3 1 IC100 BV13SJ-S6 71-76 62-65
BV14S1 3 C43 B V l4 S f 81 63
BV16S1 1 D23 BV16S1' 76 62
BV20S1 4 C74 BV20S1f 80 74
BV24SI 5 C53 BV24Slt 80 69
Notes: nt=nucleotide; aa=amino acid. The sequences used in the comparisons are 
contained in the following references; GenBank accession numbers are given in square 
brackets: Ferradini et al. (1991)a [X58814, X58809, X58810, X58815]; Concannon et 
al. (1986)b [M13860, M13863]; Li et al. (1991)° [X61445, X61447]; Tillinghast et al. 
(1986y* [M l4267]; Plaza et al. (1991)' [X57723]; Charmley et al (1993)f [Z13967]; 
Robinson (1991)® [M62376],
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5.3.3. Analysis of the protein sequence of bovine Vp regions.
An alignment of the deduced amino acid sequences of representative members of each 
bovine TCRBV subfamily is shown in Figure 5.12. The sequences for BV9 and BV16 
have been omitted as these gene segments were represented by only a single clone each, 
and the complete sequence of the V genes was not obtained. The sequences are aligned 
according to the Kabat numbering system, which has been commonly adopted in similar 
studies (Kabat et a/., 1991). The hypervariable regions (CDR1 and CDR2) defined by 
Chothia et al. (1988) are indicated by boxes. Seven amino acids that are present in >90% 
of TCR Vp sequences of other species are conserved in almost all of the bovine 
sequences; these are Cys-23, Trp-34, Tyr-35, Gln-37, Leu-77, Tyr-90 and Cys-92. The 
only exception occurs in VplO, where a lysine is found at position 37 instead of 
glutamine; however a lysine is also present at this position in the predicted human 
VplO protein sequence and in three functional mouse TCRBV genes (BV9S1, BV19S1A1 
and BV20S1). Chothia et al. modelled the three-dimensional structure of the TCR by 
comparison with the immunoglobulin structures available from crystallographic analysis, 
and identified other framework residues that are highly conserved in both molecules, 
indicating that they are probably important in maintaining the overall protein structure. 
These residues are indicated with asterisks in Figure 5.12. Recent crystallographic 
analysis of the protein structure of the a/p  TCR has confirmed the importance of some 
of these residues in interactions between the VP domain and the Cp and V a domains, 
and in determining the conformation of the CDR loops (Garcia et al., 1996).
The sequences could be further classified by comparison with defined subgroups of TCR 
Vp sequences. Schiffer et al. (1986) divided TCR VP sequences into two subgroups 
based on the presence of paired residues that can form a salt bridge, a structural feature 
of immunoglobulin domains revealed by crystallographic studies. Sequences in subgroup 
I have an aspartic acid residue at position 86, which can form a salt bridge with an 
arginine, lysine or histidine at position 64, while subgroup II sequences do not contain 
these residues. In addition, subgroup I sequences have a phenylalanine at position 65 and 
a serine at position 87, whereas subgroup II sequences have tyrosine at position 65, a 
glutamine at 86 and a threonine at 87. Chothia et al. (1988) grouped protein sequences
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that are >50% identical within a species or >40% identical between species to form five 
Vp subgroups. The majority of human Vp proteins are in subgroups I and IV. Subgroups 
I-HI correspond to Schiffer’s subgroup I, while subgroup IV corresponds to Schiffer’s 
subgroup II. Subgroup V contains only two sequences, one human (VP20) and one 
murine (Vpl4, the homologue of human VP20), which have a leucine at position 65. As 
new subfamilies were discovered the classification was extended; Robinson (1991) 
proposed that the human Vp23 sequence, along with a mouse Vp sequence homologous 
to Vp23, should form a new subgroup related to, but distinct from, subgroup I. These 
sequences contain a glutamine at position 64 rather than arginine, but have other residues 
that could potentially form a reverse salt bridge.
In general, the bovine TCR Vp protein sequences can be assigned to the same subgroups 
as their human counterparts, but there are some exceptions. One member of BVl has 
valine at position 65 instead of phenylalanine, and three members of BV2 have isoleucine 
at this position (see Figures 5.4 and 5.5). These are conservative substitutions which 
would not be expected to alter the structural features of the protein; however, both could 
arise as a result of a single base change in the nucleotide sequence. That this may be due 
to PCR or sequencing errors is unlikely in view of the fact the sequences for all these 
subfamily members except one were derived from at least three clones from two different 
PCR reactions. The bovine Vp20 sequence has an asparagine at position 64 and 
phenylalanine at position 65, but does not fit into the previous classification because it 
contains an asparagine at position 86 (see Figure 5.12). This difference is almost 
certainly genuine, as the consensus sequence for the bovine BV20 gene was derived from 
four clones from three different PCR reactions.
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10
BV1 (IC 5 8 ) . . . VTQTPKY
BV2 (IC 4 7 ) . . . VSQQPRR
BV3 (B T B 91) DAQVTQTPRY
BV4 (BTB93) GTLVSQKPSR
BV6 (D 2 2 ) . . AVSQSPRH
BV7 (B T B 27) DPGITQIPKY
BV10 (C 63) DTEVTQSPGH
BV12 ( I C 6 1 ) . . AVTQFPRR
BV13 (IC 2 0 ) HAGVTQDPRF
BV14 (C 43) DADVTQSPRH
BV15 (B T B 22) DTGVTQIPRN
BV17 (BTB90) AGGVTQTPKY
BV20 (C 74) . . TIHQWPST
BV24 (C 53) . . MWQNPRY
20
LIKSRKQQVT
AVSKSGASVT
LVKRRGEKW
AICQRGTSVM
RVAGRGQTVN
LVMGMTDKKS
LVKGKDQKAK
RILETEKEFT
QWRTGQNAT
RITETRKRVT
RIANTGKSTV
LLKKEGGAVT
RVQPAGSPLS
LVTGLGKPVT
CDR1
30 39 49
A
CVP
LRCS 
IEC  
IE C I 
IECQ 
LRCD 
LTCE 
MD 
LQCS 
LTCT 
LTCS 
LECS 
LEC 
LECT 
LSCS
RA
JPESGHL
LDFQA
2NMDHE
VDSQGN
PISGHV
2HLGHD
IKGHV
2KMNHY
2DLGHN
2NMNHD
2TKGHD
DFDYD
VKGTSN
2NMKHD
E2
SVFWYQQAL 
TTVFWYRQFP 
RMFWYRQDP 
FMYWYCQLP 
SLYWYRQTL 
AMYWYKQSA 
HVYWYHKKP 
AMYWYRQDP 
SMYWYRQDL 
AMYWYRQDP 
YMYWYRQDP 
SMYWYRQDP 
PTLYWYRQEA 
. AMYWYQQKP
GQGPQ
krglm:
ALGLR
g q s l v :
GQGPEF
QKPPE
EGAFEE
GFGLRI
GHGLRP
GLGPKI
GQGLRL
GLGLRQ
GGSLQQ
SQAPK
EL'
IMA'
ll:
IMA'
EL1
IM
IL
VQY 
.TS 
HFS 
TA 
tLTYF 
FIH  
LVYL 
IYYS 
IYYS 
IYFS  
IYFS  
IF F S  
LFYS 
LYY
CDR2
59 62 68
BV1 ( I C 5 8 ) YDGKVYQKGN
BV2 (IC 4 7 ) NVGSDATYEQ
BV3 (BTB91) IDAGTVEEGD
BV4 (BTB93) NQGSKATYES
BV6 (D 22) QNDQGIDKSG
BV7 (BTB27) NYQKLTGNES
BV10 (C 63) WNGKVTEDTA
BV12 (IC 6 1 ) TGPGSFKKGD
BV13 (IC 2 0 ) AGPPTTVKGD
BV14 (C 4 3 ) RNVGFIENGD
BV15 (B T B 22) YGIDDINKGD
BV17 (BTB90) RWNNVQKED
BV20 (C 74) VSAGQIEPRE
BV24 (C 53) YDTQITKEKN
A
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RKEEAKFSLY
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RPQDGQFTLS
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LTPLELTDSA
VTRVDPADSS
LASATTNQTS
VSNASSEDSS
IQPVEPGDSA
LNALKPQDSA
INSTEAADSA
LKSASPNQTS
LESANHSQTS
LELASTNQTS
LEPATPNQTA
VTSAQKNQTA
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VYLCASS
LYFCGAW
MYLCASS
SYFCSAR
VYLCASS
IYLCASS
LYFCASS
VYFCASA
VYFCASS
LYLCASS
IYFCASR
LYLCAAG
FYFCAWR
VYLCASS
Figure 5.12. Alignment of the protein sequences of members of the different bovine 
TCRBV subfamilies. The clones representing each subfamily are shown in parentheses. 
The sequences are numbered according to the system of Kabat et al. (1991), and the 
boxes show the CDR1 and CDR2 regions, as defined by Chothia et al. (1988). The 
asterisks indicate important structural residues conserved between immunoglobulin and 
T cell receptors (Chothia etal., 1988). Invariant (or almost invariant) residues are shown 
in red. Residues used for defining bovine TCRBV subgroups are shown in green (see text 
for explanation of subgroups).
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5.3.4. Analysis of TCRBD, 5 / and BC  sequences.
The third hypervariable region (CDR3) of the TCR (3-chain spans the region encoded by 
the 3’ end of the BV  gene segment and the BD and BJ  minigenes; the region is further 
diversified by N region addition of nucleotides at the junctions between the gene 
segments. Comparison of the sequences encoded by TCRB mRNA transcripts with those 
of germline gene segments is necessary to determine with certainty the contribution of 
different BD and B J  gene segments to the generation of junctional diversity. As yet, the 
germline sequences of bovine TCRB gene segments have not been determined, so that 
precise identification and classification of the BD and B J  genes in the transcripts 
sequenced in this study was not possible. Tanaka et al. (1990) classified the B J  gene 
segments in their cDNA clones, which they defined as the 13 codons before the TCRBC 
region, into twelve different members. This region contains the highly conserved Phe- 
Gly-X-Gly motif, which is characteristic of all TCR J segments (Kabat etal., 1991).
Based on this approach, the amino acid sequences of the J(3 segments of 100 clones 
containing unique in-frame transcripts were examined, and 21 different sequences were 
identified at the protein level. The sequences formed 13 groups containing members that 
differed by only one or two amino acids. These groups may represent different B J  gene 
segments; there are 13 functional B J  genes in humans and 12 in mice. The variant 
sequences may have arisen from germline polymorphisms but, since they are all 
represented in only one clone, it is possible that they are the result of PCR or sequencing 
errors. Three sequences differed from another by only one amino acid at the 5’ end, 
which may be accounted for by variation introduced by N nucleotide addition. The 
protein sequences of the different B J  gene segments are shown in Table 5, along with the 
frequency with which they were identified in the clones examined. All the segments 
identified by Tanaka et al. (1990) were included in these clones except for one, and are 
indicated by asterisks in Table 5. Although Tanaka et al. stated that they found 12 
different BJ sequences, sequence data for only seven were presented in the paper. In the 
present study, two BJ  genes were represented at particularly high frequencies in both the 
individuals studied. Interestingly, one of these genes was also found in 5 out of 13 clones 
sequenced by Tanaka et al. (1990). Studies in humans have also demonstrated a bias in
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BJ  gene usage, with three BJ  gene segments being preferentially rearranged in most 
individuals (Rosenberg et al., 1992; Jores and Meo, 1993).
The remainder of the junctional region, encoded by the BD gene segment and N region 
nucleotides, varied in length from 2-13 amino acids. The TCRBD genes are highly 
conserved among different species (Schrenzel et al., 1994) and encode at least one 
glycine in all three reading frames of the gene. Of the 102 clones analyzed, 70 coded for 
at least one glycine within the estimated diversity gene region.
In common with the other species examined to date, cattle possess two distinct TCRBC 
genes (BC1 and BC 2\ which were sequenced and identified as the products of separate 
loci by Tanaka et al. (1990). The location of the TCRBC-specific antisense 
oligonucleotide used in the anchor PCR resulted in the inclusion of 41 bases of the 5’end 
of the BC gene segment in the cloned transcripts. Although the BC gene segments show 
close sequence homology within the coding region, the 5* region can be used to 
distinguish which of the two genes is being used. The two nucleotides at positions 14 and 
15 differ between BC l and BC2, resulting in a glutamine (CAG) or an arginine (CGC) at 
the corresponding position in the respective peptide sequences (see Figure 5.13). 
Examination of the BC  sequences of 101 clones containing unique transcripts revealed 
that 60 clones had the codon CGG at this position, which represents a single nucleotide 
difference from the sequence of either BC l or BC2, and codes for an arginine. All three 
sequences were found in clones from animal 5158 (D), whereas only the BC2 sequence 
and the variant sequence were isolated from animal 3327 (C). The most likely 
explanation for these results is that the variant sequence represents an allele of the bovine 
BC l gene segment because, in other species, both BC  genes are usually expressed. 
Again, this question can only be resolved by examination of the BC  sequences at the 
genomic level.
212
Table 5.5. Repertoire of BJ  gene segments expressed in bovine TCR (3-chain
messenger RNA.
BJ  gene segment 
Amino acid sequence
Number of clones containing BJ  gene segment (%)
C IC D Total
PLHFGIGTRLIVT 3(6.8) - 1(5.9) 4
DYHFGPGTKLTW 9 (20.4) 9(23.1) 4 (23.5) 22
_ _ R---------- 1 (2.3) — — 1
GYHFGPGTKLSW 1 (2.3) - - 1
EVFFGKGTRLTW 1(2.3) 2(5.1) - 3
------- ! ----- i (2.3) — 1
RLYFGNGTKLSVL 2(4.5) 2(5.1) 2 (11.8) 6
TQYFGAGTRLSVL 5 (11.4) 1(2.6) _ 6
P--------- T__* 1(2.3) - - 1
EQYFGPGTKLTVL* 4(9.1) 8 (20.5) 2 (11.8) 14
R ---------------------- 1(2.3) — — 1
EQHFGPGTRLIVL* 1 (2.3) 3(7.7) - 4
-L-------------------- 1 (2.6) — 1
IQYFGPGTRLLVL 1 (2.3) 2(5.1) - 3
QLYFGAGSKLTVL 2(4.5) - - 2
p -----------------------------------------------------------------* — 2(5.1) — 2
PLYFGGGTRLLVL* 9(20.5) 7(17.9) 5 (29.4) 21
ELYFGPGTRLQVL 1(2.3) - - 1
T------------ — 1 (2.6) 3(17.6) 4
ALTFGAGSWLTW* 1(2.3) - - 1
-------- R---L — 1(2.6) — 1
44 39 17 100
Notes: The predicted amino acid sequences of the 13 codons preceding the TCRBC gene segment in 100 
clones are shown in the left-hand column. Sequences differing by only one or two amino acids have been 
grouped; identical residues are shown as dashes. Single amino acid substitutions at the 5’ end of the 
sequence may be encoded by N region nucleotides. Other differences may be due to the presence of 
allelic variants or may have arisen through sequencing errors. The sequences identified previously by 
Tanaka et al. (1990) are indicated by asterisks.
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A.
TCRB Cl 
TCRBC2 
V a r i a n t
B.
TCRBCl
TCRBC2
V a r i a n t
10 20  30 40
GAT GAT CT GAGC CAGGT C CAC C C GC C CAAGGT GACT GT GT T C GAA
 GC------------------------------------------------------
 G--------------------------------------------------------
10
DDLSQVHPPKVTVFE
Figure 5.13. Nucleotide (A) and amino acid (B) sequences of the 5’ end of the TCRBCl 
and TCRBC2 genes identified by Tanaka et al. (1990), and the variant sequence 
identified in the present study.
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5.4. Discussion.
The results presented in this chapter have expanded the available data on the extent of 
the bovine TCRBV repertoire. Previous data published by Tanaka et al. (1990) identified 
members of nine bovine TCRBV subfamilies, but the small numbers of sequences did not 
permit a detailed classification. In the present study, sequencing of more than 100 clones 
resulted in the discovery of 29 new TCRBV gene segments, and allowed a classification 
system for bovine TCRBV genes to be established. Seven new subfamilies were 
identified, on the basis that their sequences showed less than 75% nucleotide similarity to 
the published bovine TCRBV sequences, and closer homology to the corresponding 
human TCRBV subfamilies. Two of the new subfamilies, BVJO and BV13, were multi- 
membered, each containing 3 distinct sequences; the other five new subfamilies, BV9, 
BV14, BV16, BV20 and BV24, contained a single member each. In addition, a large 
number of new members were identified in subfamilies BV1 and BV2, and new single 
members were assigned to the BV4, BV6, and BV17 subfamilies. This brings the total 
number of bovine TCRB V gene segments so far identified to forty-one.
One drawback of examining the TCR repertoire at the level of mRNA expression is the 
difficulty in distinguishing between allelic variants and closely related subfamily members 
at distinct loci. This can only be resolved definitively by sequencing and mapping of 
germline TCRBV gene segments. Arden et al. (1995a,b), found that TCRBV alleles in 
mice and humans rarely differ by more than 5 nucleotides, while different subfamily 
members usually differ by at least 10 nucleotides. There are exceptions to this rule, 
however; for example, the closely related human BV8S1 and BV8S2 gene segments differ 
by only 5 nucleotides (Siu et al., 1986) and alleles of the BVJO gene in mice show 9 base 
substitutions (Smith et al., 1990). In the present study, identical sequences and those that 
differed by only a few nucleotides were grouped together to provide a consensus 
sequence and clones identical to the consensus were designated representative of that 
particular gene segment and used in sequence comparisons. The sequences that differed 
from the consensus by 1-4 bases may represent allelic variants, or alternatively could 
have arisen from misincorporation of nucleotides by the DNA polymerase enzyme during 
the amplification or sequencing reactions. In a few instances, a consensus sequence could 
also be established for the variant; however in many cases they were represented by only
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one or two clones. Sequencing of a larger number of clones from different PCR reactions 
would be required to verify the variant sequences and eliminate errors.
Sequence errors arising from misincorporation of nucleotides by enzymes could have 
been introduced at four different stages of the isolation, cloning and sequencing of the 
bovine TCRBV genes. First, errors may have occurred during the synthesis of cDNA by 
the reverse transcriptase enzyme. Errors may also have arisen during the anchored PCR 
reaction and the PCR reaction used to amplify cloned inserts for preparation of single­
stranded sequencing template. Finally, errors could have occurred during the sequencing 
reactions performed either with Taq DNA polymerase or modified T7 DNA polymerase 
(Sequenase®).
The majority of errors found in cloned sequences are most likely to have occurred during 
the amplification of cDNA in the anchored PCR. Ennis et al. (1990), in an analysis of 
errors introduced by Taq DNA polymerase during amplification of HLA-A and B alleles, 
found point mutations, deletions, insertions and recombinant sequences, with point 
mutations being the most frequent types of error. In vitro recombination can arise during 
the amplification of closely related sequences as a result of incompletely elongated DNA 
strands annealing to heterologous target sequences, followed by extension and 
completion in a subsequent cycle. The estimated error rate (mutations per nucleotide per 
cycle) of Taq DNA polymerase varies from 2 x 10"4 during PCR (Saiki et al., 1988) to 
2 x 10'5 for point mutations produced during a single round of DNA synthesis of the 
lacZa gene (Eckert and Kunkel, 1990). The fidelity of the enzyme is influenced by a 
number of variables in the reaction conditions, including the relative concentrations of 
Mg2+ and deoxynucleotide triphosphates (dNTPs), pH and temperature (Eckert and 
Kunkel, 1993). Recombination between similar sequences is promoted by high initial 
target DNA concentration, short extension times and a large number of amplification 
cycles (Meyerhans et al., 1990). In order to anneal to heterologous target sequences, 
incomplete extension products must compete with the normal oligonucleotide primers 
for target sequences. The probability of this occurring increases as the ratio of normal 
PCR primers to target DNA progressively decreases with successive rounds of 
amplification. The frequency of errors of all types also increases as the number of
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amplification cycles increases and so it is desirable to keep the number of cycles to the 
minimum possible.
Optimal conditions for high fidelity PCR have to be balanced against requirements for 
efficient amplification. Unfortunately, because of the relatively low efficiency of the 
anchored PCR, a large number of amplification cycles are required to obtain sufficient 
DNA for cloning (thirty-five in the present study). A number of modifications to the PCR 
protocol were introduced when amplifying the TCRBV sequences of CD2'CD8+ T cells 
isolated from animal 5158, to try to reduce the number of errors. More Taq DNA 
polymerase was included in the reactions to avoid exhaustion of the enzyme, and it was 
supplemented with Taq Extender, which contains 3’-5’ exonuclease (proof-reading) 
activity, and therefore reduces the rate of nucleotide misincorporation. The extension 
time at 72°C was increased from one to two minutes to reduce the likelihood of 
prematurely terminated strands resulting in recombinants. The success of these 
modifications in reducing the frequency of errors was difficult to assess, however, 
because the number of clones from this reaction that were sequenced was relatively 
small. Also, since the sequences were derived from a different animal than the one used 
with the original protocol, it was difficult to distinguish differences due to expression of 
another allele in the second animal from those due to PCR error. Nevertheless, some 
sequences derived from animal 5158 were identical to those found in animal 3327.
In an attempt to minimize errors during the amplification of cloned inserts, the reactions 
were performed using Vent® DNA polymerase (derived from Thermococcus litoralis), 
an enzyme with 3’-5’ exonuclease activity which results in increased fidelity of DNA 
replication in comparison to Taq DNA polymerase (Cariello et al., 1991). In a number of 
clones, sequence from the antisense strand was derived from cycle sequencing of 
amplified inserts, while sequence from the complementary strand was obtained by 
directly sequencing plasmid DNA using Sequenase®. In the region in which these 
sequences overlapped, there were no mismatches found between the bases. Although this 
comparison was possible only in a relatively small number of clones, it suggests that few 
errors occurred during PCR amplification of cloned inserts using Vent®. During 
sequencing reactions, more errors would be expected using cycle sequencing than with
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Sequenase, as T7 DNA polymerases have been reported to show higher fidelity than Taq 
DNA polymerase (Cariello et al., 1990). However, Koop et al. (1993) found almost 
identical error rates when comparing manual Sequenase™ and automated Taq cycle 
sequencing methods in a large-scale genome sequencing project.
Comparison of the sequences in subfamilies BV1 and BV2 with published sequences 
revealed some anomalies in the published sequences. Alignment of nucleotide sequences 
of BV1 subfamily members with BTB18 required a ffameshift in all the sequences in 
order to maximize the alignment, leading to a complete change in 9 amino acids of the 
deduced protein sequence in this region. The resultant protein sequence of BTB18 
eliminated the subgroup-specific residues Arg-64 and Phe-65 found in nearly all other 
members of the subfamily and in homologous human sequences. This suggests that the 
anomaly is due to an error in the published sequence of BTB18.
In the BV2 subfamily, maximal alignment of the sequences most closely related to BTB1 
and BTB4 with the published sequences required the introduction of a gap of two base 
pairs near the 5’end of the published sequences. This resulted in a change in the deduced 
protein sequence over the first 10-12 residues of the variable region, so that in this region 
the new sequences were identical to BTB10 at the amino acid level. The protein 
sequences for BTB4 and BTB1 do not contain a valine or isoleucine at position 4, 
glutamine at position 6 or proline at position 8, residues that are conserved in almost 
every TCR Vp gene segment. However, these residues are found in BTB10 and in the 
deduced protein sequences of every subfamily member identified in the present study. 
These findings suggest that the deletion of two nucleotides near the 5’ ends of BTB1 and 
BTB4 may arise from defective mRNA transcripts or are the result of errors in 
sequencing of these clones.
Comparison of the bovine and human TCRBV gene segments confirms the observation 
made when comparing mouse and human sequences, that members of one subfamily 
were closer to a human BV  gene than to members of other bovine subfamilies. Thus, 14 
of the 20 mouse TCRBV subfamilies share more than 60% identity to their human 
homologues at the protein level, while a comparison between subfamily members within
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a species shows identities below 40% at the amino acid level (Clark et al.7 1995; Arden 
et al., 1995b). The bovine TCRBV subfamily members also show greater than 60% 
identity to their human counterparts at the protein level, except for members o f BV 10 
(57%) and BV12 (55%). However, the average amino acid similarity between the genes 
in different bovine BV  subfamilies is 50%. In physical maps of the TCRB locus in mice 
and humans, the relative order of the TCRB V homologues is highly conserved, although 
internal duplications have occurred in the human locus (Lai et al., 1988; Rowen et al., 
1996). These observations have been cited in support of the hypothesis of trans-species 
evolution i.e. the retention of ancestral V gene segments through speciation. Different 
species have subsequently used different diversification strategies, including gene 
duplication and deletion. In contrast to mice, in which the majority of TCRBV subfamilies 
contain a single member, many human TCRBV subfamilies are multi-membered, the 
largest being BV5 (7 members), BV6 (9 members), BV8 (5 members) and BV13 (8 
members) (Arden et al., 1995a,b).
The present study shows that many bovine TCRBV subfamilies are also multi-membered, 
but the largest subfamilies are BV1 and BV2, both of which contain a single functional 
member in humans. Three members of the bovine BV13 subfamily were identified, while 
the sequence for bovine BV6 found here differs from two previously published partial 
sequences, indicating that this subfamily may also contain at least three members. Bovine 
homologues of human BV5 and BV8 were not identified in this study. These findings 
suggest that, in comparison to humans and mice, the basic germline TCRBV repertoire in 
the bovine has been diversified by different duplication and/or deletion events following 
divergence of the species. Interestingly, Schrenzel et al. (1994) identified four unique 
members in the horse TCRBV2 subfamily, suggesting that duplications involving this 
gene segment may also be found in species more closely related to cattle.
Previously, Tanaka et al. (1990) attempted to estimate the number of members within 
each bovine TCRBV subfamily and to assess polymorphism of the TCRB genes by 
genomic Southern blot analysis using DNA from four different breeds of cattle. No 
restriction fragment length polymorphisms (RFLP) were identified with two different 
5C-specific probes and eight 5F-specific probes (BV2, BV3, BV4, BV6, BV7, BV12, 
BV15 and BV17), after digestion of genomic DNA with two different enzymes (Pst I and
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Eco RI). However, in another study, four different RFLP alleles were detected in Taq I- 
digested genomic DNA with a single bovine TCRBV probe, but the BV  gene segment to 
which they corresponded was not determined (Lunden et al, 1991). Based on the number 
of bands observed in Southern blots of genomic DNA hybridized with bovine 5 F-specific 
probes, Tanaka et al. concluded that TCRBV subfamilies contain relatively few members. 
These findings are not in agreement with the present study, in which a total of seven 
potential members were identified in the BV2 subfamily, which was one of those 
examined by Tanaka et al. There are a number of possible explanations for this 
discrepancy. First, the BV2 subfamily members may be closely linked genes and therefore 
localized to only one or two restriction fragments. The major fragment of Ps/I-digested 
genomic DNA which hybridized to the PF2-specific probe in Tanaka’s study was 3.4kb 
long, and therefore could accommodate two, or possibly three, closely linked genes. 
However, a few additional faint bands were also detected with this probe. Second, the 
probe may not hybridize to all members of the subfamily with equal efficiency, so that 
some members would not be detected. This possibility is perhaps less likely, given the 
close homology between the sequences of the BV2 subfamily members and the low 
stringency of the hybridization procedure used in Tanaka’s study. Third, some of the 
unique BV2 sequences may represent allelic variants encoded at the same locus, reducing 
the estimated number of separate gene segments. Unless the allelic polymorphisms were 
associated with specific RFLPs, these variants would localize to the same fragment in the 
Southern blot. However, the different BV2 subfamily members differ by nine or more 
nucleotides, making it more probable that they are products of distinct loci.
Buitkamp et al. (1993) investigated germline polymorphisms of the BV6 gene in a 
number of artiodactyl species by sequencing of clones following amplification with 
primers based on the human sequence. In cattle, they identified only one amino acid 
polymorphism in five individuals representing three different breeds (Simmental, N ’Dama 
and Zebu), and the sequences reported here and by Tanaka et al. (1990) were not 
isolated. This may be because the PCR products selected for sequencing by Buitkamp et 
al. hybridized to a (CA)8 probe designed to detect GT dinucleotide repeats within the 
intron sequence. Thus, BV6 gene segments that lack these dinucleotide repeats in the 
intron, or hybridize inefficiently to the probe, could have been overlooked. Alternatively, 
since the primers used in the PCR were based on human BV6 sequences, they may not
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hybridize efficiently to all members of the bovine BV6 subfamily. In support of this, both 
BV6SJ (Tanaka et al., 1990) and BV6S3 (this study) show nucleotide sequence 
similarities of -85% to BV6S2 (Buitkamp et al.y 1993), but are much more closely 
related to one another (93.5% identity at the nucleotide level). This suggests that, 
following gene duplication, some gene segments diverge more rapidly than others, 
presumably as a result of selection pressure, but others show a high degree of 
conservation across species.
In summary, seven new bovine TCRBV subfamilies and about 20 new members of 
previously described subfamilies have been identified using the anchored PCR to amplify 
the V region of TCRB mRNA transcripts. Further sequencing on both strands of a 
number of clones from different PCR reactions is required to eliminate errors and 
confirm the sequence variants that differ by only a few nucleotides. The full extent of the 
bovine TCRBV repertoire and the precise definition of alleles and distinct BV  gene 
segments awaits the more detailed examination of germline BV  sequences and mapping 
of the bovine TCRB locus.
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CHAPTER SIX
ANALYSIS OF TCRBV GENE USAGE IN THE PRIMARY IMMUNE 
RESPONSE TO THEILERIA PARVA.
6.1. Introduction.
As previously discussed, the diversity of the T cell receptor variable regions is generated 
by the somatic recombination of different V, D  (p and 5 chains) and J  gene segments. 
Further diversity in the junctional regions is introduced by imprecise joining of gene 
segments and N region addition of non-germline encoded nucleotides. The pairing of 
different a  and p (or y and 8) TCR chains results in an estimated 1016 potential junctional 
combinations for the resulting heterodimers (Davis and Bjorkman, 1988). However, the 
TCR repertoire expressed by peripheral a/p  T cells is much more limited than that which 
would be predicted by completely random association of different gene segments, and is 
shaped by a variety of influences. Certain TCRBV and TCRBJ gene segments are 
preferentially used in all individuals of a species, regardless of their genetic background, 
although the mechanisms controlling differential expression are unknown (Rosenberg et 
al., 1992; Jores and Meo, 1993). Germline deletions within the TCRB locus, involving 
the loss of TCRBV gene segments, have been found in both laboratory and wild mouse 
strains and in the human population (Behlke et al., 1986; Pullen et al., 1990a; Zhao et 
al., 1994). The human TCRBV repertoire is limited by various molecular defects that 
prevent the expression of functional transcripts for a number of TCRBV gene segments 
and alleles (Charmley et al., 1993; Barron and Robinson, 1994; Posnett et al., 1994; 
Currier et al., 1996). The processes of positive and negative selection during T cell 
maturation in the thymus also have an important role in shaping the peripheral a/p  TCR 
repertoire. Although it has been shown that the MHC genes have a major influence on 
the outcome of thymic selection, there is also evidence for the involvement of non-MHC 
genes (Bill et al., 1988; Fry et al., 1989; Akolkar et al., 1993,1995). In mice, the most 
striking example of the effect of non-MHC genes on selection of the TCR repertoire is 
the deletion of subsets of T cells expressing specific Vp elements by the self­
superantigens encoded by endogenous retroviruses (reviewed by Simpson et al., 1993).
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Finally, the TCR repertoire may be modified by environmental factors such as exposure 
to antigens, superantigens or mitogens. In particular, the TCRBV repertoire of CD8+ T 
cells in the PBMC of normal human subjects can be altered by the oligoclonal expansion 
of CD8+ subsets, presumably in response to infections. These expanded subsets, which 
express the ‘memory’ cell marker CD45RO, often persist over long periods of time 
(Hingorani etal., 1993).
During immune responses to pathogenic organisms, naive T cells are activated following 
recognition of foreign antigen, i.e. peptides in association with self-MHC molecules, by 
the TCR. These antigen-specific T cells are clonally expanded to form effector 
populations of CD4+ Th cells and CD8+ cytotoxic cells. The repertoire of different V  and 
J  gene segments used by the TCR of the responding cells may be restricted or diverse, 
depending on the specific epitope, the restricting MHC element and the individual TCR 
repertoire. For example, in mice, T cell clones and lines responding to epitopes from 
proteins such as cytochrome c, myelin basic protein (MBP) or HLA-Cw3 in the context 
of a defined MHC molecule express a very limited TCR repertoire (Hedrick et al., 1988; 
Urban et al., 1988; Casanova et al., 1992). In contrast, highly diverse repertoires are 
selected in responses to epitopes derived from influenza virus haemagglutinin, 
Plasmodium berghei circumsporozoite protein and tetanus toxin (Taylor et al., 1990; 
Casanova et al., 1991; Boitel et al., 1992). Similarly, the in vivo response to viral 
infection may be dominated by CD8+ cytotoxic T cells directed against a single 
immunodominant epitope, i.e. oligoclonal, or polyclonal, depending on the MHC 
phenotype and the TCR repertoire of the individual (Pantaleo et al., 1994; Burrows et 
al., 1995; Daly etal., 1995). Oligoclonal expansions in complex mixtures of lymphocytes 
can be revealed by analysis of CDR3 length and sequence (Pannetier et al., 1995), as 
perturbations in the TCR repertoire of the whole population are not always evident based 
on the analysis of V region usage alone. The unique properties of superantigens result in 
polyclonal activation of T cells bearing a restricted subset of Vp elements, irrespective of 
the paired Va domain or the MHC molecule which presents the superantigen (Kappler et 
al., 1989). In vivo, T cell activation is often followed by clonal deletion or anergy of the 
superantigen-reactive T cells (Webb et al. 1990; MacDonald et al., 1991). A 
superantigen associated with an infectious agent would be expected to stimulate VP-
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specific expansion of T cells without clonal restriction or use of conserved CDR3 motifs, 
in individuals of differing MHC phenotype. In mice infected with MMTV by 
subcutaneous inoculation or by the oral route, initial marked expansion of superantigen- 
reactive cells is found in the drainage lymph nodes and Peyer’s patches, respectively 
(Held et al., 1992; Karapetian etal., 1994). In humans, expansions of V(32+ T cells in the 
blood of patients with toxic shock syndrome and Kawasaki syndrome, and over­
representation of Vp8+ T cells in the pleural fluid of individuals with tuberculous pleuritis 
have been taken as evidence of superantigenic stimulation (Choi et al., 1990b; Abe et al., 
1993; Ohmen et al., 1994).
In naive cattle infected with Theileria parva, there is a dramatic increase in uninfected T 
lymphoblasts in the lymph node draining the site of inoculation, coinciding with initial 
detection of very low numbers of schizonts (as discussed in Chapter 3). One possible 
explanation for this observation is that a parasite-derived superantigen may be driving the 
T cell expansion. The aim of this study was initially to determine the normal TCRBV 
repertoire expressed in a peripheral lymph node, and then to compare this with the 
TCRBV repertoire expressed by the responding T cells during T. parva infection in the 
same animal. If expansion of cells expressing a restricted repertoire of TCRBV genes 
were observed, the study could then be extended to individuals with differing MHC 
haplotypes. In addition, since an unusual subset of CD2"CD8+ a/p  T cells form a 
significant component of the early T cell response (see Chapter 3), the TCRBV repertoire 
of a purified population of these cells was also examined.
In the absence of monoclonal antibodies to bovine TCR Vp elements, TCRBV expression 
was examined at the RNA level using the anchored PCR. This technique allows 
amplification of all the TCRBV genes in the T cell population with a single pair of 
primers, so that even genes for which no sequence information is available are included. 
Since all sequences should theoretically be amplified with equal efficiency, the frequency 
with which different sequences are represented in the clones of the amplified product 
reflect their frequency in the starting mRNA population.
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6.2. Materials and Methods.
The methods used for isolation of lymphocytes and responding T cells, and amplification, 
cloning and sequencing of TCRBV genes for repertoire analysis have been described in 
detail in Chapters 2 and 5.
6.3. Results.
In initial experiments, the TCRBV repertoire of the T cell population in a normal resting 
prefemoral lymph node was determined (animal 3327). This population will be referred 
to as C below. Subsequently .the same animal was infected with T. parva, and the 
drainage lymph node (prescapular) was removed on day 9 of infection. To ensure that 
changes in the TCR repertoire were not masked by the presence of unactivated T cells, a 
purified population of T lymphoblasts were obtained from the lymph node cells by two 
colour indirect immuno-fluorescent staining with monoclonal antibodies to CD3 and 
MHC class II molecules, and FACS sorting of cells expressing both markers (population 
IC). As described in Chapter 3, the expansion of a subset of CD2'CD8+ a/p  T cells is a 
distinctive feature of the lymph node response to primary infections with T parva, and a 
large proportion of these cells appear to be blasting, based on their large size. This 
population was purified from the lymph node of a second calf (5158) on day 9 of 
infection with T. parva by two-colour indirect immunofluorescent staining and FACS 
sorting of CD2 CD8+ cells (population D). The gates used for sorting are illustrated 
inFigure 3.1. The purity of the sorted population was 99%.
The TCRBV transcripts from each population were amplified by anchor PCR and cloned 
into a plasmid vector; a random selection of clones were then sequenced to determine the 
frequency with which different BV  gene segments were represented in each population. 
Table 6.1 shows the number of clones from each population that were sequenced and the 
number that contained functional rearranged TCRBV-BD-BJ-BC transcripts. The nature 
of the inserts in clones that did not contain functional TCRB transcripts has been 
discussed in Chapter 5. The classification of the B V  genes of functional transcripts into 
different TCRBV subfamilies was also described in Chapter 5.
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Table 6.1. Numbers of clones containing functional TCRB transcripts in each T cell
population.
T cell population Total no. of clones 
sequenced
No. of clones containing 
functional TCRB transcripts
C 51 42
IC 57 45
D 26 21
Total * 134 108
Only TCRBV gene sequences from clones containing functional TCRB transcripts were 
included in the analysis of the frequency of BV  usage by the different T cell populations. 
The distribution of the BV  sequences from each population among the TCRBV 
subfamilies is illustrated in Figure 1. In this analysis, the members of different subfamilies 
have been grouped together. For multi-membered subfamilies, more detailed information 
on the frequency of representation of different members in the three cell populations is 
given in Table 2. A limited number of BV  subfamilies constituted almost 80% of the 
repertoire of T cells from a resting peripheral lymph node (BVly BV2, BV10 and BV24), 
while others were rarely used. The presence of multiple members in BV1 and BV2 
explains the dominant contribution of these subfamilies to the TCRBV repertoire. 
However, none of the gene segments within these populations were predominant, as no 
more than four copies of any particular gene were isolated.
Comparison of the TCRBV repertoire of the normal bovine lymph node T cell population 
with the repertoire of T lymphoblasts responding to T. parva (populations C and IC, 
respectively) revealed a remarkably similar pattern of BV  usage in both populations (see 
Figure 6.1. A and Table 6.2.). The numbers of sequences were too small for meaningful 
statistical analysis. However, analysis of the TCRBV repertoire of T cell blasts purified 
from the infected lymph node rather than the whole T cell population should markedly
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accentuate any differences due to expression of a restricted repertoire by the responding 
cells. In some instances, small increases in the proportion of certain gene segments (e.g. 
BV2.2, BV2.5 or BV13.3) in the IC population were due to the repeated isolation of 
clones containing identical sequences throughout the V-D-J region. These probably have 
arisen from clonal expansion of antigen-specific T cells.
The observation that an unusual subset of CD2'CD8+ a/p  T cells form a substantial 
component of the primary lymph node T cell response to T. parva suggests that these 
cells are selectively activated as a result of the parasite infection. To rule out the 
possibility that bystander activation of other T cells was masking the expression of a 
restricted number of TCRBV genes by the CD2*CD8+ subset, the BV  repertoire of a 
purified population of these cells was examined (population D). Although the TCRBV 
repertoire of this population was more restricted than that expressed by T cells in the 
resting lymph node (C), a broad range of TCRBV genes were represented (see Figure
6.1.B and Table 6.2). The most commonly represented subfamilies were BV1, BV2, BV6 
and BV10; however members of BV3, BV7, BV9, BV12, BV13, BV17 and BV24 detected 
in animal 3327 were not found. Only one member of the TCRBV2 subfamily (BV2S3) 
was detected in clones derived from CD2'CD8+ T cells. It is possible that the explanation 
for the more restricted repertoire of the CD2CD8+ T cells is that sequence analysis was 
carried out on a smaller number of clones derived from this population, than from C or 
IC. Despite the variation in the expression of individual B V  genes between populations C 
and D, the differences may reflect the differing genetic background (particularly the 
MHC phenotype) of the calves rather than changes brought about by the response to 
infection. Thus, there was no evidence of restricted TCRBV gene usage in the CD2 CD8+ 
a/p  T cell population involved in the in vivo response to T parva.
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Table 6.2. Comparison of the distribution of TCRBV genes among different
subfamilies in T cell populations C, IC and D.
T cell population C I('■'t D
TCRBV gene 
segment
No. of 
clones
% No. of 
clones
% No. of 
clones
%
BVJSJ 2 4.8 2 4.4
BV1S2 1 2.4 1 2.2 2 9.5
BV1S3 3 7.1 2 4.4 1 4.7
BV1S4 3 7.1 1 2.2 - ~
BV1S5 3 7.1 - - - -
BVIS6 1 2.4 3 6.7 2 9.5
BV1S7 - - 2 4.4 1 4.7
BV1S8 1 ' 2.4 - - 1 4.7
BVJS9 - - 3 6.7 1 4.7
BV1S10 1 2.4 - - - -
BV1S11 1 2.4 - - - -
BV2S1 2 4.8 2 4.4 _ _
BV2S2 - - 3 6.7 - -
BV2S3 1 2.4 2 4.4 3 14.3
BV2S4 1 2.4 2 4.4 - -
BV2S5 2 4.8 - - - -
BV2S6 4 9.5 - - - -
BV2S7 - - 1 2.2 - -
BV3S1 1 2.4 1 2.2 - -
BV4S2 - - - - 1 4.7
BV6S3 - - 1 2.2 3 14.3
BV7S1 1 2.4 1 2.2 - -
BV9SI 1 2.4 - - - -
BV10S1 2 4.8 2 4.4 _ -
BV10S2 2 4.8 - - - -
BV10S3 - - - - 2 9.5
BV12S1 - - 2 4.4 - -
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Table 6.2. Comparison of the distribution of TCRBV genes among different
subfamilies in T cell populations C, IC and D (continued).
T cell population C » D
TCRBV gene 
segment
No. of 
clones
% No. of 
clones
% No. of 
clones
%
BV13S1 1 2.4 2 4.4 _ _
BV13S2 1 2.4 1 2.2 - -
BV13S3 - - 2 4.4 - -
BV14S1 1 2.4 1 2.2 1 4.7
BV15SI «. 1 4.7
BVJ5S2 1 • 2.4 1 2.2 - -
BV16S1 - - - - 1 4.7
BV17S2 - - 2 4.4 - -
BV20S1 2 4.8 1 2.2 1 4.7
BV24SI 3 7.1 2 4.4 - -
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Figure 6.1. Comparison of TCRBV genes used in the primary immune response to T. 
pan’a with the TCRBV repertoire expressed in a normal lymph node. A: TCRBV 
sequences expressed by T cells from a normal peripheral lymph node of animal 3327 
were amplified in the anchored PCR, cloned and sequenced. The frequencies with which 
different TCRBV subfamilies were represented among the clones are shown (C). A 
similar analysis was performed on T cell blasts isolated from the drainage lymph node of 
the same animal during infection with T. par\>a (IC). B: the CD2CD8 subset of T cells 
was purified from the drainage lymph node of another calf undergoing infection with T. 
parva, and the TCRBV repertoire expressed by these cells was analysed as above.
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6.4. Discussion.
This study has established the normal TCRBV repertoire expressed by bovine T cells in 
the resting peripheral lymph node of one individual, providing a basis for comparison 
with the repertoire of TCRBV genes used by T cells participating in the primary lymph 
node response to T. parva. Expression of eleven TCRBV subfamilies was detected in the 
resting lymph node T cell population; however only four subfamilies (BV1, BV2, BV10 
and BV24) constituted almost 80% of the repertoire. This is consistent with studies in 
mice and humans, where a limited number of TCRBV subfamilies dominate the normal 
repertoire (Okada and Weissman, 1989; Rosenberg et a l,  1992; Malhotra et al., 1992). 
The dominance of the BV1 and BV2 subfamilies in the bovine TCRBV repertoire is 
explained by the existence of multiple members of these subfamilies, as discussed in 
Chapter 5. Examination of the T cell population activated in the drainage lymph node 
during primary infection with T. parva revealed that these cells express an unrestricted 
repertoire of TCRBV genes. The overall pattern of expression was very similar to that 
found in the uninfected lymph node. In three cases, identical TCRBV-BD-BJ-BC 
transcripts were isolated from more than one clone, suggesting antigen-specific clonal 
expansion of certain T cells; however these expansions were insufficient to cause 
significant perturbation of the TCRBV repertoire. Surprisingly, the CD2'CD8+ T cell 
subpopulation that appears to be activated specifically in reponse to infection with T. 
parva also expresses a diverse repertoire of TCRBV gene segments. Although these cells 
were isolated from a different individual, the overall pattern of TCRBV gene usage was 
similar to that found in the resting lymph node T cell population. The differences that 
occur can probably be accounted for by inter-individual variation in the expression of 
different subfamilies, and differences in the TCRBV repertoire expressed by CD4+ and 
CD8+ T lymphocytes, which have previously been reported in man (Hawes et al., 1993).
Various methods have been employed in the analysis of the TCR repertoire of mice and 
humans, including flow cytometry using VP-specific monoclonal antibodies (Akolkar et 
al., 1993; Braun et al., 1995), semi-quantitative PCR with Vp subfamily-specific primers 
(Choi et al., 1989; Genevee et al., 1992), RNase protection assays (Okada and 
Weissman, 1989; Singer et al., 1990), and anchored PCR (Rosenberg et a l, 1992;
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Sarukhan et al., 1994). The latter technique was the method of choice for the present 
study because no bovine VP-specific monoclonal antibodies are available and there was 
insufficient sequence information to generate a panel of Vp-specific primers that would 
cover the entire bovine TCRBV repertoire. The disadvantages of using this technique are 
the possibility of introducing biases during PCR amplification, and the possibility that 
levels of mRNA expression may not correlate with surface expression of protein. While 
the occurrence of biases in the present study cannot be definitely ruled out without an 
independent method of verification of the TCRBV repertoire, the fact that a large number 
of different B V  and BJ  gene segments were represented in the amplified sequences 
suggests that this is not the case. The failure to identify members of certain subfamilies 
may merely reflect a low level.of expression in the individuals studied, which would be 
revealed by sequencing larger numbers of clones. Two previous studies involving the use 
of anchored PCR to analyse the human TCR repertoire have demonstrated good 
correlation between the results obtained by this method and analysis using monoclonal 
antibodies (Loh et al., 1989; Rosenberg et al., 1992); however, due to limited availability 
of monoclonals, this verification was possible only for one or two Vp regions. More 
recently, the use of anchored PCR to examine the B V  repertoire of non-obese diabetic 
mice was validated by comparison with the results obtained by flow cytometry using a 
panel of eleven VP-specific monoclonal antibodies. There was close correlation between 
the estimates of the level of expression of different BV  genes obtained using these 
methods, confirming that anchored PCR was a reliable tool for examination of the 
TCRBV repertoire (Sarukhan et al., 1994).
The anchored PCR has a number of advantages over other techniques for analysis of the 
TCR repertoire. The amount of starting material required is small, which was important 
in this study, as the yield of cells obtained from sorting could be limiting. Sequence 
analysis allowed identification of individual subfamily members, whereas in most semi- 
quantitative PCR techniques, Vp-specific primers amplify all subfamily members 
(Genevee et al., 1992; Hall and Finn, 1992), and many monoclonal antibodies recognise 
more than one subfamily member. This is potentially significant in the investigation of 
superantigen responses, as there are examples of superantigens that selectively interact 
with only one subfamily member (Kappler et al., 1988). It is particularly relevant in the
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present study because of the large number of members identified in subfamilies BV1 and 
BV2. In addition, this technique allows analysis of CDR3 sequences and BJ  gene usage 
which can be useful in distinguishing superantigen-reactive T cells from oligoclonal 
expansions of antigen-specific T cells. Transcripts resulting from non-functional 
rearrangements can also be identified and excluded from the analysis.
The pattern of TCRBV gene usage by T cells activated in the drainage lymph node during 
primary infection with T. parva is inconsistent with a response to a superantigen or to a 
highly immunodominant peptide antigen. Responses to superantigens in vivo have been 
most extensively studied in mice. Initial experiments involving intravenous administration 
of staphylococcal enterotoxin B (SEB) or cells expressing endogenous mouse mammary 
tumour virus (MMTV) superantigens demonstrated a marked expansion of specific Vp T 
cell subsets in the spleen and lymph nodes followed by deletion and anergy of these cells 
(Webb et al., 1990; MacDonald et al., 1991). However, neither of these models can be 
applied to the role of superantigens during a natural infection. Mice inoculated 
subcutaneously with exogenous MMTV also show marked expansion of superantigen- 
reactive CD4+ T cells (approximately five-fold increase in absolute numbers) in the 
drainage lymph node (Held et al., 1992). Similarly, in neonatal mice infected with 
MMTV by the natural route (orally), expansion of Vp-specific T cells can be 
demonstrated in the intestinal Peyer’s patches as early as 5 days after birth (Karapetian et 
al., 1994). It should be noted that in all the studies mentioned above, expansions of 
superantigen-reactive cells were detected in the whole lymph node population by two- 
colour flow cytometric analysis using mAbs against CD4 and/or CD8 and specific Vp 
elements, without prior enrichment of blasting cells. In humans, superantigen-mediated T 
cell activation and deletion associated with infectious disease has been more difficult to 
investigate. However, expansions of Vp2-bearing T cells have been found in the 
peripheral blood of a number of patients with toxic shock syndrome, corresponding to 
the phenotype of T cells responding to the staphylococcal toxin TSST-1 in vitro (Choi et 
al., 1989,1990b). Expansions of Vp2+ and Vp8.1+ T cells exhibiting extensive junctional 
region diversity have also been found in the circulation during the acute phase of 
Kawasaki disease, a disease of unknown aetiology with many clinical features similar to 
toxic shock syndrome (Abe et al., 1993). Once again, these perturbations in the TCR
233
repertoire were evident from examination of whole PBMC rather than a selected 
responding population, although they were more variable and not as striking as those 
observed during MMTV infection.
Dramatic expansion of T cells expressing a restricted TCRBV repertoire can also be 
found in infections where there is no involvement of superantigens. For example, during 
the acute phase of infection with HIV, marked expansion of CD8+ cytotoxic T cells 
bearing a restricted subset of Vp subfamilies is sometimes found in the peripheral blood. 
In an extreme example, 40% of PBMC in one individual were found to express V pl9 at 
the peak of the response to acute infection (Pantaleo et al., 1994). However, in an 
outbred population, the TCR Vp usage of the dominant clones in such a response will 
vary according to the MHC phenotype and TCR repertoire of the individual (Burrows et 
al. 1995; Daly et al., 1995). The conservation of CDR3 length and sequence in the TCR 
of responding cells can also help to distinguish these responses from those driven by 
superantigens. In fact, such dramatic expansions of antigen-specific T cells are rarely 
found and oligoclonal expansions have been detected mostly at the level of the diseased 
tissue, for example, in autoimmune diseases (Oksenberg et al., 1990; Howell et al., 
1991) and chronic infections such as leprosy (Wang et al., 1993b). Even when cytotoxic 
T cells can be detected at a high frequency in peripheral blood and are dominated by 
clones expressing a highly restricted TCR repertoire, e.g. during infections with HIV or 
EBV, there may be no obvious expansion of the relevant Vp families relative to the 
overall repertoire (Silins et al., 1996).
The diverse repertoire of TCRBV genes expressed by T cell blasts isolated from the 
drainage lymph node during infection with T. parva suggest that the parasite induces 
polyclonal T cell activation. Since protozoa are much more complex organisms than 
viruses, multiple T cell immunostimulatory peptides may be generated from different 
proteins, leading to stimulation of a large number of naive T cells with a highly diverse 
TCRBV repertoire. Another possibility is that the close similarity between the TCRBV 
repertoire expressed by the responding cells and that of the normal lymph node T cell 
population may be due to mitogenic activity associated with one or more parasite 
molecules, causing antigen-independent activation of the majority of T cells.
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Interestingly, human T cells within the CD45RCT (‘memory’) population proliferate 
strongly in response to Plasmodium falciparum antigens despite lack of previous 
exposure to the parasite (Jones et al., 1990). Parasite-specific T cell clones generated 
from non-immune individuals have been shown to cross-react with common 
environmental micro-organisms (Currier et al., 1995) and express a diverse repertoire of 
TCRBV segments (Fell et al., 1996). Similarly, the strong proliferative response of 
human PBMC from naive individuals to in vitro stimulation with Trypanosoma cruzi is 
also dominated by T cells expressing a diverse TCR repertoire (Piuvezam et al., 1993). 
This suggests that polyclonal activation of T cells expressing an unrestricted repertoire of 
TCRBV genes may be a common feature of infections with a number of different 
protozoan parasites. However, recently evidence has been put forward for the existence 
of a superantigen associated with Toxoplasma gondii (Denkers et al., 1994,1996). In 
vitro stimulation of non-immune splenocytes with intact tachyzoites or soluble antigen 
induced strong proliferative responses and selective expansion of CD8+ T cells 
expressing Vp5. The response was not MHC restricted and did not depend on antigen 
processing. Although dramatic increases in T cell numbers were not observed in mice 
during the acute phase of infection with T. gondii, moderate increases in the proportion 
of V(35+ cells were found, and in chronic infections this subset exhibited specific non­
responsiveness
In summary, the present study of the TCRBV repertoire expressed by cells involved in 
the blast response observed in the drainage lymph nodes of cattle undergoing primary 
infections with T. parva provides no evidence for stimulation by a superantigen. Analysis 
of purified populations of responding cells, both T cell blasts and the CD2*CD8+ a/p  T 
cell subset, revealed expression of a diverse TCRBV repertoire that was very similar to 
that of the normal T cell population of a resting lymph node. This suggests that the 
response is directed against a number of different epitopes derived from one or more 
parasite antigens, resulting in polyclonal stimulation of T cells, or alternatively, that the 
parasite may possess a mechanism for antigen-independent T cell activation.
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CHAPTER SEVEN
GENERAL DISCUSSION.
Infection of susceptible cattle with the protozoan parasite Theileria parva results in an 
acute lymphoproliferative disease characterized by lymphadenopathy and fever, the 
outcome of which is invariably fatal. Previous studies of experimentally infected cattle 
revealed a massive increase in the cellularity of the lymph node draining the site of the 
inoculation in the early stages of the infection, at a time when the proportion of schizont- 
infected cells in the node was very low (Morrison et al., 1981). The increased cellularity 
was associated with a widespread increase in the numbers of lymphoblasts within the 
hode. These results suggested that an immune response to the parasite occurs in the 
regional lymph nodes of naive animals, but is ineffective in controlling the rapid 
multiplication of parasitized cells. However, the precise phenotype of the blast cells 
involved in the response, and possible mechanisms for widespread lymphocyte activation 
associated with parasite infection, have not been investigated. The objective of this study 
was to characterize the primary immune response in the drainage lymph nodes of cattle 
infected with T. parva, with a particular emphasis on determining whether or not a 
parasite superantigen is involved. The experiments carried out during the study led to 
four significant findings:
1) An unusual CD2 CD8+ subset of a /p  T cells forms a major component of the 
lymph node response to T. parva in susceptible animals. The phenotype of the 
responding cells in the drainage lymph nodes of infected cattle was investigated using a 
combination of flow cytometry and immunocytochemical staining of lymph node 
sections. In most animals, CD8+ T lymphocytes formed a large proportion of the 
responding cells. Most notably, a subset of CD8+ T cells that lacked expression of CD2 
was found in all the animals studied. These cells were assumed to express the a/p TCR 
because they all expressed CD3, and most of them were negative for the y/5 TCR. The 
appearance of this subset coincided with the initial detection of parasites in the node at 
about day 7 post-infection, and they reached a peak of up to 30% of the lymph node 
mononuclear cell population. However, their numbers declined rapidly as the proportion 
of parasitized cells increased. In contrast to the response in vivo, the response of PBMC
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from naive animals to in vitro stimulation with autologous parasitized cells was 
dominated by y/8 T cells, and cells with the phenotype CD2'CD8+a/(3 TCR+ were not 
detected. An in vitro model for studying the stimulatory requirements of these cells was 
therefore not available.
2) The lymph node response to T. parva also involves a large influx of 
macrophages. Another interesting feature of the response to T. parva within the 
regional lymph node was the accumulation of large numbers of macrophages in the 
cortical region from day 7 to day 9 post-infection. These cells were characterized by 
expression of CD 14, CD lib , and a molecule (MyD-1) found on bovine 
monocytes/macrophages and dendritic cells, and had an active lysosomal system, 
revealed by staining for the enzyme acid phosphatase. Macrophages play an important 
role in host resistance to a number of protozoan parasites, particularly during primary 
infections. However, in the case of T. parva, this population of macrophages is clearly 
ineffective in inhibiting parasite replication and preventing the progression of the 
infection.
3) New data on the bovine TCRBV repertoire was obtained. The TCRBV repertoire 
expressed at the mRNA level in normal lymph node T cells was established by anchored 
PCR and sequencing. Nine bovine TCRBV subfamilies (BV I, BV2, BV3, BV4, BV6, BV7? 
BV12, BV15 and BV17) were previously defined by Tanaka et al. (1990). In the present 
study, expression of 37 different TCRBV gene segments was detected, 29 of which were 
identified for the first time. Using this data and the previously published sequences, a 
classification system for bovine TCRBV gene segments was devised, in which subfamilies 
were named according to the human B V  genes to which they showed closest homology. 
A further seven TCRBV subfamilies were defined, with a total of 11 members (BV9, 
BV10, BVI 3, BV14, BV16, BV20 and BV24); the remaining 18 new sequences were 
assigned to the existing BVI, BV2, BV4, BV6 and BVI7  subfamilies. A large number of 
the new gene segments were classified as members of the BVI and BV2 subfamilies, 
indicating that considerable diversification of the bovine TCRBV repertoire has occurred 
by duplication of these genes, whereas the homologous genes in humans and mice form 
single-member subfamilies. It is probable that, although further TCRBV gene segments 
remain to be discovered, that the genes identified in this study and by Tanaka et al.
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(1990) form the major proportion of the expressed repertoire. This information and the 
reagents that have been generated will be useful in future studies of bovine immune 
responses. It should be possible to develop a panel of £F-specific primers, similar to 
those used in many studies of the human TCR repertoire, for use in a semi-quantitiative 
PCR to examine TCRBV usage by T cells involved in the immune responses to infectious 
agents. The sequence information can also be used to develop 5 F-specific probes and 
primers for mapping and sequencing of the germline TCRBV \od.
4) The lymph node T cell response is polyclonal and does not involve a superantigen.
The possibility that a superantigen might be triggering T cell activation in the drainage lymph 
node of T. /?orva-infected animals was investigated by examining the TCRBV repertoire 
expressed by the responding cells. Analysis of the TCRBV repertoire expressed by purified 
populations of activated CD3+ cells and CD2'CD8+ T cells showed no evidence for the 
restricted usage of a subset of TCRBV gene segments. The T cell response to T parva in the 
drainage lymph node is therefore unlikely to be stimulated by a parasite-derived superantigen.
Although this study has provided some interesting observations relating to the lymph node 
responses of cattle undergoing primaiy infection with T. parva, it was not possible to 
determine the mechanisms governing these processes. There is no suitable model for the 
disease in a laboratory animal species, which restricts the scope of in vivo investigations 
because of the relative lack of immunological reagents for cattle, and the constraints placed 
on the number of animals that may be used by economic and welfare considerations. In 
addition, immune responses in an outbred population are more variable so that, in 
combination with the small numbers of animals sampled, it may be difficult to attach statistical 
significance to the observations made. Under these circumstances, it is desirable to attempt to 
reproduce the response in vitro, so that an understanding of the underlying mechanisms can 
be gained from studies in a controlled environment, and tested in future in vivo experiments.
In the current study, it was a consistent observation in all infected animals that a subset of 
oc/p T lymphocytes with the phenotype CD2‘CD8+ were involved in the primary lymph node 
response to T. parva, although their numbers varied considerably in different individuals. The 
appearance of the CD2’CD8+a/p T cell subset is intriguing because cells with a similar 
phenotype have not been reported to participate in immune responses in other species, and
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there is therefore no previous information from which their function may be inferred. Using a 
sensitive limiting dilution assay, both the CD2*CD8+ and the CD2+CD8+ fractions of efferent 
lymph lymphocytes from T. parva-infected animals were shown to contain very low 
frequencies (less than 1:20000) of cytotoxic precursors, capable of killing both autologous 
and allogeneic infected target cells (Taracha, 1991). Therefore, despite the CD8+ blast cell 
response between days 7 and 10 post-infection, a normal cytotoxic T cell response is not 
induced in primary infections with T. parva. However, it is possible that the CD2’CD8+ T cell 
subset may exert an effector function through the secretion of cytokines. Studies of the small 
numbers of CD2’CD8+ T cells purified from the lymph nodes of infected animals revealed that 
they expressed mRNA for EFNy and, to a lesser extent, DL-10, and a diverse repertoire of 
TCRBV genes. The latter observation suggested that these cells were not responding to a 
parasite superantigen.
In contrast to CD2CD8+ T cells, the CD2‘CD8+a/p T cells isolated from infected animals 
were refractory to stimulation in vitro, and cells with this phenotype were not generated by in 
vitro stimulation of PBMC with autologous parasitized cell lines. The failure to generate cell 
lines prevented the functional characterization of these cells using in vitro assays, so that 
important questions relating to their possible role in pathogenesis could not be addressed. The 
explanation for the non-responsiveness of CD2’CD8+ cells in vitro may be that these cells are 
anergic or committed to programmed cell death in the activated state, or that appropriate 
conditions for stimulation of the cells were not reproduced in vitro. While the possibility that 
this subset arises as the result of downregulation of CD2 expression on activated CD8+ T 
lymphocytes cannot be excluded, it seems more likely that a small pre-existing population of 
cells is expanded during infection with T. parva, as discussed previously. Since CD2 CD8+ T 
cells were not detected in peripheral blood, the precursors of this subset may be localized 
within the lymph nodes. Further work is needed to establish whether suitable conditions can 
be found for in vitro expansion of these cells from lymph node preparations, using parasitized 
stimulator cells.
The failure to demonstrate that T lymphoblasts were responding to a superantigen does not 
rule out the possibility that T. parva has an alternative mechanism for inducing non-specific T 
cell activation, with similar effects on pathogenesis in terms of the potential for cytokines to 
promote the proliferation of parasitized cells. As discussed previously, other protozoan
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parasites such as Plasmodium falciparum and Trypanosoma cruzi are capable of inducing 
strong proliferative responses in T lymphocytes from naive individuals independently of a 
superantigen. In the case of P. falciparum, the high frequency of T cells responding to the 
parasite is due to activation of cross-reactive memory CD4+ cells. Other possible mechanisms 
by which the parasite might induce potent T cell responses are through expression of a 
molecule with mitogenic properties or presentation of multiple immunostimulatory epitopes.
In the present study, investigation of the role of cytokines in the pathogenesis of the infection 
was hampered by lack of reagents. The “background” expression of cytokines in the lymph 
nodes of apparently healthy cattle made it difficult to assess exactly which cytokines were 
produced in the response to infection. In addition, the lack of a quantitative technique to 
determine the relative levels of expression of various cytokines prevented predictions about 
their potential influence on the outcome of infection. The observation that efferent lymph 
plasma from an infected animal produced enhanced proliferation of a parasitized cell line 
suggests that soluble factors (presumably cytokines) which have a positive effect on parasite 
growth were released by responding cells in the lymph node. However, in the absence of 
ELISA assays for different bovine cytokines, and monoclonal antibodies capable of 
neutralizing their activity, it was not possible to identify which cytokines were responsible for 
this effect. In mouse models of disease, it is also possible to assess the influence of different 
cytokines on the outcome of infection in vivo by injecting neutralizing antibodies to individual 
cytokines or their receptors, or using transgenic mice with targeted disruption of specific 
cytokine genes (“knockout” mice). Such studies are much more difficult in cattle because, 
even when suitable reagents are available, large quantities may be required to produce the 
desired effect.
The failure to generate an effective immune response during primary infections with T. parva 
may also be due to inappropriate antigen presentation. Normally, T cell responses are initiated 
by “professional” antigen presenting cells that originate in the infected tissue and take up 
antigen by macropinocytosis. These cells then migrate to the regional lymph nodes and 
upregulate expression of costimulatoiy molecules, to become the mature interdigitating 
dendritic cells of the paracortical T cell areas. They are capable of inducing the activation of 
naive CD4+ and CD8+ T lymphocytes circulating through these areas, leading to their 
differentiation into effector cells. In the case of I  parva, however, it is most likely that
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infected lymphocytes act as antigen presenting cells in the drainage lymph node. It is not 
known whether costimulatory molecules are expressed on parasitized lymphoblasts but, by 
analogy with activated B and T cells of other species, they would be expected to upregulate 
expression of B7 molecules. They would therefore theoretically be capable of inducing 
activation of naive T cells. However, differences in the level of expression of costimulatory 
molecules or the range of cytokines produced by the parasitized lymphocytes might influence 
the type of response that is generated. One possible explanation for the predominance of 
CD2’CD8+ T cells in the primary response to T. parva could be that these cells are able to 
respond to parasite antigens presented by lymphocytes, while conventional naive CD4+ and 
CD8+ T cells have a strict requirement for antigen presentation on dendritic cells. The 
different anatomical location of the antigen-presenting cells may also have an influence on the 
type of cells that respond. The distribution of schizont-infected cells and lymphoblasts in the 
regional lymph nodes at different time points after infection suggests that the response is 
initiated in the medullary region, and later involves the paracortical and cortical regions as the 
infection progresses.
The presence of large numbers of macrophages in the cortical regions of the drainage lymph 
nodes of T. parva-infected cattle may result from migration of macrophages from an 
inflammatory focus at the site of stabilate inoculation in the skin, or recruitment and activation 
of monocytes from the peripheral blood. The observation of an increased proportion of 
monocytes in PBMC, coinciding with the increased numbers in the lymph node, suggests that 
the latter is the more likely explanation. Extravasation of monocytes into sites of inflammation 
occurs by a process of chemotaxis in response to a range of chemoattractant molecules, such 
as the chemokines MCP-1 and RANTES (Strieter et al., 1996). Chemokines are synthesized 
by macrophages themselves, but also by endothelial cells, keratinocytes, and fibroblasts, and 
in some instances by activated T cells. It is possible only to speculate on the role of 
macrophages in T. parva infections. Macrophage activation can be induced by IFNy and is 
characterized by increased expression of MHC molecules and costimulatory molecules, 
production of cytokines, and increased microbicidal activity mediated, for example, by 
reactive oxygen intermediates. The results of RT-PCR have demonstrated that mRNA for 
IFNy and TNFa (which synergizes with IFND in macrophage activation) are found in the 
drainage lymph nodes of cattle infected with T. parva. Therefore, the conditions necessary for 
macrophage activation do potentially exist within the infected nodes. However, the presence
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of macrophages is not sufficient to prevent the progress of the infection, suggesting that the 
microbicidal mechanisms of the macrophages may be ineffective against T. parva. 
Alternatively, the macrophages could be contributing to the pathogenesis of the infection in a 
number of ways. The oxygen metabolite NO is an important mediator of parasiticidal 
mechanisms by murine macrophages; however, NO also suppresses normal antigen-specific T 
cell responses, particularly in the Thl CD4+ subset (Liew, 1995). Spontaneous synthesis of 
NO by PBMC has been demonstrated during infections of naive cattle with T. parva (Visser 
et al., 1995), suggesting that large quantities of NO are being produced by monocytes. 
Activated macrophages also produce a range of cytokines including DL-1, IL-6, IL-12, TNFa 
and IFNa some of which may be able to potentiate the proliferation of parasitized cells.
It is clear that the primary immune response to T. parva in the regional lymph nodes of cattle 
involves complex cellular interactions, and further studies are essential to gain an 
understanding of the mechanisms governing the response and its effects on the outcome of 
infection. The complexity of the response and the practical difficulties associated with in vivo 
experiments in cattle mean that the most fruitful approaches will be through the development 
of appropriate in vitro models.
The CD2'CD8+ T cells could be relevant to the pathogenesis of the infection in a number of 
different ways. They may produce cytokines capable of promoting the proliferation of 
parasitized cells, or they may be able to suppress the generation of normal T cell responses. 
Alternatively, they could represent a component of the innate immune system, analogous to 
NK cells, which are rapidly activated on their first encounter with a pathogen, and mediate the 
recruitment and activation of macrophages. Although this would be an effective means of 
controlling the initial replication of many bacterial or parasitic pathogens in non-immune 
individuals, it may not be an appropriate response against T. parva. The intracellular location 
of the parasite within healthy, actively dividing lymphocytes would effectively allow it to 
evade phagocytosis by macrophages. In addition, as discussed above, the presence of large 
numbers of activated macrophages in the lymph nodes could actually have a detrimental effect 
on the generation of normal immune responses.
Development of methods to culture CD2‘CD8+ cells in vitro would allow several important 
questions relating to these hypotheses to be addressed. For example: What are the
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requirements for antigen recognition and activation of these cells? Which cytokines do they 
produce (including chemokines capable of recruiting macrophages)? What are the effects of 
co-culture of CD2'CD8+ T cells with macrophages? The role of macrophages could be 
further investigated by isolating these cells from the lymph nodes of infected animals, and 
examining their state of activation, the cytokines they secrete, and their production of NO. In 
addition, the influence of both CD2'CD8+ T cells and macrophages on the growth of 
parasitized cells and the induction of immune responses could be studied using in vitro co- 
culture techniques. Experiments to investigate the expression of costimulatory molecules by 
infected lymphocytes, and to examine the responses they induce in purified CD4+ and CD8+ T 
cell subsets in vitro, might shed light on their potential for effective antigen presentation in 
vivo.
In summary, the results presented in this study support the view that cattle undergoing 
primary infections with T. parva mount an abnormal immune response that is not capable of 
controlling the infection. It has been established, by analysis of the TCRBV repertoire of the 
responding T cells, that the response is not provoked by the action of a superantigen. The 
observation of large numbers of CD2’CD8+ a/p T cells and macrophages in the regional 
lymph nodes of infected cattle has raised intriguing questions for future investigation.
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Appendix A. Solutions used for Leucocyte Isolation and Culture.
A.I. Phosphate buffered saline (PBS)
NaCl 0.17M
KC1 3.4mM
Na2H P04 9.2mM
KH2PO4 1.8mM
pH 6.8
A.2. Alsever’s solution
Citric acid 2.9mM
D-glucose 113.8mM
NaCl 71.9mM
Trisodium citrate 27.2mM
A. 3. Standard culture medium
RPMI 1640 medium with Glutamax (Gibco BRL)
25mM HEPES
10% foetal bovine serum
lOOU/ml penicillin
lOOpg/ml streptomycin
A. 4. Medium for proliferation assays
RPMI 1640 medium with Glutamax (Gibco BRL)
25mM HEPES
10% foetal bovine serum
5 x 10'5M 2-mercaptoethanol (Sigma)
lOOU/ml penicillin
lOOpg/ml streptomycin
A. 5. Sheath fluid for FAC Scan analysis.
PBS filtered through a 0.2pm filter
B. Solutions used for Preparation and Examination of Lymph Node Sections.
B .l. Fixatives.
B. 1.1. Neutral buffered formalin
NaH2P 0 4 375mM
Na2H P04 387mM
NaCl 1.45M
- dissolved in formaldehyde (40% w/v)
B .l.2. Mercuric formalin
- 9 parts saturated mercuric chloride solution and 1 part formaldehyde (40% w/v)
B.2. Solutions used for in situ hybridization.
All solutions were made using water treated with diethyl pyrocarbonate (DEPC) and 
. glassware baked at 180°C for 4h to avoid contamination with ribonucleases (RNases).
B.2.1. Preparation of DEPC-treated water
- sterile double distilled water (DDW) was treated with 0.02% v/v DEPC 
(Sigma) at room temperature overnight, then autoclaved at 151b/in2 for 15min to 
inactivate DEPC
B.2.2. 20X SSC
NaCl 3M
Sodium citrate 300mM
pH 7.0
B.2.3. Buffer 1
Tris-HCl, pH 7.5 lOOmM
NaCl 150mM
B.2.4. Buffer 2
Maleic acid lOOmM
NaCl 150mM
pH 7.5
B.2.5. Buffer 3
Tris-HCl, pH9.5 lOOmM
NaCl lOOmM
MgCl2 50mM
B.2.6. Preparation of salmon sperm DNA.
- the salmon sperm DNA (Sigma) was dissolved in water to a concentration of 
lOmg/ml. DNA was sheared by passing it several times through an 18 gauge 
hypodermic needle, then boiled for lOmin, and stored in aliquots at -20°C. 
Immediately prior to inclusion on the hybridization solution, the DNA was 
denatured by heating at 95°C for 5min.
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B.2.7. Hybridization mixture.
Formamide (Gibco BRL) 5ml
50% w/v dextran sulphate (Sigma) 1ml
20X SSC 1ml
NB. High molecular weight (i.e. >500 000) dextran sulphate was used.
B.2.8. Blocking buffer.
Bovine serum albumin (BSA) 3% w/v
Triton X-100 0.05% v/v
- dissolved in buffer 1
B.2.9. Gelatin mountant (Kaiser jelly).
Gelatin 10g
Sodium azide 0.17g
Solid phenol 025g
Glycerol 70ml
DDW 60ml
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C. Reagents for Molecular Biology.
C .l. Reaction buffers.
C.1.1. 10X reverse transcriptase buffer (Promega)
Tris-HCl, pH8.3 500mM
KC1 500mM
MgCl2 lOOmM
Spermidine 5mM
Dithiothreitol (DTT) lOOmM
C. 1.2. 10X PCR buffer (Gibco BRL)
Tris-HCl, pH 8.4 200mM
KC1 500mM
C.1.3. 10X Taq Extender buffer (Stratagene)
Tris-HCl, pH8.8 200mM
KC1 lOOmM
(NH4)2S 04 lOOmM
M gS04 20mM
Triton X-100 1% v/v
BSA 1 mg/ml
C. 1.4. 10X ThermoPol PCR buffer (for use with Vent®
Tris-HCl, pH 8.8 200mM
(NH4)2S 04 lOOmM
KC1 lOOmM
M gS04 20mM
Triton X-100 0.1% v/v
C .l.5. 10X ligation buffer (Invitrogen)
Tris-HCl, pH 7.5 60mM
MgCl2 60mM
NaCl 50mM
BSA lmg/ml
P-mercaptoethanol 70mM
ATP ImM
DTT 2mM
Spermidine lOmM
C. 1. 6 . 10X restriction enzyme buffer (NEBuffer 2, New England Biolabs) 
Tris-HCl, pH 7.9 lOOmM
MgCl2 lOOmM
NaCl
DTT
500mM
lOmM
C.1.7. dNTP mixture
-lOmM each of dATP, dCTP, dGTP, and dTTP, diluted in DEPC-treated water 
from lOOmM stocks (Promega)
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C.2. Other buffers.
C.2.1. TE buffer
Tris-HCl, pH 7.5 or 8.0 lOmM
EDTA (disodium salt) ImM
C.2.2. Binding and Washing (BW) buffer for Dynabeads®.
Tris-HCl, pH 7.5 lOmM
EDTA (disodium salt) 1 mM
NaCl 2M
C.3. Buffers for agarose gel electrophoresis.
C.3.1. 10X Tris-borate electrophoresis buffer (TBE)
Tris base 890mM
Orthoboric acid 890mM
EDTA (disodium salt) 20mM
pH 8.0
C.3.2. 6X gel loading buffer
Bromophenol blue 0.25% v/v
Xylene cyanol FF 0.25% v/v
Glycerol 30% v/v
C.4. Bacteria and media used for cloning.
C.4.1. Genotype of One Shot® E. Coli (INVocF’) competent cells (Invitrogen).
F’ endAl recAl hsdK\l(T^m^+) sw/?E44 thi-1 gyr A96 relAl 
<J) 8 0/acZaAM 15 A(/acZ YA-argF) U169 X
C.4.2. Luria-Bertani (LB) medium
Bacto-tryptone lOg
Bacto-yeast extract 5g
NaCl lOg
pH adjusted to 7.0 with 5N NaOH
Made up to a total volume of 1 litre in distilled water.
C.4.3. LB agar plates with ampicillin
- LB agar has the same composition as LB medium but contains 15g/l bacto-agar.
The agar was heated until molten and a solution containing lmg/ml 
ampicillin (sodium salt; Gibco BRL) was added to give a final concentration of 
100p.g/ml ampicillin. The agar was poured in approximately 20ml amounts into 
sterile Petri dishes (Sterilin, Stone, Staffs., UK).
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C.4.4. SOC medium.
Bacto-tryptone 20g
Bacto-yeast extract 5g
NaCl 0.5g
KC1 0.186g
Glucose 20mM
pH adjusted to 7.0 with 5N NaOH
Made up to a total volume of 1 litre with distilled water.
C.5. Reagents for small-scale preparation of plasmid DNA (minipreps).
C.5.1. Resuspension buffer PI (Qiagen)
Tris-HCl, pH 8.0 50mM
EDTA (disodium salt) 1 OmM
RNase A 100pg/ml
C.5.2. GTE resuspension buffer (ABI)
Tris-HCl, pH 8.0 25mM
EDTA (disodium salt) lOmM
Glucose 5 OmM
C.5.3. Lysis buffer P2 (Qiagen and ABI) 
NaOH
Sodium dodecyl sulphate
C.5.4. Neutralization buffer P3 (Qiagen)
K acetate, pH 5.5
C.5.5 Neutralization buffer (ABI)
K acetate, pH 4.8
C.5.6. Equilibration buffer QBT (Qiagen) 
NaCl
3-[N-Morpholino]propane- 
sulphonic acid (MOPS) 
Ethanol 
Triton X-100 
pH 7.0
C.5.7. Wash buffer QC (Qiagen)
NaCl
MOPS
Ethanol
pH7.0
C.5.8. Elution buffer QF (Qiagen)
NaCl
Tris-HCl, pH8.5 
Ethanol
200mM 
1% w/v
3M
3M
750mM
50mM 
15% v/v 
0.15% v/v
1M
5 OmM 
15%
1.25M
5 OmM
15%
C.6. Reagents for sequencing reactions.
C.6.1. Terminator premix for the cycle sequencing kit (Perkin Elmer).
Dye-labelled ddATP 1.58pM
Dye-labelled ddTTP 94.74pM
Dye-labelled ddGTP 0.42pM
Dye-labelled ddCTP 47.37p.M
dITP 78.95pM
dATP 15.79pM
dCTP 15.79pM
dTTP 15.79p.M
Tris-HCl, pH 9.0 168.42mM
(NH4)2S04 4.21mM
MgCl2 42.1mM
AmpliTaq® DNA polymerase 0.42U/(il
The precise compostion of the terminator premix in the updated version of the kit 
containing AmpliTaq FS was not given, but the listed components were similar to 
those above, although (NFL^SC^ was omitted and thermal stable 
pyrophosphatase had been added.
C.6.2. Reagents for the Sequenase® version 2.0 DNA sequencing kit.
C.6.2.1. Sequenase® reaction buffer 
Tris-HCl, pH 7.5 
MgCl2 
NaCl
200mM
lOOmM
250mM
C.6.2.2. 5X labelling mix 
dGTP 
dCTP 
dTTP
7.5pM
7.5pM
7.5p.M
C.6.2.3. Termination mixes (4)
dGTP 80p.M
dATP 80pM
dCTP 80pM
dTTP 80(iM
ddGTP, ddATP, ddCTP 
or ddTTP 8pM
NaCl 50mM
C.6.2.4. Stop solution
Formamide 95% v/v
EDTA (disodium salt) 20mM
Bromophenol Blue 0.05% v/v
Xylene Cyanol FF 0.05% v/v
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C.6.2.5. Glycerol enzyme dilution buffer
Tris-HCl, pH 7.5 20mM
DTT 2mM
EDTA (disodium salt) 0.1M
Glycerol 50% v/v
C.6.2.6. 20X glycerol tolerant electrophoresis buffer 
Trisbase 1.8M
Taurine 575mM
EDTA (disodium salt) lOmM
Appendix D. Changes in the phenotype of leucocytes in the prescapular lymph 
nodes of cattle infected with T. parva.
Phenotype Calf
number
Days post-infection
0 3 6 7 8 9 10
Percentage posiltive cells
CD3 4260 72 68 53 62 76 58 58
4282 80 83 - 87 86 72 83
4291 70 37 79 87 72 54 -
5158 61 53 60 48 38 47 -
5178 45 46 61 76 67 - -
CD4 4260 35 33 20 23 30 21 24
4282 34 35 28 39 25 20 21
4291 32 17 32 37 21 24 -
5158 18 25 29 26 18 22 -
5178 18 25 36 37 30 - -
CD8 4260 24 23 20 32 37 30 33
4282 34 34 31 34 52 46 62
4291 25 13 38 39 45 27 -
5158 11 10 23 14 14 19 -
5178 13 15 19 25 30 - -
y/5 TCR 4260 12 10 10 9 8 10 14
4282 10 10 15 8 13 10 11
4291 8 16 6 12 7 10 -
5158 21 10 6 14 4 5 -
5178 5 7 7 - 5 - -
Surface Ig 4260 14 18 25 22 14 20 18
4282 15 9 12 7 11 11 7
4291 22 42 17 9 23 20 -
5158 32 34 30 34 42 37 -
5178 38 32 26 19 19 - -
Monocytes 4260 4 2 4 5 3 11 18
4282 4 2 7 2 5 11 11
4291 4 2 2 4 6 4 -
5158 3 6 2 2 3 8 -
5178 - 10 9 1 6 -
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Appendix E. Changes in the phenotype of peripheral blood mononuclear cells in
cattle infected with T. parva.
Phenotype Calf
number
Days post-infection
0 3 6 7 8 9 10
Percentage posiltive cells
CD3 4260 48 51 53 57 51 33 30
4282 55 56 52 58 53 47 45
4291 58 58 56 66 50 - -
CD4 4260 19 19 17 19 18 12 11
4282 22 21 20 23 22 18 15
4291 25 20 23 25 20 - -
CD8 4260 9 9 10 10 9 6 7
4282 18 17 13 14 10 14 20
4291 17 13 14 20 11 - -
y/5 TCR 4260 19 23 29 33 25 16 14
4282 14 16 20 22 20 13 10
4291 27 27 29 29 21 - -
Surface Ig 4260 21 13 15 19 16 18 14
4282 21 13 17 16 13 16 13
4291 20 22 27 20 18 - -
Monocytes 4260 18 22 18 17 30 49 50
4282 23 22 25 22 30 35 33
4291 18 22 21 10 32 “
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